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Abstract
This dissertation first describes a new method for the formation o f a-aryl lactams based on the 
Vicarious Nucleophilic Substitution reaction. The route involves the three-component 
coupling o f a nitroarene, an a-phenylsulfanyl lactam and an electrophile. The process 
incorporates various electrophiles and various V-substituted cyclic amides and has been 
developed for the most part using nitrobenzene. The process was also applied to a- 
phenylsulfanyl pyrazolidinones. The process also includes examples o f amides possessing a 
removable nitrogen protecting group to give access to fimctionalised amides with a free NH 
group.
Secondly, an asymmetric version o f the VNS reaction is described. The diastereoselectivity o f 
the VNS-alkylation reaction o f lactones was studied. For example using an a-phenylsulfanyl- 
y-substituted butyrolactone, nitrobenzene and an alkyl halide, diastereoselectivities o f greater 
than 7:1 were observed in some cases. The stereogenic centre at the y position is clearly able 
to exert considerable control in the generation o f the new stereogenic centre at the a-position.
The third area o f research described involves capture o f the intermediate VNS anion with aryl 
electrophiles. Activated electrophiles react in this way via an SnAt process. The VNS and 
SnAt reactions were combined to form an efficient one-pot three-component coupling process 
to give easy access to fimctionalised diarylmethanes. Reduction o f the nitro group o f selected 
products gave a quick and easy route to the oxindole structural motif
The final chapter describes our attempts to react the intermediate VNS anion with unactivated 
aryl halides in a transition metal cross-coupling process. Unfortunately, we did not find 
conditions to effect the coupling o f the anion derived from a VNS process with aryl halides. 
Nevertheless, the anion o f nitrophenylacetates prepared via deprotonation participates in cross­
coupling reactions with ease and provides an alternative way to prepare diarylmethanes. This 
has the potential to be extremely useful due to the lack o f reports o f nitroarenes in cross­
coupling processes.
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BOC ferf-Butyloxycarbonyl
CAN Ceric Ammonium Nitrate
DCC Dieyctohexylearbodiimide
DCM Diehloromethane
DDQ 2,3-Diehloro-5,6-dieyano-1,4-benzoquinone
DMAP 4-N, N-Dimethylaminopyridine
DMD Dimethyldioxirane
DMF Dimethytformamide
DMG Directing Metallating Group
DMPU 1,3-Dimethyl-3,4,5,6-tetrahydro-2( 1 H)-pyrimklinone
DMSO Dimethyl Sulfoxide
DOE Design o f Experiments
DoM Directed ortho Metalation
EWG Electron Withdrawing Group
HMPA Hexamethyl Phosphoramide
HOBt Hydroxybenzotriazole
HPLC High Performance Liquid Chromatography
IPA Isopropyl Alcohol
LDA Lithium Diisopropylamide
LiHMDS Lithium Hexametfayldisilazide
MOM Methoxy Methyl
NaHMDS Sodium Hexamethyklisilazide
NMR Nuclear Magnetic Resonance Spectroscopy
ONSH Oxidative Nucleophilic Substitution o f Hydrogen
PDT Photodynamic Therapy
SnAf Nucleophilic Aromatic Substitution
TASF Tris(dimethy]amino)su]fonium difluorotrimethylsilieate
TDA Tris[2 -(methoxyethoxy)ethylainine]
THF Tetrahydrofuran
TMAI Trimethylammonium Iodide
TM HI Trimethylhydrazinium Iodide
TMSC1 Trimethylsilyl Chloride
p-TsOH para-Tohienesulfonic Acid
VNS Vicarious Nucleophilic Substitution
Chapter 1
i
The study o f aromatic reactivity and synthesis has fascinated and occupied chemists since the 
very early days o f the subject. Derivatives o f benzene, both simple and complex, form the 
basis o f a multitude o f pharmaceuticals, agrochemicals, natural products, petrochemicals, 
synthetic polymers and materials. Methods designed to control the synthesis o f new 
unexplored aryl derivatives remain as important as ever. This PhD develops one new method 
for arene synthesis. This introduction summarises some o f the important ways by which arenes 
are prepared.
1.1 Nacleophilic Aromatic substitution (SnA t)
One o f the most important methods is the addition o f nucleophiles to the ring to form anionic 
o-adducts. There are two ways in which this can happen, firstly addition to the ring in 
positions occupied with leaving groups such as halogens to form o^adducts and secondly 
addition in positions occupied with hydrogen to form o^adducts. The case o f forming o**- 
adducts will be dealt with later in this Introduction.
The o^-adducts formed can undergo rapid elimination o f X*, to give products o f nucleophilic 
aromatic substitution (SnA t). The mechanism o f this reaction is shown in Scheme 1.
1 2
o*-adduct
Scheme 1
The presence o f electron withdrawing groups (such as nitro) ortho and para to the leaving 
group substantially enhance the rate o f substitution. The reason they can do this is because 
they stabilize negative charge on adjacent groups at the ortho and para positions but not at the 
meta position.
The best leaving group in these reactions is fluoride (F). Attack at the carbon bearing fluorine 
is fester than that bearing chlorine or bromine in the rate determining step due to the difference 
in electronegativity. This process has been known for a long time and has been reviewed 
extensively. 1'4
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1.2 Oxidative Nucleophilic Substitution o f Hydrogen (ONSH)
Direct conversion o f the o-adducts into products does not occur due to hydride being a very 
poor leaving group. Without an additional reactant, the o*1 -adducts simply revert to the starting 
material. Even when the ortho or para positions are occupied with a good leaving group such 
as a halogen, it is well known that attack at a carbon-bearing hydrogen is much fester than that 
bearing halogen.5' 7
The hydride anion needs to be removed with an additional reactant in a process that is 
equivalent to oxidation. This process was termed oxidative nucleophilic substitution o f 
hydrogen (ONSH).**11
One o f the problems with the ONSH reactions is generally the high sensitivity o f C- 
nucleophilie agents, such as carbanions or Grignard reagents towards oxidation. The 
introduction o f carbon substituents can be carried out provided that the addition o f the C- 
nucleophiles and the formation o f the a*1 -adducts proceeds to completion, so amounts o f the 
free nucleophile in the reaction vessel are negligible. Nucleophiles resistant towards oxidation 
are exemplified by the hydroxide anion and ammonia.
An example o f an ONSH reaction is the addition o f the 2-phenylpropionitrile carbanion (3) to 
nitrobenzene and its derivatives, carried out in liquid ammonia and THF at -70 °C. The 
nitroarenes are converted to the a *1 -adducts (4) almost quantitatively. These adducts are 
efficiently oxidized by external oxidants such as KM11O4 in liquid ammonia (pathway a in 
Scheme 2) and dimethyldioxirane (DMD) in THF-acetone (pathway b in Scheme 2).
Scheme 2
NO2
A THFPh CN -70 °C 
3
C
KMn0 4 /NH3Kq 
pathway a
Ph CN 
OH
DMD, H2 O
pathway b
Ph CN
Oxidation with these two oxidants gave two different products leading to the assumption that 
they react with the oAadducts at different places. Permanganate probably attacks the o*1-
3
adduct at the addition site o f the nucleophile, producing substituted nitroarene products o f
oxidative nucleophilic substitution o f hydrogen (ONSH) (5).*~10 Oxidation with DMD proceeds
at the carbon with the nitro group to give a substituted phenol 6  in which the nitro group has'
10 10been replaced by the hydroxy group.
An alternative method was developed by RajanBabu and co-workers. 14 This was the fluoride 
assisted nucleophilic addition o f enol silyl ethers to aromatic nitro compounds. It is well 
established that the stable silyl enol ethers 7 can be activated using a source o f fluoride. 15 
Oxidation o f the resulting a 11 -adducts (8 ) with DDQ or bromine gave a-nitroaryl carbonyl 
compounds 9 (Scheme 3).
R1 OTMS
M
R2  R3
TASF
c -^adduct
13  Conversion of the ^-adducts into Nitroso Compounds
Some (^-adducts can undergo spontaneous conversion into substituted nitroso compounds. 
This reaction can be considered an intramolecular redox process with release o f hydroxide ion. 
This conversion usually takes place in protie solvents via protonation o f the negatively charged 
NO2 group o f the oli-adducts and elimination o f water and is often followed by further
transformations o f the nitroso compounds16~21(Scheme 4).
Scheme 4
P h C H ^N
N Ph Ph
b
Similar conversion can be promoted by treatment o f c^-adducts with protic acids, Lewis
acids,22"23 or silylating agents.24-27
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1.4 Vicarioas Nncleophilk Substitution of Hydrogen (VNS)
Perhaps the most general and useful method for transforming oH-adducts into products o f 
nucleophilic substitution is the process discovered by Mqkosza28 and co-workers in the late 
1970’s. This is a key reaction in this PhD study, so will be reviewed in detail In this reaction, 
attack o f the nucleophile occurs at carbon bearing hydrogen ortho or para to the nitro group in 
the same way as in the ONSH process. Instead o f hydrogen, the leaving group connected with 
the carbanion departs by base induced ^-elimination o f HX (Scheme 5). Thus the leaving 
group is acting as a vicarious leaving group29 (in place of) and the reaction was therefore 
named Vicarious Nucleophilic Substitution o f hydrogen. We call 11 (and 12) the post-VNS 
anion to avoid ambiguity when referring to other anions present in the reaction.
Scheme 5
S i  
10
O^-kX)
x '  EWG EWG
Due to the fact that attack at carbons bearing hydrogen is significantly foster than at carbons 
bearing halogens,5-7 nucleophiles such as chloromethyl phenyl sulfone react with p- 
chloronitrobenzene exclusively at the ortho position to the nitro group.30 
Sterie considerations are important in the VNS reaction; if the nucleophile (10) is a secondary 
carbanion, then a mixture o f ortho and para substituted products will occur with nitrobenzene. 
If  10 is a tertiary carbanion, then exclusive para substitution will occur due to a sterie clash 
with the nitro group (Figure 1). If the para position is Mocked, exclusive ortho substitution 
will occur although with / 7-fluoronitrobenzene, the SnA t pathway competes with the VNS
29process.
Figure 1
X
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The conditions which favour VNS are sodium or potassium bases in solvents such as DMF, 
DMSO or liquid ammonia. Under these conditions the ortho/para ratio is governed by the 
kind o f carbanion, Le. the nature o f the R group. If  the base/solvent system is changed on the 
other hand to a /-BuOK/THF system, there is a unique opportunity with many secondary 
carbanions to afford selective ortho substitution even when there is a vacant para position. 
This effect is observed in the reaction o f nitroarenes with chloroniethyl phenyl sulfone31 and 
acetonitrile32 derivatives. In this base/solvent system, the carbanions are in the form o f tight 
ion pairs with potassium cations which are attracted by the negatively charged oxygen atoms of 
the nitro groups. The o-adducts are then formed ortho to the nitro group. To eliminate this 
effect, one equivalent o f a crown ether can be added.31
The main requirement for the carbanion is that it should contain a leaving group X connected 
directly to the carbanion centre. The leaving group must be capable o f its elimination as HX 
from the intermediate o-adduct. The general structure o f the carbanion can be regarded as R C  
XY where X is the leaving group, Y the electron-withdrawing group and R the substituent 
(Scheme 6 ).
Scheme 6
r' chy
Y = S02Ph, S0 2C(CH3) 3 SOjOPh, S020CH2C(CH3)3,
S 0 2N(CH2CH2)20, SOPh, POPh2, PCOEt^, CN, COOK, -N=C, PhS, Cl 
X = Cl, PhS, Me2NCCSS, PhO, CH30  
R = H, alkyl, aryl, PhS, Cl
Almost any combination o f the leaving group (X), electron-withdrawing group (Y) and 
substituent (R) shown will produce a carbanion that will undergo VNS chemistry. However to 
achieve the best results the combination must be selected meticulously to avoid side reactions 
that compete with the VNS. One such example is the carbanion derived from methyl 
chloroacetate which rapidly undergoes self condensation leaving little or no VNS product.
The post VNS anion intermediates are usually highly coloured, a feature which can have some 
diagnostic value as to whether or not the VNS process has taken place. Below is a typically 
coloured post VNS anion intermediate (Figure 2).
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Figure 2 A Typical Brightly Coloured Post-VNS anion
There are a few examples that could be considered early examples of VNS; methylation of 
nitroarenes and heterocycles with dimsylsodium33 or with dimethylsulfoxonium methylide34 
and dichloromethylation of p-halonitrobenzene with trichloromethyllithium.35 The mechanistic, 
synthetic value, and general character of these observed reactions were not, however, 
recognised.
Aromatic heterocycles bearing a nitro group can also be used in the VNS reaction. The VNS 
has been performed with 2-and 3-nitrothiophenes, 2-nitrofurans, particularly substituted at C-5, 
and V-alkylated 2- and 3-nitropyrroles.36
Previous research in the Lawrence group found that the post VNS anion can not only undergo a 
proton quench but can also undergo alkylation with electrophiles such as iodomethane. This 
gave a one-pot three-component coupling VNS/alkylation reaction (Scheme 7) to produce 
nitroarenes 13 bearing an adjacent quaternary stereogenic centre. ’ *
Scheme 7
R EWG
E EWG
■J «7 _
The VNS/alkylation process was used in a racemic synthesis of Aminoglutethimide (Figure 
3), an effective anti-cancer drug for the treatment of breast and prostate cancer.38
7
Figure 3
h2n
(+/-)-AiniiK)glutethimkie.
It was reported that a-aryl-a-hydroxyesters (14) could be formed during the reaction o f the 
post VNS anion with aldehydes.39 The expected formation of the aldol product did not occur. 
On one occasion however, when air was inadvertently introduced into the reaction flask, the 
hydroxy ester 14 was obtained in 50% yield (Scheme 8 ). It was found that when three 
equivalents o f the ester were used with respect to nitrobenzene the yield can be increased to 
66%.
Scheme 8
no2 6
1.5 Electrophilic Aromatic Substitution
This section will briefly discuss electrophilic aromatic substitution, an area of chemistry that 
has been known for a long time and has been extensively studied and is thoroughly 
documented.40 There are two fundamental sequential steps in an electrophilic aromatic 
substitution (Scheme 9) reaction, the first being the formation o f a new sigma bond by attack of 
an electrophile by the aromatic ring. The second is the removal o f the proton by breaking the 
C-H sigma bond and restoration of aromaticity.
Scheme 9
Cl
1NaH- rsK ^O E \
2. PhCHO/air
NO
HO OEt
O
14
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Substituents affect the reactivity o f the aromatic ring. Electron donating substituents such as 
OH and NH2 activate the ring making it more reactive than benzene. Electron-withdrawing 
substituents such as NO2 deactivate the ring making it less reactive than benzene.
Substituents also affect the orientation o f the reaction. The three possible disubstituted 
products- ortho, meta and para are not usually formed in equal amounts. The nature o f the 
substituent already present on the benzene ring determines the position o f the second 
substituent. Substituents can be classified into three groups: ortholpara directing activators, 
ortholpara directing deactivators and meta directing deactivators.
Reactivity and orientation in electrophilic aromatic substitutions are controlled by inductive 
and resonance effects. Nitration o f anisole could occur either ortho, meta or para to the 
methoxy group. The intermediates from ortho and para attack are stabilized. Only in ortho 
and para attack are there resonance forms in which the positive charge is stabilized by 
donation o f an electron pair from oxygen. The intermediate from meta attack has no such 
stabilization.
Toluene is ortho/para directing because these resonance forms can place the positive charge 
directly on the methyl substituted carbon, where it is a tertiary carbocation and can be 
stabilized by the electron donating effect o f the methyl group. The halogens are deactivating 
because their stronger electron withdrawing inductive effect outweighs their weaker electron 
donating resonance effect. Though weak, that electron donating resonance effect is felt only at 
the ortho and para positions. Thus a halogen substituent can stabilize the positive charge of 
the carbocation intermediates from ortho and para attack in the same way that hydroxy and 
amino substituents do.
With electron-withdrawing substituents such as nitro, both ortho and para intermediates are 
destabilized because the resonance form places the positive charge on the carbocation 
intermediate directly on the ring carbon atom that bears the deactivating group. Reaction with 
an electrophile therefore occurs at the meta position. Below are some commonly used 
transformations (Scheme 10).
9
Scheme 10
n o 2
h o 3s ^ .
u
h 2 s o 4
H2S0 4 /
h n o 3
o RCOCI, AICI3
RCI,
AICI3
O l,
1.6 Directed 0^a-M etahtion (DoM)
This process has a distinct advantage over electrophilic aromatic substitution in that harsh 
reaction conditions are not required. It can also provide convenient access to 1,2,3- and 
1,2 ,3,4- substituted aromatic systems which can be a daunting task with classical electrophilic 
aromatic substitution methods. Since its discovery by Gilman41 and Wittig,42 DoM took little 
time to establish itself as a powerful tool available to the organic chemist.
DoM requires the presence o f a Directing Metalating Group (DMG) which is an inductively 
withdrawing atom or group that contains a lone pair o f electrons. In the presence of a strong 
base, usually an alkyllithium, this functional group guides the alkyllithium, so that it attacks the 
adjacent protons. It does this by forming a complex with the Lewis-acidic metal ions, meaning 
only protons ortho to the functional group can be removed (Scheme 11).
Scheme 11
OMe
BuLi
OMe OMe
E+
DMG’s used include OMe,41"44 OMOM,45 and CO2H46 among many others.
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1.7 Palladium Catalysis.
Palladium-catalysed reactions of aryl halides and triflates with ‘hard’ organometallic 
nucleophiles have been widely used over the past 30 years. Variants of these reactions have 
found widespread applications in modem organic chemistry. Variants include the Suzuki 
(boron-mediated),47 Corriu-Kumada-Tamao (magnesium-mediated),48 Stille (tin-mediated),49 50
c | c*y #
Negishi (zinc-mediated), and Sonogashira (copper-mediated) coupling reactions.
The mechanism of palladium catalysis involves the oxidative addition of the halide or triflate 
to the initial palladium(0) complex to form a palladium(II) species. The key slow step is a 
transmetal lation, so called because the nucleophile is transferred from the metal in the 
organometallic reagent to the palladium and the counterion moves in the opposite direction. 
The new palladium(II) complex with two organic ligands undergoes reductive elimination to 
give the coupled product and the palladium(0) catalyst ready for another cycle. This process is 
shown below (Scheme 12).
Scheme 12
Pd(0) Pd(ll) Pd(0)
P d U  *  N u-M N u
Ar-X -------------- A r-P d l_2 ----------------------   A r-P dL 2 "  2
Oxidative Transmetalation M x Reductive
Addition (Slow) Elimination
The palladium catalysed coupling of soft nucleophiles has only been explored in the last 10 
years. The studies of Buchwald and Hartwig have proved successful in a wide range of soft 
organometallic nucleophiles including oxygen-,53^  sulfur,55-60 phosphorus,61'2 boron63"4 and 
silicon based nucleophiles.65"70
In recent years the cross-coupling at the a-position of carbonyl compounds such as ketones,71'9 
esters30, 83 and amides81'2 with aryl halides has been reported by the groups of Buchwald, 
Hartwig and Miura (Scheme 13).
Scheme 13
^ Y ° R Pd(0)_____________^ Ph^ " Y ° R
Phosphine ligand II
U Ph-X
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Chapter 2
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2.1 Review of VNS for the period 2000-2004
01 oi
Due to the numerous reviews ’ covering VNS before 2000 already available, only VNS 
after 2 0 0 0  will be reviewed in this chapter.
It was found by previous research in the Lawrence group that is-stilbenes could be synthesized 
efficiently via a one pot Vicarious Nucleophilic Substitution/ Homer-Wittig reaction. This was 
achieved by generation o f the anion of chloromethyl diphenylphosphinoyl oxide (15) with 
sodium hydride in DMSO and reaction with different nitro-substituted aromatics. The series o f 
VNS products were used in a Homer-Wittig reaction by treatment of base and benzaldehyde 
derivatives. The desired fs-stilbenes 17 were produced but only in modest yields. It was 
thought that the yields o f the stilbene might be improved if the anion was used directly. In 
other words the post-VNS anion 16 was treated with the benzaldehyde derivatives in the same 
pot (Scheme 14). This approach effectively constitutes a one pot VNS-Homer Wittig reaction. 
The yields were significantly better than the two step process.39,85
Scheme 14
ArCHO
The post VNS anion undergoes a 1,4-conjugate addition (Michael reaction) with Michael
A/
acceptors. The post-VNS anion formed from nitrobenzene and ethyl 2-chloropropionate in a 
NaH/DMF base/solvent system could be quenched with methyl acrylate to give 18, which is 
the product o f 1,4-conjugate addition (Scheme 15).
Scheme 15
no2
1. NaH/DMF
C 0 2Et 2. H2 C=CHC02Me
EtOzC (CH2 )2 C 02Me 
18
Derivatives o f Indoprofen have been made by a 4-step synthesis that incorporates the VNS 
process (Scheme 16). Indoprofen (21a) is an arylpropionic acid non-steroidal anti­
inflammatory drug.86 The first step in the synthesis was the VNS reaction o f ethyl 2- 
chloropropionate and nitrobenzene in a NaH/DMF base/solvent system with either an acidic or 
electrophilic quench with methyl iodide to give the VNS products 19a and 19b. After the VNS 
process had been carried out, the product was reduced under hydrogenation conditions to give
13
the aniline 20a,b. The Takahashi protocol 89-90 provided the method for obtaining the
phthalimidine derivative from the aniline with 1,2,3-1/f-benzotriazole, 2-mercaptoethanol and 
o-phthalaldehyde. Saponification o f the ester with sodium hydroxide gave Indoprofen 21a in a 
24% overall yield. An a-methyl Indoprofen derivative 21b was also produced by a 
VNS/methylation reaction followed by the same condition as the Indoprofen approach.
Scheme 16
1. NaH 
 ►
JLC I ^ X 0 2Et
no2 nh2
H2i Pd/C 1. 1,2-C6 H4 (CHO) 2
2. H+ or Mel
OEt
19a R = H 
19b R= Me
20a,b
HS(CH2)2OH 
OEt benzotriazole 
2. NaOH, EtOH
21a R = H (Indoprofen)
21b R = Me
Palmisano’s synthesis o f the natural product (-)-horsfiline (27) (Scheme 17) involved a VNS 
reaction. (-)-Horsfiline (27) is a tricyclic alkaloid, first isolated in 1990 from the leaves of 
Horsfielda superba*9 In the first step o f the synthesis 4-nitroanisole and 4-chlorophenoxy 
acetonitrile were treated with potassium terf-butoxide in DMF to give the required VNS
product 22 (Scheme 17). 
Scheme 17
f-BuOK/DMF
90
n o 2
4-chloro- 
' M_ phenoxy 
acetonitrile
MeOH 
N TMSCI
1.(CH20 )nI ‘ i ^on
A p C° 2Me
OMe 23
PhMe 
2. NaOH
C 02H
OMe 24
ROH
DCC
HOBt
DMAP
CH2CI2
. sarcosine 
C 02R (CH2Q)n 
PhMe
OMe 25
N O ,r  NMe
'CO,R* H2,Pd/C MeO
MeOH
OMe 26
(-)-Horsfiline (27)
The VNS product 22 was then converted to the ester 23 by methanolysis. On treatment o f 23 
with /wa-formaldehyde (10 equiv), in the presence of K2CO3 and tris[2- 
(methoxyethoxy)ethyl]amine (TDA-1) as a solid-liquid phase-transfer catalyst in toluene at 85 
°C for 3 hours, produced the acrylate product cleanly and in good yield. The ester was then
14
hydrolysed to the acid 24 which was then coupled to a chiral auxiliary to give 25. Treatment o f 
this with sarcosine, /?-formaldehyde, molecular sieves and toluene under reflux produced 26 
which after reduction o f the nitro group under hydrogenation conditions cyclised onto the ester 
bearing the chiral auxiliary to give (-)-horsfiline (27). Among the chiral auxiliaries tried, only 
Whitesell’s (15,2^)-2-phenyl-1 -cyclohexanol90 provided an acceptable level o f 
diastereoselectivity (8 6 % de by HPLC).
A VNS-type process has also been used in the synthesis o f the natural product (-)- 
Physostigmine (28) (Figure 4) .93 The key step in the synthesis the author claimed was a VNS 
reaction between /?-nitroanisole and a C-silylated derivative o f V-methylpyrrolidinone 29 
(Scheme 18) followed by oxidation with DDQ to give 30. This approach however was not 
strictly VNS but Oxidative Nucleophilic Substitution o f Hydrogen (ONSH).
Figure 4
MeHNOCCL V ^ l
\ (-)-Physostigmine (28)
Scheme 18
Me3S i \ / f  TASF/THF
L>-
OMe 29
-78°C
N—
OMe
DDQ N—
Vicarious Nucleophilic Substitution was used in the synthesis of 6,7-dihydroimidazo[4,5- 
<fl[l,3]diazepin-8(3//)-one (31) (Figure 5), which is an important intermediate in organic 
synthesis.92 It has been used in the synthesis o f natural products pentostatin, 93 5 and 
coformycin96 which are both anti-cancer and anti- viral nucleosides.
Figure 5
O
N ^ ~ \
O L r
N‘
e.T-dihydroim idazoH.S-cflll.SJdiazepin-fllSHJ-one (31)
The synthesis started with the commercially available 4-nitroimidazole. V-Benzylation gave a 
substrate 32 which could undergo the VNS process. It did so with the anion generated from 
chloroform and potassium ter/-butoxide (Scheme 19) to give the expected VNS product 33.
15
Scheme 19
Ph.
no2
CHCI3
KOf-6 u
THF/DMF
Ph.
Cl
32
NOz
33
When the VNS product 33 was treated with formic acid followed by NaClCVNI^SOaH, the 
carboxylic acid 34 was obtained. This acid was then coupled with nitromethane using CDI to 
give the dinitroketone 35. The nitro groups were then reduced with Fe/HCl and the benzyl 
protecting group removed with Pd/HC0 2 NH4 to give 36. Treatment o f the deprotected product 
with ethyl formate in DMSO gave the required product 37, which was isolated as a mono 
hydrochloride salt (Scheme 20).
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Fused pyrimidines are o f particular interest for the synthesis o f purine derivatives 39. The 
synthesis starts from 4-nitroimidazole-5-carbaldehyde (38), readily available from 1- 
substituted 4-nitro imidazoles via VNS dichloromethylation (Scheme 21). This is an example 
o f purine synthesis in which the 6-membered ring is constructed using an existing 5-membered 
imidazole ring, a strategy not commonly used in the synthesis o f purines.
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It has been recently reported that chloralkyloxazolines 40 and other chloroalkyl heterocycles 
under basic conditions react with nitroarenes to produce VNS products 41 (Scheme 22).
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No success was achieved when trying to capture the post VNS anion with aldehydes. If 
instead o f using chloromethyloxazolines 40, dichloromethyloxazoline 42 was used, quenching 
with benzaldehyde derivatives resulted in oxazolinyldiaryloxirane 44 as a single 
diastereoisomer (Scheme 23)."
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If  the post VNS anion 43 was however left without an electrophilic quench, a mixture o f E and 
Z 1,2-diaxolinyl-1,2-di-/?-nitrophenylethene (45) (Scheme 24) was formed. In this case, the 
post VNS anion 43, which has carbenoid character, undergoes homocoupling, followed by 
elimination o f chloride to generate 45.
Scheme 24
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Attempts to trap the post VNS anion with ketones and imines resulted in no success with only 
1,2-diaxolinyl-1,2-di-/?-nitrophenylethene (45) being formed. If  THF was used as the solvent, 
the VNS reaction occurred exclusively at the carbon ortho to the nitro group, which when 
quenched with benzaldehyde derivatives also gave efficient access to oxiranes.
The mechanistic pathway o f the formation o f the aH-adducts formed in the VNS process was 
investigated by Mqkosza and Kwast.100 The two possibilities considered were direct
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nucleophilic addition o f carbanions to nitroarenes pathway a (Scheme 24) and a two-step 
single electron transfer (SET) process pathway b. It was concluded on the basis o f their 
observations o f typical radical probes (a-halosulfones) with o-chloronitrobenzene that the 
intermediate aH-adduct is formed by a one step ionic process and not SET.
Scheme 25
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M^kosza has found that carbanions o f halomethyl aryl sulfones react with substituted 1,2,4- 
triazine-4-oxides by at least three different processes (Scheme 26).101 Pathways a and b occur 
when R1 is not H. Pathway a is the VNS process and Pathway b is deoxygenative replacement 
o f the hydrogen in the 5-position. It was found that using a-haloaryl sulfones as the carbanion 
resulted predominantly in the products o f deoxygenative replacement o f hydrogen 47. 
Formation o f the VNS product 46, all be it in small amounts, indicated that there are no large 
differences between the rates o f the competing reactions. Changing the reaction conditions had 
no visible effect on the competition between the two processes.
Scheme 26
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It was thought that instead o f using an a-bromoaryl sulfone, but an a-chloroaryl sulfone the 
reaction would proceed via the VNS pathway because ^-elimination of HBr should proceed 
much fester than HCL This proved to be the case and the VNS process (pathway a) occurred 
predominantly. Pathway c occurs when the R1 substituent is H which allows nucleophilic 
attack at this position followed by heterocyclic ring opening in the intermediate oH-adduct to 
produce 48.
The hydroxylation o f nitroarenes proceeds conveniently by the addition of ter/-butyl or cumyl 
hydroperoxides in the presence o f strong bases. 102"4 These conditions when used with azulenes 
however provided negative results. It appeared that due to the low nucleophilic activity o f the 
/-BuOO anion, the aH-adduct is not formed. However, reaction with more electrophilic 
azulenes 49 containing electron-withdrawing substituents in the 5 membered ring proceeded 
satisfactorily. 105 It was found that 4-aminotriazole 50 is an efficient animating agent o f 
azulenes when the reaction is carried out in the presence o f /-BuOK (Scheme 27). The 
products were o f moderate stability so were isolated as the corresponding acetyl derivatives 51. 
Scheme 27
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A general method for specific pora-hydroxylation of nitroarenes has been developed by Zhang. 
In basic aqueous media, the nucleophilic hydroxylation o f nitronaphthalenes with cumene 
hydroperoxide led to specific para-hydroxylation (Scheme 28).106 The reaction took place very 
slowly in water due to the insolubility o f the starting materials. When the reaction was carried 
out in anhydrous DMSO, a mixture of para- and or/^o-regio isomers were formed. In a 
mixture o f water (25%) and DMSO (75%), this nucleophilic substitution gave exclusively the 
product of/Kzra-hydroxylation 52.
Scheme 28
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A series o f tricyclic indole-2-carboxylic acid derivatives were synthesized by a route 
incorporating VNS (Scheme 29). Commercially available 4-iodonitrobenzene was treated with
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tert-butyl chloroacetate under VNS conditions to give 53. Palladium catalysed cyanation was 
carried out using zinc cyanide to give 54. Reduction o f 54 with BF3 OEt2/B(OMe)3 in THF 
followed by Boc protection and then reduction o f the nitro group gave the aniline 55.
Scheme 29
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Condensation o f 56 with 57 followed by hydrolysis o f the ester gave 58 which was obtained as 
the hydrochloride salt (Scheme 30). The tricyclic indole-2-carboxylic acid (58) was then 
evaluated by the radio-ligand binding assay and the anticonvulsant effects investigated in the
107mouse NMD A- induced seizure model.
Scheme 30
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The direct animation o f 1-substituted 3,5 -dinitrobenzenes was successfully carried out by the 
use o f 1,1,1-trimethylhydrazinium iodide (TMHI) in the presence o f /-BuOK or NaOMe in
DMSO (Scheme 31). 
Scheme 31
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With most substituents, the dinitroanilines 59 and 60 were obtained as a mixture in good yield 
with the ortho-isomer 59 being predominant (ortho with respect to the substituent X). When a 
sulfone was used as the substituent however, two equivalents o f TMHI produced a mixture of 
diamines 62 and 63 (Scheme 32) in a 9:1 ratio. When only one equivalent o f TMHI was used 
in the reaction another mixture o f products was formed comprising a mono substituted product
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64, a disubstituted product 63 as well as uureacted starting material was recovered in a 4:1:5 
ratio. In the presence o f strong base, deprotonation of TMHI occurs resulting in the formation 
o f trimethylammonium iodide (TMAI). The TMAI adds to the nitroaromatic to either the 
ortho or para position relative to X to give a c^-adduct. Base induced p-elimination of 
trimethylamine then takes place. Protonation o f the post VNS anion then gave the product 65 
(Scheme 33).
Scheme 32
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Scheme 33
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Nitrobenzyl quaternary salts o f nitrogen mustards have been reported as hypoxia selective
cytotoxins. 109-110 The VNS process was used in the synthesis o f a pyrazole analogue 6 6  that
was evaluated as a hypoxia-selective cytotoxin (Scheme 34). 
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Nitroaromatic compounds are not the only ones to undergo the VNS process. Wojciechowski 
found that the VNS process could be used in the synthesis o f novel isothiazolopyridine and 
quinoline derivatives 6 8  (Scheme 35) . 112
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In the final step an intramolecular VNS process takes place. Deprotonation of the sulfone 67 
followed by the formation o f an intermediate in which base induced (^elimination o f HC1 takes 
place. Alternatively, instead o f the pyridine V-oxide, quatemisation o f the nitrogen atom with 
electrophiles such as methyl iodide produces substrates which undergo the VNS process.
Scheme 36
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1,4-Naphthoquinones and derivatives also undergo the VNS process to give 70 (Scheme 36).113 
These VNS reactions in 2-halo substituted naphthoquinones 69 are generally fester processes 
than Vinylic Nucleophilic Substitution o f Halogen (S nV ). The halogen substituent however 
does result in fester addition of the carbanion to the position occupied by hydrogen due to the 
increased electrophilic activity. Base induced ^-elimination occurs and the expected VNS 
product 70 formed.
Selectively ort/io-deuterated nitroarenes can be synthesized in high isotopic purity using a 
process that involves a VNS step. 114 The method consists o f electrophilic aromatic substitution 
o f H for D in para-substituted anilines in the ortho position to the amino group which was 
carried out with DC1/D20 . This was followed by oxidation o f the aniline 71 to the nitro­
compound 72 followed by a VNS process with N, N, V-trimethylhydrazonium iodide to give an 
or/^o-nitroaniline 73. Diazotization and reduction of the diazonium salt gave selectively 
ortho-deuteraied nitroarenes 74 in high isotopic purity (Scheme 37).
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It has been found that the VNS process can be carried out upon 1 -methyl-4 -nitroimidazole (75) 
(Scheme 38), under mild conditions in the presence o f sodium methoxide or potassium tert- 
butoxide to give the VNS product (76).115
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The VNS Oamination does not occur with 2-methyl-4-nitroimidazole and 1,2-dimethyl-4- 
nitroimidazole. EPR spectroscopy shows that the VNS C-amination o f 1 -methyl-4-nitro-
imidazole is likely to follow a radical ion mechanism. The EPR signal o f the reaction mixture 
o f 1 -methyl-4-nitroimidazole with N, N, A^-trimethylhydrazinium iodide (TMHI) and t- 
BuOK/DMSO can be assigned as the radical ion o f 1 -methyl-4-nitroimidazole.
A practical procedure for the synthesis o f 6-aminoazulene 79 has been reported using the VNS
process. Animation o f azulene (77) occurs using 4-amino-1,2,4-triazole (78) (Scheme 39) 
Scheme 39
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Amination with TMHI o f more electrophilic derivatives, substituted at position 1 with CN or 
COPh, affords mixtures o f 4-, 6 - and 8-aminoazulenes (Figure 6 ).
Figure 6
HoN
A novel synthesis o f 4-amino-3,5-dinitro-///-pyrazole 81 was reported using the VNS process 
(Scheme 40).95 Reaction o f 1,1,1 ,-trimethylhydrazinium iodide with 3,5-dinitropyrazole (80) in 
DMSO produced 4-amino-3,5-dinitro-1 //-pyrazole (81).
Scheme 40
80 81
Two different procedures have been found as a route to 2-amino-5-nitropyridines 82 in 
moderate to good yields from the VNS process using 3-nitropyridines with either 
hydroxylamine or 4-amine 1,2,4-triazole as animating agents (Scheme 4 1).96 2-Amino-5- 
nitropyridines 82 would be useful starting materials in the synthesis o f biologically active 
compounds. The 2,5-substitution pattern o f pyridine is the base for many pharmaceuticals and 
crop protecting agents. It has proved difficult in the past to obtain this substitution pattern with 
high regioselectivity. 116 The use of hydroxylamine as the VNS animating agent provides a 
simpler and cheaper procedure. In large scale preparations, this procedure would be better 
because o f the easy work up despite the process with 4-amine 1,2,4-triazole giving slightly 
better yields. The use o f 4-amino-1,2,4-triazole demanded an inert atmosphere and DMSO as 
solvent.
Scheme 41
Some porphyrin derivatives are used as photo sensitizers in photodynamic therapy (PDT) . 117-8 
PDT is a treatment involving photo sensitising drugs and light to kill neoplastic cells. This 
simple technique is currently being evaluated in multiple clinical trials with promising 
results. 119-121 Nitration o f meso-tetraphenyl porphyrin results in mono-nitration in a para- 
position on one of the phenyl rings. 122 The transformation o f the two NH centres in the 
macrocyclic ring into the metal complex 83, where the central metal cation (Zn2+ or Cu2+) is 
playing the role o f a convenient protecting group allowed the VNS process to proceed to 84 in
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good yield (Scheme 42). The metal cation offers very labile protection o f the NH functions 
and can easily be removed after reaction if needed.
Scheme 42
NO;
EWG
83
N=<
solvent NO
2. H
EWG
84
A new range o f TPP derivatives were synthesized, substituted with a-functionalized alkyl 
groups e.g. arylsulfonyl methyl, cyanomethyl and N,A-dimethylsulfonamide. Reactions with 
tertiary carbanions were unsuccessful due to steric hindrance.
NH
85
CTNH
N = r
85*
Figure 7
Multiple attempts at utilizing unprotected nitro-meso-tetraphenylpoiphyrin derivatives however 
proved unsuccessful Under the strong basic conditions associated with the VNS process 
deprotonation o f the two NH groups occurs so the porphyrin should exist in the V-anionic form 
85 (Figure 7). At low temperatures the rotation around the C-C bond should be limited, 
leaving the four meso aryl rings orthogonal, thus limiting the conjugation. This would then 
give the opportunity for VNS to take place on the nitroaromatic as the possibility o f increasing 
the electron density on this ring has been much reduced. 123 This was found to be the case. In t- 
BuOK/THF at -30 °C to —40 °C and /-BuOK/DMF at 0 °C the unprotected porphyrins 
underwent the VNS process to give the desired products in good yield. 119 a-Halomethyl aryl 
sulfones, a-chloromethyl N, V-dialkylsulfonamide and /?-chlorophenoxyacetonitrile were all
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used as the VNS nucleophile. The products obtained gave opportunity for further 
transformations.
When investigating the effect o f halogens on reactions of carbanions with halonitroarenes, 
Makosza found that under certain conditions, the VNS reaction of chloromethyl phenyl sulfone 
with 2,4-dinitrochlorobenzene is accompanied by the formation of a considerable amount of 
(3,5-dichlorophenyl)methyl phenyl sulfone (8 6 ) (Scheme 43) . 124
The side-product was observed only when the reaction mixture was quenched after a very short
ammonium chloride or acetic acid were used, the starting materials were recovered. However
dilute strong acids such as HC1 or H2SO4.
Reaction o f 2-nitronaphthalene (87a) and 6 -nitroquinoline (87b) with a secondary carbanion 
bearing a leaving group and electron withdrawing group such as chloromethyl phenyl sulfone 
in a NaH/THF base solvent system yielded the conventional products o f vicarious nucleophilic 
substitution of hydrogen 8 8 a and 8 8 b (Scheme 44) .94
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time. It was formed by protonation o f the intermediate a H-adduct followed by elimination of 
nitrous acid. The essential part o f this cme-substitution was the acidic quench. When
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However, when secondary and tertiary carbanions were used in a NaH/DMF base solvent 
system the reactants underwent direct cyclocondensation giving dihydroisoxazolo[4,3- 
/Iquinoline V-oxides (89a) and dihydronapth[2,l-c]isoxazole JV-oxides (89b) (Scheme 45) .94
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The reaction conditions were tried with m-dinitrobenzene as the substrate with secondary and 
tertiary carbanions but in this case the reaction afforded the VNS products and the desired 2,1- 
benzisoxazole V-oxides were not obtained.
2-Chloropyrimidine and 2,4-dichloropyrimidine react at low temperatures with trihalomethyl 
carbanions to give covalent oH-adducts and the VNS products in low yield. 4,5,6- 
Trichloropyrimidine in the reactions with carbanions such as XCHSO2T0 I and CBr3_ and other 
nucleophiles such as /-BuO‘ and NH3 give diverse substituted products o f chlorine while in the
reaction with CCI3 anion the VNS process takes place albeit in low yield (Scheme 46). 
Scheme 46
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2.2 Asymmetric Vicarious Nucleophilic Substitution of Hydrogen
The VNS/alkylation process, in which the post-VNS anion was quenched with a variety of 
electrophiles to produce quaternary stereogenic centres was first reported by Lawrence and co- 
workers.38 An unprecedented asymmetric version of the VNS/alkylation reaction was then 
reported with the use o f an appropriate auxiliary incorporated into the nucleophile (Scheme 
47) . 120
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Menthol proved to be a poor auxiliary, since reaction o f the VNS nucleophile 90a with the 
nitroarene followed by a quench with benzyl bromide gave a 1:1 mixture o f diastereoisomers. 
The reaction o f the VNS nucleophile 90b derived from (-)-8-phenylmenthol however was 
much more successful Quenching with methyl iodide gave a 3:1 mixture of diastereo isomers 
while quenching with benzyl bromide gave a 8:1 mixture. Other auxiliaries were tried such as 
/ra/w-2-phenylcyclohexan-1 -ol since both enantiomeric forms are available from a variety of 
methods, most notably hydroboration121 or dihydroxylation-reduction122 o f 1-phenyl- 
cyclohexene. The diastereo selectivity however with this auxiliary was poor.
More sterically demanding auxiliaries were also tried, with quenching of the post-VNS anion 
with methyl iodide and benzyl bromide, and the results are summarised below (Table 1).
Both products o f the VNS reaction of trans-2-(2’-naphthyl)cyclohexylphenylsulfonyl acetate 
90f were crystalline. X-ray crystallography showed the major isomer to be the (IRS, 2SR, aRS) 
diastereo siomer A.
Table 1
3 _
Auxiliary
1IIP4 R1 = Bn 
A:B
(-)-Menthol 91a - 1:1 (60)
(-)-8-Phenylmenthol 91b 3:1 (67) 8:1 (70)
(-)-tra/w-2-Phenylcyclohexan-1 -ol 91c 1:1 (55) 2:1 (62)
(+/-)-/ra«s-2-(4-Biphenyl)cyclohexan-1 -ol 91d 1:1 (64) 4:3 (64)
(+/-)-trans- 2-( 1 ’-Naphthyl)cyclohexan-1 -ol 91e 3:2 (64) 4:1 (57)
(+/-)-/ra«5-2-(2’-Naphthyl)cyclohexan-1 -ol 91f 3:1 (60) 4:1 (62)
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3.1 Aims
This PhD thesis documents a possibility o f applying the VNS process to lactams and thereby 
developing a new and versatile route to a-aryl lactams. The latter are potentially useful in drug 
discovery chemistry. They possess several points o f structural diversity amenable to 
convenient derivatization thereby providing an important peptide-like scaffold.
The PhD study also set out to provide further insights into the asymmetric VNS alkylation 
process. We were keen to investigate the VNS reactions of chiral heterocyclic nucleophiles. 
The diastereo selectivity o f VNS reactions was to be assessed first using an a-thiophenyl 
lactone possessing a y-stereogenic centre such as 92 (Scheme 48).
Scheme 48
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Reaction o f the VNS nucleophile 92 with nitroarenes would generate the post-VNS anion in 
the usual way. Reaction o f this anion with a variety o f electrophiles would give the lactone 93 
possessing an a-aryl quaternary stereogenic centre. It was expected that the electrophile would 
approach anti to the R group for primarily steric reasons (Scheme 49).
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We hoped to be able to apply this methodology to the total synthesis o f Physostigmine, an 
alkaloid isolated from African Calibar seeds. It possesses interesting biological activity, it is a 
potent inhibitor o f acetylcholinesterase and is used clinically to treat glaucoma and myasthenia 
gravis.126-7 Physostigmine and analogues128 are also being evaluated as treatments o f
Alzheimer’s disease and possess morphine-like analgesic properties. The proposed synthesis 
will commence with a VNS reaction o f a-thiophenyl lactone 94 with /7-methoxynitrobenzene 
followed by selective reaction of the post-VNS anion with iodomethane (Scheme 50). 
Catalytic hydrogenation o f the nitro compound 95 will provide an aniline derivative, which
Ar
O
Minor
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will ring-open the lactone, to give, after V-methylation an oxindole. Removal o f the silyl 
protecting group will generate the diol 96.
Scheme 50
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Treatment o f the diol 96 with periodic acid will give the known aldehyde 97.129 Physostigmine 
98 can be formed from this known aldehyde by sequential reaction with methylamine and 
LiAlHU followed by transformation o f the methoxyl moiety to the TV-methyl carbamate group 
(Scheme 51).
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The following chapters describe the results o f my work in attempting to achieve these initial 
aims. Several additional areas were also studied as the programme o f work developed. Most 
notably the treatment o f the post-VNS anion with electron deficient aryl electrophiles 99 such 
as Sanger’s reagent (R2 = NO2) was investigated as a possible route to the formation of 
diarylmethanes 100 and oxindoles 101 (Scheme 52).
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4.1 C-Arylation of Lactams and Pyrazolldinones via Vicarious Nucleophilic Substitution
of Hydrogen
We have been interested in applying the VNS process to lactams and thereby developing a new 
and versatile route to a-aryl lactams. The latter are potentially useful in drug discovery 
chemistry. They possess several points o f structural diversity amenable to convenient 
derivatization thereby providing an important peptide-like scaffold. Such a scaffold has been 
incorporated into y-lactam derived inhibitors o f tumour necrosis factor a  converting enzyme 
such as 102,130 and matrix metalloproteinase-13 inhibitor 103 131(Figure 8).
Figure 8
O
Stewart and co-workers have utilized an excess o f strong base (lithium 
isopropylcyclohexylamide, 3.2-8 equivalents) in the presence of aryl halides for arylation to
benzyne mechanism, due to the products 105 and 106 being formed in equal amounts from the 
reaction ofp-bromoanisole with NMP and excess LiCA.
Scheme 53
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It has been shown that the palladium-catalyzed intermolecular coupling o f halides and keto 
enolates is a useful method for synthesizing a-aryl ketones75 and a-aryl esters.132 Arylation of 
other carboxylic acid derivatives such as amides are less common.132,133-6132,133-6
Few examples o f C-arylation o f a cyclic amide moiety have been reported in the literature.
proceed at the 3-position (Scheme 53).137 The reaction o f 104 was thought to follow the
MeO,
O
2 .
1. LiCA
N—
104
Br
On the other hand, Alonso and co-workers138 have used 1 -alkyl-2-pyrrolidinone enolate ions as 
nucleophiles to react with aryl halides under uv radiation (Scheme 54). The reaction o f 104 
apparently follows an SrnI mechanism and leads to a single product 108.
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A further example o f C-arylation o f y-lactams was reported involving the a-silylated derivative 
109 of l-methyl-2-pyrrolidinone (Scheme 55). The cleavage o f the silyl group with fluoride 
leads to the generation o f a stabilized enolate. This can then react reversibly with the 
electrophilic nitroarene to produce the aH-adduct 110 which can then be oxidized to the 
required product 111 with DDQ or Br2. Different para substituted nitroaromatics were used 
including /7-nitroanisole, p-nitrotoluene and /7-bromonitro benzene.
Scheme 55
I SiMe3
N 0 2   ^ 109
TASF/THF
110  -
DDQ
or
Br2
The a-arylation o f the zinc enolate o f TV-protected 2-piperidinones with aryl bromides in the 
presence of a palladium catalyst was reported by Cossy.139 (Scheme 56). When N- 
tosylpiperidinone 112 was treated under the conditions used for the arylation of esters no 
arylation occurred. To increase the reactivity, a transmetallation with zinc chloride was carried 
out. The a-arylation o f A-tosylpiperidinone 112 and A-benzylpiperidinones was achieved in 
good yields.
Scheme 56
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An approach for the a-arylation of esters and amides using Reformatsky reagents under a 
microwave accelerated reaction and a Pd(PPh3)4 catalyst has been reported by Moloney140 
(Scheme 57).
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We thought that a lactam or pyrazolidinone with a vicarious leaving group could undergo the 
VNS process with nitrobenzene to effect C-3 arylation. If  successful this would allow us to 
develop an asymmetric version of the reaction. We now report that a-sulfanyllactams can be 
used in the VNS-alkylation reaction without a problem.
The VNS nucleophile 119 (Scheme 58) was formed by treating V-methylpyrrolidinone with 2 
equivalents o f LDA followed by phenyl disulfide (1 eq.) and HMPA.141 We found that DMPU 
could be used as a non-toxic alternative to HMPA without compromising the yield. A-Methyl 
pyrrolidinone was chosen since it is commercially available, cheap and a method of forming 
the VNS nucleophile with the a-sulfanyIphenyl group was already available in the literature.141
Scheme 58
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The VNS nucleophile 119 dissolved in a solution of DMF with nitrobenzene (1 eq.), was added 
to a sodium hydride/DMF base solvent system at 0 °C. This produced the normal bright purple 
intermediate which was quenched with methyl iodide (2 eq.) (Scheme 59). It was found that 
two equivalents o f the electrophile were needed to maximize the yield due to the thiophenolate 
anion competing with the post-VNS anion for the electrophile. The required product 120 was 
isolated by column chromatography from the crude reaction mixture which contained 
unreacted nitrobenzene, mineral oil from the sodium hydride, methylated thiophenol and DMF.
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The two doublets at 8 8.05 and 7.52 (J 8.9 Hz) in the ]H-NMR indicated the presence of the 
para substituted nitroaromatic. The /V-methyl group appears as a singlet at 8 2.86 and the 
remaining methyl group appears as a singlet at 8 1.48. Multiplets (8 3.24-3.36), (8 2.31-2.37) 
and (8 2.11 -2.19) represent the four protons on the pyrrolidinone ring.
A further series o f electrophiles were tried in this VNS/alkylation reaction (Scheme 60). The 
results are summarised below (Scheme 60, Table 2). The electrophiles were chosen due to 
them being readily available and highly reactive alkylating agents.
Scheme 60
119
Table 2. Yields of Product Pyrrolidin-2-ones
NaH/DMF
2. E
120
Electrophile E Yield (%)
120a Methyl iodide c h 3 65
120b HC1 H 66
120c Allyl bromide Allyl 66
120d Benzyl bromide CH2Ph 72
The 2 aromatic doublets in the !H-NMR spectrum representing the para substituted 
nitroaromatic were present in the remaining compounds 120b-d. The triplet at 8 3.7 (J  9.2 Hz) 
in the ]H-NMR o f 120b indicated a simple proton quench o f the post-VNS anion had occurred 
to give the required product 120b. The multiplets (8 5.49-5.56) and (8 5.00-5.05) along with a 
doublet at 8 2.57 (J  7.2 Hz) in the !H-NMR spectrum indicated the presence of the allyl group 
in 120c. The multiplets at (8 7.16-7.19) and (8 7.00-7.02) along with the 2 doublets at 8 3.23 
and 2.96 (J  = 13.3 Hz) indicated the presence o f the benzyl group in compound 120d. For foil 
characterisation details see the experimental section.
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To introduce extra diversity into the reaction, a VNS nucleophile was made from V-Boc- 
pyrrolidinone by the same method as the VNS nucleophile 119 was obtained (Scheme 61). 
Boc pyrrolidinone (122) was obtained by treating pyrrolidinone (121) with di-tert- 
butyldicarbonate and DMPA in acetonitrile.142 The multiplets at (6 7.22-7.25) and (8 7.46- 
7.48) in the ]H-NMR spectrum along with the shift o f the singlet representing the Boc group 
from 8 1.2 in Boc pyrrolidinone to 8 1.4 in the product indicated the required product had been 
formed. Also the appearance of the ABX system at 8 3.78, (2.30-2.29) and (1.89-1.98) 
indicated the required product had been formed.
Scheme 61
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Use of the VNS nucleophile 123 in the VNS/alkylation reaction under the same conditions as 
those used with the VNS nucleophile 119 was not successful (Scheme 62). The !H-NMR 
spectrum o f the crude reaction product contained unreacted nitrobenzene, VNS nucleophile 
124 that had been methylated at the C-3 position, DMF and mineral oil from the sodium 
hydride with no trace o f the required product 125. Even though 124 was not isolated, its 
presence was indicated by the appearance o f a singlet at 8 2.71 and the disappearance o f the C- 
3 proton at 8 3.78 in the starting material 123.
Scheme 62
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We explored the scope of the process by using a further series o f pyrrolidinones in the 
VNS/alkylation process. The first o f these was based on l-phenyl-2-pyrrolidinone (128). This
I
was prepared by treating y-butyro lactone (126) with aniline (127). The VNS nucleophile
129 was then obtained by the usual method (Scheme 63).
Scheme 63
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Multiplets (8 7.81-7.84), (8 7.59-7.64) and (8 7.53-7.57) represented the required 10 aromatic 
protons. The C-3 proton of 129 appeared as a double doublet at 8 4.25 (J 6.0 & 8.6 Hz). 
Elemental analysis also indicated the required product. For full details see the experimental 
section.
The VNS nucleophile 129 was used in the VNS/alkylation process with a series o f 
electrophiles. The results are summarised below (Scheme 64, Table 3).
Scheme 64
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Table 3. Yields of Product Pyrrolidin-2-ones
Electrophile E Yield (%)
130a HC1 H 75
130b Methyl iodide c h 3 68
130c Allyl bromide Allyl 65
130d 2,4-Dinitrofluorobenzene 2,4-DNB 58
The two aromatic doublets representing the para-substituted nitroaromatic were present in 
compounds 130a-d indicating VNS had been successful. The V-phenyl group was also present 
in each compound occurring as a doublet and two triplets. Five protons in the non-aromatic 
region for compound 130a indicated the correct product.
The presence of the methyl group in 130b was indicated by a singlet at 8 3.10. The presence of 
the allyl group in 130c was indicated by the multiplets at (8 5.52-5.62), (8 5.02-5.06) and (8 
2.65-2.67) giving a combined total of 5 protons. The presence of the 2,4-substituted aromatic 
at the C-3 position o f 130d was indicated by the presence o f a doublet at 8 8.55 (J  2.4 Hz), 
double doublet at 8 8.29 (J  2.4 & 8.7 Hz) and multiplet at (8 7.47-7.50) which represented the 
required 3 protons. The aryl electrophile (2,4-dinitrofluorobenzene) was chosen to show the 
VNS-SnAt process mentioned later in this thesis could be extended to lactams with an a- 
phenylsulfanyl group as the vicarious leaving group.
The ortho selectivity o f the VNS/alkylation process was tested with the VNS nucleophile 129 
with /?-nitroanisole (Scheme 65). The VNS process did not occur under the same conditions as 
the para selective version, since the bright purple intermediate solution, associated with the 
post-VNS anion not observed.
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The *H-NMR spectrum o f the crude reaction mixture contained p-nitroanisole, the methylated 
VNS nucleophile 131, mineral oil and DMF. Although it was not isolated the presence o f 131 
was indicated by the presence o f a singlet at 8 2.69 and the disappearance of the C-3 proton at 
8 4.25. The reaction was repeated with a KO/-Bu/DMF base solvent system, which also 
resulted in no success. On this occasion, however, the bright purple colour associated with the 
post-VNS anion was observed. The problem with using p-nitroanisole as a VNS substrate is 
that it is much less electron-deficient than nitrobenzene, due to the electron-donating nature of 
the methoxy group. As an alternative to /7-nitroanisole as the VNS substrate p- 
chloronitrobenzene was tried (Scheme 66) with the same outcome as the p-nitroanisole 
substrate. The steric clash o f the tertiary carbanion with the nitro group is the most likely 
problem with this reaction (Scheme 66). The intermediates 134 and 135 are extremely 
sterieally encumbered, and may therefore not form.
Scheme 66
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The next VNS nucleophile studied was based on 1 -benzyl-2-pyrrolidinone (136). The VNS 
nucleophile was prepared by the same method as the previous ones (Scheme 67).144 This was 
chosen as it offered the opportunity for generating the NH pyrrolidinones that can then be 
further functionalised.
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The VNS nucleophile 137 was used in the VNS/alkylation reaction with a series of 
electrophiles (Scheme 68) under identical conditions as discussed previously. The results are 
summarised below (Scheme 68, Table 4).
Scheme 68
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Table 4. Yields of Product Pyrrolidin-2-ones
Electrophile E Yield (%)
138a HC1 H 62
138b Methyl iodide c h 3 66
138c Ethyl iodide CH2CH3 61
The two aromatic doublets in the !H-NMR spectrum representing the para substituted 
nitroaromatic were present in compounds 138a-c indicating that the VNS had been successful. 
A triplet at 6 3.77 (J  9.1 Hz) in the !H-NMR spectrum of 138a represents the benzylic proton. 
A singlet at 5 1.54 indicates that the alkylation with methyl iodide had been successful A 
triplet at 8 0.76 (J 7.4 Hz) and two double quartets at 5 1.95 (J 14.8 & 7.4 Hz) and 8 1.86 (J 
13.9 & 7.4 Hz) indicated that the quench with ethyl iodide had been successful.
The next VNS nucleophile studied was based on l-para-methoxyphenyl-2-pyrrolidinone (141) 
as this also offered the opportunity for deprotection and further functionalisation. The y-lactam 
141 was formed by treating 4-chlorobutyryl chloride (139) with />-anisidine and triethylamine 
(Scheme 69). The product 140 was then treated with sodium hydride to effect cyclization to 
the pyrrolidinone (Scheme 17).145
Scheme 69
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The VNS nucleophile was then formed by the usual method (Scheme 70). Treatment o f 141 
with LDA (2 eq.) followed by phenyl disulfide and DMPU gave 142 in 68% yield
Scheme 70
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The doublets at 8 7.41 and 6.91 (J 9.1 Hz) in the !H-NMR spectrum of 142 indicates the 
presence of the para substituted anisole. The multiplets at (8 7.60-7.62) and (8 7.31-7.37) 
represents the aromatic group attached to sulfur. A double doublet at 8 4.01 {J 5.8 & 8.7) 
represents the C-3 proton adjacent to the carbonyl. The three remaining protons are 
represented by multiplets (8 3.67-3.82), (8 3.56-3.60) and (8 2.60-2.65).
The VNS nucleophile 142 was used in the VNS/alkylation process with a series of 
electrophiles under identical conditions. The results are summarised below (Scheme 71, Table 
5). The two aromatic doublets representing the para-substituted nitroaromatic were present in 
compounds 143a-c indicating that the VNS had been successful
Scheme 71
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TableS. Yields of Product Pyrrolidm-2-ones
Electrophile E Yield (%)
143a HC1 H 73
143b Methyl iodide c h 3 83
143c Benzyl Bromide PhCH2 66
Having only used y-lactams so far, we decided to try 8-lactams in the VNS/alkylation process. 
The VNS nucleophile 146 was prepared in the usual way after V-benzylation o f commercially 
available 8-caprolactam (Scheme 72).
41
Scheme 72
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The VNS nucleophile 146 was used in the VN S/alkylation process with nitrobenzene and a 
series o f electrophiles under identical conditions as described earlier.146 The results are 
summarised below (Scheme 73, Table 6).
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Table 6. Yields of Product Piperidin-2-ones
Electrophile E Yield (%)
147a HC1 H 64
147b Methyl iodide c h 3 61
147c Ethyl iodide CH2CH3 58
The two aromatic doublets in the ]H-NMR spectrum representing the para substituted 
nitroaromatic were present in 147a-c indicating that the VNS process had been successful. For 
full details see the experimental section.
As an alternative to the thiophenolate as the vicarious leaving group, a VNS nucleophile 149 
with an a-chloro group was made by treatment of V-benzylated 5-valerolactam (148) with sec- 
BuLi foUowed by tosyl chloride (Scheme 74).147 This was done to give us a method where we 
could avoid the need for an excess o f electrophile due to chloride ion being a poor nucleophile.
Scheme 74
O O
148 149 38%
The VNS nucleophile 149 was then used in a VNS/alkylation reaction with nitrobenzene and 
methyl iodide (1 eq.) under identical conditions as previously described (Scheme 75).
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The reaction proceeded, but in much lower yield. The a-cWoro-V-methylpyrrolidinone (150) 
was made under the same conditions as the a-chloro V-benzylpiperidinone (149). This was 
also used in the VNS/alkylation process (Scheme 76). Again, this resulted in a much lower 
yield o f the required VNS product 122a, as compared to using the equivalent VNS nucleophile 
121.
Scheme 76
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We next tried a pyrazolidinone in the VNS/alkylation process. The 2-methylpyrazolidin-3 -one 
153 was prepared by methylation o f the commercially available pyrazolidine148 followed by 
the usual method o f adding the vicarious leaving group (Scheme 77). A multiplet at (6 3.89- 
3.96) and double doublet at 5 3.65 (J 11.3 & 14.5 Hz) in the !H-NMR spectrum o f 153 
represented the presence o f the C-3 and two C-4 protons, indicating the required product. Ten 
protons were observed in the range 6 6.79-7.33, representing the two phenyl rings. The singlet 
for the methyl group appears at 8 2.97.
Scheme 77
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The VNS nucleophile 153 was then used in the VNS/alkylation process with nitrobenzene and 
a series o f electrophiles, under the usual conditions. The results are summarised (Scheme 78, 
Table 7). The two aromatic doublets representing the para-substituted nitroaromatic were 
present in compounds 78a-b, indicating that the VNS process had been successful. For full 
characterisation details see the experimental section.
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Table 7. Yields of Product Pyrazolidin-3-ones
Electrophile E Yield (%)
154a HC1 H 69
154b Methyl iodide c h 3 47
154c Benzyl bromide CH2Ph 61
The VNS products (143a-c) represent the opportunity for oxidative removal o f the para- 
methoxy aromatic making the amide available for further fimctionalisation. This was achieved 
with eerie ammonium nitrate (Scheme 79). Treatment with eerie ammonium nitrate, according 
to the method of Giang149 gave the amide in quantitative yield. The disappearance o f the peaks 
corresponding to the anisole in the *H-NMR spectrum indicated that deprotection had occurred 
successfully, as did the appearance o f a singlet at 5 7.0 representing the NH of the amide. 
Further proof was given by an electrospray accurate mass measurement, which gave a (M + 
H)+ peak at 207.0699 corresponding to the calculated mass o f207.0691.
Scheme 79
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The VNS products (138a-c and 147a-c) can also be deprotected and further functionalised by 
removal o f the benzyl group under hydrogenation conditions (Scheme 80). Under such 
conditions it was anticipated that the nitro group would also be reduced (e.g. 138a—>156).
Scheme 80
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Hydrogenation of 138a in ethyl acetate with activated catalyst (10% Pd on C) under an 
atmosphere o f hydrogen for 24 hours did not proceed as desired. The crude product was 
checked by !H-NMR spectroscopy, which showed unfortunately that the benzyl group was still 
present (Scheme 81) by a singlet at 8 4.44 and multiplet (8 6.79-7.30). The nitro group was 
reduced as indicated by the two doublets 8 7.07 and 6.64 (J  8.4 Hz). The reaction probably 
needed to be done under pressure but the required facilities were not available to us.
Scheme 81
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Summary and Conclusion
In summary, a useful procedure has been developed that can be used for the a-arylation o f 
pyrrolidinones, piperidinones, and pyrazzolidinones. Even allowing for the limited number o f 
examples o f a-arylation o f cyclic amides reported, this is potentially o f real value. Nitrogen 
protecting groups have been used successfully which allow for subsequent deprotection and 
further functionalisation o f the amide.
Pyrrolidinones, piperidinones and pyrazolidinones have been incorporated into the 
VNS/alkylation group by adding an a-phenylsulfanyl VNS leaving group and treating with 
base and nitrobenzene. Several different V-substituted protecting groups such as benzyl and p- 
methoxyphenyl have been incorporated in the VNS nucleophile successfully. The p- 
methoxyphenyl protecting group was successfully removed with eerie ammonium nitrate and 
although we weren’t able to remove the benzyl group we were confident that under 
hydrogenation conditions above atmospheric pressure we would be able to thus providing the 
possibility for further fimctionalistaion of the a-aryl lactam. Unfortunately, however using a 
V-Boc lactam resulted in the VNS/alkylation process not taking place.
Using chloride as the VNS leaving group we were hopeful would lead to a cleaner process due 
to chloride being a poorer nucleophile than thiophenolate so removing the need for two 
equivalents o f the electrophile. Unfortunately however this resulted in a significant reduction 
in the yield o f the reaction.
All the examples discussed in this chapter have undergone the VNS process at the para- 
position of the nitroarene. When using a /?ara-substituted nitroarene to force the VNS
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nucleophile onto the ortho-position resulted in no success. The most probable reason for this s 
the clash with the nitro-group (Scheme 66). In the case of the unsuccessful reactions the *H- 
NMR spectra o f the crude reaction mixtures indicated the presence of the alkylated VNS 
nucleophile and nitrobenzene.
In conclusion we have developed a simple one pot route to a-aryl cyclic amides. This laid the 
foundations for the development o f an asymmetric process using y-substituted lactams and 
lactones as the VNS nucleophile. The lack o f success with the ortho-selective VNS reaction 
was worrying as this would be important in the synthesis o f Physostigmine (98).
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Chapter 5
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5.1 AsymmetricVicarious Nucleophiiic Substitution of Hydrogen
The biological world can be regarded as a chiral world in the chemical sense. It happens often 
in nature that one enantiomer exhibits biological activity whereas the other enantiomer does 
not. A number o f biologically active natural products contain quaternary carbon atoms. 150"2 
Interest in synthesizing them in an optically active form is reflected in the explosive increase in 
the number o f new development for the chiral construction of quaternary carbons that have 
been published in the last 15 years.
Asymmetric syntheses can be divided into two types, enantio selective syntheses and 
diastereo selective syntheses. According to Izumi, 153 a reaction is described as enantio selective 
if the reaction is carried out on an achiral molecule using an enantioselective reagent or 
catalyst. In the case o f diastereoselective synthesis, ‘if a molecule contains a centre o f chirality 
and a centre o f prochirality and the reaction results in the conversion o f the centre of 
prochirality into a new centre o f chirality, the reagent may attack from either free with the 
result that diastereo isomers are formed.’ This definition proposed by Izumi has proven useful 
for organic and medicinal chemists for classifying asymmetric synthesis.
We decided to assess the diastereo selectivity o f VNS reactions using an a-thiophenyl-y-lactone 
possessing a y-stereogenic centre to provide a further insight into the asymmetric 
VNS/alkylation process. As mentioned previously, a diastereoselective version of the 
VNS/alkylation reaction was reported in the Lawrence group using an auxiliary incorporated 
into the VNS nucleophile (Scheme 82).38
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We thought that reaction o f the VNS nucleophile 92 with nitroarenes would generate the post- 
VNS anion in the usual way. Reaction of the post-VNS anion with a variety o f electrophiles 
would hopefully give the lactone 93 possessing an a-aryl quaternary stereogenic centre 
(Scheme 83).
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It was expected that the electrophile would approach anti to the R group for primarily steric 
reasons. In other words, the R group is shielding one face o f the molecule from the incoming 
electrophile (Scheme 84). It is known that conventional alkylation o f enolates derived from a- 
aryl-y-lactones bearing a y-stereogenic centre results in such 1,3 -stereocontrol at acceptable 
levels . 2 4 0
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The ultimate aim of this section was to develop an efficient synthesis to the natural product 
physostigmine (98) using an asymmetric VNS reaction to produce the required stereochemical 
arrangement o f the molecule (Scheme 85).
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The first lactone to be studied ‘dihydro-5-phenyl(3//)furan-2-one (160), was formed by 
reduction o f 3-benzoylpropionic acid with sodium borohydride. The a-thiophenyl-y- 
butryolactones c/5-161 & trans-161 were prepared by a known process from y-butyrolactone 
160, LDA (1 eq.) and phenyldisulfide (Scheme 86) with a 6:4 ratio o f the two diastereoisomers
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in overall 70% yield. 171 This ratio matched that o f the literature procedure. The isomers were
separated by column chromatography. The diastereosomers were assigned in the literature 
procedure by nOe studies.
Scheme 86
The mixture o f VNS nucleophiles trans-161 and c/5-161 were dissolved in a solution of DMF 
containing nitrobenzene (1 eq) and added to a sodium hydride/DMF solvent system at 0 °C
9% yield. It was found that if the post-VNS anion was allowed to warm to room temperature 
and stirred for 2 hours before the electrophilic quench the yield improved to 73% (Scheme 87) 
o f the trans-162:cis-162 products (in an 88:12 ratio). The major product was isolated by 
column chromatography but unfortunately the minor diastereo isomer could not be isolated.
The presence o f the required product was indicated by the presence of doublets at 8  8.21 and
nitroaromatic. The double doublets at 8  5.65 (J  9.9 & 6.1 Hz), 2.89 (J  13.0 & 6.1 Hz) and 2.63 
{J 13.0 & 9.9 Hz) represent an ABX system consisting o f the C-4 and C-5 protons. The phenyl 
group is represented by a multiplet (8  7.33-7.41) and the methyl group as a singlet at 8  1.79. 
Fortunately the major isomer was crystalline. A crystal suitable for X-ray analysis was grown 
by dissolving a small amount o f sample in dichloromethane and then putting this vial into an 
pot containing hexane. This was then left covered in the dark until crystals were obtained. X- 
ray crystal structure determination was performed by Abdul Malik o f Cardiff University. The
NaBH*,
EtOH
2. PhSSPh
159a O frans-161 Ph
4
c/s-161 ph
6  70%
under nitrogen. After stirring at 0 °C for 2 hours the bright purple solution was quenched with 
methyl iodide at -78 °C. After work up and purification this left the required product in only
Scheme 87
NaH/DMF
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7.71 {J 8.9 Hz) in the !H-NMR spectrum indicating the presence of a para substituted
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structure clearly reveals the relative stereochemical configuration of the product and shows that 
the major product is the trans isomer, as expected. The lactone 162 adopts an envelope 
conformation as shown in Figure 9.
Figure 9
Chem3D representation of the X-ray crystal structure of the trans-162
The ratio of the majorrminor stereoisomers trans-162:cis-162 is based on analysis of the 1H- 
NMR spectrum of the crude reaction product. Because the minor isomer was present in only 
small quantities we were not confident that those peaks we were assigning as corresponding to 
the minor isomer were indeed those of the c/s-isomer. A method had to be obtained to make 
the minor diastereo isomer so that we could accurately assign the peaks in the crude ’H-NMR 
spectrum and be totally confident of quoting an accurate figure for the diastereoselectivity. 
The synthetic route chosen is illustrated in Scheme 88.
Scheme 88
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Esterification of the commercially available 4-nitrophenylpropionic acid (163) with methanol 
and sulfuric acid and heating under reflux for 3 hours gave the ester 164 in 90% yield. The 
ester 164 was then treated with sodium hydride (1 eq.) followed by 2-bromoacetophenone at 0 
°C to give 165 in 65% yield. The presence of the required product is indicated by the presence 
of a singlet at 5 1.85 in the ’H-NMR spectrum representing the methyl group at the quaternary 
centre. In the starting material 164, this methyl group appears as a doublet at 5 1.4 (J 7.2 Hz). 
The doublets at 5 3.92 and 3.65 (J 17.8 Hz) represent the CH2 group next to the quaternary
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centre. The methyl group of the ester appears as a singlet at 5 3.74. The appearance of singlets 
at 8 196.3 and 174.7 in the 13C-NMR spectrum indicate the presence of two carbonyl groups. 
We hoped that reduction of the ketone to the alcohol would cause cyclization onto the ester to 
give the required lactone 162. This was achieved using sodium borohydride as the reducing 
agent although the reaction was capricious with the lactone being sometimes reduced in the 
process. Other reducing agents were attempted such as sodium acetoxyborohydride and 
tetramethyldisiloxane/TBAF154 with little success.
The sodium borohydride method did however eventually give the two required 
diastereoisomeric products in a 1:1 ratio and overall yield of 83%. These two products were 
the same products formed in the VNS reaction but formed in a different ratio. The two 
diastereoisomers were then separated by column chromatography. Doublets at 5 8.15 and 7.67 
(«/ 8.8 Hz) in the 1 H-NMR spectrum indicated the presence of a /?ara-substituted nitroaromatic. 
The ABX system was represented by double doublets at 8 5.17 (J  5.4 & 10.6 Hz), 3.08 (J 5.4 
& 13.3 Hz) & 2.46 (J  10.6 & 13.3 Hz). The phenyl group appeared as a multiplet (8 7.29-7.37) 
and the methyl group as a singlet at 8 1.69. Comparing with the 1 H-NMR spectrum of the 
crude reaction product 162 prepared earlier we could deduce which peaks belonged to the 
minor diastereoisomer cis-162 and the ratio of the two products had therefore been accurately 
calculated. An X-ray structure was obtained of the minor diastereoisomer (Figure 10): This 
was done by growing a crystal under the same conditions as mentioned previously for the 
major product in the VNS reaction. The structure clearly reveals the relative stereochemical 
configuration of the product and shows that the product is indeed in the cis form (cis defined as 
a cis relationship between the methyl and phenyl groups).
Figure 10
Chem3D representation of the X-ray crystal structure of the cis-162
A further series of electrophiles were used in the VNS reaction with nitrobenzene and 5- 
phenyl-3-phenylsulfanylfiiran-2-one (92) under identical conditions (Scheme 89). The results 
are summarised below (Table 8).
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Scheme 89
1.
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Table 8. Yields of Product Furan-2-ones
Electrophile E Yiekl (%) Ratio trans. cis
162a HC1 H 73 73:27
162b Allyl bromide CH2CHCH2- 67 85:15
162c Benzyl bromide PhCH2- 65 >87:13
162d 2-Bromo acetophenone PhCH2(CO)- 67 >87:13
The doublets representing the 1,4-disubstituted aromatic were present in compounds 162a-d 
indicating that the VNS process had been successful. The double doublet at 8  5.50 (J  10.7 & 
5.5 Hz) in the 1 H-NMR spectrum o f 162a indicated a proton quench of the post-VNS anion 
had taken place. The allyl group in the 1 H-NMR spectrum of 162b is represented by multiplets 
(5 5.49-5.68) and (8  5.09-5.17) and a doublet at 8  2.73 (J 7.4 Hz). The benzyl group in the !H- 
NMR spectrum o f 162c is represented by doublets at 8 3.63 and 3.16 (J 13.2 Hz) along with a 
multiplet (8  7.19-7.45). The presence o f the acetophenone group in the 1 H-NMR spectrum of 
162d is indicated by doublets at 8  3.81 and 3.65 (J  18.1 Hz).
To be confident o f quoting an accurate ratio of diastereo isomers again, the minor 
diastereo isomers were again required. This was done by a similar method as described 
previously (Scheme 90).
Scheme 90
M eOH/H+
166
NO2 N O
1. NaH NaBK
PhW 168
75%
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Again chemoselective reduction of the ketone 168 proved to be capricious, but the required 
product was eventually isolated, giving a 1:1 mixture o f the two diastereo isomers 162a. 
However, separation by column chromatography proved to be difficult but the 1 H-NMR 
spectrum of the crude reaction still gave the position of signals of the minor diastereoisomer. 
From this the accurate ratio o f the two diastereo isomers 162a (c/£-162a: trans- 162a 73:27), 
obtained from the VNS process o f 92 with a proton quench could be quoted.
Scheme 91
1. NaH 
q  2. Allyl bromide 
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1. NaH
Q 2. BrCH2(CO)Ph
O 168
NONO-
NaBH.
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The minor diastereoisomer o f compound 162b was formed again based on the same method 
(Scheme 91). Deprotonation o f methyl 4-nitrophenylacetate (167) with sodium hydride at 0 °C 
followed by quenching with allyl bromide (1 eq) gave 168 in 93% yield. Treatment o f 168 
with sodium hydride followed by quenching with 2-bromoacetophenone (1 eq.) gave 169 in 
8 6 % yield. The presence of 169 was indicated by the disappearance o f the benzylic proton of 
the starting material at 5 3.78 in the crude 1 H-NMR spectrum and the appearance o f doublets at 
8 3.82 and 3.74 (J  18.0 Hz). Doublets at 8  8.16 and 7.89 (J  8.9 Hz) represent the para 
substituted nitroaromatic. The phenyl group is represented by a triplet at 8  7.41 (J  7.9 Hz) and 
muhiplet (8  7.49-7.55). The allyl group is represented by multiplets (8  5.28-5.36 & 4.85-4.93 
& 2.94-3.07). The singlet representing the methyl group appeared at 8  3.63.
Reduction o f 169 with sodium borohydride gave the two diastereo isomers o f 162b in a 1:1 
ratio in 62% overall yield. The doublets at 8  8.28 and 7.72 (J 8.9 Hz) in the 1 H-NMR spectrum 
o f the cis product represent the para-substituted nitroaromatic. The phenyl group appears as a 
muhiplet (8  7.33-7.43), the allyl group appears as multiplets (8  5.61-5.70 & 5.02-5.18 & 2.68- 
2.80). The three protons on the ring appear as an ABX system at 8  5.22 (J 5.4 & 10.9 Hz),
3.01 (J  5.4 & 13.6 Hz) and 2.56 (J  10.9 & 13.6 Hz). From this data an accurate ratio o f the two 
diastereo isomers was calculated.
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Scheme 92
NaBH
2. BrCH2(CO)PhO 2. Benzyl Bromide
not isolated
To make the minor diastereoisomer of compound 162c, the same route was followed (Scheme 
92). Deprotonation of methyl 4-nitrophenylacetate (167) with sodium hydride at 0 °C followed 
by an electrophilic quench with benzyl bromide (1 eq) gave 171 in 76% yield. Treatment o f 
171 with sodium hydride followed by an electrophilic quench with 2-bromoacetophenone (1 
eq) gave 172 in 87% yield. The presence of 172 was indicated by the presence o f a doublet at 
8 8.20 (J 8.9 Hz) and muhiplet (6  7.45-7.51) representing the /Tara-substituted nitroaromatic. 
A doublet at 6  3.58 (J 13.7 Hz) and muhiplet (6  3.68-3.72) represent the two CH2 groups. A 
singlet at 8 3.72 represents the methyl group. The remaining aromatic protons are represented 
by doublets at 8 7.95 (J 7.5 Hz) and 6.52 (J 7.4 Hz), triplets at 8 7.62 (J 7.5 Hz), 7.14 (J 7.4 
Hz) and 7.05 (J 7.4 Hz) and a muhiplet (6  7.45-7.51). As before the selective reduction o f 
compound 172 proved capricious but this time the required products could not be isolated.
The minor diastereoisomer o f compound 162d was not formed by this method due to the 
precursor having two identical carbonyl groups of which we only want to reduce the one. 
Nevertheless in these last two cases, we are not unduly concerned that the ratio we quote in 
Scheme 89 does not represent the true level o f diastereo selectivity.
It was expected that the larger the electrophile, the higher the level o f selectivity which would 
be obtained. The lowest level o f selectivity achieved was with a simple proton quench of the 
post-VNS anion with HC1. Using methyl iodide as the electrophile however produced slightly 
better stereoselectivity than using allyl bromide as the electrophile. However, all the alkyl 
halides produced veiy similar results o f stereoselectivity.
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To study the diastereo selectivity in an ort/io-selective VNS reaction, p-chloronitrobenzene was 
used as the VNS substrate (Scheme 93). Compound 173 was formed in an overall yield of 
51% with a 80:20 ratio o f trans: cis diastereo isomers. The presence o f the required compound 
173 was indicated by the presence o f a singlet 2d 5 1.69 in the 1 H-NMR spectrum representing 
the methyl group. An ABX system at 6  5.29 (J  9.2 & 6 .8  Hz), 2.69 (J 13.6 & 6 .8  Hz) and 2.49 
(J 13.6 & 9.2 Hz) represents the three protons on the lactone ring. The three protons on the 
nitroaromatic ring are represented by doublets at 8 8.35 (J  8.9 Hz) & 8.01 (J  1.1 Hz) and a 
double doublet at 8  7.89 (J 1.1 & 8.9 Hz). The remaining aromatic protons are represented by 
a muhiplet (8  7.31-7.45). The major diastereoisomer was isolated by column chromatography. 
From the results o f the previous asymmetric VNS reaction using nitrobenzene, we were 
confident that the major diastereosiomer could be assigned as the trans product.
All the examples o f asymmetric VNS discussed so far have produced racemic products. The 
next stage was to develop the protocol to incorporate a chiral lactone to produce an 
enantiomerically pure product. The chiral lactone we chose to try was made by the following 
route (Scheme 94), that has been developed by Herdeis, Tse, Drioh and Hanessian. 155-8
Scheme 94
h o 2c  0  O o
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95%175 51% 55% 177
To check that the lactone 177 was enantiomerically enriched the <xd was measured (+35.3, c = 
1.09 in EtOH) and compared to the literature value (+ 35.5 c = 1.09 in EtOH) . 172 The first step 
of the synthesis involves diazotisation o f glutamic acid (174). The process involves 
diazotisation o f the amine group followed by cyclisation o f the adjacent acid that involves an 
Sn2 inversion. The resulting a-lactone 179 is ring-opened by attack o f the other acid to give
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the y-lactone 180. Due to the two consecutive Sn2 reactions the reaction takes place in an 
overall retention of configuration (Scheme 95).
Scheme 95
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Esterification o f 180 with EtOH/p-TsOH/benzene gave the ester 175. Reduction of the ester 
with sodium borohydride gave the alcohol 176. Protection of the alcohol with tert-butyl 
diphenylchlorosilane gave the required product 177. Treatment o f 177 with LDA (2 eq.), 
phenyl disulfide (1 eq.) and DMPU (1 eq.) gave the VNS nucleophiles {trans-181 & c/s-181) 
(Scheme 96). These were then separated by column chromatography.
Scheme 96
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The VNS nucleophiles trans-181 & c/5-181 were used in the VNS/alkylation process under the 
conditions developed previously, namely sodium hydride, nitrobenzene and methyl iodide 
(Scheme 97).
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Despite numerous attempts to get this reaction to work, all were unsuccessful. Using sodium 
hydride as the base resulted in no brightly coloured intermediate being observed. In the 1H- 
NMR spectrum o f the crude reaction mixture nitrobenzene was observed along with the a-
57
methylated VNS nucleophile 183 although attempts to isolate this compound foiled. Changing 
the base/solvent system to KOr-Bu/DMF resulted in the usual bright purple solution. The 1H- 
NMR spectrum o f the crude reaction mixture however showed no sign of the required VNS 
product. Nitrobenzene was observed as well as a singlet at 6  0.95 along with aromatic protons 
at (5 7.41-7.55). There was no indication o f the product lactone in the 1 H-NMR spectrum, and 
also no indication of the starting material 181.
An alternative protecting group was then attempted. This was formed under the same 
conditions as the previous lactone but using TBDMS-C1 instead o f TBDPS-C1 (Scheme 98). 
The protected lactone 184 was then treated with LDA (2 eq.), DMPU and phenyl disulfide to 
give the cis and trans diastereo isomers in a 1:1 ratio (Scheme 98). The two diastereo isomers 
were separated by column chromatography.
Scheme 98
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The presence of the required products was indicated by the presence of a double doublet at 8 
4.05 (J  7 A & 9.3 Hz) in one diastereosiomer and a triplet at 5 3.89 (J 10.2 Hz) in the other 
diastereoisomer representing the C-3 protons. The VNS nucleophiles trans-185 & cis-185 
were studied in the asymmetric VNS reaction under the previous conditions using both sodium 
hydride and potassium ter/-butoxide as the base. Using sodium hydride as the base resulted in 
no VNS product 186, but only nitrobenzene and the a-methylated VNS nucleophile 187 
present in the 1 H-NMR spectrum of the crude reaction mixture (Scheme 99).
Scheme 99
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Using potassium ter/-butoxide as the base again it looked as if the protecting group was being 
removed by the base as a singlet at 8  0.82 and doublet at 0.00 (J  3.7 Hz) was observed in the
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‘H-NMR of the crude reaction mixture. Nitrobenzene was also present although there was no 
sign o f the peaks associated to a lactone.
A further VNS nucleophile was studied with a trityl protecting group. This was formed from 
the commercially available lactone 188 and treatment with LDA (2 eq.), DMPU and phenyl 
disulfide in THF (Scheme 100) to produce the cis and trans VNS nucleophiles although these 
could not be separated by column chromatography.
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These nucleophiles were studied in the VNS reaction under the same conditions as before. 
Using sodium hydride as the base resulted in nitrobenzene and the a-methylated VNS 
nucleophile 191 being observed in the 1 H-NMR spectrum of the crude reaction mixture with no 
trace o f the required product 190 (Scheme 101). The same result was observed when potassium 
terf-butoxide was used as the base instead o f sodium hydride.
Scheme 101
- n o 2
NaH/DMF
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A possible reason as to why these reactions foiled is that in formation o f the an-adduct causes 
the large PhS group to be forced cis to the large protecting group making the reaction highly 
unfavourable (Scheme 102). One possible solution is looking for a smaller VNS leaving group.
Scheme 102
1. Nitrobenzene
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Despite the lack of success with nitrobenzene an attempt was made to study the VNS 
nucleophile 181 in the VNS reaction with /?ara-substituted mtroaromatics to obtain the ortho- 
VNS product (Scheme 103) as this would be important in the synthesis of physostigmine (98). 
The same conditions were used as in the earlier attempts with nitrobenzene.
Scheme 103
Unfortunately this also resulted in no success with the para-substituted nitroaromatic and only 
the a-methylated VNS nucleophile 183 was observed in the 1 H-NMR spectrum o f the crude
of the methoxy group.
As an alternative to the VNS/alkylation process, we considered Hartwig’s palladium-catalysed 
a-arylation o f esters by forming a silyl ketene acetal 195 and then forming the enolate by
VNS process which could then be protonated and quenched with electrophiles to carry out a 
diastereoselective alkylation process. This would hopefully allow us to obtain the substrate 
required to continue with the proposed synthesis of the natural product physostigmine (98).
Scheme 104
The silyl ketene acetal 197 was formed by treatment o f the lactone with LiHMDS followed by 
chlorotrimethylsilane at -78 °C (Scheme 105). Purification of the product proved to be 
problematic, so the crude product was used directly in a cross-coupling process with p- 
chloronitrobenzene (Scheme 105).
OTBDPS
- n o 2
NaH/DMF
Not formed
/
194a R = Cl TBDPSO^ 
194b R = OMe
TBDPSO R
frans-181 183
R = Cl or OMe
reaction mixture. A possible problem with the para-nitroanisole is the electron-donating nature
treatment with a fluoride source (Scheme 104).82 If we could successfully apply this 
methodology to effect C-arylation of the lactone, we could obtain the same products as the
pi — ^ Pd(dba)2(1 mol%) O
196195
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To probe the reactivity o f the system, the silyl ketene acetal 197, P(f-Bu)3, Pd2(dba)3, zinc 
fluoride and bromobenzene were heated in DMF for 12 hours at 80 °C. The process however 
also resulted in no success, with the starting materials recovered. 3-Bromo-4-nitroanisole 
(201) was also used in this method as an alternative electrophile. This was prepared by 
treatment o f 3-bromophenol (199) with sulphuric acid and sodium nitrate (Scheme 106).159-160 
The product was then methylated with K2CO3 and methyl iodide to give the 3-bromo-4-
nitroanisole (2 0 1 ) in 8 6 % yield, 
Scheme 106 
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The electrophile 201 was then studied in the cross-coupling of the silyl ketene acetal 197 under 
Hartwig’s conditions (Scheme 107). If this proved successful, it would give us the required 
substrate to continue with the physostigmine synthesis.
Scheme 107
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This attempt also resulted in no success with the starting materials being recovered. Silyl 
ketene acetals o f different lactones were also attempted (Scheme 108) as a test to see if the
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problem was with the sterically hindered lactone 188. Again this resulted in the starting 
materials being recovered.
Scheme 108
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An attempt was made to use the enolate generated from a silyl ketene acetal in a SnAt reaction 
(Scheme 109) as an alternative method to effect C-arylation of the lactone. This again 
proceeded without success, with the starting materials recovered. 3-Fluoro-4-nitroanisole was 
also used as an electrophile in this attempted S n A t reaction (Scheme 109). This also resulted 
in the starting materials being recovered.
Buchwald’s method of cross-coupling esters with aryl bromides was also attempted as a further 
alternative for forming a C-3 arylation of the lactone. We chose bromobenzene as our 
electrophile as a test as there was no successful reactions with a nitroaromatic reported by
Buchwald (Scheme 110). 
materials.
162 However this method also resulted in recovery o f the starting
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Scheme 110
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Due to the failure o f the cross-coupling and SnAt approaches, we wondered if we could use an 
a-carbonyloxylactone 210 and decarboxylate to give the required product 211 (Scheme 111). 
This again would be an alternative route to get through to the substrate we needed to continue 
with the synthesis o f physostigmine. An a-carbonyloxylactone provides a  stabilized enolate 
similar to that o f a  malonate which are known to successfully undergo the SnAt process.
Scheme 111
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Firstly, we needed to know if a malonate substituted at the carbon between the two carbonyl 
groups would undergo the SnAt process. The commercially available malonate 212 was 
treated with sodium hydride (1 eq.) in DMF at 0 °C and then 2,4-dinitrofluorobenzene before 
being allowed to warm to room temperature (Scheme 112). This reaction proceeded in 83% 
yield.
Scheme 112
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Due to the success o f this reaction we decided to form an a-carbonyloxylactone from the 
lactone. This was done by treating the lactone 214 with LDA followed by dimethyl carbonate 
(Scheme 113).163 This reaction proceeded in 73% yield. The product 215 was treated with 
sodium hydride at 0 °C followed by 2,4-dinitrofluorobenzene and allowed to warm to room 
temperature (Scheme 113).
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This reaction proceeded in 8 6 % yield. The presence of the required product was indicated by a 
triplet at 6  3.43 (J  8.4 Hz) in the starting material disappearing. Doublets at 8 8 .8 6  (,J 2.4 Hz) 
and 7.64 {J 8.4 Hz) and a double doublet at 8  8.44 {J 2.4 & 8.4 Hz) indicated the presence of 
the aryl group. We took the product 216 and attempted to decarboxylate using Krapcho 
conditions (Scheme 114).164 The product 216 was heated in a flask at 180 °C containing 
DMSO, sodium chloride and water.
Scheme 114
NO-
216
NO
217
The required product 217 was not formed in this reaction and no starting materials were 
recovered. The crude 1 H-NMR spectrum was no help as it was extremely complicated. We 
thought that maybe a competing process was taking place as a lactone is a cyclic ester and the 
C-5 position is unhindered it could be susceptible to attack by the chloride which could then 
ring open the lactone (eg 218—>219) (Scheme 115). Unfortunately no products could be 
isolated by column chromatography. Use o f Lil instead o f water and NaCl resulted in no 
improvement to the process. We thought that the problem could be avoided, however, if the 
lactone was substituted at the y-position which would undergo the competing process more 
slowly.
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o 2n
M e02C
NO
OH
Cl 219
y-Methyl-y-butyrolactone 220 was treated with LDA followed by dimethyl carbonate (Scheme 
116). This reaction proceeded in 75% yield. A 1:1 mixture o f diastereo isomers was observed. 
This mixture was treated with sodium hydride at 0 °C followed by 2,4-dinitrofluorobenzene to 
give 223 (Scheme 116). However the stereochemistry of the lactone was not assigned due to 
the chiral centre being destroyed in the next step. Nevertheless it is highly likely that the aryl 
group is trans to the methyl group.
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The reaction proceeded in 80% yield. Only one product 221 was observed. The product 221 
was then treated under Krapcho conditions to undergo decarboxylation (Scheme 117). 
Unfortunately, however, this process did not occur cleanly, with the 1 H-NMR spectrum of the 
crude reaction product being extremely complex.
Scheme 117
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A further alternative method for forming the required product was treating the enolate of an 
ester with an epoxide. Despite there being few examples o f ester enolates reacting with 
epoxides in the literature we were hopeful that the nitrophenyl acetates would be more 
successful due to the similar pA# of malonates. Malonates readily undergo reactions with 
epoxides. 165 Isopropyl 2-nitrophenylacetate (225) was treated with sodium hydride at 0 °C to
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form the enolate followed by an electrophilic quench with allyl glycidyl ether as a simple test. 
The epoxide was chosen as it was readily available at hand (Scheme 118). Unfortunately, 
however this resulted in the starting materials being recovered. The reaction was tried several 
times with heating but all with no success.
Scheme 118
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Due to this lack o f success we tried treating 4-nitrophenylacetic acid (166) with 2 equivalents 
o f base, followed by treatment with the allyl glycidyl ether 226 (Scheme 119) This was tried 
due to precedent o f carboxylic acids reacting with epoxides with 2  equivalents o f base to 
produce a y-lactone. 166 This however also resulted in the starting materials being recovered.
Scheme 119
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We wondered if oxidative nucleophilic substitution of hydrogen would provide an alternative 
process to get through to the same products. y-Phenyl-y-butyro lactone (160) was treated with 
potassium ter/-butoxide and 4-chloronitrobenzene followed by DDQ (Scheme 120). ONSH 
had already been used in the synthesis o f physostigmine using the enolate o f W-methyl 
pyrrolidinone as mentioned previously. However again this resulted only in the recovery of the 
starting materials.
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We decided to try a chiral lactam as a VNS nucleophile due to the success with the lactams in 
the previous chapter. This would hopefully give us a valuable method for forming a-aryl 
quaternary centres in high selectivity, which as mentioned previously possesses a scaffold with 
several points o f diversity amenable to covenient derivatization thereby providing an important 
peptide-like scaffold. The chiral lactam was made from commercially available L- 
pyroglutamic acid (230) (Scheme 121) according to the method of Thottathil.167
Schem e 121
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The pyroglutamic acid 230 was esterified with ethanol and sulphuric acid. The ester 231 was 
then reduced to the primary alcohol 232 with sodium borohydride. The alcohol 232 was 
protected with trityl chloride, a bulky group required to shield one side o f the lactam in the 
asymmetric VNS alkylation process. Triethylamine and trityl chloride were added to a 
solution o f 5 -hydroxymethylpyrrolidin-2-one (232) in dichloromethane. The amide nitrogen 
was then methylated with sodium hydride and methyl iodide at 0 °C to give the required 
product 233. To prove no racemisation had occurred at the chiral centre the aD was measured 
(+ 28.4 c = 1.71 in ethanol) and compared with the literature value (+28.9 c = 1.71 in 
ethanol).16*
The lactam 234 was then treated with LDA (2 eq) followed by phenyl disulfide (1 eq.) and 
DMPU (1 eq.) to give the VNS nucleophile 235 (Scheme 122). This process occurred in 55% 
yield with only the one diastereoisomer observed The stereochemistry of the lactam was not 
assigned due to the chiral centre being destroyed in the next step. Nevertheless it is highly 
likely that the thiophenyl group is trans to the trityl group. The presence of the desired product 
was indicated by a presence of a triplet at 6  4.00 {J 8.3 Hz). This was then used in the 
VNS/alkylation process with sodium hydride and nitrobenzene (Scheme 123). The required 
product was not observed in the crude ^-N M R  spectrum with only nitrobenzene and the a- 
methylated VNS nucleophile observed. Potassium ter/-butoxide was tried as a base but also 
with no success.
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An alternative lactam was also tried in the VNS/alkylation process. This was formed by 
treatment o f succinimide with methylmagnesium iodide followed by treatment of the 
intermediate with sodium cyanoborohydride (Scheme 123).169-170
Scheme 123
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V-Methylation o f the resulting product 238 with sodium hydride and methyl iodide at 0 °C 
gave 239. Treatment o f 239 with LDA (2 eq.) followed by phenyl disulfide (1 eq.) and DMPU 
(1 eq.) at -78 °C gave 240 (Scheme 124). A mixture of the two diastereoisomers were formed 
which proved difficult to separate by column chromatography. The lactam 240 was used in the 
VNS/alkylation process (Scheme 124). However this resulted in no VNS product, with 
nitrobenzene and the a-methylated lactam 241 being recovered.
Scheme 124
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Summary and Conclusion
In conclusion, the one pot asymmetric VNS alkylation was developed successfully using 
Dihydro-5-phenyl-3-(phenylthio)(3H)furan-2-one (161) as the VNS nucleophile. Significant 
diastereoselectivities were observed using 161 as the VNS nucleophile. The method provided
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diastereoselectivities o f greater than 7:1. The ortho-selective VNS reaction was successful 
using 167 and /?-chloronitrobenzene, this was important as it gave us hope that the proposed 
route to physostigmine could be carried out using this method.
Attempting to use a silyl protected lactone resulted in deprotection of the alcohol and loss of 
the lactone in the work up. Changing to a trityl group also resulted in no success. We 
considered the possibility that in forming the an-adduct the large PhS group is forced cis to the 
large protecting group making the reaction highly unfavourable (Scheme 102). A possible 
solution would be to use a smaller VNS leaving group or another solution would be to use a 
smaller alcohol protecting group although this would probably compromise on the level of 
diastereoselectivity. The advantage of the PhS VNS leaving group was that it was easy to add 
to the lactone. An a-chloro lactone is more difficult to form.
We concluded that due to the difficulties associated with getting the conditions right for the 
VNS reaction an alternative process for the VNS step might be more favourable. We 
considered Hartwig’s cross-coupling of silyl ketene acetals, Buchwald’s cross-coupling of 
esters, the use o f an a-carbonyloxylactone followed by decarboxylation and finally treating the 
enolate o f an ester with an epoxide. Hartwig’s cross-coupling o f silyl ketene acetals and 
Buchwald’s method for cross-coupling of esters both resulted in the recovery of starting 
materials. The Krapcho decarboxylation of an a-carbonyloxylactone resulted in a complicated 
‘H-NMR spectrum with a possible competing process occurring (Scheme 115). The 
asymmetric VNS/alkylation of lactams was also studied but again with no success. Clashes of 
the large PhS group with the protecting group could again be the problem when the PhS group 
is forced cis on forming the an-adduct.
We conclude that in our efforts to obtain high diastereoselectivities that we under estimated the 
sensitivity o f the VNS reaction to steric effects, and should not have used such a bulky 
directing group. We should have started with a much smaller alcohol protecting group. Future 
work will be to investigate a smaller VNS leaving group in the reaction to try and avoid the 
problem of a steric clash between the VNS leaving group and the bulky protecting group 
(Scheme 102) and also try different alcohol protecting groups in the reaction.
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Chapter 6
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6.1 Synthesis of DiaryImethanes
Diarylmethanes and diarylacetates are extremely useful synthetic intermediates173'5 and the 
diarylmethyl motif is found in many pharmacologically important agents176-9 such as 
Tolterodine (242) and Nomifensine (243) (Figure 11). A versatile route to this important 
scaffold incorporating several points o f diversity is potentially useful.
Figure 11
.OH
Tolterodine (242) Nomifensine (243)
A synthesis o f (p-nitroaryl)diaryImethanes via VNS o f hydrogen has been reported by 
Katritzky (Scheme 125).180 (Diarylmethyl)benzotriazoles 245 were prepared from
benzotriazole and diarylmethanoIs 244 in the presence of a catalytic amount o f p- 
toluenesulfonic acid (PTSA) in benzene with azeotropic removal of water. In these 
compounds, the benzotriazoyl moiety serves as a carbon-stabilizing and leaving group, in the 
course o f the VNS reaction. (Diarylmethyl)benzotriazoles 245 were reacted with a series o f o- 
and m-substituted nitrobenzenes. An equimolar mixture of 245 and the nitroarene were added 
to a solution o f potassium /er/-butoxide in dry THF to give a deep red reaction mixture. Upon 
quenching with saturated ammonium chloride solution, (nitroaryl)diaryImethanes 248 were 
obtained.
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A synthesis o f (p-nitroaryl)diarylmethanes via VNS of hydrogen was also reported by Makosza 
(Scheme 126).181 This process used the carbanions of benzhydryl sulfides 249. These reacted
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with nitroarenes in the usual way to produce oH-adducts 250 from which base induced p- 
elimination’ can take place to give the VNS product 252. The benzhydiyl sulfides 249 were 
prepared from the reaction o f diarylchloromethanes 253 with /?-chlorothiophenol (254) in 
K^CCh/acetone in yields close to quantitative (Scheme 127). The p-chlorophenyl sulfides 249 
were used as the VNS nucleophile due to p-chlorophenylthiolate being a better leaving group 
than thiophenolate (pKa (H2O) is 10 compared to the pK* / 7-chlorophenylthiolate is 8 .1) . 182
Scheme 126
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6.2 The Synthesis of Diary lacetates via a Sequential VNS-SnAf Three Component 
Coupling Reaction
It has been shown that the VNS nucleophiles exhibit reactivity similar to that o f the malonate 
anion. This is not surprising given that other properties such as acidity are similar. For 
example, the pK+ (DMSO) o f ethyl p-nitrophenylacetate is 15.1183 while that o f diethyl 
malonate is 16.4.184 Malonate is an excellent nucleophile for many SnAt reactions185-6 and 
some examples o f the use o f nitrophenylacetates in the SnAt reaction have been reported. 187’9 
We were therefore hopeful that the anion derived from the VNS reaction (Scheme 128), would 
react with activated aryl electrophiles such as 255 to give products such as 256.
Scheme 128
X  R e w g n o 2
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The post VNS anion was generated by addition of nitrobenzene and ethyl 2-chloropropionate 
in DMF to a suspension o f sodium hydride in DMF at -50 °C. This generated the usual 
brightly coloured intermediate, which after warming to room temperature was cooled back to -  
50 °C then was quenched with 2,4-dinitrofluorobenzene. The desired diarylacetate 257 was 
isolated after column chromatography in 77% yield (Scheme 129). The two doublets at 8  8.22 
and 7.68 (J  9.0 Hz) in the *H-NMR spectrum indicated the presence of a 1,4-disubstituted aryl 
group. Doublets at 5 8.80 (J  2.4 Hz) and 7.16 {J 8.7 Hz) along with a double doublet at 8  8.30 
{J 2.4 and 8.7 Hz) indicates the presence o f a 1,2,4-trisubstituted aryl group. The methyl group 
appears as a singlet at 8  2.26 indicating that it was attached to a quaternary centre.
Scheme 129
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To investigate whether this was a general process the reaction was repeated with several other 
electrophiles under the same conditions as described. The electrophiles were chosen due to 
their highly reactive nature and because they were commercially available.
Scheme 130
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257a c f 3 n o 2 73%
257b n o 2 n o 2 77%
257c n o 2 CN 88%
257d n o 2 c f 3 89%
Diarylacetate 257a was formed using the conditions described above (Scheme 130). The seven 
aromatic protons representing the two aryl groups appear as a multiplet (8  8.20-8.23) along 
with doublets at 8  7.72 (J 8.4 Hz) (H-5”), 7.67 (J 9.0 Hz) (H-2’ & H-6 ’) and 7.06 (J 8.4 Hz) 
(H-6 ”). The methyl group appears as a singlet at 2.25 indicating the presence of a quaternary 
centre.
Diarylacetate 257c was formed in 8 8% yield using slightly different conditions, instead of 
using just the one equivalent o f ethyl 2 -chloropropionate increasing to two equivalents to
73
increase the yield based on nitrobenzene. This was discovered by previous research in the 
Lawrence group.86 The excess nucleophile undergoes self condensation. It was also found that 
there was no need to cool the reaction mixture to -50 °C for the electrophilic quench. Cooling 
to 0 °C was sufficient. Diarylacetate 262d was formed in 89% yield also using two equivalents 
o f ethyl 2-chloropropionate and cooling to 0 °C for the electrophilic quench. The !H-NMR 
spectra for both these compounds were consistent with what was observed in diarylacetates 
257a and 257b. The products were characterized in foil (see Experimental section).
It was decided to investigate different nucleophiles in the VNS-SnAt process. Methyl 2- 
chloropropionate was investigated as the nucleophile as it was commercially available (Scheme 
131).
Scheme 131
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Diarylacetate 257e was formed in 69% yield using one equivalent o f methyl 2- 
chloropropionate. The reaction was also cooled to -50 #C for the electrophilic quench. One of 
the two doublets in the !H-NMR spectrum representing the 1,4-disubstituted aryl group 
overlaps with one o f the signals from the second aryl group to give a multiplet (5 8.19-8.23). 
The other doublet o f the 1,4-disubstituted aryl group appears at 8  7.68 {J 8.9 Hz). Doublets at 
8 7.72 (J 8.3 Hz) and 7.09 (J 8.3 Hz) represent the other two protons on the second aryl group. 
The methyl group appears as a singlet at 8  2.25 indicating the presence of a quaternary centre. 
The process was applied to 257f, 257g and 257h. The products were obtained in good yields 
(Scheme 7). Diarylacetate 257f was formed using one equivalent o f methyl 2-chloropropionate 
and the electrophilic quench at -50 °C. Diarylacetates 257g and 257h were formed using two 
equivalents o f methyl 2-chloropropionate and the electrophilic quench carried out at 0 °C. The 
products were characterized in foil (see experimental section).
The next nucleophile investigated was methyl 2-chlorobutanoate (259) to give us access to 
butanoates as well as propionates. This was prepared by esterification of chlorobutyric acid 
(258) (Scheme 132).190
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Methyl 2-chlorobutanoate was used in the VNS-SnAt process with a series of electrophiles 
(Scheme 133). The process was used to make 257i, 257j and 257k. The products were 
obtained in good yields (Scheme 133). Diarylacetate 257i was formed using one equivalent of 
methyl 2-chlorobutanoate and the electrophilic quench at 0 °C. 257j and 257k were formed 
using two equivalents o f methyl 2-chlorobutanoate under the same conditions. The products 
were characterized in full (see Experimental section).
Scheme 133
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The results clearly indicate that the process is general and efficient. The efficiency of the SnAt 
process is high, as the yields are close to that expected for protonation of the post-VNS anion.39 
The use o f activated arenes allows the SnAt reaction to proceed conveniently at ambient 
temperature, avoiding the need for heating. Heating can be problematic for sodium hydride in 
DMF when the reaction is performed on a large scale. 191 To overcome the problems associated 
with the NaH/DMF base/solvent system, we next showed the process has potential for scale up 
using potassium /erf-butoxide as the base (Scheme 134).
Scheme 134
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257b, R1 = N 0 2  ,R2  = N 0 2  57%
257d, R1 = N 0 2  ,R2  = CF3  69%
Diarylacetate 257b was formed in 57% yield using potassium /ert-butoxide as the base with 
one equivalent o f ethyl 2-chloropropionate. The reaction was cooled to -50 °C and allowed to 
warm to -20 °C before cooling back to -50 °C for the electrophilic quench. It was important to
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use a maximum of two equivalents of potassium ter/-butoxide and a slight excess o f the
electrophile, as indicated by LC-MS (Scheme 135). Diarylacetate 257d was formed in 69% 
yield using the same conditions as described earlier.
Scheme 135
The process is not limited to the use of fluoronitroarenes. 2,4-Dinitrochlorobenzene was used 
in place of 2,4-dinitrofluorobenzene to give 257b in 69% yield (Scheme 136). This reaction 
was carried out with one equivalent of ethyl 2-chloropropionate and cooling to -50 °C. 
Similarly the VNS-SnAt reaction with 4-chloro-3-nitrobenzonitrile as the electrophile gave the 
required product 2571 in 72% yield using one equivalent of ethyl 2-chloropropionate and 
cooling to -50 °C. The doublets at 5 8.15 and 7.58 (J 9.0 Hz) in the *H-NMR spectrum 
indicate the presence of a 1,4-disubstituted aryl group. The doublets at 8 8.17 (J 1.8 Hz) and 
6.97 (J 8.7 Hz) along with a double doublet at 6  7.66 (J  1.8 & 8.7 Hz) represent the three 
protons on the second aryl group. The methyl group appears as a singlet at 2.16 indicating the 
presence of a quaternary centre.
Scheme 136
The less activated 4-fluoronitrobenzene proved sufficiently reactive to enter the VNS-SnAt 
process to give 257m in 74% yield (Scheme 136). This was performed using two equivalents 
of ethyl 2-chloropropionate and cooling to 0 °C for the electrophilic quench. The two aryl 
groups were identical so the presence of doublets at 6  8.10 and 7.33 (J 8.9 Hz) in the !H-NMR 
spectrum when compared to the integration of the methyl group indicates the presence o f two
electrophile as a side reaction also took place with the /er/-butoxide anion reacting with the
F O
255
260
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1,4-disubstituted aryl groups. The methyl group appears as a singlet at 5 1.93 indicating that 
the electrophilic quench had been successful
Scheme 137
The use o f 2-fluoronitrobenzene as the electrophile did not result in the required product. 
Instead the post VNS anion underwent a coupling reaction with another post VNS anion to
fluoronitrobenzene (263) must be acting as an oxidising agent. The doublets at 8 8.01 7.92,
7.02 and 6.99 (J  8 .8  Hz) in the ]H-NMR spectrum indicated the presence of two 1,4- 
disubstituted aryl groups. The multiplet (5 4.02-4.21) and two triplets at 1.15 and 1.17 (J 1A 
Hz) represent the two ethyl groups. Singlets at 8 1.88 and 1.60 represent the other two methyl 
groups. As far as we can tell this is a novel process.
Scheme 138
Branched esters behaved well in the reaction although the reaction only proceeded with 
potassium te/7-butoxide as base and not sodium hydride. The isopropyl ester 266 was prepared 
by esterification o f 2-chloropropionic acid in 69% yield (Scheme 139).
1. NaH, DMF
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give the dimer 264 as a 1:1 mixture o f diastereoisomers presumably by a radical pathway
107(Scheme 138). This process has been observed by previous work in the group. The 2-
NaH/DMF
264263
262
77
Scheme 139
ipa/h2s o 4
Cl __________ Cl
' ^ C 0 2i-Pr 
267 6 9 %
reflux, 3 h
The isopropyl ester was used in the VNS process with nitrobenzene and 4-fluoro-3- 
nitrobenzotrifluoride as the electrophile (Scheme 140). Using sodium hydride as the base 
produced no VNS product with nitrobenzene being recovered. Using potassium ter/-butoxide 
as the base and keeping the temperature o f the reaction mixture between -50 °C and -20 °C 
gave the VNS product 268 in 64% yield.
Scheme 140
overlaps with one of the signals from the second aryl group to give a multiplet (5 8.13-8.16). 
The other doublet of the 1,4-disubstituted aryl group appears at 8 7.60 (J  9.0 Hz). A double 
doublet at 8  7.64 (J 1.7 and 8.5 Hz) and a doublet at 7.00 (J 8.5 Hz) represent the other two 
protons on the second aryl group. The methyl group appears as a singlet at 8 2.16 indicating 
the presence of a quaternary centre.
The ter/-butyl ester 270 was obtained in 52% yield by treatment of 2-chloropropionyl chloride 
(269) with ter/-butanol and triethylamine (Scheme 141).193 The tert-butyl ester 270 was used 
in the VNS-SnAt process (Scheme 142) with potassium ter/-butoxide as the base and using 
conditions identical to those used with the isopropyl ester nucleophile. The required VNS 
product was formed but we had trouble removing excess 2,4-dinitrofluorobenzene from the 
product.
Scheme 141
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Scheme 142
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To remove this excess 2,4-dimtrofluorobenzene, we considered the use o f a scavenger. We 
thought that a polymer-supported amine would be successful. As a test, we added benzylamine 
(1 eq.) to a solution of 2,4-dinitrofluorobenzene in ethyl acetate (Scheme 143) and left the 
solution to stir overnight. The reaction produced the required product 273 as the HF salt o f the 
amine in quantitative yield.
Scheme 143
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As this test was successful, the contaminated VNS product 271 was dissolved in a small 
amount o f ethyl acetate and added to a small filter syringe containing poly(styrene-co 
divinylbenzene)amino methylated polymer (0.75 g) (2.0-3.5 mmol/g) and the mixture were 
shaken for 24 hours (Scheme 144). The solution was filtered and the solvent removed on a 
rotary evaporator to leave the pure product 271 in 61% yield.
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To further expand the scope of this reaction we attempted to use activated pyridines and 
pyrimidines in the V N S-S nA t process (Scheme 145). Pyridines and pyrimidines are important 
heterocyclic compounds. Several examples of these class o f compounds are well known as 
important biologically active compounds for example 2 -(benzylamino)pyrimidine is a 
antihistaminic agent. 194 2-Chloro-3-nitropyridine (272) and 2-chloropyrimidine (274) were
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chosen as they were commercially available and known to undergo the SnAt process. For
These examples were chosen to extend the methodology so that heterocyclic rings could be 
utilized, which are important in many drugs. There were also literature examples of these
with the post VNS anion was observed as expected, but the electrophilic quench with both 
electrophiles did not occur at room temperature. Careful heating of the reaction mixture to 50 
°C also resulted in no success. In both cases the protonated post-VNS anion (ethyl 4- 
nitrophenylpropionate) was recovered.
Scheme 145
To provide some examples o f the ortho selectivity of the V N S-S nA t process, chloromethyl 
phenyl sulfone was chosen as the VNS nucleophiles, and / 7-chloronitrobenzene as the substrate 
(Scheme 146 and Table 9).
Scheme 146
example 2 -chloropyrimidine readily reacts with thiophenolates, phenolates and anilines. 195
electrophiles undergoing C-arylation with enolates. 196-8 The bright purple colour associated
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Table 9. Yields of Product Sulfones
R1 R3 Yield (%)
276a Cl n o 2 c f 3 75
276b Cl n o 2 n o 2 74
276c Cl CN n o 2 74
276d Cl c f 3 n o 2 75
276e CF3 n o 2 c f 3 79
276f c f 3 NCh n o 2 81
276g c f 3 CN NOz 78
276h c f 3 c f 3 N0 2 78
Sulfone 276a was obtained in 75% yield by adding a mixture of chloromethyl phenyl sulfone 
(1 eq.) and /7-chloronitrobenzene in DMF to a suspension of sodium hydride in DMF at 0 °C. 
This produced a bright purple solution which was allowed to warm to room temperature, 
stirred for 30 minutes and then cooled back to 0 #C for the electrophilic quench with 4-fluoro-
3-nitrobenzotrifluoride. The doublets at 6  8.53 (J  8.3 Hz), 8.23 (J 1.3 Hz) and double doublet 
at 5 8.02 (J 1.3 and 8.3 Hz) in the *H-NMR spectrum indicate the presence of a trisubstituted 
aryl group. The doublets at 8.30 (J  2.2 Hz), 7.93 (J 8.8  Hz) and double doublet at 7.55 (J  2.2 
& 8 . 8 Hz) indicate the presence of a second trisubstituted aryl group. The mono substituted 
aryl group was represented by a doublet at 5 7.69 (J 7.6 Hz) and triplets at 6  7.64 (J  7.6 Hz) 
and 7.48 (J  7.6 Hz). The benzylic proton appears as a singlet at 8 7.40.
The same process was then applied to a range of electrophiles and nitroarenes, to produce 
276b-h in good yield (see Table 2). The nitroarenes p-chloronitrobenzene and p- 
trifluoromethylnitrobenzene were chosen as the VNS substrates as they were both 
commercially available and it is known that they undergo the VNS process exclusively at the 
ortho position with no competitive SnAt observed. The products were characterized in full 
(see Experimental section).
6.3 Formation of Oxindoles
The oxindole moiety is a common motif in many alkaloids and is also found in a number of
IOO TAAmarketed drugs (Figure 12). " Ziprasidone (277) is a serotonin and dopamine antagonist, 
and effective as an antipsychotic drug. Many currently available antipsychotropic drugs have 
the side effect o f inducing significant weight gain, which is distressing and stigmatising to
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patients and increases the risk of cardiovascular complications,211 but ziprasidone avoids this 
side effect.
F igure 12
» Ziprasidone™ (277) Ropinirole™ (278)
Parkinson’s disease causes the brain to lose dopamine, which results in stillness and rigidity of 
the muscles, slowness in movement and the tremor of the arms and legs. Levodopa, the main 
treatment for the disease, is metabolised to the brain as dopamine. The brain’s ability to 
metabolise and store levodopa diminishes alter time and it becomes more dependant on the 
external supply of levodopa. Eventually most patients experience fluctuations when the 
medication is working and when it is not working in the body.
Ropinirole (278) is a direct dopamine receptor agonist that works by minimising the actions of 
dopamine in the brain and thereby reducing the symptoms of Parkinson’s disease.
Because of the very potent and diverse biological activity exhibited by various oxindole 
derivatives, this heterocyclic system has attracted considerable attention in chemistry, biology 
and medicine.
Previous methods for the synthesis of the oxindole motif include Lewis acid mediated 
cyclization of a-haloacetanilides, cyclization of (o-aminophenyl)acetic acid derivatives and the 
Gassman procedure (Scheme 147). In the Gassman procedure, 3-methylthio-2-oxindoles are 
produced. The methodology of choice is dependent on the nature of the aromatic ring. When 
electron withdrawing groups are present, the oxindole can be synthesized by treatment of the 
aniline with a methylthioacetate ester to furnish an azasulfonium salt (Scheme 147, Method A). 
Electron-donating groups destabilize the intermediate 281, and thus give diminished yields of 
the oxindole 282. A second method of generation of this salt by reaction of the 
chlorosulfonium salt 280 with an appropriate aniline (Scheme 147, Method B) gives better 
yields o f the 3-methylthio-2-oxindoles 282.
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Buchwald reported a novel variant of the Friedel-Crafts procedure using palladium catalysed 
C-H functionalisation, avoiding the need for harsh reaction conditions (Scheme 148).202 The 
combination of catalytic amounts of palladium acetate, 2 -(di-ter/-butylphosphino)biphenyl 
(284) as a ligand, triethylamine as base and a-chloroacetanilides (283) can be smoothly 
converted to oxindoles in good yields with high levels of regioselectivity. The process is most 
likely initiated by oxidative addition of the a-chloroamide to Pd(0), resulting in a Pd(II) 
enolate. The formation of the carbon-carbon bond may proceed by an electrophilic aromatic 
substitution to give a six-membered palladacycle, which undergoes reductive elimination to 
afford the product oxindole 285 and regenerate the Pd(0) species.
Scheme 148
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One of the most attractive and general methods for the synthesis of oxindoles is the reductive 
cyclization of a-nitroaryl carbonyl compounds (Scheme 149). Reduction of the nitroarene 286 
to aniline 287 furnishes a nucleophilic nitrogen atom. This can then attack the electrophilic 
ester to promote cyclization to the oxindole 288.
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Scheme 149
286 287 288
This reaction has been one of the oldest methods for the synthesis of oxindoles even though the 
availability o f the starting materials has been limited. Rajanbabu reported a synthesis o f 
oxindoles based on an oxidative nucleophilic substitution o f hydrogen (ONSH) reaction 
followed by reductive cyclization (Scheme 150). Addition o f the silyl ketene acetal 289 to 
the nitro-aromatic in the presence of tris(dimethylamino)sulfonium difluorotrimethylsiliconate 
(TASF) followed by oxidation of the resulting oH-adduct gave an a-nitroarylester 290. 
Cyclization to the oxindole 291 occurred after hydrogenation of the nitro group o f290.
Scheme 150
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The diarylacetates 257a-m synthesized by our VNS-SnAt process with an ortho-nitro group 
provided the opportunity for formation o f 3,3-substituted oxindoles by reduction of the nitro 
group. This was achieved by hydrogenation (Method A)204 or Sn(II)-mediated reduction205 
(Scheme 151).
Scheme 151
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257a & 2571
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292b Method A 77% 
Method B 76% 
292c Method A 69% 
Method B 79%
292b R = CF3  
292c R = CN
Oxindole 292a was formed (method A) by adding 5% Pd/C to a solution of 257b dissolved in 
an ethyl acetate/acetic acid mixture in a multi-Parr reaction vessel. While stirring, the mixture 
was purged with nitrogen and then hydrogen. The reaction mixture was then left stirrii^ under 
a hydrogen atmosphere (50 psi) for 16 hours. The product was then filtered through a celite 
plug and the solvent removed on a rotary evaporator to leave the crude product. The crude 
product was then washed with chloroform to leave the pure product in 54% yield. The 
doublets at 8  7.05 and 6.70 (J 8 .6  Hz) in the !H-NMR spectrum indicate the presence of a 1,4- 
disubstituted aryl group. The doublets at 5 6.87 («/ 8.0 Hz) and 6.56 (J  2.0 Hz) along with a 
double doublet at 8 6.46 (J  2.0 and 8.0 Hz) indicate the presence of a trisubstituted aryl group. 
The methyl group appears as a singlet at 8  1.6 6 .
As an alternative method (method B), the ester was dissolved in an ethanol:ethyl acetate 4:1 
mixture. Tin(II) chloride dihydrate and a few drops o f hydrochloric acid were added and the 
mixture was heated under reflux for 36 hours. Following an aqueous work up the solvent was 
removed on a rotary evaporator to leave the crude product. Washing the crude product with 
chloroform left the pure product 292a in 71% yield.
Both methods were applied to 257a and 2571 to give the products 292b and 292c. Both 
methods led to the A-hydroxyoxindole being exclusively formed. This was formed because 
cyclisation of the hydroxylamine was faster than reduction to form the aniline. We found that 
under the hydrogenation conditions the acid was crucial to forming exclusively the N- 
hydroxyoxindole. Without the acid, a mixture of the oxindole and the A-hydroxyoxindole 
occurred.
Other nitro groups present in the molecules were also reduced under these conditions providing 
additional points for further functionalization and incorporation of extra diversity. The ester 
257b cleanly gives the oxindole 292a by both methods of reduction of the nitro group. 
However, reduction of both 257a and 2571 gave the 1-hydroxy-oxindoles 292b and 292c. It 
seems that the presence o f the electron-withdrawing group impedes reduction of the 
intermediate hydroxylamine such that cyclization to form the hydroxyoxindole occurs fester.
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The formation of the oxindoles involves first reduction of the less hindered nitro group at 
position 4. Sodium disulfite179 has been used to reduce similar nitro esters to oxindoles. 
However when applied to diarylacetates 257a & 1 the starting materials remained untouched.
Summary and Conclusion
In conclusion we have therefore shown that intriguing one-pot VNSat- S nAt combination of 
two types of nucleophilic substitution reaction can be integrated to provide an excellent 
synthesis of diarylacetate derivatives. The process has been shown to tolerate activated fluoro 
electrophiles bearing electron withdrawing groups such as cyano, nitro and trifluoromethyl. 
Chloro electrophiles have also been shown to undergo the SnAt process with the post VNS 
anion. The use of 2 -fluoronitrobenzene however the post VNS anion underwent a homo 
coupling reaction to give a dimmer (264) as a 1:1 mixture of diastereoisomers presumably by a 
radical pathway. The 2-fluoronitrobenzene must be acting as an oxidizing agent.
Unfortunately our attempts to use activated pyridines and pyrimidines met with no success 
with just the VNS product being formed, the post VNS anion did not undergo the SnAt 
process.
Due to the problems associated with the sodium hydride/DMF base solvent system a potassium 
terf-butoxide/DMF base solvent system was shown to be acceptable so the process could be 
conveniently carried out on a large scale. Due to a side with the ter/-butoxide anion reacting 
with the electrophile an excess of the electrophile is required. In the case of 271 the excess 
electrophile could not be separated from the product. We therefore developed a process to 
scavenge for the excess electrophile using poly(styrene-co-divinylbenzene)amino methylated 
polymer.
The VNS/SnAt process was shown to proceed with chloromethyl phenyl sulfone as the VNS 
nucleophile, para-substituted nitroarenes and aryl electrophiles. This provided examples of the 
ortho selectivity of the VNS-SnAt process.
The diarylacetates 257a-m provide convenient access to the oxindole motif by reductive 
cyclization of the nitrogroup. Reduction of the nitro group proceeded of hydrogen (50 psi) 
over a palladium on carbon catalyst and also using a tin(II)chloride dihydrate and acid. 
Cyclisation then occurred to produce the required oxindole or the V-hydroxy oxindole. The 
latter being formed because cyclisation of the V-hydroxylamine occurred faster than reduction 
of the V-hydroxylamine to the aniline. The only product to go to the required oxindole was 
257b which had a second nitro group present on the second aromatic ring. This would 
presumably be reduced before the nitro group undergoing the cyclisation due to it being 
unhindered. As cyclisation the nitro group would be present as the aniline, so therefore an
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electron donating group. It seemed that the ring with electron withdrawing groups give the N- 
hydroxyoxindole while those with an electron donating group give the required oxindole.
Future work would be to adapt the conditions of the reductive cyclization so that we could get 
through to the oxindole without the need to reduce the hydroxyoxindole. Possible options 
include changing the hydrogenation catalyst or finding an additional method for reduction of 
nitro groups.
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Chapter 7
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7.1 Cross-coupling of Nitrophenylacetates
The VNS-SnAt process covered in Chapter 6  provided a convenient one step process for the 
formation of diaryl acetates and sulfones. The process is limited to the use of an electron- 
deficient arene as the electrophile. The least electron-deficient electrophile which was 
successfully used was p-fluoronitrobenzene, which only has one electron-withdrawing group in 
addition to the leaving group. Electron-rich electrophiles can not be used in this process.
We considered the possibility that the VNS process could be extended to a VNS cross-coupling 
process (Scheme 152). This would give the opportunity to add electron-rich aromatic rings to 
the post-VNS anion.
Scheme 152
1. Base
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There are very few examples of nitro compounds in transition metal-catalysed cross-coupling 
reactions. The area o f cross-coupling in organic synthesis has been reviewed by Prim206, 
Miura207-8 and Hartwig.209 One of the few examples was carried out by Miura210 who reported 
that p-nitrotoluene could effectively react with aryl bromides at its benzylic position in the 
presence of catalytic amounts of Pd(OAc)2 and PPI13 with cesium carbonate as a base to give 
the corresponding mono and/or di-aiylated products 293 and 294 (Scheme 153).
Scheme 153
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Palladium-catalysed coupling o f esters and derivatives was first carried out in the groups of 
Buchwald162 and Hartwig.79 The synthesis o f a-aryl esters and their derivatives is extremely 
important in the synthesis o f useful pharmaceutical products. The a-aryl carboxylic acid 
structure is of particular interest as it forms part of the structure of several marketed drugs such 
as Ibuprofen, Naproxen and Ketoprofen (Figure 13). These compounds have anti­
inflammatory and analgesic properties.
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Figure 13
Ibuprofen Naproxen Ketoprofen
The palladium-catalysed a-arylation of ketones was reported in 1997 by the groups of 
Buchwald,75 Hartwig79 and Miura.211 Buchwald subsequently reported a significant 
improvement on the initial system based on the use of electron rich, bulky o-biphenyl
phosphines 114, 296 and 297 (Figure 14). 
Figure 14
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This catalyst system demonstrated a good functional group tolerance and a high selectivity for 
ketones with two enolizable positions where the less substituted position is aiylated. Buchwald 
also reported an asymmetric version of the ketone arylation system using a Pd/(5)-BINAP
catalyst (298—*299) (Scheme 154) 
Scheme 154
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Pd(0)/(S)-BINAP (10-20 mo!%)
NaOf-Bu/PhMe, 100 °C R
299 6 6 % (73% ee) when
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Buchwald took the conditions for the ketone arylation to explore the palladium-catalysed 
arylation of esters. The initial attempts using l-bromo-4-terf-butylbenzene with ter/-butyl 
acetate using NaHMDS and a catalyst derived from 295 and Pd(OAc)2 gave a mixture o f mono 
and di-arylated products 300 and 301 along with significant amounts of the Claisen product 
302 (Scheme 155). No nitro-containing substrates were included in this protocol.
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To search for better conditions, a number o f reaction variables were tried including 
temperature, base and ligands. It was found that with a combination of 114 as the ligand, 
LiHMDS as base and toluene as the solvent it was possible to carry out the reaction at room 
temperature which suppressed the formation of the diarylated product (Scheme 156). The 
limitation with this method is the necessity to use 2.3 equivalents of ester and 2.5 equivalents 
o f base to affect complete conversion of the aryl bromide.
Scheme 156
Br Vo
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.212Hartwig also reported a procedure for the palladium-catalysed a-arylation of esters usmg 
palladium catalysts ligated by P(/-Bu)3 or the hindered carbene precursor SiPr (304) (Figure 
15) in the presence of 2 equivalents o f LiHMDS or NaHMDS. Reactions of terf-butyl acetate 
or ter/-butyl propionate with a range of aryl bromides proceeded at room temperature with fast 
rates and high selectivity for mo no arylation. No nitro groups were included in this protocol 
however.
Figure 15
Pr
BF. SiPr (304)
Use of the stronger hindered amide base LiNCy2 and generation of the enolate prior to the 
addition of the palladium catalyst and aryl halide provided even more efficient couplings of 
terf-butyl acetate and a,a-disubstituted esters (Scheme 157).213 Lower catalyst loadings and 
only a slight excess of ester and base were required.
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Hartwig also reported two procedures for the a-arylation of esters and amides under more 
neutral conditions. The first procedure involved the use o f zinc enolates and rests upon the 
development of catalysts bearing the hindered pentaphenyl ferrocenyldi-ter/-butylphosphine 
(Qphos) (308) or the highly reactive dimeric Pd(I) complex [P(f-Bu)3(PdBr)2]. No nitro groups 
were included in this protocol.
The catalysts above also catalysed the coupling of Reformatsky reagents prepared from 
activated zinc and a-bromo esters with a variety of base sensitive substrates (Scheme 158). 
or/Zzo-nitrobromo benzene and pora-nitrobromobenzene were successfully used as electrophiles 
in this process.
Scheme 158
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Hartwig also reported the palladium-catalysed arylation of trimethylsilyl enolates of esters (or 
silyl ketene acetals) with zinc fluoride as a co-catalyst (Scheme 159). This protocol 
incorporated nitro groups in the electrophile. p-Bromonitrobenzene and p-chloronitrobenzene 
were successfully cross-coupled with esters using this procedure.214
Scheme 159
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It was therefore clear that a general method for the cross-coupling of haloarenes and 
arylacetates possessing nitro substituents would be valuable. Modification of such a process to 
allow the direct cross-coupling of a nitroarylacetate anion derived from a VNS reaction would
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be a second aim. To find suitable conditions for a VNS cross-coupling process, we first 
attempted to cross-couple the preformed VNS product 311 with bromobenzene (Scheme 160) 
under the same conditions as used by Miura in the cross-coupling of 4-nitrotoluene with 
bromobenzene which were heating at 140 °C for 1 hour in DMF.210 The preformed VNS 
substrate 311 was formed from commercially available p-nitrophenylacetic acid (166) by 
heating under reflux in ethanol with 3 drops of H2SO4. The cross-coupling reaction however 
was unsuccessful, with the starting materials being recovered and no trace of 312. An attempt 
to repeat the same reaction carried out by Miura’s group to validate the procedure also proved 
unsuccessful with the starting materials being recovered and a tiny trace of product observed 
byLC-MS.
Scheme 160
CS2CO3
Pd(OAc)2 (5 mol%)
EtOH
HoSO,
O 312 not isolated
As an alternative approach cesium carbonate (dried) was added to a two necked round bottom 
flask fitted with a condenser and nitrogen bubbler. This approach was adapted from a method 
used by Buchwald who cross-coupled ethyl phenyl acetate with aryl bromides.162 Anhydrous
1,4-dioxane was added to the cesium carbonate. A solution of ethyl 4-nitrophenylacetate in 
dioxane was then added followed by bromobenzene, palladium acetate and tri(/- 
butyl)phosphine. The mixture was then heated at 100 °C for 24 hours. After cooling to room 
temperature ethyl acetate was added to the reaction mixture which was then filtered through a 
silica gel plug. Removal of the solvent on a rotary evaporator gave the crude product which 
was purified by column chromatography to leave the pure product in 46% yield (Scheme 161). 
The benzylic proton appears as a singlet at 8 5.10 compared to 3.73 in the starting material. 
The mono substituted aryl group is represented by a multiplet (8 7.28-7.37). Using an Electron 
Ionisation mass-spectrometry technique a molecular ion was found at 285.1014 which 
corresponds to the calculated molecular ion at 285.1001 indicating that the required product 
had been formed.
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Scheme 161
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Using potassium phosphate as the base under identical conditions resulted in a slight 
improvement with the required product being formed in 56% yield. In order to make the 
process more efficient a different ligand was tried. This was the sterically hindered biphenyl 
295 (Figure 14) which was used in the Buchwald group in the cross coupling of the enolates of
1 ft)esters with aryl halides. This was first attempted using the previous conditions (Scheme
162) to produce the required product 312 in 71% yield.
Scheme 162
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It was important, if we were to establish methodology for the one-pot VNS cross-coupling 
reaction, that this process could be performed with typical bases that are used in the VNS 
reaction such as sodium hydride and potassium ter/-butoxide. The experiments we carried out 
with this aim provided very encouraging results. The yields were better than anything 
encountered previously when potassium terf-butoxide was employed as the base. (Scheme
163).
Scheme 163
Base
Pd(OAc) 2  (5 mol%)
 ►
Buchwald ligand 114 (10 mol%) 
PhBr, Dioxane, 100 °C
Base Yield
Sodium hydride 59%
Potassium terf-butoxide 90%
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As we had found good conditions for the cross coupling of the nitrophenylacetate, we then 
needed to find out if these conditions could be transferred to the cross coupling of nitrophenyl 
propionates. The parent ester 311 cannot be prepared exclusively in a VNS reaction. The use 
of a secondary carbanion would result in a mixture of ortho and para phenylacetates. 
Different conditions were tried to cross-couple the nitrophenylpropionate 313 with aryl halides 
as summarised (Scheme 164), but all without success. The starting materials were recovered 
after the reaction every time.
Scheme 164
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Since the nitrophenylpropionates could not be cross-coupled with aryl halides, an attempt to 
cross-couple the preformed ortho-VNS product 315 with aryl halides was made (Scheme 165).
Scheme 165
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The reaction failed with the starting materials being recovered. The reaction was repeated 
changing the solvent to 1,4-dioxane, DMF and acetonitrile, all resulting in no success. The 
reaction time was increased to 48 hours and the reaction temperature increased to the boiling 
point of the individual solvents. After continuous heating the starting materials decomposed 
when using THF and 1,4-dioxane as the solvent. The crown ether 18-crown-6 was tried in the 
reaction due to a literature precedent in which it was used in the alkylation with methyl iodide, 
but this also resulted in no success.217 Different bases were also tried: potassium carbonate, 
potassium phosphate, sodium ter/-butoxide, sodium hydride and cesium carbonate but all with 
no success. Iodobenzene was tried instead of bromobenzene also with the same result. A 
transmetallation with ZnCfe was also tried with no success.
Despite the lack of success in the cross-coupling of the preformed VNS substrate 313, the one- 
pot VNS cross-coupling reaction was attempted. Using a KO/-Bu/THF base/solvent system 
we expected the VNS process to proceed exclusively at the ortho position due to tight ion pairs
being formed.31 This reaction was carried out and the required product 318 isolated in 47% 
yield.
Scheme 166
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The one-pot VNS cross-coupling process was then attempted but without success with the 
VNS product 323 being isolated in 43% yield and no sign of the required product 321. 
Nitrobenzene and bromobenzene were also present in the crude reaction mixture.
Scheme 167
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The process was repeated but using chloromethyl phenyl sulfone (322) as the VNS nucleophile 
(Scheme 168). This reaction also resulted in no success. The ’H-NMR showed the VNS 
product, bromobenzene and nitrobenzene. A very small amount of the VNS cross coupling 
product 323 was observed by LC-MS. Different bases and solvents were also used in this 
reaction, however none gave a positive result.
Scheme 168
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In the VNS reaction the base is normally present in a slight excess. To determine whether this 
excess o f the base would be a problem in the cross-coupling part of the reaction a cross­
coupling reaction of ethyl 4-nitrophenylacetate with bromobenzene was carried out using 1.5 
equivalents o f potassium /er/-butoxide (Scheme 169).
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When the same reaction was carried out with 1 equivalent of base the product 312 was 
obtained in 90% yield. Using 1.5 equivalents o f potassium terf-butoxide however resulted in 
the yield for the reaction dropping to 38%. This was a problem for any possible one-pot VNS 
cross-coupling process as at least 2 equivalents of base are required for the VNS reaction but 
the reaction never runs to completion so there would always be excess potassium terf-butoxide 
around to lower the yield for the cross-coupling part of the process.
Different aryl electrophiles were also used in the cross-coupling with nitrophenylacetates under 
identical conditions (Scheme 170).
Scheme 170
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324a DMF H OMe 59%
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Changing the solvent to DMF improved the yield of324a to 59%. Doublets at 5 8.16 and 7.48 
{J 8.8 Hz) in the *H-NMR spectrum indicated the presence of a 1,4-disubstituted aiyl group. 
Accurate mass data for 324a was also consistent with the assigned structure.
The next electrophile attempted was 3-bromobenzotrifluoride, as it was much more electron 
deficient. This produced the required product 324b, which was shown by a doublet at 5 8.21 (,J 
8.8 Hz) and multiplets (5 7.57-7.60 & 7.48-7.51) representing the required number of aromatic 
protons. The benzylic proton appears as a singlet at 5 5.15. Accurate mass spectrometry was 
consistent with the assigned structure.
A further example 324c was found with the use of 3 -bromobenzonitrile. The ^-N M R 
spectrum was consistent with what was expected, as was the accurate mass data.
Using l-iodo-2-nitrobenzene as the electrophile, the reaction did not proceed with the 
nitrophenylacetate and nitrobenzene being recovered. Presumably, the catalyst undergoes 
oxidative insertion into the C-I bond but cannot react with the enolate so the electrophile is
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reduced to nitrobenzene. Using l-bromo-2-nitrobenzene as the electrophile also resulted in no 
success this time with both starting materials being recovered although a trace amount of the 
desired product was observed by LC-MS.
Scheme 171
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The effect of bromo electrophiles was then compared with the chloro and iodo equivalents 
under identical conditions (Scheme 171). As can be seen, bromobenzene was the most 
efficient with the iodo equivalent being only slightly less efficient. Even chlorobenzene gave 
the required product in good yield.
We attempted to cross-couple the me/a-nitrophenylacetate 326 with an aryl halide, even though 
these products could not be formed by a VNS reaction. The me/a-nitrophenylacetate 326 was 
formed by esterification of the commercially available acid 325. The cross-coupling of the 
nitrophenylacetate 326 with bromobenzene proceeded in 69% yield (Scheme 172) to give the 
desired product 327.
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Doublets at 8 8.12 and 7.48 {J 8.3 Hz) along with a triplet at 8 7.67 (J 8.3 Hz) and a singlet at 8 
8.21 in the ]H-NMR spectrum indicate the presence of a 1.3-disubstituted aryl group. The 
mono substituted aryl group is represented by a multiplet (8 7.28-7.36). The benzylic proton 
occurs as a singlet at 8 5.11. Using an electron spray mass-spec technique a (M + H)+ peak 
was found at 303.1342 which corresponded to the calculated (M + H)+ peak of 303.1339 
indicating the correct product had been obtained.
We thought that since the cross-coupling of ortho substituted nitrophenylacetates with aryl 
halides did not proceed (Scheme 165), an intramolecular process might be more favourable.
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This is based on Hartwig’s report of an intramolecular method for the formation of N-
1T2substituted oxindoles (Scheme 173).
Scheme 173
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The substrate 332 was formed by addition of 2-nitrophenylacetic acid (330), dichloromethane, 
carbonyldiimidazole (CDI) and 2-chloro-iV-methylaniline (331) to a two neck round bottom 
flask fitted with a condenser and nitrogen bubbler. The mixture was heated under reflux to 
give the required product in 49% yield after column chromatography (Scheme 174). Doublets 
at 8 8.07 (J  8.1 Hz) assigned to the proton adjacent to the nitro group and 7.29 (J  8.4 Hz) along 
with multiplets (8 7.53-7.57 and 7.38-7.42) in the ^-N M R  spectrum indicate the presence of 
two disubstituted aiyl groups. Doublets at 8 3.97 and 3.45 (J  16.6 Hz) show the presence of 
the two benzylic protons, while the methyl group appears as a singlet at 8 3.25.
Scheme 174
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The substrate 332 was added to a solution of potassium /er/-butoxide in 1,4-dioxane followed 
by palladium acetate and tricyclohexylphosphine (Scheme 175). The reaction mixture was 
then heated at 100 °C for 2 hours. After cooling to room temperature, the reaction mixture was 
filtered through a silica gel plug to remove the palladium and then purified by column 
chromatography to give the required oxindole 333 in 67% yield. Doublets at 8 8.09 (J 8.3 Hz) 
assigned to the proton adjacent to the nitro group and 7.27 (J  8.3 Hz) along with multiplets (8 
7.52-7.57 and 7.40-7.45) indicate the presence of the two disubstituted aryl groups. A singlet 
at 8 5.19 represents the benzylic proton and the methyl group is observed as a singlet at 8 3.22.
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Summary and Conclusion
To conclude, a method for the cross coupling o f nitrophenylacetates with aryl halides has been 
developed. This is potentially very useful due to the lack o f palladium cross-coupling reactions 
for compounds containing a nitro group. Aryl electrophiles with electron withdrawing groups
the process to nitrophenylpropionates met with no success with the starting materials being 
recovered. Presumably this failed due to the propionates being more sterically hindered than 
the acetated.
Unfortunately the reaction only proceeded with para and /weta-nitrophenylacetates, and the 
method for the cross-coupling of orf/zo-nitrophenylacetates remains elusive. Different reaction 
conditions were tried to get the cross-coupling of ortho nitrophenylacetates to proceed such as 
different solvents, ligands and bases but all with no success. Presumably the problem is due to 
a steric clash with the nitro group but could also be due to the electronic nature of the 
nitrogroup. This is unfortunate as this process would provide convenient access to the 
oxindole structural motif.
An intramolecular cross-coupling process to form V-methyloxindoles was successfully carried 
out. The intramolecular process is more thermodynamically favourable than the intermolecular 
equivalent but due to the success with the intramolecular process we were hopeful that 
conditions could be found to get the intermolecular process to proceed.
The one-pot VNS cross-coupling process however proved more difficult, and remains a
challenge. The problems we encountered were the lack of success with the
nitrophenylpropionates in the cross-coupling process. If we used a secondary carbanion to 
generate the equivalent post VNS anion a mixture of ortho and para-substituted VNS products 
would be formed. We therefore needed a tertiary carbanion to get exclusively the para-
substituted product. The post VNS anion would then be too hindered to undergo the cross­
coupling process.
With an excess of potassium ter/-butoxide present in the reaction mixture, this produced lower 
yields, presumably because the terr-butoxide anion is adding to the catalyst by oxidative 
addition. This was a problem as an excess of base is always present in the VNS reaction due to
and electron donating groups have been shown to proceed in the reaction. Attempts to extend
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the reaction never going to completion. Suitable conditions would have to be found to 
minimize this excess.
Even if we used a para-substituted nitroaromatic and secondary carbanion to generate the 
ortho VNS product exclusively we had no success in getting the preformed product to undergo 
the cross-coupling process.
We conclude that it is going to be very difficult to get the one-pot VNS/cross-coupling process 
to work. The excess of base in the VNS reactions is a serious problem. Possible future work 
would be to find conditions to cross-couple the orf/jo-nitrophenylacetates with aryl halides and 
possibly get the one-pot VNS cross-coupling reaction to proceed. This could perhaps be 
achieved by a different catalyst/ligand system or maybe a base/solvent system we have not 
tested. A DoE (Design of Experiments) test could perhaps provide the answer in which 
different catalysts, ligands and bases are screened against each other to attempt to find the ideal 
conditions.
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Chapter 8
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8.1 Experimental
General Considerations: Anhydrous TV,TV-dimethy lformamide was purchased from Aldrich in 
a Sure/Seal™ bottle. All other reagents were purchased from commercial suppliers except 
those described below and used without further purification.
Thin layer chromatography was performed using Merck silica gel 60 F254 plates. Column 
chromatography was performed using silica gel 60 (220-440 mesh). Melting points were 
obtained using an Electrothermal digital melting point apparatus model 9100. IR spectra was 
obtained for all previously unreported compounds using a Perkin Elmer 1600 series FTIR 
instrument. Elemental analyses were performed by the Analytical Department of the School of 
Chemistry; ]H NMR and 13C NMR spectra were obtained on a Bruker 400 MHz spectrometer; 
chemical shifts for ]H NMR are referenced to tetramethylsilane (TMS) as an internal standard 
while chemical shifts for 13C NMR are referenced to the solvent used. Low resolution mass 
spectra were determined using a Fisons VG Platform II Quadrupole instrument. High 
resolution mass spectroscopy was carried out by the EPSRC National Mass Spectrometry 
Service Centre at Swansea University.
O DMAP, CH3N O
N-H I N -B oc
(Boc)20
l-tert-Butyloxycarbonyl-pyrrolidin-2-one142 (122)—To a solution of 2-pyrrolidinone (5.0 g,
58.74 mmol) in acetonitrile (100 ml) at 0 °C was added 4-dimethylaminopyridine (0.72 g,
58.74 mmol) and di-tert-butyldicarbonate (25.64 g, 117 mmol) with stirring. The reaction was 
slowly allowed to warm to room temperature overnight. The solvent was removed on a rotary 
evaporator to give the crude product (12.41 g) as an orange oil. The crude product was then 
purified by column chromatography Rf 0.4 (silica, hexane:ethyl acetate; 1:1) to give the pure 
product (10.75 g, 99%) as a yellow oil. umax (neat, NaCl plates/ cm'1) 3619 (s), 3544 (s), 2980 
(s), 2880 (m), 1786 (s) (C=0), 1560 (w), 1478 (s); 6H(400 MHz; CDC13) 3.46 (2H, t, J  7.1 Hz, 
H-5) 2.22 (2H, t, 7  8.1 Hz, H-3), 1.68-1.76 (2H, m, H-4), 1.23 (9H, s, Boc); 6C(100 MHz; 
CDCI3) 174.8 (s) (C=0), 150.3 (s) (C=0), 82.7 (s) (C-(CH3)3), 46.7 (s) (C-5), 33.1 (s) (C-3),
28.2 (s) (3 x CH3), 17.6 (s) (C-4); m/z (APCI) 186.0 [(M + H)+, 100%].
General Method for TV-Alkylation—To a slurry of sodium hydride (60% dispersion in oil) 
(100 mmol) in anhydrous DMF (50 ml) under an inert atmosphere at 0 °C was added the cyclic 
amide (100 mmol) dropwise. The solution was slowly allowed to warm to room temperature
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and stirred for 1 hour. After cooling to 0 °C the electrophile (100 mmol) was added dropwise. 
The solution was allowed to warm to room temperature and stirred overnight. The reaction 
mixture was then poured onto ice/HCl (1M solution). The product was extracted with 
dichloromethane ( 3  x 100 ml). The organic solution was then washed with water (5  x 100 ml) 
and dried over Na2SC>4. The drying agent was filtered off and the solvent removed on a rotary 
evaporator to give the crude product.
l-Benzyl-piperidin-2-one147 (145)—This was prepared by the General Method using sodium 
hydride (60% dispersion in oil) (4.04 g, 100 mmol), DMF (50 ml), piperidin-2-one (10.0 g, 100 
mmol) and benzyl bromide (12.0 ml, 100 mmol) to give the crude product (20.9 g) as an 
orange oil. The crude product was then purified by column chromatography Rf 0.4 (silica, 
hexane:ethyl acetate; 1:1) to give the pure product (18.1 g, 96%) as a yellow oil. Umax (neat, 
NaCl plates/ cm'1) 3483 (s), 2946 (s), 2967 (m), 2356 (m), 1618 (s), 1495 (s), 1451 (s), 1418 
(s), 1353 (s), 1263 (s), 1177 (s), 1073 (m), 993 (m); 5H(400 MHz; CDC13) 7.10-7.20 (5H, m, 
Ph) 4.43 (2H, s, CH2-Ph), 3.04 (2H, t, J  5.7 Hz, H-6 ), 2.32 (2H, t, J  6.3 Hz, H-3), 1.55-1.68 
(4H,m, H-4 & H-5); 6C(100 MHz; CDC13) 170.0 (s) (C=0), 137.5 (s) (C, Ar), 128.8 (s) (2 x 
CH, Ar), 128.4 (s) (2 x CH, Ar), 127.5 (s) (CH, Ar), 50.2 (s) (CH2), 47.4 (s) (CH2), 32.6 (s) 
(CH2), 23.3 (s) (CH2), 21.6 (s) (CH2); m/z (APCI) 190.0 [(M+H)+, 100%].
O
d 1. NaHNH --------------™ 2. CH3I
Ph
l-Phenyl-2-methylpyrazolidin-3-one148 (152)—This was prepared by the General Method 
using sodium hydride (60% dispersion in oil) (2.0 g, 49.6 mmol), l-phenyl-pyrazolidin-3-one 
(151) (8.0 g, 49.6 mmol) and methyl iodide (6.24 ml, 99.2 mmol) to give the crude product 
(9.84 g) as an orange oil. The crude product was then purified by column chromatography Rf
0.3 (silica, hexane:ethyl acetate; 1:1) to give the pure product 152 (8.01 g, 92%) as a yellow 
oil. (neat, NaCl plates/ cm'1) 2981 (s), 1691 (s), 1401 (m); 5H(400 MHz; CDCI3) 7.30 
(2H, app. t, J  7.6 Hz, Ph) 7.08 (1H, app. t, J  7.6 Hz, Ph), 6.95 (2H, app. t, J  7.6 Hz, Ph), 3.79 
(2H, t, J  7.5 Hz, H-4), 3.03 (3H, s, CH3), 2.50 (2H, t, J  7.5 Hz, H-3); 5C(100 MHz; CDCh)
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172.6 (s) (C=0), 149.7 (s) (C, Ar), 129.4 (s) (2 x CH, Ar), 124.0 (s) (CH, Ar), 119.0 (s) (2 x 
CH, Ar), 55.6 (s) (CH2), 30.6 (s) (CH3), 29.4 (s) (CH2); m/z (APCI) 177.0 [(M+H)+, 100%].
4-Chloro-N-(4-methoxyphenyl)butyramide145 (140)—Triethylamine (20.4 ml) was added to a 
solution of p-anisidine in dry THF (150 ml) at 0 °C. The solution was then stirred at 0 °C for 
30 minutes. The acid chloride (10.2 ml, 122 mmol) was then added dropwise at 0 °C over a 10 
minute period. The solution was then stirred at 0 °C for 1 hour. The solution was then allowed 
to warm to room temperature and stirred for a further 2 hours. Water (150 ml) was then added 
to the reaction mixture and the crude product was extracted with ethyl acetate (3 x 100 ml). 
The combined organic extracts were then washed with sodium bicarbonate. The solution was 
then dried over MgSC>4 and the solvent removed on a rotary evaporator to give the crude 
product as a brown crystalline solid. M.p. 83-85 °C (lit. 85 °C)145; Umax (nujol, NaCl plates/ 
cm ') 2981 (s), 1665 (s), 1625 (m), 1517 (s); 8H(400 MHz; CDC13) 8.10 (1H, s, NH), 7.39 (2H, 
d, J  8.3 Hz, H-2 & H-6 ), 6.81 (2H, d, J  8.3 Hz, H-3 & H-5), 3.76 (3H, s, OCH3), 3.58 (2H, t, J
6 . 2  Hz, CH2CONH) 2.48 (2H, t, J  7.2 Hz, CH2C1), 2.13 (2H, tt, J  7.2 & 6.2 Hz, CH2CH2C1); 
5C(100 MHz; CDCI3) 169.9 (s) (C O ), 156.4 (s) (C, Ar), 130.7 (s) (C, Ar), 121.8 (s) (2 x CH, 
Ar), 114.1 (s) ( 2  x CH, Ar), 55.4 (s) (O-CH3), 44.5 (s) (CH2), 33.9 (s) (CH2), 27.9 (s) (CH2); 
m/z (APCI) 228.0 [(M+H)+, 100%].
l-(4-Methoxyphenyl)pyrrolidin-2-one (141)—A solution of 4-chloro-.Y-(4'-
methoxyphenyl)butyramide (140) (5.0 g, 21.98 mmol) dissolved in anhydrous THF (20 ml) 
was slowly added to a suspension of sodium hydride (60% dispersion in oil) (0.87 g, 21.98, 
mmol) in anhydrous THF (20 ml) at 0 °C. The solution was then stirred at room temperature 
for 24 hours. The solution was then poured into saturated ammonium chloride (100 ml) and 
extracted with ethyl acetate (3 x 75 ml). The combined organic extracts were then dried over 
Na2S0 4 . The drying agent was filtered off and the solvent removed on a rotary evaporator to 
give the crude product (4.26 g) as a brown crystalline solid. The crude product was the
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recrystallised from ethanol to give the pure product 141 (3.7 g, 8 8 %) as a brown crystalline 
solid. M.p. 107-109 °C (lit. 108 °C)145; umax (nujol, NaCl plates/ cm'1) 2980 (s), 1678 (s), 1612 
(m), 1514 (s); 5H(400 MHz; CDC13) 7.48 (2H, d, J  8.4 Hz, H-2 & H-6 ), 6.81 (2H, d, J  8.4 Hz, 
H-3 & H-5), 3.80 (2H, t, J  8.1 Hz, H-5), 3.78 (3H, s, OCH3), 2.56 (2H, t, J  8.1 Hz, H-3) 2.12 
(2H, tt, J8 .1  & 7.0 Hz, H-4); 6C(100 MHz; CDC13) 173.8 (s) (C=0), 156.4 (s) (C, Ar), 132.5 
(s) (C, Ar), 121.7 (s) (2 x CH, Ar), 114.0 (s) (2 x CH, Ar), 55.4 (s) (0-CH3), 49.1 (s) (CH2),
33.4 (s) (CH2), 18.0 (s) (CH2); m/z (APCI) 192.0 [(M+H)+, 100%].
General Method for a-phenylsulfanylation—To a solution of diisopropylamine (54 mmol), 
in dry THF (25 ml) was added /z-butyl lithium (2.5 M in hexanes) (54 mmol) at 0°C. The 
reaction was allowed to stir at this temperature for 10 minutes before cooling to -78°C with an 
acetone/dry ice cooling bath. The cyclic amide (26 mmol) dissolved in dry THF (10 ml) was 
added dropwise to the reaction mixture. The mixture was then stirred at -78 °C for 35 minutes. 
Phenyl disulfide (26 mmol) dissolved in dry THF (20 ml) containing DMPU (26 mmol) was 
then added dropwise to the reaction mixture over a 20 minute period. The mixture was then 
left to stir at -78 °C for another 35 minutes. The mixture was then slowly left to warm to room 
temperature over an hour and a half. The reaction mixture was then poured into water (200 ml) 
and then extracted with diethyl ether (3 x 150 ml). The ether extracts were combined and 
washed consecutively with 1 0 % sodium hydroxide ( 1 0 0  ml), water ( 1 0 0  ml), 1 0 % hydrochloric 
acid (100 ml) and finally water (100 ml). The solvent was then dried over sodium sulfate. The 
drying agent was filtered off and the solvent was removed on a rotary evaporator to give the 
crude product
O 1) LDA (-78 °C)
c V  ----------------------
^  2) PhSSPh
DMPU
l-Methyl-3-phenylsulfanyl-pyrrolidin-2-one218 (119)—This was prepared by the General 
Method using diisopropylamine (7.6 ml, 54 mmol, /i-butyllithium (2.5 M in hexanes) (21.6 ml, 
54 mmol), 1 -methyl-2-pyrrolidinone (104) (5.0 g, 27 mmol), phenyl disulfide (5.7 g, 26 mmol) 
and DMPU (3.14 ml, 26 mmol) to give the crude product (2.63 g) as a yellow oil. The crude 
product was then purified by column chromatography Rf 0.42 (silica, diethyl ether) to give the 
pure product (2.63 g, 60%) as a yellow oil. Umax (neat, NaCl plates/ cm'1) 3549 (br, st), 3055 
(w), 2933 (s), 2880 (m), 1706 (s) (C=0), 1582 (m), 1488 (m), 1437 (s), 1402 (m), 1300 (s),
1273 (s), 1107 (m), 1026 (w), 984 (w); 5H(400 MHz; CDC13) 7.26-7.31 (2H, m, Ph), 7.04-7.08
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(3H, m, Ph), 3.56 (1H, dd, /5 .8  & 8 . 8  Hz, H-3), 2.93-2.99 (1H, m, H-5a), 2.76-2.82 (1H, m, 
H-5P), 2.18-2.27 ( 1 H, m, H-4a), 1.74-1.82 (1H, m, H-4p); 5C(100 MHz; CDC13) 172.2 (s) 
(C=0), 133.4 (s) (C, Ar), 133.0 (s) (2 x CH, Ar), 129.2 (s) (2 x CH, Ar), 128.1 (s) (CH, Ar),
47.9 (s) (N-CH3), 47.5 (s) (C-3), 30.4 (s) (CH2), 26.8 (s) (CH2); m/z (APCI) 209.0 [(M+H)\ 
100%].
l-Butyloxycarbonyl-3-phenylsulfanylpyrrolidin-2-one (123)—This was prepared by the 
General Method using diisopropylamine (7.9 ml, 56 mmol), /z-butyllithium (2.5M in hexanes) 
(22.4 ml, 56 mmol), l-boc-2-pyrrolidinone (122) (5.0 g, 27 mmol), phenyl disulfide (5.9 g, 27 
mmol), DMPU (3.26 ml, 27 mmol) to give the crude product (4.15 g) as a yellow oil. The 
crude product was then purified by column chromatography Rf 0.20 (silica, ethyl 
acetate:hexane; 1:3) to give the pure product (3.7 g, 47%) as a yellow oil. Umax (neat, NaCl 
plates/ cm'1) 2979 (s), 2251 (w), 2933 (s), 1783 (s), 1748 (s), 1717 (s), 1583 (m), 1477 (m), 
1437 (m), 1368 (s), 1301 (s), 1257 (s), 1151 (s), 1088 (m), 1041 (w), 1014 (s), 909 (s), 849 (s),
4P), 1.44 (9H, s, H-Boc); 5C(100 MHz; CDC13) 171.9 (s) (C=0), 150.4 (s) (C=0), 133.6 (s) (2
49.7 (s) (CH-S), 44.7 (s) (C-5), 28.4 (s) (3 x CH3), 25.9 (s) (C-4); m/z (APCI) 209.0 [(M+H)+, 
100%].
1-Phenyl-3-phenylsulfanylpyrrolidin-2-one (129)—This was prepared by the General Method 
using diisopropylamine (8.72 ml, 62.2 mmol, «-butyllithium (2.5 M in hexanes) (24.88 ml,
62.2 mmol), l-phenyl-2-pyrrolidinone (5.0 g, 31.1 mmol), phenyl disulfide (6.79 g, 31.1 
mmol), DMPU (3.75 ml, 31.1 mmol) to give the crude product (5.59 g) as an orange powder. 
The crude product was then recrystallized from ethanol to give the pure product (5.8 g, 69%) 
as a slightly brown powder. M.p. 82.5-83.5 °C; (Found C, 71.31; H, 5.63; N 5.20. C16H15NOS 
requires C, 71.35; H, 5.61; N, 5.20%); umax (nujol, NaCl plates/ cm'1) 2912 (s), 1682 (s), 1599
O 1) LDA (-78 °C) O
2) PhSSPh 
DMPU
779 (s); 5h(400 MHz; CDC13) 7.46-7.48 (2H, m, Ph), 7.22-7.25 (3H, m, Ph), 3.78 (1H, dd, J  
6.3 & 8.4 Hz, H-3), 3.46-3.58 (2H, m, H-5), 2.30-2.39 (1H, m, H-4a), 1.89-1.98 (1H, m, H-
x CH, Ar), 132.8 (s) (C, Ar), 129.5 (s) (2 x CH, Ar), 128.6 (s) (CH, Ar), 83.6 (s) (C-(CH3)3),
O 1) LDA (-78 °C) O
2) PhSSPh 
DMPU
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(w), 1457 (s), 1379 (s), 1302 (s), 1115 (w), 1091 (w), 895 (m); 5H(400 MHz; CDCI3) 7.81-7.84 
(4H, m, Ph), 7.59-7.64 (2H, m, Ph), 7.53-7.57 (3H, m, Ph), 7.42 (1H, t, J1A  Hz, Ph), 4.25 (1H, 
d d ,/6 .0  & 8 . 6  Hz, H-3), 3.95-4.01 (1H, m, H-5a), 3.84-3.90 (1H, m, H-5P), 2.81-2.91 (1H, m, 
H-4a), 2.40-2.49 (1H, m, H-40); 5C(100 MHz; CDC13) 171.8 (s) (C=0), 139.5 (s) (C, Ar),
133.7 (s) (2 x CH, Ar), 133.2 (s) (C, Ar), 129.4 (s) (2 x CH, Ar), 129.3 (s) (2 x CH, Ar), 128.5 
(s) (CH, Ar), 125.3 (s) (CH, Ar), 120.4 (s) (CH, Ar), 49.7 (s) (C-3), 46.9 (s) (C-5), 26.7 (s) (C- 
4); m/z (APCI) 270.1 [(M+H)+, 100%] 203.2 (14); (Found: (M + H)+ (ES+), 270.0953 
C16H15NOS requires (M + H)+ 220.0947).
O 1) LDA (-78 °C)
c C  ----------------------^  Ph 2 ) PhSSPh 
DMPU
l-Benzyl-3-phenylsulfattylpyrrolidin-2-one144 (137)—This was prepared by the General 
Method using diisopropylamine (8.97 ml, 64.0 mmol, «-butyllithium (2.5 M in hexanes) (25.60 
ml, 64.0 mmol), l-benzyl-2-pyrrolidinone (5.0 ml, 32.0 mmol), phenyl disulfide (6.99 g, 32.0 
mmol), DMPU (3.83 ml, 32.0 mmol) to give the crude product (7.46 g) as an orange oil. The 
crude product was then purified by column chromatography Rf 0.20 (silica, 
ethylacetate:hexane; 1:3) to give the pure product (5.4 g, 60%) as a yellow oil. umax (neat, 
NaCl plates/ cm’1) 2901 (s), 1684 (s), 1600 (w); 5H(400 MHz; CDC13) 7.51 (2H, d, J7 .9  Hz, 
Ph), 7.19-7.35 (8 H, m, Ph), 4.56 (1H, d, J  14.5 Hz, HCH), 4.45 (1H, d, J  14.5 Hz, HCH), 4.21 
(1H, dd, J  5.9 & 8.1 Hz, H-3), 3.93-3.99 (1H, m, H-5a), 3.83-3.89 (1H, m, H-5p), 2.77-2.89 
(1H, m, H-4a), 2.39-2.46 (1H, m, H-4p); 6C(100 MHz; CDCI3) 173.9 (s) (C=0), 135.3 (s) (C, 
Ar), 133.4 (s) (C, Ar), 133.0 (s) (2 x CH, Ar), 131.1 (s) (2 x CH, Ar), 129.2 (s) (2 x CH, Ar),
128.6 (s) (2 x CH, Ar), 128.1 (s) (CH, Ar), 127.5 (s) CH, Ar), 50.9 (s) (CH2), 47.4 (s) (C-3), 
30.1 (s) (CH2), 26.7 (s) (CH2); m/z (APCI) 284.0 [(M+H)+, 100%].
2-Methyl-l-Phenyl-4-pyrazolidin-3-one (153)—This was prepared by the General Method 
using diisopropylamine (3.18 ml, 22.72 mmol, H-butyllithium (2.5 M in hexanes) (9.1 ml, 
22.72 mmol), 2-methyl-1-phenyl pyrazolidin-3-one (2.0 g, 11.36 mmol), phenyl disulfide (2.48 
g, 11.36 mmol), DMPU (1.37 ml, 11.36 mmol) to give the crude product (2.54 g) as a yellow
) 1) LDA (-78 C) O
--------------   PhSv <N— I N-
2) PhSSPh N
>h DMPU Ph
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oil. The crude product was then purified by column chromatography Rf 0.45 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (1.59 g, 49%) as a yellow oil; umax (neat, 
NaCl plates/ cm'1) 3058 (s), 2922 (s), 2244 (w), 1951 (w), 1875 (w), 1690 (s) (C=0), 1597 (s),
124.2 (s) (CH, Ar), 118.7 (s) (2 x CH, Ar), 61.7 (s) (C-5), 47.0 (s) (C-5), 31.8 (s) (N-CH3); m/z 
(APCI) 285.5 [(M+H)+, 100%] 112.7 (33) (Found: (M + H)+ (ES+), 285.1056 Ci6Hi6N2OS 
requires (M + H)+ 285.1056).
l-Benzyl-3-Phenylsulfanyl~piperiditt-2-one219 (146)—This was prepared by the General 
Method using diisopropylamine (4.45 ml, 31.72 mmol, H-butyllithium (2.5M in hexanes) 
(12.69 ml, 31.72 mmol), l-benzylpiperidin-2-one (145) (3.0 g, 15.86 mmol), phenyl disulfide 
(3.46 g, 15.86 mmol), DMPU (1.92 ml, 15.86 mmol) to give the crude product (3.81 g) as a 
yellow oil. The crude product was then purified by column chromatography Rf 0.25 (silica, 
3:1. hexane:ethyl acetate; v/v) to give the pure product (3.15 g, 67%) as a yellow oil; umax 
(neat, NaCl plates/ cm'1) 3059 (m), 2948 (s), 2862 (m), 1952 (w), 1650 (s) (C=Q), 1582 (m),
1490 (s), 1388 (s), 1284 (m), 1112 (m); 5H(400 MHz; CDC13) 7.31-7.33 (2H, m, Ph), 7.19 (2H, 
app. t, J  7.8 Hz, Ph), 7.11-7.12 (2H, m, Ph), 6.97 (1H, app. t, J  7.3 Hz, Ph), 6.79 (2H, app. d, J
7.8 Hz, Ph), 3.89-3.96 (2H, m, H-4 or H-5), 3.65 (1H, dd, J 11.3 & 14.5 Hz, H-4 or H-5), 2.97 
(3H, s, N-CH3); 6C(100 MHz; CDC13) 170.1 (s) (C=0), 149.4 (s) (C, Ar), 132.9 (s) (C, Ar),
132.8 (s) (2 x CH, Ar), 129.8 (s) (2 x CH, Ar), 128.9 (s) (2 x CH, Ar), 127.4 (s) (CH, Ar),
O O
2) PhSSPh 
DMPU
1488 (s), 1438 (s), 1350 (s), 1255 (s), 1177 (s); 5H(400 MHz; CDC13) 7.55 (2H, app. d, J  7.8 
Hz Ph), 7.21-7.31 (8 H, m, Ph), 4.7 (1H, d, J  14.6 Hz, CH2-Ph), 4.46 (1H, d, J  14.6 Hz, CH2- 
Ph), 3.93 (1H, t, J  5.6 Hz, H-3), 3.13-3.18 (2H, m, H-6 ), 1.88-2.11 (3H, m, H-4a, 2 x H-5), 
1.61 (1H, m, H-4P); 8C(100 MHz; CDCb) 168.7 (s) (C=0 ), 137.3 (s) (C, Ar), 134.9 (s) (C, Ar),
133.0 (s) (2 x CH, Ar), 129.4 (s) (2 x CH, Ar), 128.8 (s) (2 x CH, Ar), 128.5 (s) (2 x CH, Ar),
128.0 (s) (CH, Ar), 127.9 (s) (CH, Ar), 51.0 (s) (CH2), 49.4 (s) (CH), 47.6 (s) (CH2), 28.8 (s) 
(CH2), 20.7 (s) (CH2); m/z (APCI) 298 [(M+H)+, 100%].
2) PhSSPh
DMPU
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l-(4-Methoxyphenyl)-3-pyrrolidin-2-one (142)—This was prepared by the general method 
using diisopropylamine (4.40 ml, 31.42 mmol, w-butyllithium (2.5 M in hexanes) (12.58 ml, 
31.42 mmol), l-(4-methoxyphenyl)-pyrrolidin-2-one (141) (3.0 g, 15.71 mmol), phenyl 
disulfide (3.43 g, 15.71 mmol), DMPU (1.89 ml, 15.71 mmol) to give the crude product (4.3 g) 
as a yellow oil. The crude product was then purified by column chromatography Rf 0.45 
(silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product (3.21 g, 6 8 %) as a yellow 
crystalline solid. M.p. °C; Umax (nujol, NaCl plates/ cm'1) 2912 (s), 1677 (s) (C=0), 1514 (m), 
1417 (s), 1350 (s); 5H(400 MHz; CDC13) 7.60-7.62 (2H, m, Ph), 7.47 (2H, d, J9 .1  Hz, Ph), 
7.31-7.33 (3H, m, Ph), 6.91 (2H, d, J9 .1  Hz, Ph), 4.01 (1H, dd, J  5.8 & 8.7 Hz, H-3), 3.67- 
3.82 (1H, m, H-5a), 3.56-3.60 (1H, m, H-5p), 2.60-2.65 (1H, m, H-4a), 2.18-2.24 (1H, m, H- 
4p); 5C(100 MHz; CDC13) 171.1 (s) (C=0), 156.8 (s) (C, Ar), 133.3 (s) (2 x CH, Ar), 132.9 (s) 
(C, Ar), 132.3 (s) (C, Ar), 129.0 (s) (2 x CH, Ar), 128.1 (s) (CH, Ar), 121.9 (s) (2 x CH, Ar),
114.0 (s) (2 x CH, Ar), 55.5 (s) (0-CH3), 49.2 (s) (C-3), 47.0 (s) (C-5), 26.4 (s) (C-4); m/z 
(APCI) 300 [(M+H)+, 100°/ 
requires (M + H)+ 300.1053).
%] 191 (10); (Found: (M + H)+ (ES+), 300.1057 Ci7H17N 02S
General Method for VNS-Alkylation of Lactams—Sodium hydride (60% dispersion in oil) 
(14.4 mmol) in anhydrous DMF (5 ml) was flushed with nitrogen and cooled to 0 °C. 
Nitrobenzene (4.8 mmol) and the VNS nucleophile (4.8 mmol) dissolved in anhydrous DMF (5 
ml) was added dropwise to the sodium hydride slurry. The mixture was left to stir at 0 °C for 
30 minutes before being allowed to warm to room temperature. The purple reaction mixture 
was left to stir at room temperature for 2 hours before cooling back down to 0 °C. The 
electrophile (9.6 mmol) was then added drop-wise to the reaction mixture. The mixture was 
then allowed to warm to room temperature and stirred for 2 hours. The reaction mixture was 
then poured onto ice/hydrochloric acid (1M solution). The product was then extracted with 
dichloromethane (3 x 100 ml), washed with water ( 5  x 100 ml), sodium bicarbonate (3 x 100 
ml) and dried over sodium sulfate. The drying agent was then filtered off and the solvent 
removed on a rotary evaporator to give the crude product.
no2
1) NaH, DMF
PhSy A  _  -------------
2 ) lodomethane
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l,3-Dimethyl-3-(4’-nitrophenyl)pyrrolidin-2-one (120b)—This was prepared by the General 
Method using sodium hydride (60% dispersion in oil) (0.58 g, 14.4 mmol), l-methyl-3- 
phenylsulfanyl-pyrrolidin-2-one (119) (1.0 g, 4.8 mmol), nitrobenzene (0.50 ml, 4.8 mmol) and 
iodomethane (0.45 ml, 7.2 mmol) to give 2.2 g of crude product as a brown oil. The crude 
product was then purified by column chromatography Rf 0.30 (silica, hexane:ethyl acetate; 
1:1) to give the pure product (0.73 g, 65%) as a brown oil. Umax (neat, NaCl plates/ cm'1) 3463 
(br, st), 3077 (m), 2910 (s), 2455 (w), 1689 (s) (C=0); 6H(400 MHz; CDC13) 8.05 (2 H, d, J8 .9  
Hz, H-3’ & H-5’), 7.52 (2H, d, J8 .9  Hz, H-2’ & H-5’), 3.24-3.36 (2H, m, H-5), 2.86 (3H, s, N- 
CH3), 2.31-2.37 (1H, m, H-4a), 2.11-2.19 (1H, m, H-4p), 1.48 (3H, s, CH3); 6C(100 MHz; 
CDC13) 176.5 (s) (C O ), 152.1 (s) (C, Ar), 146.8 (s) (C, Ar), 127.7 (s) (2 x CH, Ar), 123.9 (s) 
(2 x CH, Ar), 49.1 (s) (C, quaternary), 46.3 (s) (N-CH2), 35.2 (s) (CH2), 30.5 (s) (N-CH3), 25.1 
(s) (CH3); m/z (APCI) 235.0[(M+H)+, 100%]; (Found: (M + H)+, 235.1078. Ci2Hi4N20 3 
requires (M + H)+ 235.1077).
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l-Methyl-3-(4’-nitrophenyl)pyrrolidin-2-one (120a)—This was prepared by the General 
Method using sodium hydride (60% dispersion in oil) (0.29 g, 7.2 mmol), l-methyl-3- 
phenylsulfanyl-pyrrolidin-2-one (119) (0.50 g, 2.4 mmol), nitrobenzene (0.25 ml, 2.4 mmol). 
No electrophile was added and the mixture was poured onto a mixture of ice and hydrochloric 
acid (1M) to give the crude product (2.2 g) as a brown oil. The crude product was then 
purified by column chromatography Rf 0.34 (silica, hexane:ethyl acetate; 1:1) to give the pure 
product (0.37 g, 6 6 %) as a orange crystalline solid. M.p. 74-76 °C; (nujol, NaCl plates/ 
cm'1) 2917 (s), 1672 (m), 1599 (w), 1518 (w), 1461 (s), 1376 (s), 1092 (w), 850 (w); 6H(400 
MHz; CDC13) 8.10 (2H, d, J  8.7 Hz, H-3’ & H-5’), 7.38 (2H, d, J  8.7 Hz, H-2’ & H-5’), 3.71 
(1H, t, J  9.2 Hz, H-3), 3.40-3.44 (2H, m, H-5), 2.87 (3H, s, N-CH3), 2.48-2.56 (1H, m, H-4a),
2.02-2.12 (1H, m, H-4p); 5C(100 MHz; CDC13) 173.8 (s) (C=0), 147.9 (s) (C, Ar), 147.2 (s) 
(C, Ar), 129.4 (s) (2 x CH, Ar), 124.2 (s) (2 x CH, Ar), 48.2 (s) (C-3), 47.9 (s) (C-5), 30.5 (s) 
(N-CH3), 28.0 (s) (C-4); m/z (APCI) 220.8[(M+H)+, 100%]; (Found: (M + NH4)+, 238.1186. 
CnHi2N20 3 requires (M + N H ^  238.1186).
I l l
no2
1) NaH, DMFO
2) Allyl bromide
3-Allyl-l-methyl-3-(4’-nitrophenyl)pyrrolidin-2-one (120c)—This was prepared by the
(0.29 g, 7.2 mmol), 1-methyl-3-phenylsulfanyl-pyrrolidin-2-one (119) (0.50 g, 2.4 mmol), 
nitrobenzene (0.25 ml, 2.4 mmol) and allyl bromide (0.41 ml, 4.8 mmol) to give the crude 
product (1.46 g) as a brown oil. The crude product was then purified by column 
chromatography Rf 0.38 (silica, hexane:ethyl acetate; 1:1) to give the pure product (0.37 g, 
6 6 %) as a yellow oil. Umax (neat, NaCl plates/ cm'1) 3075 (m), 2922 (s), 1682 (s), 1640 (w), 
1602 (s), 1514 (s), 1435 (s), 1403 (s), 1346 (s), 1304 (s), 1101 (s) 1014 (s), 922 (s), 853 (s), 
729 (s); 6h(400 MHz; CDC13) 8.10 (2H, d, J 8.9 Hz, H-3’ & H-5’), 7.63 (2H, d, J  8.9 Hz, H-2’ 
& H-5’), 5.49-5.56 (1H, m, CH), 5.00-5.05 (2H, m, =CH2), 3.21-3.31 (2H, m, H-5), 2.84 (3H, 
s, N-CH3) 2.57 (2H, d, J  1.2 Hz, H2C=CH-CH2-), 2.28-2.39 (2H, m, H-4); 5C(100 MHz; 
CDC13) 175.1 (s) (C=0), 150.3 (s) (C, Ar), 146.9 (s) (C, Ar), 133.3 (s) (H2C=CH-), 128.1 (s) (2 
x CH, Ar), 123.8 (s) (2 x CH, Ar), 119.8 (s) (H2C=) 52.4 (s) (C, quaternary), 47.0 (s) (CH2),
43.8 (s) (C-5), 30.5 (s) (C-4), 30.4 (s) (N-CH3); m/z (APCI) 260.9[(M+H)+, 100%], 205.8 (14); 
(Found: (M + H)+, 261.1234. C14H16N20 3 requires (M + H)+ 261.1236).
3-Benzyl-l-methyl-3-(4’-nitrophenyl)pyrrolidin-2-one (120d)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.29 g, 7.2 mmol), l-methyl-3- 
phenylsulfanyl-pyrrolidin-2-one (119) (0.50 g, 2.4 mmol), nitrobenzene (0.25 ml, 2.4 mmol) 
and benzyl bromide (0.57 ml, 4.8 mmol) to give the crude product (2.0 g) as a brown oil. The 
crude product was then purified by column chromatography Rf 0.38 (silica, hexane:ethyl 
acetate; 1:1) to give the pure product (0.55g, 72%) as an orange crystalline solid. M.p. 113- 
115°C; Umax (nujolt, NaCl plates/ cm'1) 2852 (s), 1668 (s), 1598 (m), 1515 (m), 1377 (m), 1347
general method used in the previous compound using sodium hydride (60% dispersion in oil)
2) Benzyl bromide
Ph
(m), 1312 (m); 6H(400 MHz; CDC13) 8.11 (2H, d, J8 .9  Hz, H-3’ & H-5’), 7.68 (2H, d, J8 .9  
Hz, H-2’ & H-6 ’), 7.16-7.19 (3H, m Ph), 7.00-7.02 (2H, m, Ph), 3.23 (1H, d, J  13.3 Hz, HCH- 
Ph), 2.99-3.03 (1H, m, H-4a), 2.96 (1H, d, J  13.3 Hz, HCH-Ph), 2.70 (3H, s, N-CH3), 2.47-
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2.53 (1H, m, H-4p), 2.25-2.40 (2H, m, H-5); 8C(100 MHz; CDC13) 175.2 (s) (C=0), 150.9 (s) 
(C, Ar), 147.1 (s) (C, Ar), 136.6 (s) (C, Ar), 130.5 (s) (2 x CH, Ar), 128.6 (s) (2 x CH, Ar),
128.2 (s) (2 x CH, Ar), 127.5 (s) (CH, Ar), 123.8 (s) (2 x CH, Ar), 53.8 (s) (C, qaurtemary),
46.4 (s) (CH2), 46.1 (s) (CH2), 30.1 (s) (N-CH3), 30.5 (s) (CH2); m/z (APCI) 311.3 [(M+H)+, 
100%]; (Found: (M + H)+, 311.1390 Ci8Hi8N20 3 requires (M + H)+ 311.1390).
l-Phenyl-3-(4’-nitrophenyl)pyrrolidin-2-one (130a)—This was prepared by the general 
method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), l-phenyl-3- 
phenylsulfanyl-pyrrolidin-2-one (129) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 mmol) 
to give the crude product (0.70 g) as a brown oil. The crude product was then purified by 
column chromatography Rf 0.38 (silica, hexane:ethyl acetate; 1:1) to give the pure product 
(0.39 g, 75%) as an orange crystalline solid. M.p. 117-119 °C; Umax (nujol, NaCl plates/ cm'1) 
2916 (s), 1690 (s), 1596 (m), 1513 (w), 1463 (s), 1377 (s), 1303 (m); 5H(400 MHz; CDC13)
8.08 (2H, d, J  8.7 Hz, H-3’ & H-5’), 7.56 (2H, app. d, J  8.0 Hz, Ph), 7.42 (2H, d, J  8.7 Hz, H- 
2’ & H-6 ’), 7.28 (2H, app. t, J  8.0 Hz, Ph), 7.08 (1H, app. t, J  8.0 Hz, Ph), 3.79-3.90 (3H, m, 
H-3 & H-4), 2.53-2.61 (1H, m, H-5<x), 2.13-2.23 (1H, m, H-50), 6C(100 MHz; CDC13) 173.0 
(s) (C=0), 147.4 (s) (C, Ar), 147.0 (s) (C, Ar), 139.5 (s) (C,Ar), 129.6 (s) (2 x CH, Ar), 129.4 
(s) (2 x CH, Ar), 125.4 (s) (CH, Ar), 124.3 (s) (2 x CH, Ar), 120.3 (s) (2 x CH, Ar), 49.7 (s) 
(CH), 47.1 (s) (CH2), 27.7 (s) (CH2); m/z (APCI) 283.5 [(M+H)+, 16 %]; (Found: (M + H)+, 
283.1079 Ci6Hi4N20 3 requires (M + H)+ 283.1077).
3-Methyl-3-(4’-nitrophenyl)-l-phenylpyrrolidin-2-one (130b)—This was prepared by the 
general method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), l-phenyl-3- 
phenylsulfanyl-pyrrolidin-2-one (129) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 mmol) 
and iodomethane (0.23 ml, 3.72 mmol) to give the crude product (0.8 g) as a brown oil. The 
crude product was then purified by column chromatography Rf 0.61 (silica, hexane:ethyl 
acetate; 1:1) to give the pure product (0.38 g, 6 8 %) as a yellow crystalline solid. (Found C,
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68.81; H, 5.39; N 9.57. Ci7H 16N20 3 requires C, 68.91; H, 5.44; N, 9.45%); M.p. 160-162°C; 
Umax (nujol, NaCl plates/ cm'1) 2921 (s), 1686 (s) (C=0), 1592 (m), 1456 (s), 1378 (s); 6h (400 
MHz; CDC13) 8.12 (2H, d, J  8.7 Hz, H-3’ & H-5’), 7.31-7.35 (4H, m, Ar), 7.10 (2H, app. d, J
7.4 Hz, Ph), 6.95 (2H, app. d, J1.6  Hz, Ar), 3.29-3.39 (2H, m, H-5), 2.93 (3H, s, N-CH3), 2.38 
(1H, tdd, J  13.7 Hz & 11.9 Hz & 2.01 Hz, H-4a), 2.19 (1H, tdd, J  13.7 Hz & 11.9 Hz & 2.01 
Hz, H-4p); 5C(100 MHz; CDC13) 171.6.(s) (C=0), 149.3 (s) (C, Ar), 147.7 (s) (C, Ar), 143.9 
(s) (C, Ar), 130.1 (s) (2 x CH, Ar), 129.9 (s) (2 x CH, Ar), 125.0 (s) (CH, Ar), 124.3 (s) (2 x 
CH, Ar), 119.3 (s) (2 x CH, Ar), 77.7 (s) (C, q), 63.6 (s) (C-5), 45.9 (s) (C-4), 31.6 (s) (CH3); 
m/z (APCI) 297.3 [(M+H)+, 100 %]; (Found: (M + H)+, 297.1235. C17H16N2O3 requires (M + 
H)+ 297.1234).
2) Allyl Bromide
3-Allyl-3-(4’-nitrophenyl)-l-phenylpyrrolidin-2-one (130c)—This was prepared by the 
general method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), l-phenyl-3- 
phenylsulfanyl-pyrrolidin-2-one (129) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 mmol) 
and allyl bromide (0.32 ml, 3.72 mmol) to give the crude product (1.40 g) as a brown oil. The 
crude product was then purified by column chromatography Rf 0.5 (silica, hexane:ethyl 
acetate; 1:1) to give the pure product (0.39 g, 65%) as a yellow crystalline solid. M.p. 62-63 
°C; Umax (nujol, NaCl plates/ cm'1) 3076 (m), 2979 (m), 2892 (m), 2249 (w), 1943 (w), 1861 
(w), 1686 (s) 1596 (s) 1502 (s), 1394 (s) 1346 (s); 6H(400 MHz; CDC13) 8.09 (2 H, d, J  8.9 Hz, 
H-3’ & H-5’), 7.65 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.55 (2H, app. d, J  8.0 Hz, Ph), 7.29 (2H, 
app. t, J  8.0 Hz, Ph), 7.08 (1H, app. t, J  8.0 Hz, Ph), 5.52-5.62 (1H, m, H2C=CH-), 5.02-5.06 
(2H, m, H2C=), 3.72-3.78 (1H, m, H-5a), 3.66 (1H, dd, J 1 A  & 17.1 Hz, H-5P), 2.65-2.67 (2H, 
m, =CH-CH2), 2.39-2.53 (2H, m, 2 x H-4); 6C(100 MHz; CDC13) 174.5.(s) (C=0), 149.2 (s) 
(C, Ar), 147.3 (s) (C, Ar), 139.5 (s) (C,Ar), 133.1 (s) (CH, Ar), 129.4 (s) (2 x CH, Ar), 128.2 
(s) (2 x CH, Ar), 125.4 (s) (CH, Ar), 124.0 (s) (2 x CH, Ar), 120.4 (s) (2 x CH, Ar), 120.2 (s) 
(CH, Ar), 54.0 (s) (C, q), 45.7 (s) (CH2), 44.0 (s) (CH2), 30.0 (s) (CH2); m/z (APCI) 323.3 
[(M+H)+, 100 %]; (Found: (M + H)+, 323.1390. Ci9H18N20 3 requires (M + H)+ 323.1390).
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2) 2,4-dinitro- 
fluorobenzene
3-(2 ”,4”-dinitrophenyl)-3-(4 f-nitrophenyl)-l-phenylpyrrolidin2-one (130d)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 
mmol), 1-phenyl-3-phenylsulfanyl-pyrrolidin-2-one (129) (0.50 g, 1.86 mmol), nitrobenzene 
(0.19 ml, 1.86 mmol) and 2,4-dinitrofluorobenzene (0.47 ml, 3.72 mmol) to give the crude 
product (1.42 g) as a brown oil. The crude product was then purified by column 
chromatography Rf 0.19 (silica, hexane:ethyl acetate; 3:1) to give the pure product (0.48 g, 
58%) as an orange oil. Umax (nujol, NaCl plates/ cm'1) 3071 (m), 2892 (m), 1681 (s), 1487 (s); 
5h(400 MHz; CDC13) 8.55 (1H, d , J 2 A  Hz, H-3”), 8.29 (1H, dd, J 2.4 & 8.7 Hz, H-5”), 8.14 
(2H, d, J 8.9 Hz, H-3’ & H-5’), 7.60 (2H, d, J8 .9  Hz, H-2’ & H-6 ’), 7.47-7.50 (3H, m, H-6 ” & 
Ph), 7.3 (2H, app. t, J  7.6 Hz, Ph), 7.13 (1H, t, J  7.6 Hz, Ph), 3.98-4.09 (2H. m, H-4a & H-40),
3.38 (1H, ddd, J  2 & 6.5 & 13.9 Hz, H-5 a), 2.98 (1H, m, 2.94-3.02, H-5P); 6C(100 MHz; 
CDC13) 170.8.(s) (C=0), 150.6 (s) (C, Ar), 148.1 (s) (C, Ar), 147.3 (s) (C, Ar), 144.4 (s) (C, 
Ar), 144.1 (s) (C, Ar), 138.8 (s) (C, Ar), 133.8 (s) (CH, Ar), 129.5 (s) (2 x CH, Ar), 129.0 (s) 
(CH, Ar), 126.8 (s) (CH, Ar), 126.3 (s) (CH, Ar), 124.4 (s) (2 x CH, Ar), 121.2 (s) (CH, Ar),
120.8 (CH, Ar), 58.9 (s) (C, q), 46.3 (s) (CH2), 31.9 (s) (CH2); m/z (APCI) 449 [(M+H)+, 65 
%]; (Found: (M + NH4)+, 466.1358 C22H16N40 7 requires (M + NH4)+ 466.1357).
1-Benzyl-3-(4’-nitrophenyl)pyrrolidin-2-one (138a)—This was prepared by the General 
Method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), l-phenyl-3- 
phenylsulfanyl-pyrrolidin-2-one (137) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 mmol) 
and hydrochloric acid (1 M) (2 ml) to give the crude product (3.34 g) as a brown oil. The 
crude product was then purified by column chromatography Rf 0.40 (silica, hexane:ethyl 
acetate; 1:1) to give the pure product (0.34 g, 62%) as a white crystalline solid M.p. 91-93°C; 
Umax (nujol, NaCl plates/ cm'1) 2907 (s), 1675 (s), 1601 (m), 1514 (m), 1456 (s), 1377 (w),
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1347 (s), 1285 (m); 5H(400 MHz; CDCI3) 8.12 (2H, d, JS.7 Hz, H-3’ & H-5’), 7.38 (1H, d, J
8.7 Hz, H-2’ & H-6 ’), 7.19-7.31 (5H, m, Ph), 4.51 (1H, d, J  14.6 Hz, HCH), 4.41 (1H, d, J  14.6 
Hz, HCH), 3.77 (1H, t, J9A  Hz, H-3), 3.25-3.31 (2H, m, H-5), 2.44-2.52 (1H. m, H-4a), 2.04 
(1H, ddd, / 8 . 6  & 13.0 & 17.1 Hz, H-40); 6C(100 MHz; CDC13) 173.7 (s) (C=0), 147.6 (s) (C, 
Ar), 147.4 (s) (C, Ar), 136.5 (s) (C,Ar), 129.4 (s) (2 x CH, Ar), 129.3 (s) (2 x CH, Ar), 128.6 
(s) (2 x CH, Ar), 128.3 (s) (CH, Ar), 124.3 (s) (2 x CH, Ar), 48.3 (s) (CH), 47.6 (s) (CH2), 45.2 
(s) (CH2), 27.9 (s) (CH2); m/z (APCI) 297 [(M+H)+, 100%]; (Found: (M + H)+ (ES*), 
297.1238. Ci7Hi6N20 3 requires M + H)+ 297.1234).
3-Methyl-l-benzyl-3-(4’-nitrophenyl)pyrrolidin-2-one (138b)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), 1-phenyl- 
3-phenylsulfanyl-pyrrolidin-2-one (137) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 
mmol) and methyl iodide (0.23 ml, 3.72 mmol) to give the crude product (2.21 g) as an orange 
oil. The crude product was then purified by column chromatography Rf 0.21 (silica, 
hexane:ethyl acetate; 3:1) to give the pure product (0.34 g, 6 6 %) as a yellow oil. umax (neat, 
NaCl plates/ cm'1) 3506 (w), 3064 (s), 2967 (m), 2967 (m), 2927 (w), 2872 (w), 1686 (s) 
(C=0), 1603 (m), 1520 (s), 1495 (m), 1454 (m), 1429 (m), 1348 (s), 1270 (s); 5H(400 MHz; 
CDC13) 8.09 (2H, d, J  8.9 Hz, H-3’ & H-5’), 7.53 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 6.70-7.27 
(5H, m, Ph), 4.45 (2H, s, CH2-Ph), 3.10-3.22 (2H, m, H-5), 2.28-2.34 (1H, m, H-4a), 2.08-2.16 
(1H, m, H-4|3), 1.54 (3H, s, CH3); 5c(100 MHz; CDCI3) 176.5.(s) (C=0), 151.9 (s) (C, Ar),
147.0 (s) (C, Ar), 136.5 (s) (C, Ar), 129.8 (s) (2 x CH, Ar), 129.2 (s) (2 x CH, Ar), 128.6 (s) 
(CH, Ar), 128.2 (s) (2 x CH, Ar), 124.0 (s) (2 x CH, Ar), 49.3 (s) (C, quaternary), 47.5 (s) 
(CH2), 43.6 (s) (CH2), 35.2 (s) (CH2), 24.9 (s) (CH3); m/z (APCI) 311 [(M+H)+, 100%]; 
(Found: (M + H)+ (ES+), 311.1392 Ci8Hi8N20 3requires (M + H)+ 311.1390).
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3-Ethyl-l-benzyl-3-(4’-nitrophenyl)pyrrolidin-2-one (138c)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.23 g, 5.72 mmol), 1-phenyl- 
3-phenylsulfanyl-pyrrolidin-2-one (137) (0.50 g, 1.86 mmol), nitrobenzene (0.19 ml, 1.86 
mmol) and ethyl iodide (0.28 ml, 3.50 mmol) to give the crude product (1.04 g) as an orange 
oil. The crude product was then purified by column chromatography Rf 0.21 (silica, 
hexane:ethyl acetate; 3:1) to give the pure product (0.35 g, 61%) as a yellow crystalline solid. 
M.p. 110-111 °C; Umax (neat, NaCl plates/ cm'1) 3480 (s), 2932 (s), 1666 (s), 1602 (m), 1515 
(m), 1454 (s), 1378 (s), 1106 (m), 855 (m); 5H(400 MHz; CDC13) 8.10 (2H, d, 78.9 Hz, H-3’ & 
H-5’), 7.63 (2H, d, 7  8.9 Hz, H-2’ & H-6 ’), 7.19-7.24 (3H, m, Ph), 7.12 (2H, app. d, 7  7.8 Hz, 
Ph), 4.48 (1H, d, 7  14.6 Hz, HCH), 4.37 (1H, d, 7  14.6 Hz, HCH), 3.08-3.19 (2H, m, H-5), 2.35 
(1H, dt, 7  7.4 & 12.9 Hz, H-4a), 2.20 (1H, dt, 7  7.4 & 12.9 Hz, H-4p), 1.95 (1H, dq, 7  14.8 &
7.4 Hz, HCH-CH3), 1.86 (1H, dq, 7  13.9 & 7.4 Hz, HCH-CH3), 0.76 (3H. t, 7  7.4 Hz, CH3); 
6C(100 MHz; CDC13) 175.6.(s) (O O ), 150.3 (s) (C, Ar), 147.1 (s) (C, Ar), 136.6 (s) (C,Ar),
129.2 (s) (2 x CH, Ar), 128.5 (s) (2 x CH, Ar), 128.1 (s) (2 x CH, Ar), 123.9 (s) (2 x CH, Ar),
53.2 (s) (C, quaternary), 47.4 (s) (CH2), 43.7 (s) (CH2), 32.3 (s) (CH2), 30.7 (s) (CH2), 9.4 (s) 
(CH3); m/z (APCI) 325 [(M+H)+, 100%]; (Found: (M + H)+ (ES+), 325.1553 Ci9H20N2O3 
requires (M + H)+ 325.1547).
l-(4’-methoxyphenyl)-3-(4”-nitrophenyl)pyrrolidin-2-one (143a)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.01 mmol), l-(4- 
methoxyphenyl)-3-phenylsulfanyl-pyrrolidin-2-one (142) (0.50 g, 1.67 mmol), nitrobenzene 
(0.17 ml, 1.67 mmol) and saturated ammonium chloride (0.50 ml) to give the crude product 
(1.85 g) as brown oil. The crude product was then purified by column chromatography Rf 0.20 
(silica, hexane:ethyl acetate; 3:1) to give the pure product (0.38 g, 73%) as a yellow crystalline 
solid. M.p. 157-159 °C; Umax (nujol, NaCl plates/ cm'1) 2909 (s), 2360 (s), 1694 (s), 1603 (m),
no2
1. NaH, DMF
1514 (m), 1492 (s), 1377 (s), 1346 (m), 1252 (m); 5H(400 MHz; CDC13) 8.14 (2H, d, 78.6 Hz, 
H-3’ & H-5’), 7.48 (2H, d, 79.0 Hz, H-2” & H-6 ”), 7.44 (2H, d, 7  8 . 6  Hz, H-2’ & H-6 ’), 6.85 
(2H, d, 79.0 Hz, H-3” & H-5”), 3.80-3.95 (3H, m, H-3 & H-5), 3.73 (3H, s, O-CH3), 2.57-2.67 
(1H, m, H-4a), 2.17-2.27 (1H, m, H-4P); 6C(100 MHz; CDC13) 172.6.(s) (0=0), 157.3 (s) (C, 
Ar), 147.5 (s) (C, Ar), 147.1 (s) (C, Ar), 132.6 (s) (C, Ar), 129.5 (s) (2 x CH, Ar), 124.3 (s) (2
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X CH, Ar), 122.1 (s) (CH, Ar), 114.5 (s) (2 x CH, Ar), 55.9 (s) (0-CH3), 49.5 (s) (CH), 47.5 (s) 
(CH2), 27.8 (s) (CH2); m/z (APCI) 313 [(M+H)+, 100%]; (Found: (M + H)+ (ES+) 313.1184. 
Ci7Hi6N20 4requires (M + H)+ 313.1183).
no 2
O 1. NaH, DMF OMe
PhS
OMe
2. CH3I
3-Methyl-l-(4 ’-methoxyphenyl)-3-(4”-nitrophenyl)pyrrolidin-2-one (143b)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.01 
mmol), l-(4-methoxyphenyl)-3-phenylsulfanyl-pyrrolidin-2-one (142) (0.50 g, 1.67 mmol), 
nitrobenzene (0.17 ml, 1.67 mmol) and methyl Iodide (0.21 ml, 3.34 mmol) to give the crude
Rf 0.19 (silica, hexanerethyl acetate; 3:1) to give the pure product (0.45 g, 83%) as a yellow 
crystalline solid. M.p. 84-85 °C; Umax (nujol, NaCl plates/ cm'1) 2922 (s), 1688 (s), 1603 (m), 
1463 (s), 1377 (m), 1296 (w), 1244 (w), 1024 (w), 840 (m); 8H(400 MHz; CDC13) 8.10 (2H, d,
(s) (2 x CH, Ar), 55.9 (s) (0-CH3), 50.5 (s) (C, quaternary), 45.9 (s) (CH2), 34.8 (s) (CH2),
25.6 (s) (CH3); m/z (APCI) 327 [(M+H)+, 100%]; (Found: (M + H)+ (ES+) 327.1337 
Ci8H18N20 4requires (M + H)+ 327.1339).
3-Benzyl-l-(4’-methoxyphenyl)-3-(4”-nitrophenyl)-pyrrolidin-2-one (143c)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.01 
mmol), l-(4-methoxyphenyl)-3-phenylsulfanyl-pyrrolidin-2-one (142) (0.50 g, 1.67 mmol), 
nitrobenzene (0.17 ml, 1.67 mmol) and benzyl bromide (0.40 ml, 3.34 mmol) to give the crude 
product (2.60 g) as brown oil. The crude product was then purified by column chromatography 
Rf 0.41 (silica, hexane:ethyl acetate; 3:1) to give the pure product (0.44 g, 6 6 %) as an orange
product (1.41 g) as brown oil. The crude product was then purified by column chromatography
78.7 Hz, H-3’ & H-5’), 7.58 (2H, d, 7  8.7 Hz, H-2’ & H-6 ’), 7.48 (2H, d, 78.9 Hz, H-2” & H- 
6 ”), 6.84 (2H, d, 78.9 Hz, H-3” & H-5”), 3.73-3.78 (1H, m, H-5a), 3.72 (3H, s, 0-CH3), 3.62- 
3.68 (1H, m, H-5p), 2.47-2.57 (1H, m, H-4a), 2.25-2.31 (1H, m, H-40), 1.58 (3H, s, CH3); 
5C(100 MHz; CDC13) 175.4.(s) (C=0), 157.2 (s) (C, Ar), 151.4 (s) (C, Ar), 147.1 (s) (C, Ar),
132.8 (s) (C, Ar), 127.8 (s) (2 x CH, Ar), 124.1 (s) (2 x CH, Ar), 122.1 (s) (2 x CH, Ar), 114.5
n o 2
1. NaH, DMF OMe
2. BnBr
Ph
N Ph
oil. Umax (neat, NaCl plates/ cm 1) 2956 (s), 1681 (s), 1453 (s), 1110 (s); 8H(400 MHz; CDCI3)
8.20 (2H, d, 7  8.9 Hz, H-3’ & H-5’), 7.80 (2H, d, 7 8.9 Hz, H-2’ & H-6 ’), 7.40 (2H, d, 7  9.0 
Hz, H-2” & H-6 ”), 7.24-7.28 (3H, m, Ph), 7.10-7.12 (2H, m, Ph), 6.91 (2H, d, 79.0 Hz, H-3” 
& H-5”), 3.81 (3H, s, O-CH3), 3.50 (1H, dt, 7  7.0 & 9.5 Hz, H-5a), 3.43 (1H, d, 7 13.4 Hz, 
HCH-Ph), 3.21-3.27 (1H, m, H-5p), 3.15 (1H, d, 713.4 Hz, HCH-Ph), 2.51-2.57 (2H, m, H-4); 
8C(100 MHz; CDCI3) 174.1 (s) (C=0), 157.3 (s) (C, Ar), 150.0 (s) (C, Ar), 147.2 (s) (C, Ar),
136.6 (s) (C, Ar), 132.5 (s) (C, Ar), 130.6 (s) (2 x CH, Ar), 128.7 (s) (2 x CH, Ar), 127.6 (s) 
(CH, Ar), 123.9 (s) (2 x CH, Ar), 122.5 (s) (2 x CH, Ar), 114.4 (s) (2 x CH, Ar), 55.9 (s) (0- 
CH3), 55.0 (s) (C, quaternary), 46.1 (s) (CH2), 46.0 (s) (CH2), 30.0 (s) (CH3); m/z (APCI) 403 
[(M+H)+, 100%]; (Found: (M + H)+ (ES+) 403.1581 Ci8Hi8N20 4requires (M + H)+ 403.1580).
NO, O
phc  I  _  1. NaH, DMF
T j 1 Ph _____ -
2. H+
l-Benzyl-3-(4”-nitrophenyl)piperidin-2-one (147a)—This was prepared by the General 
Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.01 mmol), l-benzyl-3- 
phenylsulfanyl-piperidin-2-one (146) (0.50 g, 1.67 mmol), nitrobenzene (0.17 ml, 1.67 mmol) 
and saturated ammonium chloride (2 . 0  ml) to give the crude product (1.80 g) as a brown oil. 
The crude product was then purified by column chromatography Rf 0.41 (silica, hexaneiethyl 
acetate; 3:1) to give the pure product (0.33 g, 64%) as a yellow crystalline solid. M.p. 104-105 
°C; Umax (nujol, NaCl plates/ cm"1) 3458 (s), 3029 (s), 2940 (s), 2240 (m), 1710 (s), 1627 (s), 
1518 (s), 1452 (s), 1348 (s), 1249 (m), 1195 (m), 1108 (m), 1015 (m); 8H(400 MHz; CDC13) 
8.11 (2H, d, J  8 . 8  Hz, H-3’ & H-5’), 7.31 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.21-7.29 (5H, m, 
Ph), 4.59 (3H, s, CH2), 3.76 (1H, dd, J  6.1 & 9.2 Hz, H-3), 3.24-3.36 (2H, m, H-6 ), 2.09-2.17 
(1H, m, H-4a), 1.73-1.93 (3H, m, H-4P & H-5); 8C(100 MHz; CDC13) 169.8.(s) (C=0), 149.7 
(s) (C, Ar), 147.1 (s) (C, Ar), 137.4 (s) (C, Ar), 129.8 (s) (2 x CH, Ar), 129.1 (s) (2 x CH, Ar),
128.7 (s) (2 x CH, Ar), 128.1 (s) (CH, Ar), 124.1 (s) (2 x CH, Ar), 51.0 (s) (CH2), 49.2 (s) 
(CH), 47.6 (s) (CH2), 30.3 (s) (CH2), 21.4 (s) (CH2); m/z (APCI) 311 [(M+H)+, 100%]; (Found: 
(M + H)+ (ES+) 311.1388 Ci8Hi8N20 3 requires (M + H)+ 311.1390).
1. NaH, DMF
N Ph
N Ph
2. CH3I
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3-Methyl-1-benzyl-3-(4”-nitrophenyl)piperidin-2-one (147b)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.16 g, 4.05 mmol), 1-Benzyl- 
3-phenylsulfanyl-piperidin-2-one (146) (0.40 g, 1.35 mmol), nitrobenzene (0.14 ml, 1.35 
mmol) and methyl iodide (0.17 ml, 2.70 mmol) to give the crude product (1.30 g) as an orange 
oil. The crude product was then purified by column chromatography Rf 0.10 (silica, 
hexane:ethyl acetate; 3:1) to give the pure product (0.27 g, 61%) as a yellow oil. Umax (neat, 
NaCl plates/ cm'1) 3460 (s), 3027 (s), 2938 (s), 1701 (s), 1637 (s), 1518 (s), 1453 (s), 1350 (s), 
1249 (m), 1199 (m), 1101 (m), 1012 (m); 6H(400 MHz; CDC13) 8.08 (2H, d, J8 .9  Hz, H-3’ & 
H-5’), 7.41 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.19-7.30 (5H, m, Ph), 4.73 (1H, d, J  14.4 Hz, 
HCH-Ph), 4.45 (1H, d, J  14.4 Hz, HCH-Ph) 3.19-3.27 (2H, m, H-6 ), 2.11-2.18 (1H, m, H-4a), 
1.87-1.96 (1H, m, H-4p), 1.63-1.71 (1H, m, H-5a), 1.44-1.55 (1H, m, H-5P), 1.58 (3H, s, CH3); 
5C(100 MHz; CDC13) 173.0.(s) (C=0), 153.9 (s) (C, Ar), 146.8 (s) (C, Ar), 137.6 (s) (C, Ar),
129.1 (s) (2 x CH, Ar), 128.7 (s) (2 x CH, Ar), 128.0 (s) (2 x CH, Ar), 127.8 (s) (2 x CH, Ar),
124.0 (s) ( 2  x CH, Ar), 51.2 (s) (CH2), 48.5 (s) (C, quaternary), 48.1 (s) (CH2), 37.0 (s) (CH2),
27.9 (s) (CH3), 19.6 (s) (CH2); m/z (APCI) 325 [(M+H)+, 100%]; (Found: (M + H)+ (ES+) 
325.1551. Ci9H20N2O3 requires (M + H)+ 325.1547).
1. NaH, DMF
N Ph N Ph
2. Et-I
3-Ethyl-l-benzyl-3-(4”-nitrophenyl)piperidin-2-one (147c)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.04 mmol), 1-benzyl-
3-phenylsulfanyl-piperidin-2-one (146) (0.50 g, 1.68 mmol), nitrobenzene (0.18 ml, 1.68 
mmol) and ethyl iodide (0.52g, 3.36 mmol) to give the crude product (1.43 g) as an orange oil. 
The crude product was then purified by column chromatography Rf 0.27 (silica, hexane:ethyl 
acetate; 3:1) to give the pure product (0.33 g, 58%) as a yellow oil. umax (neat, NaCl plates/ 
cm 1) 2929 (s), 1618 (s), 2938 (s), 1494 (s), 1377 (m), 1194 (m); 5H(400 MHz; CDCb) 8.07 
(2H, d, J  8.9 Hz, H-3’ & H-5’), 7.47 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.19-7.27 (5H, m, Ph); 
5C(100 MHz; CDC13) 172.0.(s) (C=0), 152.7 (s) (C, Ar), 146.8 (s) (C, Ar), 137.6 (s) (C, Ar),
129.7 (s) (2 x CH, Ar), 129.1 (s) (2 x CH, Ar), 128.6 (s) (2 x CH, Ar), 128.0 (s) (CH, Ar),
123.9 (s) (2 x CH, Ar), 52.4 (s) (C, quaternary), 51.2 (s) (CH2), 48.0 (s) (CH2), 34.3 (s) (CH2),
31.3 (s) (CH2), 19.0 (s) (CH2), 9.6 (s) (CH3); m/z (APCI) 339 [(M+H)+, 100%]; (Found: (M + 
H)+ (ES+) 339.1708. C20H22N2O3 requires (M + H)+ 339.1703).
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2. H+
Ph
1-Phenyl-2-methyl-4-(4”-nitrophenyl)pyrazolidin-3-one (154a)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.21 g, 5.28 mmol), 1-phenyl-
2-methyl-4-phenylsulfanyl-pyrazolidin-3-one (153) (0.50 g, 1.76 mmol), nitrobenzene (0.18 
ml, 1.76 mmol) and saturated ammonium chloride (2.0 ml) to give the crude product (1.01 g) 
as an orange oil. The crude product was then purified by column chromatography Rf 0.14 
(silica, hexane:ethyl acetate; 3:1) to give the pure product (0.36 g, 69%) as a yellow crystalline 
solid. M.p. 170-172 °C; Umax (nujol, NaCl plates/ cm'1) 2918 (s), 1699 (s), 1595 (m), 1513 (m), 
1462 (s), 1377 (m); 5H(400 MHz; CDC13) 7.97 (2H, d, JS.S Hz, H-3’ & H-5’), 7.17-7.23 (4H, 
m, H-2’, H-6 ’, H-3” & H-5”), 6.96 (1H, app. t, J  7.5 Hz, H-4”), 6.81 (2H, d, /7 .5  Hz, H-2” & 
H-6 ”), 3.76-3.96 (3H, m, H-3 & H-4), 2.96 (3H, s, CH3); 5C(100 MHz; CDC13) 171.6.(s) 
(C=0), 149.3 (s) (C, Ar), 147.6 (s) (C, Ar), 143.9 (s) (C, Ar), 130.1 (s) (2 x CH, Ar), 129.9 (s) 
(2 x CH, Ar), 125.0 (s) (CH, Ar), 124.3 (s) (2 x CH, Ar), 119.2 (s) (2 x CH, Ar), 63.6 (s) 
(CH2), 45.9 (s) (CH3 or CH), 31.6 (s) (CH3 or CH); m/z (APCI) 298 [(M+H)+, 100%]; (Found: 
(M + H)+ (ES+) 298.1181. Ci6Hi5N30 3 requires (M + H)+ 298.1186).
phS 9 i.NaH .PM F
L 'N _N
Ph
2. CH3I
o 2n ^
4-Methyl-l-phenyl-2-methyl-4-(4”-nitrophenyl)pyrazolidin-3-one (154b)—This was prepared 
by the General Method using sodium hydride (60% dispersion in oil) (0.21 g, 5.28 mmol), 1- 
phenyl-2-methyl-4-phenylsulfanyl-pyrazolidin-3-one (153) (0.50 g, 1.76 mmol), nitrobenzene 
(0.18 ml, 1.76 mmol) and methyl iodide (0.22 ml, 3.52 mmol) to give the crude product (1.22 
g) as a brown oil. The crude product was then purified by column chromatography Rf 0.50 
(silica, hexane:ethyl acetate; 1:1) to give the pure product (0.26 g, 47%) as a yellow crystalline 
solid. M.p. 200 °C dec\ Umax (nujol, NaCl plates/ cm'1) 3383 (s), 2923 (s), 2455 (w), 1939 (m), 
1462 (m), 1376 (m); 5H(400 MHz; CDC13) 7.96 (2H, d, J 8 . 8  Hz, H-3’ & H-5’), 7.42 (2H, d, J
8 . 8  Hz, H-2’ & H-6 ’), 7.13 (2H, app. t, 78.1 Hz, Ph), 6.89 (1H, app. t, J 8.1 Hz, Ph), 6.73 (2H, 
app. d, J 8.1 Hz, Ph), 4.20 (1H, d, /11 .7  Hz, HCH), 3.95 (1H, d, J 11.7 Hz, HCH), 3.07 (3H, s, 
N-CH3), 1.44 (3H, s, CH3); 5c(100 MHz; CDC13) 174.3.(s ) (C=0), 149.7 (s) (C, Ar), 149.6 (s)
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(C, Ar), 147.0 (s) (C, Ar), 129.7 (s) (2 x CH, Ar), 128.6 (s) (2 x CH, Ar), 124.0 (s) (CH, Ar),
123.9 (s) (2 x CH, Ar), 118.1 (s) (2 x CH, Ar), 67.8 (s) (CH2), 49.4 (s) (C, quaternary), 32.1 (s) 
(CH3), 25.4 (s) (CH3); m/z (APCI) 312.0 [(M+H)+, 100%]; (Found: (M + H)+ (ES+) 312.1340 
C,7H17N30 3 requires (M + H)+ 312.1343).
1. NaH, DMF 0 2 N ~ ^
2. BnBr
4-Benzyl-l-phenyl-2-methyl-4-(4”-nitrophenyl)pyrazolidin-3-one (154c)—This was prepared 
by the General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.01 mmol), 1- 
phenyl-2-methyl-4-phenylsulfanyl-pyrazolidin-3-one (153) (0.50 g, 1.76 mmol), nitrobenzene 
(0.18 ml, 1.76 mmol) and benzyl bromide (0.40 ml, 3.34 mmol) to give the crude product (2.60 
g) as a brown oil. The crude product was then purified by column chromatography Rf 0.41 
(silica, hexane:ethyl acetate; 3:1) to give the pure product (0.41 g, 61%) as a yellow crystalline 
solid. Umax (nujol, NaCl plates/ cm'1) 2920 (s), 2440 (w), 1921 (w), 1690 (s), 1595 (m), 1507 
(m), 1462 (s) (s); 6H(400 MHz; CDC13) 7.97 (2H, d, J  8 . 8  Hz, H-3’ & H-5’), 7.39 (2H, d, J 8 . 8  
Hz, H-2’ & H-6 ’), 7.21-7-29 (3H, m, Ph), 7.15 (2H, app. t, J  8.0 Hz, Ph), 7.10-7.13 (2H, m, 
Ph), 6.91 (1H, t, J  8.0 Hz, Ph), 6.70 (2H, app. d, J  8.0 Hz, Ph), 4.19 (1H, d, J  11.9 Hz, HCH), 
3.93 (1H, d, J 11.9 Hz, HCH), 3.41 (1H, d, J  13.1 Hz, HCH-Ph), 3.13 (1H, d, J  13.1 Hz, HCH- 
Ph), 3.10 (3H, s, N-CH3); 5c(100 MHz; CDC13) 173.7 (s) (C=0), 149.9 (s) (C, Ar), 149.7 (s) 
(C, Ar), 146.9 (s) (C, Ar), 130.0 (s) (2 x CH, Ar), 128.5 (s) (2 x CH, Ar), 127.9 (s) (CH, Ar),
127.0 (s) (2 x CH, Ar), 126.7 (s) (2 x CH, Ar), 123.9 (s) (CH, Ar), 123.7 (s) (2 x CH, Ar),
117.9 (s) (2 x CH, Ar), 67.9 (s) (CH2), 49.9 (s) (C, quaternary), 43.0 (s) (CH2), 32.2 (s) (CH3); 
m/z (APCI) 388.0 [(M+H)+, 100%]; (Found: (M + H)+ (ES*) 388.1586 Ci7Hi7N30 3requires (M 
+ H)+ 388.1583).
O CAN'-OJUT o2n^
3-(4”-Nitrophenyl)-pyrrolidin-2-one (155)—Cerium ammonium nitrate (0.53 g, 0.96 mmol) 
was dissolved in water (6 . 0  ml) and added to a solution of l-(4’-methoxyphenyl)-3-(4”- 
nitrophenyl)-pyrrolidin-2-one (143a) (200 mg, 0.32 mmol) in acetonitrile (12.0 ml) at 0 °C. 
After stirring for 1 hour excess solid sodium sulfite was added. The solvent was then removed
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on a rotary evaporator. Ethyl acetate (20.0 ml) was then added to the organic residue. The 
solution was then washed with brine, dried over magnesium sulfate and the solvent removed on 
a rotary evaporator to leave the crude product (0.21 g) as a brown oil. The crude product was 
then purified by column chromatography Rf 0.10 (silica, hexane:ethyl acetate; 1:1) to give the 
pure product (98 mg, 81%) as a yellow crystalline solid. M.p. 168-170 °C; Umax (nujol, NaCl 
plates/ cm'1) 2922 (s), 1676 (s), 1598 (m), 1528 (m), 1464 (s), 1377 (m), 1346 (s); 5h (400 
MHz; CDC13) 8.15 (2H, d, J  8 . 8  Hz, H-3’ & H-5’), 7.41 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.0 
(1H, s, NH), 3.73 (1H, t, J  9.4 Hz, H-3), 3.41-3.46 (2H, m, H-5), 2.55-2.64 (1H, m, H-4a), 
2.15-2.25 (1H, m, H-4P); 5C(100 MHz; CDC13) 177.9.(s) (C=0), 147.5 (s) (C, Ar), 147.0 (s) 
(C, Ar), 129.5 (s) (2 x CH, Ar), 124.4 (s) (2 x CH, Ar), 47.7 (s) (CH), 41.0 (s) (CH2), 30.8 (s) 
(CH2); m/z (APCI) 207 [(M+H)+, 100%]; (Found: (M + H)+ (ES+) 207.0699 Ci0H10N2O3 
requires (M + H)+ 207.0691).
General Method for a-chlorination of Lactams—To a stirred solution of the lactam (31.26 
mmol) in dry THF (30 ml) at -78 °C under an inert atmosphere was added sec-Buli (34.3 
mmol) (1.4 M in cyclohexanes) and the reaction mixture was stirred for 30 minutes, p- 
Toluenesulfonyl chloride (50 mmol) dissolved in dry THF (25 ml) was added dropwise to the 
reaction mixture, which was then allowed to warm to room temperature. After stirring for 16 
hours the resulting suspension was quenched with saturated ammonium chloride ( 1 0 0  ml) and 
the aqueous layer was washed with ethyl acetate (3 x 50 ml). The organic layers were 
combined, washed with water (50 ml), dried over Na2SC>4, the solvent removed on a rotary 
evaporator to give the crude product.
1-Methyl-3-chloro-pyrrolidin-2-one220 (150)—This was prepared by the General Method 
using l-methyl-2-pyrrolidinone (104) (3.0 ml, 31.26 mmol), sec-BuLi (25.0 ml, 35 mmol) (1.4 
M in cyclohexanes), and /?-toluenesulfonyl chloride (9.1 g, 50.1 mmol) to give the crude 
product as an orange oil. The crude product was then purified by column chromatography Rf
0.0.37 (silica, dichloromethane:ethyl acetate; 1:1) to give the pure product (2.09 g, 50%) as a 
yellow oil. Umax (neat, NaCl plates/ cm'1) 1698 (s), 1513 (m), 1344 (m); 5H(400 MHz; CDCI3)
4.29 (1H, dd, J  4.6 & 7.7 Hz, H-3), 3.40-3.51 (1H, m, H-5a), 3.22-3.33 (1H, m, H-5p), 2.81 
(3H, s, CH3), 2.42-2.60 (1H, m, H-4a), 2.06-2.21 (1H, m, H-4P); 6C(100 MHz; CDC13)
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169.1.(s) (C=0), 56.9 (s) (C-3), 48.4 (s) (N-CH3), 47.8 (s) (C-5), 32.1 (s) (C-4); m/z (APCI)
134.0 [(M+H)+, 100%].
l-Benzyl-3-chloro-piperidin-2-one142 (149)—This was prepared by the General Method using 
l-benzyl-piperidin-2-one (145) (1.3 g, 6.87 mmol), sec-Buli (5.5 ml, 7.7 mmol) (1.4 M in 
cyclohexanes), and p-toluenesulfonyl chloride (2 .0 g, 1 1 . 0  mmol) to give the crude product as a 
yellow oil. The crude product was then purified by column chromatography Rf 0.10 (silica, 
hexane:ethyl acetate; 3:2) to give the pure product (0.58 g, 38%) as a yellow crystalline solid. 
M.p. 71-73 °C (lit. 72-73 °C)142; i w  (nujol, NaCl plates/ cm'1) 2956 (s), 2240 (w), 1657 (s), 
1493 (s), 1452 (s), 1353 (s), 1173 (s), 1079 (m), 951 (m); 5H(400 MHz; CDC13) 7.12-7.24 (5H, 
m, Ph), 4.61 (1H, d, J  14.6 Hz, HCH-Ph), 4.40 (1H, t, J 4 A  Hz, H-3), 4.33 (1H, d, J  14.6 Hz, 
HCH-Ph), 3.08-3.19 (2H, m, H-6 ), 1.99-2.14 (3H, m, H-5 & H-4 a), 1.62-1.67 (1H, m, H-4P); 
5C(100 MHz; CDC13) 173.6.(s) (C=0), 136.9 (s) (C, Ar), 130.3 (s) (2 x CH, Ar), 129.0 (s) (2 x 
CH, Ar), 127.9 (s) (CH, Ar), 55.6 (s) (CH), 50.8 (s) (CH2), 47.4 (s) (CH2), 31.4 (s) (CH2), 19.0 
(s) (CH2); m/z (APCI) 224.0 [(M+H)+, 100%].
10% Pd/C 
EtOAc
3-Methyl-l-benzyl-3-(4’-aminophenyl)pyrrolidin-2-one (156)—In a two necked round bottom 
flask was added 10% palladium on carbon (25 mg) and ethyl acetate (2 ml). The catalyst was 
activated by flushing with hydrogen 3 times. 3-Methyl-1-benzyl-3-(4’-nitrophenyl)- 
pyrroldinin-2-one (138a) was added to the flask. The mixture was flushed with hydrogen and 
then left to stir under hydrogen at atmospheric pressure for 24 hours. The reaction mixture was 
then filtered through celite and then reduced on a rotary evaporator to give the crude product 
(210 mg) as a brown oil. The crude product was then purified by column chromatography Rf
0.20 (silica, hexane: ethyl acetate 1:3) as a yellow oil. Umax (neat, NaCl plates/ cm'1) 3489 (s), 
3410 (s), 2981 (s), 1691 (s); 5H(400 MHz; CDC13) 7.07 (2 H, d, J  8.4 Hz, H-2’ & H-6 ’), 6.79-
7.30 (5H, m, Ph), 6.64 (2H, d, J8 .4  Hz, H-3’ & H-5’), 4.44 (2H, s, CH2-Ph), 3.49 (2H, s, CH3), 
3.09-3.21 (2H, m, H-5), 2.23-2.29 (1H, m, H-4a), 2.03-2.11 (1H, m, H-4P), 1.52 (3H, s, CH3); 
5C(100 MHz; CDC13) 177.1 (s) (C=0), 149.2 (s) (C, Ar), 146.3 (s) (C, Ar), 135.7 (s) (C, Ar),
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129.5 (s) (2 x CH, Ar), 128.3 (s) (CH, Ar), 128.0 (s) (2 x CH, Ar), 123.5 (s) (2 x CH, Ar),
119.8 (s) (2 x CH, Ar), 49.7 (s) (C, quaternary), 47.4 (s) (CH2), 43.2 (s) (CH2), 35.1 (s) (CH2),
24.8 (s) (CH3); m/z (APCI) 281.0 [(M+H)+, 100%].
NaBH,
EtOH
Ph
Dihydro-5-phenyl(3H)furan-2-one221 (160)—3-Benzoylpropionic acid (2.0 g, 11.2 mmol) was 
dissolved in ethanol (50 ml). A solution of sodium borohydride (0.85 g, 22.4 mmol) in ethanol 
(25 ml) was slowly added at 0 °C. Following the addition the reaction mixture was stirred at 
room temperature for four hours. The reaction was followed by TLC. After acidification with 
10% HC1 most of the ethanol was removed on a rotary evaporator. The resulting mixture was 
cooled to room temperature and extracted with dichloromethane (3 x 50 ml). The 
dichloromethane was removed on a rotary evaporator to give the crude product (1.70 g) as a 
white solid. The product was then purified by column chromatography Rf 0.25 (silica, 
hexane:ethyl acetate 3:1) to give the pure product (1.39 g, 51%) as a white crystalline solid. 
M.p.35-37 °C (lit. 37-38 °C) . 221 i w  (nujol on NaCl plates/ cm'1) 2921 (s), 1794 (s) (C=0), 
1459 (s), 1376 (s), 1170 (m), 939 (w), 698 (w), 5H(400 MHz; CDC13) 7.25-7.45 (5H, m, 
aromatic), 5.5, (1H, m, CH-O), 2.80 (3H, m, CH2-C=0 + HCH), 2.25 (1H, m, HCH), 6C(400 
MHz; CDC13) 177.0 (s) (C=0), 139.4 (s) (C, Ar), 128.8 (s) (2 x CH, Ar), 128.5 (s) (CH, Ar),
125.3 (s) (2 x CH, Ar), 81.2 (s) (Ph-C-O), 31.0 (s) (C-C=0), 29.0 (s) (CH2-CH2-CH) m/z 
(APCI) 162.9 [(M + H)+, 100%].
2. PhSSPh
SPh
(3SR,5RS) & (3RS,5RS)-Dihydro-5-phenyl-3-(phenylthio)(3H)furan-2-one 171 (161)—To a
solution of di-isopropylamine (0.33 ml, 2.35 mmol) in dry THF (10 ml) was added n- 
butyllithium (0.67 ml, 2.35 mmol) at -78 °C under nitrogen. The mixture was stirred for half 
an hour at this temperature. The lactone 166 (0.35 g, 2.35 mmol) was dissolved in dry THF (5 
ml), cooled to -78 °C and added to the LDA solution. The reaction mixture was stirred at -78 
°C for a further half hour. Phenyl disulfide (0.55 g, 2.56 mmol) was dissolved in dry THF (5
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ml) at -78 °C and added drop wise to the reaction mixture. The mixture was stirred at -78 °C 
for three hours. The reaction was then quenched with saturated aqueous ammonium chloride 
(2 ml). The organic product was extracted with chloroform (3 x 25 ml) and washed with water 
(3 x 25 ml), sodium, bicarbonate (25 ml) and the solvent was dried (magnesium sulfate) and 
removed to give the crude product (0.63 g) as a yellow crystalline solid. The product was then 
purified by column chromatography (silica, hexane:ethyl acetate 3:1) to give the cis and trans 
products (0.40 g, 70% overall yield). C/5-161 (0.24 g) as a white crystalline solid: Rf 
(Hexane:Ethyl acetate 3:1) 0.28, M.p. 92-94 °C (lit. 94 °C) 171 ; Umax (nujol; NaCl plates/ cm"1) 
2926 (s), 1772 (s), 1457 (m), 1376 (w), 1176 (m), 1017 (m), 940 (m), 756 (m); 6H(400 MHz; 
CDCI3) 7.48-7.51 (2H, m. aromatic), 7.26-7.35 (6 H, m, aromatic), 7.05-7.08 (2H, m, aromatic),
5.30 (1H, dd, J  10.0 & 6.1 Hz, H-5), 4.08 (1H, dd, J  11.5 & 8.7 Hz, H-3), 2.97 (1H, ddd, J  
13.4, 8.9 & 6.3 Hz, H-4a), 2.20 (1H, ddd, J  13.4, 11.5 & 10.1 Hz, H-4p); 5C(400 MHz; CDCI3)
174.5 (s) (C=0), 138.5 (s) (C, Ar), 134.5 (s)(C, Ar), 132.0 (s) (C, Ar), 129.5 (s) (C, Ar), 129.0 
(s) (C, Ar), 128.5 (s) (C, Ar), 126.5 (s) (C, Ar) 126.0 (s) (C, Ar), 79.0 (s) (C-O), 47.0 (s) (C-S),
39.0 (s) (CH2) m/z (APCI) 271.0 [(M+H)+, 100%]; Trans-161 (0.16 g) as a white crystalline 
solid: Rf (Hexane:ethyl acetate) 0.32, M.p. 80-81 °C (lit. 81-82 °C)250; Umax (nujol; NaCl plates/ 
cm"1) 2928 (s), 1769 (s), 1460 (m), 1372 (w), 1177 (m), 1020 (m), 755 (m); 6H(400 MHz; 
CDCI3) 7.49-7.51 (2H, m, aromatic), 7.20-7.35 (8 H, m, aromatic), 5.39 (1H, t, J  7.6 Hz, H-5),
3.96 (1H, dd, J  8.0 & 4.2 Hz, H-3), 2.56 (2H, m, H-4a & H-4p); 6C(400 MHz; CDC13) 174.0 
(s) (C=0), 137.5 (s) (C, Ar), 133.0 (s) (C, Ar), 131.0 (s) (C, Ar), 129.0 (s) (C, Ar), 128.0 (s) 
(C, Ar), 127.5 (s) (C, Ar), 124.5 (s) (C, Ar), 78.5 (s) (C-O), 44.0 (s) (C-S), 37.5 (s) (CH2); m/z 
(APCI) 271 [(M+H)+, 100%].
General Method for Asymmetric VNS—Sodium hydride (60% dispersion in oil) (4.6 mmol) 
was added to anhydrous DMF (3 ml) and the mixture flushed with nitrogen and cooled to 0 °C. 
The thiophenylated lactone 167 (4.6 mmol) and nitrobenzene (4.6 mmol) were dissolved in 
anhydrous DMF (5 ml) and added dropwise to the sodium hydride slurry. The reaction was 
stirred at 0 °C for thirty minutes before being allowed to warm to room temperature and stirred 
at this temperature for two hours. The reaction was then cooled to -50 °C using a 
methanol/cardice cooling bath. The electrophile (9.2 mmol) was added to the solution. The 
solution was then allowed to warm to room temperature and stirred at this temperature for two 
hours. The reaction mixture was poured onto ice/hydrochloric acid (1 M solution) (50 ml). 
The product was then extracted with dichloromethane (5 x 50 ml) and then washed with water
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(5 x 50 ml), sodium bicarbonate (3 x 50 ml) and dried (sodium sulfate). The solvent was 
removed on a rotary evaporator to give the crude product.
(3SR,5RS)-3-Methyl-3-(4 ’-nitrophenyl)-5-phenyldihydro(3H)furan-2-one (162)—This was 
prepared by the General Method using sodium hydride (0.19 g, 4.6 mmol), the thiophenylated 
lactone 161 (0.50 g, 1.85 mmol), nitrobenzene (0.20 ml, 1.85 mmol) and iodomethane (0.24 
ml, 3.7 mmol) to give the crude product (0.62 g) an orange oil. The crude product was purified 
using column chromatography (silica, hexane:ethyl acetate 3:1 Rf 0.20) to give the pure 
product (0.41g, 73%) as a white crystalline solid. M.p. 122-124 °C; (Found C, 6 8 .8 ; H, 4.9; N 
4.8% C17H15NO4 requires C, 68.7; H, 5.1; N, 4.7%); umax (nujol on NaCl plates/ cm'1) 2918 
(m), 1758 (s) (C=0), 1344 (m), 1177 (m), 848 (m), 732 (m), 694 (m), 5H (400 MHz; CDC13),
8.21 (2H, d, J 8.9 Hz, H-3’ and H-5’), 7.71 (2H, d, J 8.9 Hz, H-2’ and H-6 ’), 7.33-7.41 (5H, m, 
Ph), 5.65 (1H, dd, J 9.9 & 6.1 Hz, H-5), 2.89 (1H, dd, J  13.0 & 6.1 Hz, H-4a), 2.63 (1H, dd, J
13.0 & 9.9 Hz, H-4p), 1.79 (3H, s, CH3); 8C(100 MHz; CDC13), 178.5 (s) (C=0), 149.5 (s) 
N(C, Ar), 147.4 (s) (C, Ar), 138.7 (s) (C, Ar), 129.3 (s) (2 x CH, Ar), 129.2 (s) (CH, Ar), 127.8 
(s) (2 x CH, Ar), 125.8 (s) (2 x CH, Ar), 124.2 (s) (2 x CH, Ar), 78.4 (s) (C-5), 49.0 (s) (C-3),
46.6 (s) (CH2), 25.6 (s) (CH3); m/z (APCI) 298.0 [(M + H)+, 100 %], 282.0 (24), 252.0 (24),
220.9 (7), 219.9 (62), 192.0 (8 ), 79.2 (9); (Found: (M + NKU)* (ES+), 315.1348. C17Hi5N 04 
requires (M + NH4)+ 315.1345).
ph \  /
y °
Ph
(3SR,5RS)-Dihydro-3-(4’-nitrophenyl)-5-phenyl(3H)furan-2-one (162a)—This was prepared 
by the General Method using sodium hydride (0.19 g, 4.6 mmol), the thiophenylated lactone
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161 (0.50 g, 1.85 mmol), nitrobenzene (0.20 ml, 1.85 mmol) and saturated aqueous ammonium 
chloride (2.0 ml) to give the crude product (0.94 g) as a brown oil. The crude product was then 
purified by column chromatography Rf 0.28 (silica, hexane:ethyl acetate; 3:1) to give the pure 
product (0.41 g, 73%) as a white crystalline solid. M.p. 117-119 °C; (Found C, 67.93; H, 4.87; 
N 4.86%. C16H13NO4 requires C, 67.8; H, 4.6; N, 4.9%); umax (nujol on NaCl plates/ cm'1) 
2917 (m), 1759 (s) (C=0), 1367 (m), 1321 (w), 1172 (m), 907 (m), 848 (m), 732 (m); 5H(400 
MHz; CDCI3) 8.16 (2H, d, J 8 . 8  Hz, H-3’ & H-5’), 7.46 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.27-
7.38 (5H, m, Ph), 5.50 (1H, dd, J  10.7 & 5.5 Hz, H-5), 4.11 (1H, dd, J  12.8 & 8.4 Hz, H-3),
3.03-3.10 (1H, m, H-4a), 2.30-2.39 (1H, m, H-4P); 5C (100 MHz; CDC13), 177.7 (s) (C=0),
149.2 (s) (C, Ar), 147.7 (s) (C, Ar), 138.9 (s) (C, Ar), 129.3 (s) (2 x CH, Ar), 129.0 (s) (CH, 
Ar), 127.9 (s) (2 x CH, Ar), 125.7 (s) (2 x CH, Ar), 124.3 (s) (2 x CH, Ar), 78.7 (s) (C-5), 50.9 
(s) (C-3), 46.4 (s) (C-4); m/z (APCI) 284.0 [(M + H)+, 100 %]; (Found: (M + H)+ (APCI) 
283.0846 Ci6Hi3N 0 4 requires (M + H)+ 283.0845.
2. Allyl Bromide
(3SR,5RS)-3-Allyl-3-(4’-nitrophenyl)-5-phenyldihydro(3H)furan-2-one (162b)—This was 
prepared by the General Method using sodium hydride (0.19 g, 4.6 mmol), the thiophenylated 
lactone 161 (0.50 g, 1.85 mmol), nitrobenzene (0.20 ml, 1.85 mmol) and allyl bromide (0.16 
ml, 1.85 mmol) to give the crude product (1.0 g) as a brown oil. The crude product was then 
purified by column chromatography Rf 0.28 (silica, hexane:ethyl acetate; 3:1) to give the pure 
product (0.41 g, 67%) as a white crystalline solid. M.p. 124-126 °C; (Found C, 70.71; H, 5.22; 
N 4.03. C19H 17NO4 requires C, 70.6; H, 5.3; N, 4.3%); Umax (nujol on NaCl plates/ cm'1) 2919 
(m), 1760 (s) (C=0), 1341 (m), 1173 (m), 840 (m); 5H (400 MHz; CDC13) 8.12 (2H, d, J  9.0 
Hz, H-3’ & H-5’), 7.67 (2H, d, J9.Q Hz, H-2’ & H-6 ’), 7.21 (5H, m, Ph), 5.49-5.68 (2H, m, H- 
4 & -CH=CH2), 5.09-5.17 (2H, m, CH2=CH-), 2.98 (1H, dd, J 6.7 & 13.2 Hz, H-3a), 2.73 (2H, 
d, J  7.40 Hz, -CH2-CH=CH2), 2.55 (1H, dd, J  9.2 & 13.2 Hz, H-3|3); 6 C (100 MHz; CDC13)
177.0 (s) (C=0), 147.4 (s) (C, Ar), 147.0 (s) (C, Ar), 138.6 (s) (C, Ar), 128.9 (s) (CH), 128.8 
(s) (2 x CH, Ar), 127.8 (s) (2 x CH, Ar), 125.9 (s) (C, Ar), 125.3 (s) (2 x CH, Ar), 123.5 (s) (2 
x CH, Ar), 121.1 (s) (CH2), 77.8 (s) (C-5), 51.9 (s) (C, quaternary), 43.7 (s) (CH2), 42.0 (s)
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(CH2); m/z (APCI) 324.0 [(M + H)+, 100%], 296.0 (19), 279.0 (9), 105.1 (5), 71.4 (4); (Found: 
(M + H)+ (APCI), 324.1236 C19H17NO4 requires (M + H)+ 324.1236).
N 0 2
1. NaH, DMF
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(3SR,5RS)-3-Benzyl-3-(4’-nitrophenyl)-5-phenyldihydro(3H)furan-2-one (162c)—This was 
prepared by the General Method using sodium hydride (0.19 g, 4.6 mmol), the thiophenylated 
lactone 161 (0.50 g, 1.85 mmol), nitrobenzene (0.20 ml, 1.85 mmol) and benzyl bromide (0.32 
g, 1.85 mmol) to give the crude product (0.95 g) as an orange oil. The crude product was then 
purified by column chromatography Rf 0.46 (silica, hexane:ethyl acetate; 3:1) to give the pure 
product (0.34 g, 65%) as a white crystalline solid. M.p. 139-141 °C; (Found C, 74.17; H, 5.23; 
N 3.60%. C23H19NO4 requires C, 74.0; H, 5.1; N, 3.75%); Umax (nujol on NaCl plates/ cm'1) 
2918 (s), 1759 (s) (C O ), 1671 (w), 1595 (m), 1501 (w), 1462 (s), 1373 (m), 1353 (m); 5H(400 
MHz; CDCI3) 8.19 (2H, d, J  8 . 8  Hz, H-3’ & H-5’), 7.69 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.19- 
7.45 (10H, m, Ph), 5.58 (1H, dd, J  10.0 & 6.2 Hz, H-5), 3.63 (1H, d, J  13.2 Hz, HCH-Ph), 3.16 
(1H, d, J  13.2 Hz, HCH-Ph), 2.94 (1H, dd, J 1 A  & 14.1 Hz, H-4a), 2.48 (1H, dd, J 9.0 & 14.1 
Hz, H-4p); 5C (100 MHz; CDC13) 178.1 (s) (C=0), 149.0 (s) (C, Ar), 147.6 (s) (C, Ar), 140.2 
(s) (C, Ar), 138.9 (s) (C, Ar), 129.7 (s) (2 x CH, Ar), 129.3 (s) (CH, Ar), 127.7 (s) (2 x CH, 
Ar), 125.5 (s) (2 x CH, Ar), 125.3 (s) (CH, Ar), 125.0 (s) (2 x CH, Ar), 124.3 (s) (2 x CH, Ar),
123.6 (s) (2 x CH, Ar), 78.0 (s) (C-5), 48.7 (s) (C-3), 46.1 (s) (CH2), 44.7 (s) (CH2); m/z 
(APCI) 374.0 [(M + H)+, 100 %]; (Found: (M + H)+ (APCI) 373.1316 C23Hi9N0 4 requires (M 
+ H)+ 373.1314).
no 2 
6
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(3SR,5RS)-3-(2-oxo-2-phenylethyl)-3-(4’-nitrophenyl)-5-phenyldihydro(3H)furan-2-one 
(162d)—This was prepared by the General Method using sodium hydride (0.19 g, 4.6 mmol), 
the thiophenylated lactone 161 (0.50 g, 1.85 mmol), nitrobenzene (0.20 ml, 1.85 mmol) and 2- 
bromoacetophenone (0.37 g, 1.85 mmol) to give the crude product (1.2 g) as an orange oil. 
The crude product was then purified by column chromatography Rf 0.42 (silica, hexane:ethyl 
acetate; 3:1) to give the pure product (0.41 g, 67%) as a white crystalline solid. M.p. 152-154 
°C; umax (nujol on NaCl plates/ cm'1) 2918 (s), 1765 (s) (C=0), 1673 (m), 1596 (m), 1510 (m), 
1462 (s), 1377 (m), 1348 (m), 1203 (w); 5H(400 MHz; CDC13) 8.05 (2H, d, J  8.9 Hz, H-3’ & 
H-5’), 7.84 (2H, app. d, /  8.0 Hz, Ph), 7.61 (2H, d, J8 .9  Hz, H-2’ & H-6 ’), 7.53 (1H, app. t, J
7.3 Hz, Ph), 7.39 (2H, app. t, J 7.8 Hz, Ph), 7.17-7.24 (3H, m, Ph), 7.08-7.14 (2H, m, Ph), 5.83 
(1H, dd, J  5.8 & 8.4 Hz, H-5), 3.81 (1H, d, J  18.1 Hz, HCH), 3.65 (1H, d, J  18.1 Hz, HCH),
3.29 (1H, dd, J  8.5 & 13.6 Hz, H-4a), 2.81 (1H, dd, J  5.8 & 13.6 Hz, H-40); 5C (100 MHz; 
CDCI3) 196.4 (s) (C=0), 178.0 (s) (C=0), 148.5 (s) (C, Ar), 147.4 (s) (C, Ar), 140.0 (s) (C, 
Ar), 136.2 (s) (C, Ar), 134.5 (s) (CH, Ar), 129.3 (s) (2 x CH, Ar), 129.1 (s) (2 x CH, Ar), 128.7 
(s) (CH, Ar), 128.5 (s) (2 x CH, Ar), 128.1 (s) (2 x CH, Ar), 125.5 (s) (2 x CH, Ar), 124.2 (s) 
(2 x CH, Ar), 78.8 (s) (C-5), 50.1 (s) (C, quaternary), 48.5 (s) (CH2), 42.1 (s) (CH2); m/z (ES+)
402.0 [(M + H)+, 100%]; (Found: (M + H)+ (ES+), 402.1337. C24Hi9N 0 5 requires (M + H)+ 
402.1335).
NO
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(3SR, 5RS)-3-Methyl-3-(5’-chloro-2 ’-nitrophenyl)-5-phenyldihydro(3H)furati-2-one (173)—
This was prepared by the General Method using sodium hydride (0.19 g, 4.6 mmol), the 
thiophenylated lactone 161 (0.50 g, 1.85 mmol), 4-chloronitrobenzene (0.29 g, 1.85 mmol) and 
methyl iodide (0.25 ml, 1.85 mmol) to give the crude product (1.2 g) as an orange oil. The 
crude product was then purified by column chromatography Rf 0.37 (silica, hexane:ethyl 
acetate; 3:1) to give the pure product (0.28 g, 51%) as a white crystalline solid. M.p. 179-181 
°C; (Found C, 61.65; H, 4.30; N 4.19%. C17H14CINO4 requires C, 61.55; H, 4.25; N, 4 .2 2 %); 
Umax (nujol on NaCl plates/ cm'1) 2918 (s), 1762 (s) (C=0), 1666 (w), 1592 (m), 1496 (w);
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8h(400 MHz; CDC13) 8.35 (1H, d ,78.9 Hz, H-3’), 8.01 (1H, d . J l . l  Hz, H-6 ’), 7 .89(lH ,dd ,7
1.1 & 8.9Hz, H-4’), 7.31-7.45 (5H, m, Ph), 5.29 (1H, dd, J9 .2  & 6 . 8  Hz, H-5), 2.69 (1H, dd, J
13.6 & 6 . 8  Hz, H-4a), 2.49 (1H, dd, J  13.6 & 9.2 Hz, H-40), 1.69 (3H, s, CH3); 8C(100 MHz; 
CDC13), 174.6 (s) (C=0), 148.1 (s) (C, Ar), 139.9 (s) (C, Ar), 138.2 (s) (C, Ar), 136.9 (s) (C, 
Ar), 129.9 (s) (CH, Ar), 129.1 (s) (CH, Ar), 127.9 (s) (CH, Ar), 125.3 (s) (2 x CH, Ar), 124.0 
(s) (2 x CH, Ar), 122.8 (s) (CH, Ar), 80.4 (s) (C-5), 49.8 (s) (C-3), 44.6 (s) (CH2), 23.6 (s) 
(CH3); m/z (APCI) 332.0 [(M + H)+, 100%]; (Found: (M + H)+ (APCI), 336.0614. 
C,7H 14C1N0 4 requires (M + H)+ 331.0611).
General Method for Alkylation of Nitrophenylacetates/propionates—Sodium hydride 
(60% dispersion in oil) (1 eq.) was added to anhydrous DMF and the mixture flushed with 
nitrogen and cooled to 0 °C. Methyl 4-nitrophenyl propionate (173) (24.4 mmol) dissolved in 
DMF (20 ml) was then added and the solution was stirred at 0 °C for one hour. The 
electrophile (24.4 mmol) dissolved in DMF (10 ml) was added dropwise to the solution at -50 
°C. The solution was then allowed to warm to room temperature and stirred for a further two 
hours. The reaction mixture was then poured onto ice/hydrochloric acid (1M solution) and 
extracted with dichloromethane (3 x 50 ml). The combined organic extracts were washed well 
with water (5 x 50 ml), sodium bicarbonate (3 x 50 ml), dried (sodium sulfate) and the solvent 
removed on a rotary evaporator to give the crude product.
n o 2 NaH, DMF
OMe
Ph
Br
NO
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O
Methyl (2-methyl-2-(4’-nitrophenyl)-4-oxo-4-pheny)butyrate (165)—This was prepared by 
the General Method using sodium hydride (60% dispersion in oil) (0.98 g, 24.4 mmol, methyl
4-nitrophenylpropionate (164) (5.1 g, 24.4 mmol) and 2-bromoacetophenone (4.86 g, 24.4 
mmol) to give the crude product (5.6 g) as an orange crystalline solid. The crude product was 
recrystallized from ethanol to give the pure product (5.2 g, 65%) as a yellow crystalline solid. 
R.f. 0.40 (silica, 3:1 hexaneiethyl acetate). M.p.134-136 °C; (Found C, 66.61; H, 4.5.32; N 
4.11%. C18H17NO5 requires C, 66.1; H, 5.2; N, 4.3%); umax (nujol, NaCl plates/ cm'1) 2974 (s), 
1726 (C=0) (m), 1684 (C=0) (m), 1596 (m), 1460, 1377 (m), 854 (m). 6H(400 MHz; CDC13) 
8.19 (2H, d, J9 .0  Hz, H-3’ & H-5’), 7.95 (2H, app. d, J  7.6 Hz, aromatic), 7.57-7.63 (3H, m,
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aromatic), 7.45 (2H, app. t, J1.6 Hz, aromatic), 3.92 (1H, d, J  17.8 Hz, HCH), 3.74 (3H, s, 
OCH3) 3.65 (1H, d, J  17.8 Hz, HCH), 1.85 (3H, s, CH3). 5C(400 MHz; CDC13) 196.3 (s) 
(C O ), 174.7 (s) (C O ), 150.4 (s) (C, Ar), 146.9 (s) (C, Ar), 136.5 (s) (C, Ar), 133.6 (s) (CH, 
Ar), 128.7 (s) (2 x CH, Ar), 128.0 (s) (2 x CH, Ar), 127.1 (s) (2 x CH, Ar), 123.8 (s) (2 x CH, 
Ar), 52.7 (s) (0-CH3), 48.3 (s) (C, quaternary), 47.7 (s) (CH2), 23.6 (s) (CH3). m/z (APCI)
328.0 [(M + H)+, 100 %], 296.0 (58), 279.0 (11), 263.0 (3), 105.1 (18); (Found: (M + H)+ 
(ES+), 328.1187. Ci8H17N 05 requires (M + H)+ 328.1185).
General Method for Reduction of Ketones—The ester (1.53 mmol) was dissolved in 
chloroform (10 ml). A solution of sodium borohydride (3.06 mmol) in methanol (10 ml) was 
slowly added to the solution at 0 °C. Following the addition the reaction mixture was stirred at 
room temperature for four hours. The reaction was monitored by TLC. After acidification 
with 10% hydrochloric acid most of the methanol was removed on a rotary evaporator. The 
resulting mixture was cooled to room temperature and extracted with dichloromethane (3 x 25 
ml). The dichloromethane was washed with water (3 x 20 ml), sodium bicarbonate (20 ml) and 
dried (sodium sulfate) to give the crude product.
NaBH4
(3SR,5RS) & (3RS,5RS)-3-Methyl-3-(4’-nitrophenyl)-5-phenyldihydro(3H)furan-2-one
(162)—This was prepared by the General Method using methyl (2-methyl-2-(4’-nitrophenyl)-
4-oxo-4-pheny)butyrate (165) (1.00 g, 3.06 mmol) and sodium borohydride (232 mg, 6.12 
mmol) to give the crude product (0.83 g, 83%) as a 1:1 mixture of the two diastereoisomers. 
The two diastereoisomers were then separated by column chromatography (silica, 3:1, hexane: 
ethyl acetate, v/v).CVs isomer (0.41 g): Rf 0.28 (silica, hexane:ethyl acetate 3:1); M.p. 129-132 
°C; (Found C, 68.55; H, 4.99; N 4.88, C17H15NO4 requires C, 68.7; H, 5.1; N, 4.7%); i w  
(nujol on NaCl plates/ cm'1) 2920 (m), 1761 (s) (C=0), 1343(m), 1178 (m), 848 (m), 731 (m); 
5h(400 MHz; CDCI3) 8.15 (2H, d, J  8.8 Hz, H-3’ & H-5’), 7.67 (2H, d, J  8.8 Hz, H-2’ & H- 
6’), 7.31-7.41 (5H, m, aromatic), 5.17 (1H, dd, J  5.4 & 10.6 Hz, H-5), 3.08 (1H, dd,J5.4 &
13.3 Hz, H-4a), 2.46 (2H, dd, J  10.7 & 13.3 Hz, H-40), 1.69 (3H, s, CH3); 5C (400 MHz;
132
CDC13) 178.0 (s) (C=0), 149.1 (s) (C, Ar), 146.9 (s) (C, Ar), 138.2 (s) (C, Ar), 128.9 (s) (2 x 
CH, Ar), 128.8 (s) (CH, Ar), 127.1 (s) (2 x CH, Ar), 125.5 (s) (2 x CH, Ar), 124.3 (s) (2 x CH, 
Ar), 78.0 (s) (HC-O), 50.5 (s) (C, quaternary), 46.4 (s) (CH2), 26.4 (s) (CH3); m/z (APCI) 298.0 
[(M + H)+, 100 %], (Found: (M + NH4)+ (ES+), 315.1348. Ci7H15N 04 requires (M + NH4)+ 
315.1345).
OMe
1. NaH
2. 2-Bromoacetophenone
NO
OMePh
Methyl (2-(4’-nitrophenyl)-4-oxo-4-phenyl)butyrate (168)—This was prepared by the General 
Method using sodium hydride (1.03 g, 25.62 mmol), methyl 4-nitrophenylacetate (167) (5.0 g, 
25.62 mmol) and 2-bromoacetophenone (5.10 g, 25.62 mmol) to give the crude product (7.9 g) 
as a yellow crystalline solid. The crude product recrystallised from hot ethanol to give the pure 
product as a yellow crystalline solid (6.05 g, 75%). M.p. 161-163 °C; Umax (nujol on NaCl 
plates/ cm'1) 2926 (s), 1725 (s) (C=0), 1681 (s) (C O ), 1594 (m), 1519 (s), 1462 (s), 1377 (m), 
1348 (m), 1259 (m), 1234 (m), 1205 (m), 1163 (m), 1110 (m), 997 (m), 964 (m), 866 (m), 834 
(m), 762 (m), 736 (m), 690 (m); 6H(400 MHz; CDC13) 8.22 (2H, d, J  8.7 Hz, H-3’ & H-5’),
7.97 (2H, d, J 8.7 Hz, H-2’ & H-6’), 7.41-7.61 (5H, m, Ph), 4.44 (1H, dd, J 5.0 & 9.4 Hz, CH), 
3.95 (1H, dd, J  9.4 & 18.0 Hz, HCH), 3.72 (3H, s, OCH3), 3.36 (1H, dd, J  5.0 & 18.0 Hz, 
HCH); 6C(400 MHz; CDC13) 196.7 (s) (C O ), 172.7 (s) (O -CO ), 148.0 (s) (C, Ar), 145.6 (s) 
(C, Ar), 136.0 (s) (C, Ar) 133.7 (s) (CH, Ar), 129.0 (s) (2 x CH, Ar), 128.7 (s) (2 x CH, Ar),
128.1 (s) (2 x CH, Ar), 124.1 (s) (2 x CH, Ar), 52.8 (s) (C-O), 46.2 (s) (Ph-CH), 42.2 (s) 
(CH2); m/z (APCI) 314.0 [(M + H)+, 100 %], 283.0 (2), 282.0 (42), 60.4 (8) (Found: (M + H)+ 
(ES+), 314.0953. C17Hi5N 05 requires (M + H)+ 314.0950).
NaBH,
EtOH
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(3SR,5RS) & (3RS,5RS)-3-(4’-Nitrophenyl)-5-phenyldihydro(3H)furan-2-one (162a)—This 
was prepared by the General Method using sodium borohydride (60 mg, 1.60 mmol), 2-(4’- 
nitrophenyl)-4-oxo-4-phenyl butyric acid methyl ester (168) (0.50 g, 1.60 mmol), ethanol (20 
ml) and chloroform ( 1 0  ml) to give the crude product as a 1:1 mixture of diastereoisomers 
(0.63 g) as a yellow oil. Trans-162a: M.p. 117-119 °C; (Found C, 67.93; H, 4.87; N 4.86%. 
C16H13NO4 requires C, 67.8; H, 4.6; N, 4.9%); Umax (nujol on NaCl plates/ cm'1) 2917 (m), 
1759 (s) (C=0), 1367 (m), 1321 (w), 1172 (m), 907 (m), 848 (m), 732 (m); 5H(400 MHz; 
CDCI3) 8.16 (2H, d, J  8 . 8  Hz, H-3’ & H-5’), 7.46 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.27- 7.38 
(5H, m, Ph), 5.50 (1H, dd, J  10.7 & 5.5 Hz, H-5), 4.11 (1H, dd, J  12.8 & 8.4 Hz, H-3), 3.03- 
3.10 (1H, m, H-4a), 2.30-2.39 (1H, m, H-40); 6 C (100 MHz; CDCI3), 177.7 (s) (C=0), 149.2 
(s) (C, Ar), 147.7 (s) (C, Ar), 138.9 (s) (C, Ar), 129.3 (s) (2 x CH, Ar), 129.0 (s) (CH, Ar),
127.9 (s) (2 x CH, Ar), 125.7 (s) (2 x CH, Ar), 124.3 (s) (2 x CH, Ar), 78.7 (s) (C-5), 50.9 (s) 
(C-3), 46.4 (s) (C-4); m/z (APCI) 284.0 [(M + H)+, 100 %]; (Found: (M + H)+ (APCI) 
283.0846 C16H 13NO4 requires (M + H)+ 283.0845. It was not possible to isolate the cis 
diastereoisomer from the crude products.
1. NaH, DMF
OMe 2. Allyl Bromide
NO
OMe
O
Methyl (2-(4’-nitrophenyl)pent-4-enoate222 (168)—This was prepared by the General Method 
using sodium hydride (0.14 g, 10.3 mmol), methyl 4-nitrophenylacetate (167) (2.0 g, 10.3 
mmol) and allyl bromide (0.89 ml, 10.3 mmol) to give the crude product (2.98 g) as an orange 
oil. The crude product was then purified by column chromatography Rf 0.30 (silica, 
hexane:ethyl acetate; 3:1) to give the pure product (2.25 g, 93%) as a yellow oil. umax (neat, 
NaCl plates/ cm 1) 2925 (s), 1736 (s) (C=0), 1685 (s) (C=C), 1596 (s), 1518 (s), 1461 (s), 1376 
(s), 1344 (s), 1254 (m ), 1168 (s), 1110 (m), 1053 (m); 5H(400 MHz; CDC13) 8.18 (2H, d, J  8.9 
Hz, H-3’ & H-5’), 7.49 (2H, d, /8 .9  Hz, H-2’ & H-6 ’), 5.63-5.73 (1H, m, H2C=CH-), 5.01-
5.09 (2H, m, H2C=C), 3.78 (1H, t, J  7.7 Hz, CH-Ar), 3.69 (3H, s, OCH3), 2.82-2.90 (1H, m, 
HCH-C-Ar), 2.51-2.58 (1H, m, HCH-C-Ar); 8C(100 MHz; CDC13) 173.0 (s) (C=0), 147.6 (s) 
(C, Ar), 146.1 (s) (C, Ar), 134.5 (s) (CH), 129.4 (s) (2 x CH, Ar), 124.2 (s) (2 x CH, Ar), 118.3
134
(s) (CH2), 52.7 (s) (CH, Ar), 51.5 (s) (0-CH3), 37.8 (s) (CH2); m/z (APCI) 236.0 [(M + H)+, 
100 %], 209.9 (8), 175.9 (16), 73.3 (7).
NO.
OMe
O
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2. 2-Bromoacetophenone ,OMe
° Y  °
Ph
Methyl (2-(4-nitrophenyl)-2-(2-oxo-2-phenyl-ethyl)pent-4-enoate (169)—This was prepared 
by the General Method using sodium hydride (0.08 g, 2.13 mmol), methyl ester 168 (0.5 g,
2.13 mmol) and 2-bromoacetophenone (0.42 g, 2.13 mmol) to give the crude product (0.74 g) 
as an orange oil. The crude product was then purified by column chromatography Rf 0.30 
(silica, hexane:ethyl acetate; 3:1) to give the pure product (0.65 g, 86%) as a yellow crystalline 
solid. M.p. 152-154 °C; Umax (nujol on NaCl plates/ cm'1) 3080 (s), 2952 (s), 2854 (m), 2455 
(m), 1931 (m), 1737 (s), 1642 (s), 1604 (s), 1517 (s), 1435 (s), 1435 (s), 1109 (s), 995 (s); 
5h(400 MHz; CDCI3) 8.16 (2H, d, J  8.9 Hz, H-3’ & H-5’), 7.89 (2H, d, J  8.9 Hz, H-2’ & H- 
6’), 7.49-7.55 (3H, m, Ph), 7.41 (2H, app. t, J7 .9  Hz, Ph), 5.28-5.36 (1H, m, H2C=CH-), 4.85- 
4.93 (2H, m, H2C=), 3.82 (1H, d, J  18.0 Hz, 0=C-HCH), 3.74 (1H, d, J  18.0 Hz, OC-HCH), 
3.63 (3H, s, OCH3), 2.94-3.07 (2H, m, H2C=CH-CH2-); 8C(100 MHz; CDC13) 196.5 (s) (C=0),
174.1 (s) (C=0), 148.5 (s) (C, Ar), 146.9 (s) (C, Ar), 136.6 (s) (C, Ar) 134.0 (s) (CH), 132.6 (s) 
(CH), 128.9 (s) (2 x CH, Ar) 128.2 (s) (2 x CH, Ar) 127.6 (s) (2 x CH, Ar), 123.7 (s) (2 x CH, 
Ar), 120.0 (s) (CH2), 54.1 (s) (O-CH3), 51.6 (s) (C, quaternary), 42.5 (s) (CH2), 40.5 (s) (CH2); 
m/z (APCI) 354.0 [(M + H)+, 100 %], 322 (88); (Found: (M + NH4)+ (ES+) 371.1611 
C20H19NO5 requires (M + NH4)+ 371.1607).
NaBH
EtOH
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(3SR,5RS) & (3RS, 5RS)-3-A llyl-3-(4 ’-n itroph enyl)-5-phenyldihydro(3 H)fur an -2-on e
(162b)—This was prepared by the General Method using sodium borohydride (80 mg, 2.17 
mmol), methyl (2-(4-nitrophenyl)-2-(2-oxo-2-phenylethyl))pent-4-enoate (169) (0.64 g, 2.17 
mmol), ethanol (10 ml) and chloroform (5 ml) to give the crude product as a 1:1 mixture of 
diastereoisomers (0.60 g) as an orange oil. The two diastereoisomers were then separated by 
column chromatography (silica, 3:1, hexane: ethyl acetate, v/v) (62% overall yield). Cis isomer 
(0.30 g) Rf 0.34 (silica, hexane:ethyl acetate; 3:1) M.p. 127-130 °C; Umax (nujol on NaCl plates/ 
cm'1) 2918 (m), 1758 (s) (C=0), 1339 (m), 1172 (m), 843 (m); 5H (400 MHZ; CDC13) 8.28 (2 H, 
d, J  8.9 Hz, H-3’ & H-5’), 7.72 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.33-7.43 (5H, m, Ph), 5.61- 
5.70 (1H, m, -CH=CH2), 5.22 (1H, d d , J 5 A  & 10.9 Hz, H-5), 5.02-5.18 (2H, m, CH2=CH-),
3.01 (1H, dd, J5.4 & 13.6 Hz, H-3a), 2.68-2.80 (2H, m, -CH2-CH=CH2), 2.56 (1H, dd, J  10.9 
& 13.6 Hz, H-3p); 6C(100 MHz; CDC13) 176.9 (s) (C=0), 147.5 (s) (C, Ar), 146.9 (s) (C, Ar),
138.0 (s) (C, Ar), 131.8 (s) (CH), 128.9 (s) (2 x CH, Ar), 128.8 (s) CH), 127.6 (s) (2 x CH, 
Ar), 125.6 (s) (C, Ar), 124.2 (s) (2 x CH, Ar), 120.7 (s) (CH2), 77.3 (s) (C-5), 54.0 (s) (C, 
quaternary), 43.7 (s) (CH2), 41.8 (s) (CH2); m/z (APCI) 324 [(M + H)+, 100%]; (Found: (M + 
H)+ (APCI) 324.1236. C19H17NO4 requires (M + H)+ 324.1236).
no2
1. NaH, DMF
I QMe 2. Benzyl Bromide
O
Methyl (2-(4-nitrophenyl)-3-phenyl)propionate223 (171)—This was prepared by the General 
Method using sodium hydride (0.14 g, 10.3 mmol), methyl 4-nitrophenylacetate (167) (2.0 g,
10.3 mmol) and benzyl bromide (1.22 ml, 10.3 mmol) to give the crude product (2.80 g) as an 
orange crystalline solid. The crude product was then recrystallized from ethanol to give the 
pure product (2.22 g, 76%) as a yellow crystalline solid. M.p. 59-60 °C (lit. 60-61 °C)223; Umax 
(nujol on NaCl plates/ cm’1) 2921 (s), 1741 (s) (C=0), 1596 (m), 1458 (s), 1346 (m); SH(400 
MHz; CDCI3) 8.15 (2H. d, J 8 . 8  Hz, H-3’ & H-5’), 7.44 (2H, d, J 8 . 8  Hz, H-2’ & H-6 ’), 7.17- 
7.26 (3H, m, Ph), 7.06 (2H, app. d, J  8.3 Hz, Ph), 3.97 (1H, t, J  7.8 Hz, CH), 3.64 (3H, s, 
OCH3), 3.44 (1H, dd, J  13.8 & 7.8 Hz, HCH), 3.04 (1H, dd, J  13.8 & 7.8 Hz, HCH); 5C(100 
MHz; CDCI3) 172.7 (s) (C=0), 147.2 (s) (C, Ar), 145.6 (s) (C, Ar), 137.8 (s) (C, Ar), 129.1 (s)
NO
OMe
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(2 x CH, Ar), 128.8 (s) (2 x CH, Ar), 128.5 (s) (2 x CH, Ar), 126.8 (s) (CH, Ar), 123.8 (s) (2 x
CH, Ar), 53.4 (s) (0-CH3), 52.4 (s) (CH,Ar), 39.6 (CH2); m/z (APCI) 286.0 [(M + H)+, 100%].
NO
OMe
O
1. NaH, DMF
2. Bromoacetophenone
NO
OMe
Ph
Methyl (2-benzyl-2-(4-nitrophenyl)-4-oxo-4-phenylbutyrate (172)—This was prepared by the 
General Method using sodium hydride (67 mg, 1.79 mmol), methyl (2-(4-nitrophenyl)-3- 
phenyl)propionate (171) (0.5 g, 1.79 mmol) and 2-bromoacetophenone (0.36g, 1.79 mmol) to 
give the crude product (0.74 g) as a yellow crystalline solid. The crude product was then 
purified by column chromatography Rf 0.41 (silica, hexane:ethyl acetate; 3:1) to give the pure 
product (0.63 g, 87%) as a yellow crystalline solid. M.p. 170-171 Umax (nujol on NaCl plates/ 
cm'1) 2929 (s), 1716 (s), 1687 (m), 1595 (m), 1521 (m), 1464 (s), 1376 (m), 1349 (m), 1219 
(m), 1062 (m), 860 (m); 5H(400 MHz; CDC13) 8.20 (2H, d, J  8.9 Hz, H-3’ & H-5’), 7.95 (2H, 
app. d, J7.5  Hz, Ph), 7.62 (1H, app. t, J  7.5 Hz, Ph), 7.45-7.51 (4H, m, Ph), 7.14 (1H, app. t, J
7.4 Hz, Ph), 7.05 (2H, app. t, J  7.4 Hz, Ph), 6.52 (2H, d, J  1.4 Hz, Ph), 3.72 (3H, s, 0-CH3), 
3.68-3.72 (3H, m, CH2 & HCH), 3.58 (1H, d, J  13.7 Hz, HCH); 8C(100 MHz; CDC13) 197.2 (s) 
(C=0), 174.7 (s) (C=0), 149.2 (s) (C, Ar), 147.3 (s) (C, Ar), 137.0 (s) (C, Ar) 136.4 (s) (C, 
Ar), 134.0 (s) (CH, Ar), 130.5 (s) (2 x CH, Ar), 129.2 (s) (2 x CH, Ar) 128.6 (s) (2 x CH, Ar),
128.4 (s) (2 x CH, Ar), 128.1 (s) (2 x CH Ar), 127.4 (s) (CH, Ar), 124.0 (s) (2 x CH, Ar), 53.1 
(s) (0-CH3), 53.0 (s) (C, quaternary), 42.5 (s) (CH2), 42.0 (s) (CH2); m/z (APCI) 404.0 [(M + 
H)+, 100 %], 372 (40); (Found: (M + H)+ (APCI), 404.1500. C24H2iN05 requires (M + H)+ 
404.1498).
O
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(S)-Dihydro-5-carboethoxy(3H)furan-2-one156 (175)—To a solution of L-glutamic acid (174) 
(90.0 g, 0.61 mol) in water (240 ml) and conc. hydrochloric acid (126 ml) was added slowly 
over a period of 6 hours at 0 °C a solution of sodium nitrite (63.0 g, 0.91 mol) in water (135 
ml). The clear solution was then stirred at room temperature overnight. Evaporation to 
dryness gave a pale yellow oil. Ethyl acetate (300 ml) was added to the oil, the insoluble 
material was filtered off and the organic solution dried over Na3S0 4 . The solvent was then 
removed on a rotary evaporator to leave a pale yellow syrup (80.6 g). Ethanol (130 ml), 
benzene (300 ml) and /?-TsOH (2.0 g) were added to the yellow syrup. The solution was then 
heated under reflux for 5 hours using a Dean-stark apparatus. The solvents were removed 
under reduced pressure. Benzene (100 ml) was added and the solution was washed with water 
(100 ml), Na2CC>3 (100 ml) and water (100 ml) before drying over Na2SC>4. Removal of the 
solvent left the crude product as a colourless oil (92.3 g, 95%). Umax (neat, NaCl plates/ cm'1) 
1784 (s) (C=0), 1747 (s) (C=0); 8H(400 MHz; CDC13) 4.91-4.97 (1H, m, H-5), 4.31 (2H, q, J
7.0 Hz, 0-CH2), 2.20-2.80 (4H, m, H-3 & H-4), 1.34 (3H, t, J  7.0 Hz, CH3); 8C(100 MHz; 
CDC13) 177.9 (s) (C=0), 88.9 (s) (C-5), 59.5 (s) (CH2), 35.2 (s) (C-3), 17.7 (s) (C-4), 13.6 (s) 
(CH3); m/z (APCI) 159.0 [(M + H)+, 100%].
NaBH,
(S)-(+)-5-Hydroxymethyldihydro(3H)furan-2-one224 (176)—A solution of dihydro-5- 
carboethoxy(3H)furan-2-one (175) (53.12 g, 0.34 mol) in ethanol (300 ml) was added dropwise 
to a stirred suspension of sodium borohydride (8.3 g, 0.22 mol) in ethanol (180 ml). The 
solution was stirred at room temperature for 90 minutes before being acidified to pH 3 with 
10% aq. HC1 at 0 °C. The resulting white precipitate was filtered off and the filtrate was 
evaporated under vacuum. Methanol (100 ml) was added to the residue and evaporated under 
vacuum (4 times) to give the crude product (28.8 g) as a clear oil. The crude product was then 
purified by column chromatography Rf 0.35 (silica, ethanol:chloroform; 7:93) to give the pure 
product (19.8 g, 51%) as a clear oil. umax (neat, NaCl plates/ cm'1) 3403 (s) (O-H), 1767 (s) 
(C=0), 1190 (s); 8h(400 MHz; CDC13) 4.58-4.62 (1H, m, H-5), 3.84 (1H, dd, J3.2 & 12.8 Hz,
O-HCH), 3.61 (1H, dd, J 4.4 & 12.8 Hz, O-HCH), 3.53 (1H, s, O-H), 2.46-2.63 (2H, m, H-3),
138
2.19-2.28 (1H, m, H-4a), 2.10-2.15 (1H, m, H-40); 5C(100 MHz; CDC13) 178.3 (s) (C O ), 81.1
(s) (CH2), 63.9 (s) (CH), 28.5 (s) (CH2), 23.1 (s) (CH2); m/z (APCI) 117.0 [(M + H)+, 100%].
General Method for Silyl protection of Alcohols—A mixture of alcohol (155 mmol), 
triethylamine (43.0 ml), silyl chloride (155 mmol), DMAP (15.5 mmol) and dichloromethane 
(200 ml) were stirred together for 24 hours. The reaction mixture was then poured into water 
(200 ml) and extracted with dichloromethane (3 x 100 ml). The combined organic extracts 
were then dried over sodium sulfate. The drying agent was filtered off and the solvent 
removed on a rotary evaporator to give the crude product.
NEt3
DMAP
TBDPS-CI
DCM
(S)-(+)-5-(tert-Butyldiphenylsilanyloxymethyl)-dihydro(3H)furan-2-one158 (177)—This was 
prepared by the General Method using (5)-(+)-y-hydroxymethyl-y-butyrolactone (176) (18.0 g, 
155 mmol), DMAP (1.89 g, 15.5 mmol), TBDPS-CI (40.35 g, 155 mmol), triethylamine (43 
ml, 313 mmol) and dichloromethane to give the crude product (51.9 g) as a black oil. The 
crude product was then purified by column chromatography Rf 0.18 (silica, ethyl 
acetate:hexane; 1:3) to give the pure product (30.2 g, 55%) as a white crystalline solid. [a]o 
+35.3° [a]D (c 1.09 in ethanol) (lit. +35.5° c 1.09 in ethanol)158; M.p. 74-75 °C (lit. 75-77 
°C)255; Umax (nujol, NaCl plates/ cm'1) 2966 (s), 1769 (s) (C O ), 1457 (s), 1377 (s), 1266 (m), 
1170 (s); 8h(400 MHz; CDC13) 7.56 (2H, app. d, 7  7.5 Hz, Ph), 7.26-7.32 (3H, m, Ph), 4.46 
(1H, ddd, 73.1 & 5.7 & 8.3 Hz, H-5), 3.76 (1H, dd, 73.1 & 11.4 Hz, O-HCH), 3.55 (1H, dd, 7
3.1 & 11.4 Hz, H-5), 2.54 (1H, ddd, 77.2 & 10.1 & 17.5 Hz, H-3a), 2.36 (1H, ddd, 76.7 & 9.9 
& 16.7 Hz, H-3p), 2.02-2.19 (2H, m, H-4), 0.95 (9H, s, (CH3)3); 8C(100 MHz; CDC13) 178.0 
(s) (C O ), 136.1 (s) (CH, Ar), 136.0 (s) (CH, Ar), 133.3 (s) (C, Ar), 132.9 (s) (C, Ar), 130.4 (s) 
(CH, Ar), 128.3 (s) (CH, Ar), 80.4 (s) (CH), 65.9 (s) (CH2), 29.1 (s) (CH2), 27.2 (s) (CH3), 24.0 
(s) (CH2), 19.6 (s) C, quaternary); m/z (APCI) 355.0 [(M + H)+, 100%].
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NEt3
DMAP
TBDMS-CI
DCM OTBDMS
(S)-(+)-5-(tert-Butyl-dimethylsilyloxymethyl)dihydro(3H)furan-2-one 225 (184)—This was 
prepared by the General Method using (5 )-(+)-y-hydroxymethyl-y-butyrolactone (176) (2.53 g, 
21.78 mmol), DMAP (0.27 g, 21.7 mmol), TBDMS-CI (3.28 g, 21.78 mmol), triethylamine 
(6.04 ml, 44.0 mmol) and dichloromethane (50 ml) to give the crude product (4.89 g) as a 
brown oil. The crude product was then purified by column chromatography Rf 0.20 (silica, 
ethyl acetate:hexane; 1:3) to give the pure product (3.62 g, 73%) as a colourless oil. [a]o -  
10.7° (c 0.5 in CHCI3) (lit. -11.0° c 0.5 in ethanol) 225 ; Umax (nujol, NaCl plates/ cm'1) 2931 (s), 
2857 (s), 1778 (s), 1462 (s), 1361 (m), 1257 (s); 6H(400 MHz; CDCI3) 4.52 (1H, ddd, J  3.2 &
5.2 & 8.0 Hz, Ph), 3.79 (1H, dd, J3 .2  & 11.2 Hz, O-HCH), 3.55 (1H, dd, J  3.2 & 11.2, HCH),
2.52 (1H, ddd, J 1 2  & 9.9 & 17.5 Hz, H-3a), 2.37 (1H, ddd, J  6.7 & 9.9 & 16.7 Hz, H-30), 
2.05-2.25 (2H, m, H-4), 0.81 (9H, s, (CH3)3), 0.00 (6 H, d, J3 .6  Hz, 2 x (CH3)); 6C(100 MHz; 
CDCI3) 178.0 (s) (C=0), 80.5 (s) (CH, Ar), 65.2 (s) (CH2), 28.9 (s) (CH2), 26.1 (s) (CH3), 23.9 
(s) (CH2), 18.6 (s) (C, quaternary); m/z (APCI) 231.0 [(M + H)+, 100%].
General Method for a-phenylsulfanylation of lactones—A solution of diisopropylamine 
(28.2 mmol) in dry THF (5 ml) was cooled to 0 °C and flushed with nitrogen. /z-Butyllithium 
(28.2 mmol) (2.5 M in hexanes) was added dropwise to the reaction mixture. The mixture was 
stirred at 0 °C for 10 minutes before cooling to -78 °C in a dry ice/acetone cooling bath. The 
lactone (14.1 mmol.) dissolved in dry THF (5 ml) was added dropwise to the solution. The 
mixture was stirred at -78 °C for 35 minutes. Phenyl disulfide (14.12 mmol) and DMPU 
(14.12 mmol) dissolved in dry THF (5 ml) was added dropwise to the reaction mixture. The 
mixture was stirred at -78 °C for a further 35 minutes before being allowed to warm to room 
temperature. The reaction mixture was then poured into water (100 ml) and extracted with 
ether (3 x 100 ml). The combined organic extracts were then washed successively with 10% 
NaOH (100 ml), water (100 ml), 10% HC1 (100 ml) and water (100 ml). The organic solution 
was then dried over Na2SC>4. The drying agent was filtered off and the solvent removed on a 
rotary evaporator to give the crude product.
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(3R,5S) & (3S, 5S)-5-(tert-Butyldiph enylsilyloxym ethyl)-3-ph enylsulfanyldihydro(3 H)fur an -
2-one 226(181)—This was prepared by the General Method using diisopropylamine (3.96 ml,
28.2 mmol, H-butyllithium (2.5 M in hexanes) (11.3 ml, 28.24 mmol), the lactone 178 (5.0 g, 
14.12 mmol), phenyl disulfide (3.08 g, 14.12 mmol), DMPU (1.71 ml, 14.12 mmol) to give the 
crude product (6.40 g) as an orange oil. The crude product was then purified by column 
chromatography (silica, ethyl acetaterhexane; 1:3) to give the two diastereoisomers (4.96 g, 
76%) in a cis. trans ratio of 3:7 as colourless oils. Cis product (1.49 g): Rf 0.28 (ethyl acetate: 
hexane 1:3) Umax (neat, NaCl plates/ cm'1) 2928 (s), 1771 (s), 1457 (m), 1376 (m), 1180 (m), 
1020 (m); 5H(400 MHz; CDC13) 7.51-7.55 (4H, m, Ph), 7.44-7.47 (2H, m, Ph), 7.28-7.35 (6H, 
m, Ph), 7.21-7.25 (3H, m, Ph), 4.35 (1H, ddd, 7  2.9 & 4.9 & 7.6 Hz, H-5), 4.04 (1H, dd, 7  7.4 
& 9.3Hz, H-3), 3.78 (1H, dd, 72.8 & 11.5 Hz, HCH-O), 3.53 (1H, dd, 7  2.8 & 11.5 Hz, HCH- 
O), 2.55-2.63 (1H, m, H-4a), 2.17-2.26 (1H, m, H-4P), 0.94 (9H, s, (CH3)3; 6C(100 MHz; 
CDC13) 175.1 (s) (C=0), 136.1 (s) (CH, Ar), 136.0 (s) (CH, Ar), 135.3 (s) (CH, Ar), 133.7 (s) 
(C, Ar), 133.6 (s) (C, Ar), 133.3 (s) (C, Ar), 130.5 (s) (CH, Ar), 129.7 (s) (CH, Ar), 128.8 (s) 
(CH, Ar), 128.4 (s) (CH, Ar), 78.6 (s) (C-5), 64.8 (s) (CH2), 46.3 (s) (CH), 31.6 (s) (CH2), 27.2 
(s) (CH3), 19.7 (s) (C); m/z (APCI) 463.0 [(M + H)+, 100%]; trans product (3.47 g): Rf 0.32 
(ethyl acetate: hexane 1:3) u max (neat, NaCl plates/ cm'1) 2928 (s), 1769 (s), 1458 (m), 1376 
(m), 1179 (m), 1017 (m); 5H(400 MHz; CDC13) 7.51-7.56 (4H, m, Ph), 7.39-7.44 (2H, m, Ph), 
7.25-7.35 (6H, m, Ph), 7.15-7.19 (3H, m, Ph), 4.38 (1H, ddd, 74.5 & 6.4 & 8.9 Hz, H-5), 3.88 
(1H, t, 7  10.2 Hz, H-3), 3.65 (1H, dd,73.9 & 11.5 Hz, HCH-O), 3.53 (1H, dd,74.6 & 11.5 Hz, 
HCH-O), 2.49 (1H, ddd, 76.6 & 9.3 & 15.9 Hz, H-4a), 2.07-2.16 (1H, m, H-4p), 0.93 (9H, s, 
(CH3)3; 6c (100 MHz; CDC13) 174.6 (s) (C=0), 135.7 (s) (CH, Ar), 135.6 (s) (CH, Ar), 133.2 
(s) (CH, Ar), 132.9 (s) (C, Ar), 132.7 (s) (C, Ar), 132.5 (s) (C, Ar), 129.9 (s) (CH, Ar), 129.2 
(s) (CH, Ar), 128.4 (s) (CH, Ar), 127.8 (s) (CH, Ar), 78.1 (s) (C-5), 64.4 (s) (CH2), 45.9 (s) 
(CH), 31.3 (s) (CH2), 26.7 (s) (CH3), 19.2 (s) (C); m/z (APCI) 463.0 [(M + H)+, 100%].
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(3R,5S) & (3S,5S)-5-(tert-Butyldimethylsilyloxymethyl)-3-phenylsulfanyldihydro(3H)furan-
2-one (185)—This was prepared by the gGeneral Method using diisopropylamine (1.23 ml, 
8.68 mmol, /z-butyllithium (2.5 M in hexanes) (3.47 ml, 8.68 mmol), the lactone 177 (1.0 g, 
4.34 mmol), phenyl disulfide (0.95 g, 4.34 mmol), DMPU (0.52 ml, 4.34 mmol) to give the 
crude product (1.19 g) as a yellow oil. The crude product was then purified by column 
chromatography (silica, ethyl acetate:hexane; 1:3) to give the two diastereo isomers (0.88 g, 
60%) in a cisitrans ration of 1:1 as colourless oils, cis product (0.44 g): Umax (neat, NaCl plates/ 
cm 1) 2927 (s), 1772 (s), 1457 (m), 1377 (m), 1183 (m), 1021 (m); 8H(400 MHz; CDC13) 7.27-
7.30 (2H, m, Ph), 7.03-7.09 (3H, m, Ph), 4.36 (1H, ddd, J  3.0 & 4.9 & 7.6 Hz, H-5), 4.05 (1H, 
dd,7 7.4 & 9.3Hz, H-3), 3.78 (1H, dd,J2.9  & 11.5 Hz, HCH-O), 3.53 (1H, dd,J2.9  & 11.5 
Hz, HCH-O), 2.54-2.62 (1H, m, H-4a), 2.16-2.25 (1H, m, H-4p), 0.80 (9H, s, (CH3)3), 0.00 
(6H, d, J3 .6  Hz, 2 x  (CH3)); 5C(100 MHz; CDC13) 175.0 (s) (C=0), 133.7 (s) (C, Ar), 133.1 (s) 
(2 x  CH, Ar), 129.3 (s) (2 x  CH, Ar), 128.0 (s) (CH, Ar), 78.5 (s) (C-5), 64.7 (s) (CH2), 46.2 
(s) (CH), 31.6 (s) (CH2), 27.2 (s) (CH3), 19.7 (s) (C); m/z (APCI) 339.0 [(M + H)+, 100%]; 
trans product (0.44 g): Umax (neat, NaCl plates/ cm"1) 2928 (s), 1774 (s), 1458 (m), 1376 (m), 
1181 (m), 1020 (m); 5H(400 MHz; CDC13) 7.26-7.29 (2H, m, Ph), 7.04-7.10 (3H, m, Ph), 4.39 
(1H, ddd, 74.5 & 6.4 & 9.0 Hz, H-5), 3.89 (1H, t, J  10.2 Hz, H-3), 3.66 (1H, dd, J  3.9 & 11.5 
Hz, HCH-O), 3.53 (1H, dd, J  4.6 & 11.5 Hz, HCH-O), 2.50 (1H, ddd, J 6.6 & 9.3 & 16.0 Hz, 
H-4a), 2.06-2.15 (1H, m, H-4P), 0.93 (9H, s, (CH3)3), 0.00 (6H, d, J3 .6  Hz, 2 x  (CH3)); 8C(100 
MHz; CDC13) 174.9 (s) (C=0), 133.8 (s) (C, Ar), 133.0 (s) (2 x  CH, Ar), 129.4 (s) (2 x  CH, 
Ar), 127.9 (s) (CH, Ar), 78.0 (s) (C-5), 64.3 (s) (CH2), 45.9 (s) (CH), 31.4 (s) (CH2), 26.7 (s) 
(CH3), 19.1 (s) (C); m/z (APCI) 339.0 [(M + H)+, 100%].
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(3R,5S) & (3S,5S)-5-(trityloxymethyl)-3-phenylsulfanyldihydro(3H)furan-2-one (189)—This 
was prepared by the General Method using diisopropylamine (3.96 ml, 28.2 mmol, n- 
butyllithium (2.5 M in hexanes) (11.3 ml, 28.24 mmol), the lactone 188 (5.0 g, 14.12 mmol),
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phenyl disulfide (3.08 g, 14.12 mmol), DMPU (1.71 ml, 14.12 mmol) to give the crude product 
(6.40 g) as an orange oil. The product was purified by column chromatography (ethyl 
acetate:hexane 1:3) to give the two diastereoisomers (4.34 g, 6 6 %) in a 7:3 ratio. The two 
diastereoisomers were not able to be separated by column chromatography.
NaNO
3-Bromo-4-nitrophenol159 (200)—In a 3 necked (500 ml) round bottom flask fitted with a 
condenser and nitrogen bubbler was added sodium nitrate (2 2 . 6  g, 266 mmol), sulphuric acid 
(31.4 g) and water (60 ml). /w-Bromophenol (25.0 g, 144.5 mmol) in ethanol (20 ml) was 
slowly added keeping the temperature below 25 °C. After stirring at room temperature for two 
hours, the mixture was diluted with water (150 ml). The product was then extracted with ether 
(3  x 100 ml). The combined organic extracts were dried over Na2SC>4 and the solvent removed 
on a rotary evaporator to give the crude product (29.71 g) as an orange solid. The crude 
product was then purified by column chromatography Rf 0.20 (silica, ethyl acetateihexane; 
1:3) to give the pure product (19.3 g, 61%) as white needles. M.p. 129-131 °C (lit. 131 °C)159; 
Umax (nujol, NaCl plates/ cm'1) 2926 (s), 1556 (s), 1460 (s), 1376 (m), 1297 (m), 1194 (m); 
5h(400 MHz; CDC13) 7.93 (1H, d, J 8 .8  Hz, H-5), 7.17 (1H, d, J  2.4 Hz, H-2), 6 . 8 8  (1H, dd, J
2.4 & 8 . 8  Hz, H-6 ); 5C(100 MHz; CDC13) 163.7 (s) (C, Ar), 143.2 (s) (C, Ar), 129.7 (s) (CH, 
Ar), 122.7 (s) (CH, Ar), 117.6 (s) (C, Ar), 116.4 (s) (CH, Ar); m/z (APCI) 218.0 [(M + H)+, 
50%], 220.0 (50%)
3-Bromo-4-nitroanisole161 (201)—3-Bromo-4-nitrophenol (200) (10.0 g, 45.66 mmol) was 
dissolved in acetone (75 ml) and treated with potassium carbonate (12.63 g, 90 mmol) at 40 °C 
for 10 minutes. The resulting suspension was then cooled to 0 °C. Methyl iodide (5.63 ml, 90 
mmol) was added dropwise. The solution was stirred at 40 °C for 3 hours. The solvent was 
removed on a rotary evaporator and dichloromethane (50 ml) was added to the residue. The 
insoluble material was filtered off and the solvent removed on a rotary evaporator to leave the 
product (9.1 g, 8 6 %) as yellow needles. M.p. 44-46 °C (lit. 44-45 °C)161; UmaX (nujol, NaCl
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plates/ cm'1) 2926 (s), 1554 (s), 1459 (s), 1371 (m), 1296 (m), 1190 (m); 6H(400 MHz; CDC13) 
7.91 (1H, d, J  8.9 Hz, H-5), 7.18 (1H, d, J  2.4 Hz, H-2), 6.89 (1H, dd, J  2.4 & 8.9 Hz, H-6 ),
3.73 (3H, s, OCH3); 5c(100 MHz; CDC13) 163.5 (s) (C, Ar), 143.0 (s) (C, Ar), 129.5 (s) (CH, 
Ar), 122.4 (s) (CH, Ar), 117.3 (s) (C, Ar), 116.2 (s) (CH, Ar), 56.3 (s) (OCH3); m/z (APCI)
232.0 [(M + H)+, 50%], 234 (50%)
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Diethyl 2‘allyl-2-(2,4-dinitrophenyl)malonate (213)—In a two necked round bottom flask 
fitted with a condenser and nitrogen bubbler was added sodium hydride (60% dispersion in oil 
(0.11 g, 2.75 mmol) followed by dry THF (5 ml). The flask was then cooled to 0 °C. Diethyl 
allyl malonate (0.50 ml, 2.54 mmol) in dry THF (5 ml) was then added dropwise. The reaction 
mixture was stirred at 0 °C for 20 minutes. 2,4-Dinitrofluorobenzene (0.47 g, 2.54 mmol) was 
then added dropwise to the reaction mixture. The solution was stirred at 0 °C for a further 30 
minutes. The solution was then allowed to warm to room temperature and stirred for 3 hours. 
The reaction mixture was then poured into an ice/HCl solution (1M) and then extracted with 
dichloromethane (3 x 25 ml). The organic solution was then washed with water (3 x 25 ml) 
and then dried over Na2S0 4 . The solvent was then removed on a rotary evaporator to give the 
crude product (0.84 g) as a yellow oil. The crude product was then purified by column 
chromatography Rf 0.33 (silica, ethyl acetate:hexane; 1:3) to give the pure product (0.77 g, 
83%) as a clear oil. Umax (neat, NaCl plates/ cm'1) 3098 (s), 1554 (s), 2982 (s), 1733 (s), 1639 
(w), 1606 (m), 1539 (s), 1466 (s), 1351 (s), 1202 (s), 1028 (s); 5H(400 MHz; CDC13) 8.78 (1H, 
d, J  2.4 Hz, H-3’), 8.34 (1H, dd, J 2.4 & 8 .8  Hz, H-5’), 7.53 (1H, d, J  8 . 8  Hz, H-6 ’), 5.60-5.70 
(1H, m, H2C=CH-), 4.97-5.02 (2H, m, H2C=), 4.08-4.20 (4H, m, CH2-0), 3.25 (2H, d, J  7.2 
Hz, CH2-C-Ar), 1.16 (6 H, t, J 1 2  Hz, CH3-CH2); 8C(100 MHz; CDC13) 168.1 (s) (C=0), 150.0 
(s) (C, Ar), 147.2 (s) (C, Ar), 139.1 (s) (C, Ar), 133.1 (s) (CH), 132.5 (s) (CH), 126.8 (s) (CH),
121.2 (s) (CH), 120.6 (s) (CH2), 63.5 (s) (C, quaternary), 62.8 (s) (CH2), 40.1 (s) (CH2), 14.4 
(s) (CH3); m/z (APCI) 367.0 [(M + H)+, 100%]. (Found: (M + H)+ (APCI), 367.1068. 
Ci6H 18N20 8 requires (M + H)+ 367.1063).
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Dihydro-3-carbomethoxy(3H)furan-2-one163 (215)—To a solution of diisopropylamine (3.65 
ml, 26.0 mmol) and dry THF (10 ml) was added at 0 °C n-butyllithium (2.5 M in hexanes) 
(10.42 ml, 26.0 mmol). The solution was stirred at 0 °C for 10 minutes before being cooled to 
-78 °C. y-Butyrolactone (1.0 ml, 13.0 mmol) was added dropwise to the stirred solution. The 
solution was stirred for a further 20 minutes at -78 °C before dimethyl carbonate (6.57 ml, 78.0 
mmol) was added dropwise. The solution was allowed to warm to room temperature and 
stirred overnight. Saturated NH4CI (5 ml) was then added slowly to the solution. The product 
was then extracted with ether (3 x 50 ml). The combined extracts were dried over Na2SC>4 and 
the solvent removed on a rotary evaporator to give the crude product (2.06 g) as a yellow oil. 
The crude product was then purified by column chromatography Rf 0.38 (silica, ethyl 
acetateihexane; 1:1) to give the pure product (1.36 g, 73%) as a clear oil. Umax (neat, NaCl 
plates/ cm 1) 3098 (s), 1740 (s), 1538 (s), 1465 (s), 1351 (s), 1028 (s); 8H(400 MHz; CDC13)
167.7 (s) (C=0), 6 6 . 6  (s) (CH2), 51.9 (s) (CH3), 44.8 (s) (CH), 25.5 (s) (CH2); m/z (APCI)
145.0 [(M + H)+, 100%].
Dihydro-3-(2’-4'-Dinitrophenyl)-3-carbomethoxy(3H)furan-2-one (216)—This was prepared 
by the General Method using sodium hydride (60% dispersion in oil) (167 mg, 4.16 mmol), 
dihydro-3-carbomethoxy (3H) furan-2-one (215) (0.50 g, 3.47 mmol) and 2,4-
dinitrofluorobenzene (0.65 g, 3.47 mmol) to give the crude product (1.11 g) as an orange oil. 
The crude product was then purified by column chromatography Rf 0.19 (silica, hexane:ethyl 
acetate; 3:1) to give the pure product (0.93 g, 8 6 %) as an orange oil. umax (neat, NaCl plates/ 
cm'1) 3028 (s), 1733 (s), 1539 (s), 1465 (s), 1348 (s); 6H(400 MHz; CDC13) 8 . 8 6  (1H, d, J 2 A
4.24 (1H, dt, J5 .2  & 8.4 Hz, H-5a), 4.13 (1H, dt, J5 .2  & 8 . 8  Hz, H-5p), 3.57 (3H, s, 0-CH3), 
3.43 (1H, t, / 8 .4  Hz, H-3), 2.30-2.45 (2H, m, H-4); 6C(100 MHz; CDC13) 172.0 (s) (C=0),
no 2
Hz, H-3’), 8.44 (1H, dd, J2.4  & 8.4Hz, H-5’), 7.64 (1H, d, J  8.4 Hz, H-6’), 4.60 (1H, ddd, J
6.0 & 8.0 & 8.8 Hz, H-5a), 4.30 (1H, ddd, J  6.4 & 8.0 & 8.8 Hz, H-5P), 3.69 (3H, s, OCH3),
3.57 (1H, ddd, J  6.4 & 8.0 & 14.0 Hz, H-4a), 2.55 (1H, ddd, J  5.6 & 8.0 & 14.0 Hz); 6C(100
MHz; CDC13) 172.4 (s) (C O ), 167.3 (s) (C=0), 148.9 (s) (C, Ar), 147.9 (s) (C, Ar), 138.6 (s)
Dihydro-3-(2 ’-4 dinitrophenyl)-3-carbomethoxy-5-methyl(3H)furan-2-one (223)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.38 g, 9.49 
mmol), 5-methyldihydro-3-carbomethoxyf3H)furan-2-one (221) (1.50 g, 9.49 mmol) and 2,4- 
dinitrofluorobenzene (1.76 g, 9.49 mmol) to give the crude product (2.76 g) as an orange oil 
(only the trans product was observed). The crude product was then purified by column 
chromatography Rf 0.20 (silica, hexane:ethyl acetate; 3:1) to give the pure product (2.44 g, 
80%) as a yellow crystalline solid. M.p. 120-121 °C; Umax (nujol, NaCl plates/ cm"1) 2922 (s), 
2853 (s), 1668 (s), 1538 (m), 1462 (s), 1376 (s), 1158 (w); 6H(400 MHz; CDC13) 8.99 (1H, d, J
2.4 Hz, H-3’), 8.51 (1H, dd, J 2.4 & 8.6 Hz, H-5’), 7.63 (1H, d, J8 .6  Hz, H-6’), 4.54 (1H, ddd, 
/6 .1  & 12.1 & 16.2 Hz, H-5), 3.73 (3H, s, OCH3), 3.30 (1H, dd,J  10.1 & 14.1 Hz, H-4a), 2.69 
(1H, dd, J  6.1 & 14.1 Hz, H-4P), 1.55 (3H, d, J  6.1 Hz, CH3), 2.55 (1H, ddd, J  5.6 & 8.0 &
14.0 Hz); 5C(100 MHz; CDC13) 172.3 (s) (C=0), 167.4 (s) (C O ), 148.4 (s) (C, Ar), 148.1 (s) 
(C, Ar), 138.7 (s) (C, Ar), 131.7 (s) (CH, Ar), 128.5 (s) (CH, Ar), 122.4 (s) (CH, Ar), 76.1 (s) 
(O-CH3), 63.5 (s) (C, quaternary), 54.3 (s) (CH), 43.6 (s) (CH2), 20.6 (CH3); m/z (APCI) 325.0 
[(M + H)+, 100%]. (Found: (M + H)+ (APCI), 325.0591 C13H12N2O8 requires (M + H)+ 
325.0594).
(C, Ar), 131.9 (s) (CH, Ar), 128.3 (s) (CH, Ar), 121.9 (s) (CH, Ar), 67.1 (s) (CH2), 60.7 (s) (C, 
quaternary), 54.4 (s) (CH3), 36.3 (s) (CH2); m/z (APCI) 311.0 [(M + H)+, 100%].
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227(S)-5-Carboethoxypyrrolidin-2-one (231)—To a stirred suspension of L-pyroglutamic acid 
(230) (52.0 g, 403 mmol) in dry toluene (260 ml) was added ethanol (50 ml) and sulphuric acid 
(1 ml). The reaction vessel was fitted with a Dean-Stark apparatus and the mixture was heated 
under reflux with azeotropic removal of water for six hours. After cooling the reaction mixture 
was diluted with chloroform (250 ml) and then treated with potassium carbonate (20.0 g, 145 
mmol). After effervesence ceased the reaction mixture was filtered through celite and 
concentrated in vacuo to afford the product (63.3 g, 100%) as a white crystalline solid. M.p. 
53-54 °C (lit. 54-55 °C)227; i w  (neat, NaCl plates/ cm'1) 2985 (s), 1700 (s), 1404 (s), 1377 (s), 
1203 (s), 1111 (m), 1021 (s), 918 (m); 6H(400 MHz; CDC13) 4.14 (1H, dd, J4 .9  & 8.7 Hz, H- 
5), 4.07 (2H, q, J  7.1 Hz, O-CH3), 2.20-2.38 (3H, m, H-3 & H-4a), 2.02-2.06 (1H, m, H-40),
1.14 (3H, t, /  7.1 Hz, CH3); 8C(100 MHz; CDC13) 179.3 (s) (C=0), 172.6 (s) (C=0), 61.7 (s) 
(CH), 56.0 (s) (CH2), 29.7 (s) (CH2), 25.0 (s) (CH3), 14.3 (s) (CH2); m/z (APCI) 158.0 [(M + 
H)+, 100%].
NaBH,
(S)-S-Hydroxymethylpyrrolidin-2-one228 (232)—The ester 231 (5.0 g, 31.85 mmol) dissolved 
in ethanol (30 ml) was treated at 0 °C with sodium borohydride (1.25 g, 33.0 mmol) 
portionwise over 10 minutes. The reaction mixture was slowly allowed to warm to room 
temperature and stirred for a further 90 minutes. The reaction was then cooled to 0 °C 
hydrochloric acid (2 ml) was cautiously added to quench the reaction mixture. Filtration of the 
precipitated salts through celite and concentration of the resultant liquor afforded the crude 
product (4.6 g) as a colourless oil. The crude product was then purified by column 
chromatography Rf 0.20 (silica, hexaneiethyl acetate; 2:1) to give the pure product (2.97 g, 
81%) as a white solid. M.p. 85-87 °C (lit. 86-67 °C)228; \jmax (neat, NaCl plates/ cm'1) 2926 (s), 
1680 (s), 1460 (s), 1377 (s), 1081 (w), 1017 (w), 722 (m); 5H(400 MHz; CDC13), 7.54 (1H, s,
O-H), 4.89 (1H, s, NH), 3.70-3.74 (1H, m, H-5), 3.65 (1H, dd, J3 .1  & 11.6 Hz, HCH-O), 3.48 
(1H, dd, J  4.7 & 11.6 Hz, HCH-O), 2.25-2.34 (1H, m, H-4), 2.08-2.12 (1H, m, H-3a), 1.70-
1.74 (1H, m, H-3P); 5C(100 MHz; CDC13) 179.8 (s) (C=0), 65.8 (s) (CH2), 56.8 (s) (CH), 30.5 
(s) (CH2), 22.8 (s) (CH2); m/z (APCI) 116.0 [(M+H)+, 100%].
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(S)-5-Trityloxymethyl pyrrolidin-2-one168 (233)—To a solution of the alcohol 232 (2.37 g, 
20.61 mmol) in dichloromethane (50 ml) was added triethylamine (5.60 ml, 40.0 mmol) and 
triphenylchloromethane (7.75 g, 28 mmol) and the reaction mixture was stirred at room 
temperature for 20 hours. Water (30 ml) was then added and the product was extracted with 
dichloromethane (3 x 50 ml). The combined extracts were dried over Na2SC>4 and the solvent 
removed on a rotary evaporator to give the crude product (9.1 g) as an orange powder. The 
crude product was then purified by column chromatography Rf 0.43 (silica, hexane:ethyl 
acetate; 1:3) to give the pure product (4.81 g, 65%) as a white powder. [a]o +28.4° (c 1.71 in 
ethanol) (lit. +28.9° c 1.71 in ethanol)168; M.p. 164-166 °C (lit. 165.5-166 °C)168; umax (nujol on 
NaCl plates/cm'1) 2922 (s), 1668 (s) (C=0), 1462 (s), 1377 (s); 5H(400 MHz; CDC13) 7.27-7.44 
(15H, m, Ph), 3.84-3.94 (1H, m, H-5), 3.22 (1H, dd, 74.0 & 9.3 Hz, HCH-O), 3.02 (1H, dd, 7
8.3 & 9.3 Hz, HCH-O), 2.33 (2H, t, 7  8.1 Hz, H-3), 2.12-2.21 (1H, m, H-5a), 1.63-1.74 (1H, 
m, H-5p); 8C(100 MHz; CDC13) 178.5 (s) (C=0), 144.0 (s) (C, Ar), 129.0 (s) (2 x CH, Ar),
128.3 (s) (2 x CH, Ar), 127.6 (s) (CH, Ar) 87.2 (s) (C-Ph), 67.5 (s) (CH2), 54.5 (s) (CH), 30.1 
(s) (CH2), 23.7 (s) (CH2); m/z (APCI) 358.0 [(M+H)+, 100%].
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(S)-l-Methyl-5-trityloxymethylpyrrolidin-2-one (234)— 5-Trityloxymethyl pyrrolidin-2-one 
(233) (1.5 g, 4.2 mmol) in dry THF (5 ml) was added dropwise at 0 °C to a suspension of 
sodium hydride (60% dispersion in oil) (0.50 g, 12.6 mmol). The mixture was then stirred at 0 
°C for 20 minutes. Methyl iodide (1.26 ml, 20.3 mmol) was slowly added and the mixture was 
stirred overnight at room temperature. The mixture was filtered through a celite plug and 
which was washed several times with THF. The filtrate and the washings were pooled together 
and evaporated to dryness. The residue was partitioned between chloroform (50 ml) and water 
(50 ml). The water layer was washed with chloroform (3 x 25 ml). The combined extracts 
were pooled together and dried over MgSC>4 . The solvent was removed on a rotary evaporator
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to give the crude product (2.3 g) as a yellow oil. The crude product was then purified by 
column chromatography Rf 0.43 (silica, hexane:ethyl acetate; 1:3) to give the pure product 
(0.97 g, 62%) as a yellow oil. Umax (nujol on NaCl plates/cm'1) 2936 (s), 2235 (w), 1963 (w), 
1681 (s), 1449 (s); 5H(400 MHz; CDC13) 7.27 (6H, app. d, 7  7.3 Hz, Ph), 7.15 (6H, app. t, 7  7.3 
Hz, Ph), 7.10 (3H, app. t, 77.3 Hz, Ph), 3.59 (1H, dd, 73.6 & 10.0 Hz, HCH-O), 2.99 (1H, dd,
74.5 & 10.0 Hz, HCH-O), 2.61 (3H, s, N-CH3), 2.33-2.43 (1H, m, H-3a), 2.11-2.22 (1H, m, H- 
3p), 1.86-1.97 (1H, m, H-4a), 1.64-1.72 (1H, m, H-40); 5C(100 MHz; CDC13) 175.8 (s) (C=0),
144.0 (s) (C, Ar), 129.3 (s) (2 x CH, Ar), 128.8 (s) (2 x CH, Ar), 127.8 (s) (CH, Ar) 87.3 (s) 
(C-Ph), 64.5 (s) (CH2), 60.4 (s) (CH), 30.7 (s) (CH2), 28.8 (s) (CH3), 22.0 (s) (CH2); m/z 
(APCI) 372.0 [(M+H)+, 100%].
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(S)-l-Boc-5-trityloxymethylpyrrolidin-2-one30 (234a)—To a solution of 5-Trityloxymethyl 
pyrrolidin-2-one (238) (1.5 g, 4.20 mmol) in acetonitrile (50 ml) at 0 °C was added DMAP (52 
mg, 0.42 mmol) and di-tert-butyldicarbonate (1.83 g, 8.4 mmol) with stirring. The reaction 
was allowed to slowly warm to room temperature and stirred overnight. The solvent was then 
removed on a rotary evaporator to give the crude product (2.56 g) as a brown solid. The crude 
product was then purified by column chromatography Rf 0.12 (silica, hexane:ethyl acetate; 
3:1) to give the pure product (1.24 g, 65%) as a white solid. M.p. 107-108 °C (lit. 108 °C)230; 
Umax (nujol on NaCl plates/cm1) 2928 (s), 1685 (s), 1449 (s) 1376 (s); 6h (400 MHz; CDC13)
7.30 (6H, app. d, 7  7.6 Hz, Ph), 7.13 (6H, app. t, 7  7.6 Hz, Ph), 7.06 (3H, app. t, 77.6 Hz, Ph), 
4.13-4.16 (1H, m, H-5), 3.41 (1H, dd, 74.3 & 13.7 Hz, HCH-O), 2.87 (1H, dd, 72.5 & 9.4 Hz, 
HCH-O), 2.67-2.74 (1H, m, H-3a), 2.27-2.34 (1H, m, H-3p), 1.91-1.98 (1H, m, H-4a), 1.78- 
1.83 (1H, m, H-4P) 1.34 (9H, s, (CH3)3); 6C(100 MHz; CDC13) 175.7 (s) (C=0), 150.1 (s) (C, 
Ar), 144.0 (s) (2 x CH, Ar), 129.0 (s) (2 x CH, Ar), 128.4 (s) (CH, Ar) 127.3 (s) (C-Ar), 87.3 
(s) (C-Ph), 83.1 (s) (C), 64.6 (s) (CH), 58.0 (s) (CH2), 32.7 (s) (CH2), 28.3 (s) (3 x CH3), 21.8 
(s) (CH2); m/z (APCI) 458.0 [(M+H)+, 100%].
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(5S,3R)-3-Phenylsulfanyl-l-methyl-5-trityloxymethylpyrrolidin-2-one (235)—To a solution 
of diisopropylamine (0.38 ml, 2.70 mmol) in dry THF (5 ml) was added at 0 °G «-butyllithium 
(2.5 M in hexanes) (1.08 ml, 2.31 mmol). The solution was stirred at 0 °C for 20 minutes 
before cooling to -78 °C. 1-Methyl-5-trityloxymethyl pyrrolidin-2-one (234) (0.50 g, 1.35 
mmol) dissolved in dry THF (5 ml) was added dropwise to the solution which was then stirred 
at -78 °C for 35 minutes. Phenyl disulfide (0.30 g, 1.35 mmol) and DMPU (1.08 ml, 1.35 
mmol) in dry THF (5 ml) was added dropwise to the reaction mixture. The solution was then 
stirred for a further 35 minutes at -78 °C and then allowed to warm to room temperature. The 
reaction mixture was then poured into water (20 ml) and extracted with ether (3 x 20 ml). The 
combined extracts were washed successively with 10% NaOH (25 ml), Water (25 ml), 10% 
HC1 (25 ml) and water (25 ml) and then dried over Na2SC>4 . The solvent was removed on the 
rotary evaporator to give the crude product (0.80 g) as a yellow oil. The crude product was 
then purified by column chromatography Rf 0.43 (silica, hexane:ethyl acetate; 3:1) to give the 
pure product (0.36 g, 55%) as a yellow oil. Umax (neat, NaCl plates/cm'1) 2929 (s), 1689 (s); 
6h(400 MHz; CDC13) 7.41-7.49 (2H, m, Ph), 7.17-7.31 (18H, m, Ph), 4.00 (1H, t, /  8.3 Hz, H- 
3), 3.27-3.30 (1H, m, H-5), 3.22 (1H, dd,73.3 & 10.2 Hz, HCH-O), 3.02 (1H, dd, J3 .9  & 10.2 
Hz, HCH-O), 2.65 (3H, s, CH3), 2.24-2.28 (1H, m, H-4a), 2.01-2.10 (1H, m, H-4p); 6C(100 
MHz; CDC13) 172.7 (s) (C=0), 143.4 (s) (C, Ar), 133.6 (s) (C, Ar), 132.6 (s) (CH, Ar), 128.9 
(s) (2 x CH, Ar) 128.6 (s) (2 x CH-Ar), 128.0 (s) (CH, Ar), 127.9 (s) (2 x CH, Ar), 127.7 (s) 
(CH, Ar), 127.3 (s) (2 x CH, Ar), 87.0 (s) (C), 63.1 (s) (CH2), 58.1 (s) (CH), 47.5 (s) (CH),
30.5 (s) (CH2), 28.8 (s) (CH); m/z (APCI) 480.0 [(M+H)+, 100%]. (Found: (M + H)+ (APCI), 
480.1924 C3iH29N 02S requires (M + H)+ 480.1919).
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5-Phenyl-pyrrolidin-2-one169 (238)—In a 500 ml round bottom flask was added magnesium 
turnings (4.75 g, 200 mmol) followed by dry ether (100 ml). Bromobenzene (7.9 g, 51.4 
mmol) was slowly added to the flask over a period of 30 minutes. The reaction mixture was
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then cooled to 0 °C. Succinimide (5.0 g, 50.4 mmol) dissolved in dichloromethane (200 ml) 
was then added to the solution which was then allowed to warm to room temperature and 
stirred for 18 hours. Sodium cyanoborohydride (3.8 g, 60.55 mmol) was added to the solution 
followed by slow addition of a 6  M HC1 solution to keep the pH 3-4. After stirring for 30 
minutes the solution was neutralised with 10% NaOH and extracted with dichloromethane (3 x 
100 ml). The solvent was removed on a rotary evaporator to give the crude product (9.14 g) as 
an orange oil. The crude product was then purified by column chromatography Rf 0.42 (ethyl 
acetate) to give the pure product (4.95 g, 61%) as a white solid. M.p. 105-107 °C (lit. 107 
°C)169; Umax (nujol on NaCl plates/cm'1) 3451 (s), 2938 (s), 1663 (s), 1458 (s), 1395 (s), 1351 
(s); 5h(400 MHz; CDC13) 7.21-7.41 (5H, m, Ph), 6.72 (1H, s, N-H), 4.76 (1H, t, J  7.1 Hz, H-5), 
2.31-2.72 (3H, m, H-3 & H-4a), 1.92-1.97 (1H, m, H-4 P); 5C(100 MHz; CDC13) 178.9 (s) 
(C=0), 142.5 (s) (C, Ar), 128.9 (s) (2 x CH, Ar), 127.9 (s) (CH, Ar), 125.6 (s) (2 x CH, Ar)
58.2 (s) (CH), 31.3 (s) (CH2), 30.4 (s) (CH2); m/z (APCI) 162.0 [(M+H)+, 100%].
l-Methyl-5-phenyl-pyrrolidin-2-one170 (239)—To a suspension of sodium hydride (60% 
dispersion in oil) (0.37 g, 9.32 mmol) in dry THF (10 ml) was added dropwise at 0 °C a 
solution of 5-phenyl-2-pyrrolidinone (238) (1.5 g, 9.32 mmol) in dry THF (5 ml). The mixture 
was stirred at 0 °C for 10 minutes before being allowed to warm to room temperature and 
stirred for a further 30 minutes. The reaction mixture was then cooled to 0 °C and 
iodomethane (0.58 ml, 9.32 mmol) was added dropwise to the reaction mixture which was then 
allowed to warm to room temperature and stirred overnight. The reaction mixture was then 
poured onto ice/HCl (1 M solution) and extracted with dichloromethane (3 x 50 ml). The 
combined extracts were then washed with water (3 x 50 ml) and dried over MgSC>4. The 
solvent was then removed on a rotary evaporator to give the crude product (1.45 g) as a brown 
oil. The crude product was then purified by column chromatography Rf 0.34 (silica, 
hexane:ethyl acetate; 3:1) to give the pure product (1.51 g, 92%) as a yellow oil. umax (neat, 
NaCl plates/cm'1) 1692 (s), 1377 (m), 1134 (s); 8H(400 MHz; CDC13) 7.06-7.54 (5H, m, Ph),
4.52 (1H, dt, J  2.1 & 6.5, H-5), 2.66 (3H, s, N-CH3), 1.48-2.94 (4H, m, H-3 & H-4); 8C(100 
MHz; CDCI3) 176.0 (s) (C=0), 141.5 (s) (C, Ar), 129.4 (s) (2 x CH, Ar), 128.5 (s) (CH, Ar),
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126.7 (s) (2 x CH, Ar) 65.0 (s) (CH), 30.6 (s) (CH2), 28.8 (s) (CH3), 28.6 (s) (CH2); m/z 
(APCI) 176.0 [(M+H)+, 100%].
l-Methyl-5-phenyl-3-phenylsulfanylpyrrolidin-2-one (240)—This was prepared by the 
General Method using diisopropylamine (1.52 ml, 10.8 mmol) w-butyllithium (2.5 M in 
hexanes) (4.32 ml, 9.24 mmol), 1-methyl-5-phenyl-pyrroldin-2-one (239) (0.94g, 5.40 mmol), 
DMPU (4.32 ml, 5.4 mmol) and phenyl disulfide (1.2 g, 5.4 mmol) to give the crude product as 
a yellow oil ( 0.31 g). The crude product was then purified by column chromatography Rf 0.31 
(hexane: ethyl acetate 3:1) to give a mixture of diastereoisomers (0.56 g, 37%) that could not 
be separated by column chromatography.
General Method for the VNS-SflAr Process
Sodium hydride (60% dispersion in oil) (20.3 mmol) was added to anhydrous DMF (5 ml) and 
the mixture flushed with nitrogen and cooled to 0 °C. The VNS nucleophile (8.13 mmol) and 
the nitroarene (8.13 mmol) were dissolved in anhydrous DMF (5 ml) and added dropwise to 
the sodium hydride slurry. The reaction mixture was stirred at 0 °C for 30 minutes and then 
allowed to warm to room temperature. The reaction mixture was then cooled to -50 °C using 
C02/methanol cooling bath. The electrophile (8.13 mmol) in anhydrous DMF (2 ml) was then 
added and the resulting mixture was allowed to warm to room temperature and stirred for a 
further two hours. The reaction mixture was poured onto ice/hydrochloric acid (50 ml, 1 M 
solution) and extracted with dichloromethane (3 x 30 ml). The combined organic extracts were 
washed well with distilled water (5 x 50 ml), saturated aqueous sodium bicarbonate solution (3 
x 50 ml), dried (magnesium sulfate) and the solvent removed under reduced pressure to give 
the crude product.
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Ethyl 2-(4’-nitrophenyl)-2-(2”-nitro-4”-trifluoromethylphenyl)propionate (257a)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.81 g, 20.3 
mmol), ethyl 2-chloropropionate (1.11 g, 8.13 mmol), nitrobenzene (0.84 ml, 8.13 mmol) and
4-fluoro-3-nitrobenzotrifluoride (1.14 ml, 8.13 mmol) to give the crude product (3.09 g) as a 
brown oil. The crude product was then purified by column chromatography Rf 0.21 (silica, 
3:1. hexane:ethyl acetate; v/v) to give the pure product (2.42 g, 73%) as a yellow crystalline 
powder. M.p. 114-115.5 °C; (Found C, 52.40; H, 3.72; N 6.82. C18H15F3N2O6 requires C, 
52.43; H, 3.67; N, 6.79%); t w  (nujol on NaCl plates/cm'1) 2924 (s), 1708 (s) (C=0), 1626 
(m), 1604 (m), 1571 (m), 1518 (m), 1462 (s), 1349 (s), 1129 (s), 905 (m), 857 (s), 796 (m), 729 
(s), 706 (m); 5H(400 MHz; CDC13) 8.20-8.23 (3H, m, H-3’ & H-5’ & H-3”), 7.72 (1H, d, 78.4 
Hz, H-5”), 7.67 (2H, d, 79.0 Hz, H-2’ & H-6 ’), 7.06 (1H, d, 78.4 Hz, H-6 ”), 4.13-4.16 (1H, m, 
HCH), 4.01-4.08 (1H, m, HCH), 2.25 (3H, s, CH3), 1.18 (3H, t, 7  7.1 Hz, CH2CH3); 5C(100 
MHz; CDC13) 170.8 (s) (C=0), 149.2 (s) (C, Ar), 148.6 (s) (C, Ar), 147.4 (s) (C, Ar), 143.3 (s) 
(C, Ar), 132.5 (s) (CH, Ar), 130.8 (q) (C-CF3, 734.3 Hz), 129.2 (s) (2 x CH, Ar) 124.0 (s) (2 x 
CH, Ar), 122.6 (s) (CH, Ar), 122.6 (q) (CF3, 7  271.1 Hz), 62.4 (s) (CH2), 56.0 (s) (C, 
quaternary), 25.6 (s) (C-CR), 13.6 (CH2CH3); m/z (APCI) 413.1 [(M+H)*, 100%] 412.5 (49); 
(Found (ES+): (M + NR,)* 430.1224 C,8Hi5N20 6F3 requires (M + NR)* 430.1226).
Ethyl 2-(2’,4’-dinitrophenyl)-2-(4”-nitrophenyl)propionate (257b)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.81 g, 20.3 mmol), ethyl 2- 
chloropropionate (1.11 g, 8.13 mmol), nitrobenzene (0.84 ml, 8.13 mmol) and 2,4- 
dinitrofluorobenzene (1.02 ml, 8.13 mmol) to give the crude product (2.85 g) as a brown oil. 
The crude product was then purified by column chromatography Rf 0.17 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (2.41 g, 77%) as a brown oil. omax (liquid 
film on NaCl plates/ cm'1) 2984 (m), 1738 (s) (C=0), 1604 (s), 1521 (s), 1349 (s), 909 (m), 835 
(m), 650 (m); SH (400 MHz; CDC13) 8.80 (1H, d, 7  2.4 Hz, H-3’), 8.30 (1H, dd, 72.4  & 8.7 
Hz, H-5’), 8.22 (2H, d, 79.0 Hz, H-3” & H-5”), 7.68 (2H, d, 79.0 Hz, H-2” & H-6 ”), 7.16 (1H, 
d, 7  8.7 Hz, H-6 ’), 4.15-4.22 (1H, m, O-HCH-CR), 4.01-4.09 (1H, m, O-HCH-CR), 2.26
no 2
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(3H, s, CH3), 1.18 (3H, t, 7  7.2 Hz, CH3-CH2); 8C(100 MHz; CDC13) 170.5 (s) (C=0), 149.4 
(s) (C, Ar), 148.0 (s) (C, Ar), 147.6 (s) (C, Ar), 146.7 (s) (C, Ar), 146.0 (s) (C, Ar), 132.9 (s) 
(CH, Ar), 129.3 (s) (2 x CH, Ar), 126.8 (s) (CH, Ar), 123.8 (s) (2 x CH, Ar), 120.9 (s) (CH, 
Ar), 62.6 (s) (CH2), 56.2 (s) (C, quaternary), 25.6 (s) (CH3), 13.7 (s) (CH3-CH2); m/z (APCI)
389.9 [(M+H)+ , 100%], 345.1 (36); (Found (APCI) (M + H)+, 390.0943 Ci7H i5N30 8 requires 
(M + H)+ 390.0937).
c r  C 02Et
NO.
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Ethyl 2-(2’-cyano-4’-nitrophenyl)-2-(4”-nitrophenyl)propionate (257c)—This was prepared 
by the General Method, but cooling to 0 °C instead of -50 °C using sodium hydride (60% 
dispersion in oil) (0.25 g, 6.09 mmol), ethyl 2-chloropropionate (0.52 ml, 4.07 mmol), 
nitrobenzene (0.21 ml , 2.03 mmol) and 2-fluoro-5-nitrobenzonitrile (0.34 g, 2.03 mmol) to 
give the crude product (1.08 g) as a brown oil. The crude product was then purified by column 
chromatography Rf 0.18 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product (0.66 
g, 88%) as a yellow crystalline powder. M.p. 115-117 °C; Umax (nujol on NaCl plates/ cm'1) 
2954 (s), 2853 (s), 1715(s), 1606 (m), 1527 (s), 1463 (s), 1377 (m), 1355 (s), 1257 (m), 1217 
(m), 1089 (m), 1046 (m), 906 (w), 864 (m), 736 (m); 6H (400 MHz; CDC13) 8.56 (1H, d, J  1.9 
Hz, H-3’), 8.33 (1H, dd, /1 .9  & 8.8 Hz, H-5’), 8.28 (2H, d, J 8.6 Hz, H-3” & 5”), 7.63 (2H, d, 
J  8.6 Hz, H-2” & 6”), 7.21 (1H, d, J  8.8 Hz, H-6’), 4.31-4.41 (1H, m, HCH-CH3), 4.23-4.29 
(1H, m, HCH-CH3), 2.17 (3H, s, CH3), 1.28 (3H, t,77.1 Hz, CH3-CH2); 5C(100 MHz; CDC13)
171.4 (s) (C=0), 154.0 (s) (C, Ar), 147.7 (s) (C, Ar), 146.8 (s) (C, Ar), 146.5 (s) (C, Ar), 129.9 
(s) (CH, Ar), 129.6 (s) (CH, Ar), 129.1 (s) (2 x CH, Ar), 127.2 (s) (CH, Ar), 124.0 (s) (2 x CH, 
Ar), 115.8 (s) (CN or C-CN), 114.5 (s) (CN or C-CN), 63.1 (s) (CH2), 56.9 (s) (C, quaternary),
25.3 (s) (CH3), 13.8 (s) (CH3-CH2); m/z (APCI) 369.8 [(M+H)+, 100%], 341.8 (18), 295.8 (42); 
(Found (ES+) (M + NH4)+, 387.1306 C jgH isN ^ requires (M + NFLO* 387.1305).
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Ethyl 2-(4 ’-nitrophenyl)-2-(4”-nitro-2 ”-trifluoromethylphenyl)propionate (257d)—This was 
prepared by the General Method, cooling to 0 °C instead o f-50 °C using sodium hydride (60% 
dispersion in oil) (0.25 g, 6.09 mmol), ethyl 2-chloropropionate (0.52 ml, 4.07 mmol), 
nitrobenzene (0.21 ml, 2.03 mmol) and 2-fluoro-5-nitrobenzotrifluoride (0.43 g, 2.03 mmol) to 
give the crude product (1.20 g) as an orange oil. The crude product was then purified by 
column chromatography Rf 0.26 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product 
(0.75 g, 89%) as a yellow crystalline powder. M.p. 117-118.2 °C; (Found C, 51.74; H, 3.64; N
6.83. C18H 15F3N2O6 requires C, 52.43; H, 3.67; N, 6.79%); Umax (nujol on NaCl plates/cm'1) 
1737 (s) (C=0), 1591 (m), 1527 (s), 1462 (s), 1349 (m), 1309 (m), 1117 (w), 910 (w), 857 (w),
Ar), 122.7 (q) (CF3, J 273 Hz), 62.4 (s) (CH2), 56.2 (s) (C, quaternary), 28.4 (s) (CH3), 13.7 (s) 
(CH3-CH2); m/z (APCI) 369.8 [(M+H)+, 100%], 341.8 (17.5), 295.8 (42); m/z (APCI) 412.9 
[(M+H)\ 100%], 370.1 (65), 364.9 (14); (Found (APCI) (M + H)+, 413.0960. Ci7H15N30 8 
requires (M + H)+ 413.0953).
Methyl 2-(4’-nitrophenyl)-2-(2”-nitro-4”-trifluoromethylphenyl)propionate (257e)—This 
was prepared by the General Method using sodium hydride (60% dispersion in oil) (0.81 g,
20.3 mmol), methyl 2-chloropropionate (1.0 g, 8.13 mmol), nitrobenzene (0.84 ml, 8.13 mmol)
737 (w); 8 h (400 MHz; CDC13) 8.58 (1H, d, J2 .4  Hz, H-3”), 8.32 (1H, dd, J  2.4 & 8.9 Hz, H- 
5”), 8.20 (2H, d, J  8.9 Hz, H-3’ & H-5’), 7.64 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.41 (1H, d, J
8.9 Hz, H-6 ”), 4.23-4.29 (1H, m, HCH-CH3), 4.11-4.20 (1H, m, HCH-CH3), 2.10 (3H, s, CH3), 
1.19 (3H, t, J  7.1 Hz, CH3-CH2) ; 5C (100 MHz; CDC13) 172.1 (s) (C=0), 149.4 (s) (C, Ar),
148.3 (s) (C, Ar), 147.1 (s) (C, Ar), 146.8 (s) (C, Ar), 131.2 (s) (CH, Ar), 130.9 (q) (C-CF3, J
32.6 Hz), 128.8 (s) (2 x CH, Ar), 126.1 (s) (CH, Ar), 124.4 (s) (CH, Ar), 123.6 (s) (2 x CH,
Cr CQ2Me
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and 4-fluoro-3-nitrobenzotrifluoride (1.14 ml, 2.03 mmol) to give the crude product (3.59 g) as 
an orange oil. The crude product was then purified by column chromatography Rf 0.30 (silica, 
3:1. hexane:ethyl acetate; v/v) to give the pure product (2.21 g, 69%) as a yellow crystalline 
solid. M.p. 125.5-127.5 "C; t w  (nujol on NaCl plates/cm'1) 2925 (s), 1974 (w), 1722 (s), 1626 
(m), 1572 (m), 1518 (s), 1464 (s), 1321 (s), 1136 (s) 1048 (m), 1013 (w), 974 (m), 899 (m), 
882 (m); 5H(400 MHZ; CDC13) 8.19-8.23 (3H, m, H-3’ & H-5’ & H-3”), 7.72 (1H, d,78.3 Hz, 
H-5”), 7.68 (2H, d, 7  8.9 Hz, H-2’ & H-5’), 7.09 (1H, d, 78.3 Hz, H-6 ”), 3.66 (3H, s, O-CH3),
2.25 (3H, s, CH3); 8c (400 MHz; CDC13) 171.5 (s) (C=0), 149.3 (s) (C, Ar), 148.3 (s) (C, Ar),
147.5 (s) (C, Ar), 143.2 (s) (C, Ar), 132.3 (s) (CH, Ar), 131.0 (q) (C-CF3,734.5 Hz), 129.3 (s) 
(2 x CH, Ar), 129.3 (s) (CH, Ar), 123.7 (s) (2 x CH, Ar), 122.8 (s) (C, Ar), 122.3 (q) (CF3, 7
271.1 Hz), 55.9 (s) (C, quaternary), 52.9 (s) (H3C-0-), 25.8 (s) (CH3); m/z (El) 398.1 [(MI), 
100%] (Found (El) M+398.0723 C,7H,3F3N20 6  requires M+ 398.0720).
C r  C 0 2Me
NO
1) NaH, DMF
NONO
Methyl 2-(2’,4 ’-dinitrophenyl)-2-(4”-nitrophenyl)propionate (257f)—This was prepared by 
the General Method using sodium hydride (60% dispersion in oil) (0.20 g, 5.10 mmol), methyl
2-chloropropionate (0.25 g, 2.03 mmol), nitrobenzene (0.21 ml, 2.03 mmol) and 2,4- 
dinitrofluorobenzene (0.26 ml, 2.03 mmol) to give the crude product (0.79 g) as a brown oil. 
The crude product was then purified by column chromatography, Rf 0.45 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (0.53 g, 71%) as a yellow crystalline solid. 
M.p. 153-155 °C; Umax (nujol on NaCl plates/cm'1) 2925 (s), 1731 (s), 1600 (s), 1463 (s), 1349 
(s), 1204 (m), 1125 (w), 1093 (m), 1046 (w), 1012 (w), 981 (m), 919 (m), 900 (w), 869 (w), 
834 (m), 737 (m); 6H(400 MHz; CDC13) 8.80 (1H, d, .72.4 Hz, H-3’), 8.30 (1H, dd, J 2 A  & 8 . 8  
Hz, H-5’), 8.23 (2H, d, J 9.0 Hz, H-3” & H-5”), 7.66 (2H, d, J9 .0  Hz, H-2” & H-6 ”), 7.14 (1H, 
d, J  8 . 8  Hz, H-6 ’), 3.72 (3H, s, 0-CH3), 2.26 (3H, s, CH3); 5C (100 MHz; CDC13) 171.1 (s) 
(C=0), 149.4 (s) (C, Ar), 147.8 (s) (C, Ar), 147.7 (s) (C, Ar), 146.7 (s) (C, Ar), 145.8 (s) (C, 
Ar), 132.8 (s) (CH, Ar), 129.3 (s) (2 x CH, Ar), 126.8 (s) (CH, Ar), 123.9 (s) (CH, Ar), 120.9 
(s) (CH, Ar), 56.1 (s) (C, quaternary), 53.1 (s) (0-CH3), 25.7 (s) (CH3); m/z (APCI) 375.9
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[(M+H)+, 100%], 343.8 (44), 315.8 (13),; (Found (ES+) (M + NH4)+, 393.1041, CujKtaNsOg 
requires (M + NH4)+ 393.1046).
no2
NO1) NaH, DMF
COoMe
CN
o 2n CN
Methyl 2-(2’-cyano-4’-nitrophenyl)-2-(4”-nitrophenyl)propionate (257g)—This was prepared 
by the General Method, cooling to 0 °C instead of -50 °C using sodium hydride (60% 
dispersion in oil) (0.25 g, 6.09 mmol), methyl 2-chloropropionate (0.47 ml, 4.07 mmol), 
nitrobenzene (0.21 ml, 2.03 mmol) and 2-fluoro-5-nitrobenzonitrile (0.34 g, 2.04 mmol) to 
give the crude product (1.0 g) as a brown oil. The crude product was then purified by column 
chromatography, Rf 0.19 (silica, 3:1. hexanerethyl acetate; v/v) to give the pure product (0.62 
g, 8 6 %) as a yellow crystalline solid. M.p. 163-164.4 °C; (Found C, 58.04; H, 3.85; N 11.93. 
C18H 15F3N2O6 requires C, 57.47; H, 3.69; N, 11.82%); umax (nujol on NaCl plates/ cm'1) 2922 
(s), 2852 (s), 2225 (w), 1724 (s), 1607 (m), 1520. (s), 1464 (s), 1377 (w) 1356 (s), 1256 (m), 
1217 (m), 1088 (m), 1046 (m), 905 (m), 836 (m), 736 (m); 5H (400 MHz; CDCI3) 8.57 (1H, d, J
2.4 Hz, H-3’), 8.32 (1H, dd, J  2.4 & 8 . 8  Hz, H-5’), 8.30 (2H, d, J8 .9  Hz, H-3” & H-5”), 7.63 
(2H, d, J 8.9 Hz, H-2” & H-6 ”), 7.18 (1H, d, 78.8 Hz, H-6 ’), 3.86 (3H, s, O-CH3), 2.26 (3H, s, 
CH3); 5c (100 MHZ; CDC13) 171.9 (s) (C=0), 153.9 (s) (C, Ar), 147.7 (s) (C, Ar), 146.6 (s) (C, 
Ar), 129.9 (s) (CH, Ar), 129.6 (s) (CH, Ar), 129.1 (s) (2 x CH, Ar), 127.2 (s) (CH, Ar), 124.1 
(s) (2 x CH, Ar), 115.7 (s) (CN or C-CN), 114.4 (s) (CN or C-CN), 56.9 (s) (C, quaternary),
53.7 (s) (O-CH3), 25.3 (s) (CH3); m/z (APCI) 355.9 [(M+H)+, 100%], 335.7 (1 0 ), 295.9 (1 2 ); 
(Found (ES+) (M + NH4)+, 373.1147, C17H13N3O6 requires (M + NH4)+ 373.1148).
C r  C 0 2Me
NO
1) NaH, DMF
o 2n CFCF
Methyl 2-(4 ’-nitrophenyl)-2-(4 ”-nitro-2 ”-trifluoromethyl)phenylpropionate (257h)—This 
was prepared by the General Method, cooling to 0 °C instead of -50 °C using sodium hydride
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(60% dispersion in oil) (0.25 g, 6.09 mmol), methyl 2-chloropropionate (0.47 ml, 4.07 mmol), 
nitrobenzene (0.21 m l, 2.03 mmol) and 2-fluoro-5-nitrobenzotrifluoride (0.45 ml, 2.04 mmol) 
to give the crude product (1.27 g) as an orange oil. The crude product was then purified by 
column chromatography, Rf 0.24 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure 
product (0.70 g, 8 6 %) as a yellow crystalline solid. M.p. 135.5-137.5 °C; (Found C, 51.43; H, 
3.27; N 6.92. C18H15F3N2O6 requires C, 51.27; H, 3.29; N, 7.03%); i w  (nujol on NaCl 
plates/cm'1) 2922 (s), 1742 (m), 1594 (w), 1512 (m), 1461 (s), 1377 (s), 1170 (m), 1124 (m), 
1071 (w), 920 (w), 854 (m); 6 H (400 MHz; CDC13) 8.59 (1H, d, /  2.4 Hz, H-3”), 8.34 (1H, dd, 
J 2.4 & 8.9 Hz, H-5”), 8.13 (2H, d, J 9.0 Hz, H-3’ & H-5’), 7.64 (2H, d, J  9.0 Hz, H-2’ & H- 
6 ’), 7.44 (1H, d, J 8.9 Hz, H-6 ”), 3.74 (3H, s, O-CH3), 2 . 1 2  (3H, s, CH3); 5C(100 MHZ; CDC13)
173.0 (s) (C=0), 149.6 (s) (C, Ar), 148.6 (s) (C, Ar), 147.6 (s) (C, Ar), 147.3 (s) 131.6 (s) (CH, 
Ar), 131.2 (q) (C-CF3, J32.1 Hz), 130.3 (s) (CH, Ar), 129.1 (s) (2 x CH, Ar), 126.5 (s) (CH, 
Ar), 124.8 (s) (C, Ar), 124.0 (s) (2 x CH, Ar)123.6 (q) (CF3, J  273.5 Hz), 123.0 (C, Ar), 56.5 
(s) (C, quaternary), 53.5 (s) (O-CH3), 28.8 (s) (CH3); m/z (APCI) 399.0 [(M+H)+, 100%]; 
(Found (Cl) (M + NH4)+, 416.1067, C17H13N3O6 requires (M + m U )+ 416.1069).
NO
NOF
1) NaH, DMF
NO
Methyl 2-(4’-nitrophenyl)-2-(2”-nitro-4”-trifluoromethyl)butanoate (257i)—This was
prepared by the General Method, cooling to 0 °C instead of -50 °C using sodium hydride (60% 
dispersion in oil) (0.19 g, 4.60 mmol), methyl 2-chlorobutanoate (0.25 g, 1.83 mmol), 
nitrobenzene (0.19 ml, 1.83 mmol) and 4-fluoro-3-nitrobenzotrifluoride (0.26 ml, 1.83 mmol) 
to give the crude product (0.78 g) as a brown oil. The crude product was then purified by 
column chromatography Rf 0.38 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product 
(0.45 g, 60%) as a yellow oil. Umax (liquid film on NaCl plates/cm'1) 3090 (m), 2955 (s), 1739 
(s), 1629 (s), 1606 (m), 1538 (s), 1462 (m), 1327 (s), 1127 (s) 1014 (s), 903 (s), 883 (w), 851 
(s), 798 (m), 752 (m); 5H (400 MHz; CDCI3) 8.21 (1H, d, J  1.3 Hz, H-3”), 8.16 (2H, d, J  9.0 
Hz, H-3’ & H-5’), 7.85 (1H, dd, J  1.3 & 8.4 Hz, H-5”), 7.63 (2H, d, J9.0  Hz, H-2’ & H-6 ’), 
7.46 (1H, d, J  8.4 Hz, H-6 ”), 3.65 (3H, s, O-CH3), 2.74-2.83 (1H, m, HCH-CH3), 2.64-2.72 
(1H, m, HCH-CH3), 0.90 (3H, t, J 1 A  Hz, CH3); 5C (100 MHZ; CDC13) 171.0 (s) (C=0), 150.0 
(s) (C, Ar), 147.4 (s) (C, Ar), 147.0 (s) (C, Ar), 140.1 (s) (C, Ar), 132.6 (s) 131.1 (q) (C-CF3, J
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34.7 Hz), 129.6 (s) (2 x CH, Ar), 128.6 (s) (CH, Ar), 123.4 (s) (2 x CH, Ar), 123.1 (s) (CH, 
Ar), 59.5 (s) (C, quaternary), 52.7 (s) (0-CH3), 30.6 (s) (CH2), 9.7 (s) (CH3); m/z (APCI) [(M + 
H)+, 100%], (Found: (M + NH4)+ (ES+): 430.1221 C igH uF ^O s requires (M + NH4)+ 
430.1226).
NO
1) NaH, DMF
COoMe
NO
NO
Methyl 2-(2’,4’-dinitrophenyl)-2-(4”-nitrophenyl)butanoate (257j)—This was prepared by 
the General Method, cooling to 0 °C instead of -50 °C using sodium hydride (60% dispersion 
in oil) (0.23 g, 5.75 mmol), methyl 2-chlorobutanoate (0.50 g, 3.66 mmol), nitrobenzene (0.19 
ml, 1.83 mmol) and 2,4-dinitrofluorobenzene (0.23 ml, 1.90 mmol) to give the crude product 
(0.85 g) as an orange oil. The crude product was then purified by column chromatography Rf 
0.12 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product (0.57 g, 80%) as a yellow 
crystalline solid. M.p. 59.1-61.7 °C; Umax (nujol on NaCl plates/ cm'1) 2922 (s), 1738 (s), 1462 
(s), 1376 (m); 5H (400 MHZ; CDC13) 8.78 (1H, d, J 2.4 Hz, H-3’), 8.45 (1H, dd, J2A  & 8.9 Hz, 
H-5’), 8.16 (2H, d, J 9.0 Hz, H-3” & H-5”), 7.64 (2H, d, J 9.0 Hz, H-2” & H-6”), 7.59 (1H, d, 
J  8.9 Hz, H-6’), 3.66 (3H, s, 0-CH3), 2.79-2.89 (1H, m, HCH), 2.67-2.77 (1H, m, HCH), 0.92 
(3H, t, y 7.4 Hz, CH3-CH2); 6c (100 MHz; CDC13) 170.7 (s) (C=0), 150.1 (s) (C, Ar), 147.1 (s) 
(C, Ar), 146.9 (s) (C, Ar), 142.9 (s) (C, Ar), 133.1 (s) (CH, Ar), 129.7 (s) (2 x CH, Ar), 126.3 
(s) (CH, Ar), 123.5 (s) (2 x CH, Ar), 121.2 (s) (CH, Ar), 59.7 (s) (C, quaternary), 52.8 (s) (O- 
CH3), 30.8 (s) (CH2), 9.7 (s) (CH3); m/z (APCI) [(M + H)+, 100%], (Found: (M + NH4)+ (ES+): 
407.1198 Ci7H,5N308 requires (M + NH4)+ 407.1203).
NOs NO
1) NaH, DMF
CF
o 2n CF
Methyl 2-(4’-nitrophenyl)-2-(4”-nitro-2”-trifluoromethylphenyl)butanoate (257k)—This was 
prepared by the General Method, cooling to 0 °C instead o f-50 °C using sodium hydride (60%
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dispersion in oil) (0.18 g, 4.50 mmol), methyl 2-chlorobutanoate (0.25 g 1.83 mmol), 
nitrobenzene (0.19 ml, 1.83 mmol) and 2-fluoro-5-nitrobenzotrifluoride (0.38 g, 1.83 mmol) to 
give the crude product (0.72 g) as a brown oil. The crude product was then purified by column 
chromatography R f 0.23 (silica, 3:1. hexaneiethyl acetate; v/v) to give the pure product (0.52 g, 
69%) as a yellow crystalline solid. M.p. 119-121 °C; umax (nujol on NaCl plates/cm'1) 2966 (s), 
1737 (s), 1618 (m), 1591 (m), 1529 (m), 1376 (s), 1173 (m), 1122 (m), 1051 (m), 998 (m), 909
Ar), 59.4 (s) (C, quaternary), 53.0 (s) (O-CH3), 34.8 (s) (CH2), 10.2 (s) (CH3CH2); m/z (APCI)
412.9 [(M+H)+, 100%], (Found: (M + NFL*)* (Ammonia Cl) 430.1228, Ci8Hi5F3N206 requires 
(M + NH4 )+ 430.1226).
General Method for VNS-SNAr with KOf-Bu— In a three necked round bottomed flask fitted 
with a condenser and nitrogen bubbler was added potassium tert-butoxide (7.2 mmol) followed 
by anhydrous DMF (5 ml). Nitrobenzene (2.39 mmol) the VNS nucleophile (4.8 mmol) 
dissolved in anhydrous DMF (2 ml) were added at -4 0  °C. The reaction mixture was stirred 
for 30 minutes allowing the temperature to warm to -2 0  °C. The reaction mixture was then 
checked by LC. The electrophile (3.59 mmol) was then added dropwise to the reaction 
mixture. The solution was then allowed to warm to room temperature and stirred for 4 hours. 
The reaction mixture was then poured onto ice/HCl (1M solution) and then extracted with 
dichloromethane (3 x 50 ml). The organic solution was then washed with water (3 x 50 ml) 
and then dried over Na2 SC>4 . The solvent was removed to give the crude product.
(m), 854 (m), 740 (m); 5H (400 MHZ; CDC13) 8.50 (1H, d, J  2.5 Hz, H-3”), 8.38 (1H, dd, J2.5  
& 8 . 8  Hz, H-5”), 8.06 (2H, d, / 9 .0  Hz, H-3’ & H-5’), 7.73 (1H, d, J 8 . 8  Hz, H-6 ”), 7.57 (2H, 
d, J  9.0 Hz, H-2’ & H-6 ’), 3.62 (3H, s, 0-CH 3), 2.53-2.62 (1H, m, HCH), 2.28-2.37 (1H, m, 
HCH), 0.84 (3H, t, J  7.3 Hz, CH2CH3); Sc (100 MHZ; CDC13) 171.9 (s) (C=0), 149.0 (s) (C, 
Ar), 147.3 (s) (C, Ar), 147.1 (s) (C, Ar), 147.0 (s) (C, Ar), 131.8 (q) (C-CF37 32 Hz), 131.2 (s) 
(CH, Ar), 129.4 (s) (2 x CH, Ar), 126.4 (s) (CH, Ar), 124.9 (s) (CH, Ar), 123.6 (s) (2 x CH,
no2
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Ethyl 2-(2’,4’-dinitrophenyl)-2-(4”-nitrophenyl)propionate (257b)—This was prepared by the 
method above using potassium tert-butoxide (0.80 g, 7.2 mmol), ethyl 2-chloropropionate 
(0.61 ml, 4.8 mmol), nitrobenzene (0.25 ml, 2.39 mmol) and 2,4-dinitrofluorobenzene (0.45 
ml, 3.59 mmol) to give the crude product as an orange oil (2.02 g). The crude product was 
then purified by column chromatography Rf 0.17 (silica, 3:1. hexane:ethyl acetate; v/v) to give 
the pure product (0.53 g , 57%) as an orange oil. Umax (liquid film on NaCl plates/ cm'1) 2984 
(m), 1738 (s) (C=0), 1604 (s), 1521 (s), 1349 (s), 909 (m), 835 (m), 650 (m); 6 H (400 MHz; 
CDCI3) 8.80 (1H, d, J 2.4 Hz, H-3’), 8.30 (1H, dd, J 2.4 & 8.7 Hz, H-5’), 8.22 (2H, d, J9 .0  Hz, 
H-3” & H-5”), 7.68 (2H, d, J  9.0 Hz, H-2” & H-6 ”), 7.16 (1H, d, J  8.7 Hz, H-6 ’), 4.15-4.22 
(1H, m, O-HCH-CH3), 4.01-4.09 (1H, m, O-HCH-CH3), 2.26 (3H, s, CH3), 1.18 (3H, t, J1.2 
Hz, CH3-CH2); 6 c (100 MHz; CDC13) 170.5 (s) (C=0), 149.4 (s) (C, Ar), 148.0 (s) (C, Ar),
147.6 (s) (C, Ar), 146.7 (s) (C, Ar), 146.0 (s) (C, Ar), 132.9 (s) (CH, Ar), 129.3 (s) (2 x CH, 
Ar), 126.8 (s) (CH, Ar), 123.8 (s) (2 x CH, Ar), 120.9 (s) (CH, Ar), 62.6 (s) (CH2), 56.2 (s) (C, 
quaternary), 25.6 (s) (CH3), 13.7 (s) (CH3-CH2); m/z (APCI) 389.9 [(M+H)+ , 100%], 345.1 
(36); (Found (APCI) (M + H)+ 390.0943. Ci7H15N30 8 requires (M + H)+ 390.0937).
NO
1) NaH, DMF
OoN CF CF
Ethyl 2-(4’-nitrophenyl)2-(4”-nitro-2”- trifluoromethylphenyl)propionate (257d)—This was 
prepared by the General Method using potassium terf-butoxide (0.80 g, 7.2 mmol), ethyl 2- 
chloropropionate (0.61 ml, 4.8 mmol), nitrobenzene (0.25 ml, 2.39 mmol) and 2-fIuoro-5- 
nitrobenzotrifluoride (0.44 ml, 3.1 mmol) to give the crude product (1.10 g) as an orange oil. 
The crude product was then purified by column chromatography Rf 0.26 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (0.68 g, 69%) as a yellow crystalline 
powder. M.p. 117-118.2 °C; (Found C, 51.74; H, 3.64; N 6.83. C]8Hi5F3N20 6  requires C, 
52.43; H, 3.67; N, 6.79%); i w  (nujol on NaCl plates/cm'1) 1737 (s) (C=0), 1591 (m), 1527 
(s), 1462 (s), 1349 (m), 1309 (m), 1117 (w), 910 (w), 857 (w), 737 (w); 5H (400 MHz; CDC13)
8.58 (1H, d, J 2 A  Hz, H-3”), 8.32 (1H, dd, /2 .4  & 8.9 Hz, H-5”), 8.20 (2H, d, J  8.9 Hz, H-3’ 
& H-5’), 7.64 (2H, d, J  8.9 Hz, H-2’ & H-6 ’), 7.41 (1H, d, J8 .9  Hz, H-6 ”), 4.23-4.29 (1H, m, 
HCH-CH3), 4.11-4.20 (1H, m, HCH-CH3), 2.10 (3H, s, CH3), 1.19 (3H, t, J  7.1 Hz, CH3-CH2) 
; 6 C (100 MHz; CDC13) 172.1 (s) (C=0), 149.4 (s) (C, Ar), 148.3 (s) (C, Ar), 147.1 (s) (C, Ar),
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146.8 (s) (C, Ar), 131.2 (s) (CH, Ar), 130.9 (q) (C-CF3, J  32.6 Hz), 128.8 (s) (2 x CH, Ar),
126.1 (s) (CH, Ar), 124.4 (s) (CH, Ar), 123.6 (s) (2 x CH, Ar), 122.7 (q) (CF3, J273 Hz), 62.4 
(s) (CH2), 56.2 (s) (C, quaternary), 28.4 (s) (CH3), 13.7 (s) (CH3-CH2); m/z (APCI) 369.8 
[(M+H)+, 100%], 341.8 (17.5), 295.8 (42); m/z (APCI) 412.9 [(M+H)+, 100%], 370.1 (65),
364.9 (14); (Found (APCI) (M+ H)+ 413.0960. Ci7Hi5N30 8 requires (M + H)+ 413.0953).
c r  C 0 2Et
NO
1) NaH, DMF
C 0 2Et
NOOoN
Ethyl 2-(2\ 4 ’-dinitrophenyl)-2-(4”-nitrophenyl)propionate (257b)—This was prepared by the 
General Method used in the previous compound using sodium hydride (60% dispersion in oil) 
(0.81 g, 20.3 mmol), ethyl 2-chloropropionate (1.1 lg, 8.13 mmol), nitrobenzene (0.84 ml, 8.13 
mmol) and 2,4-dinitrochlorobenzene (1.64 g, 8.13 mmol) to give the crude product (2.85 g) as 
a brown oil. The crude product was then purified by column chromatography Rf 0.17 (silica, 
3:1. hexane:ethyl acetate; v/v) to give the pure product (2.16 g, 69%) as a brown oil. Umax 
(liquid film on NaCl plates/ cm'1) 2984 (m), 1738 (s) (C=0), 1604 (s), 1521 (s), 1349 (s), 909 
(m), 835 (m), 650 (m); 5H (400 MHz; CDC13) 8.80 (1H, d, J 2.4 Hz, H-3’), 8.30 (1H, dd, J2A  
& 8.7 Hz, H-5’), 8.22 (2H, d, J  9.0 Hz, H-3” & H-5”), 7.68 (2H, d, J  9.0 Hz, H-2” & H-6 ”),
7.16 (1H, d, J  8.7 Hz, H-6 ’), 4.15-4.22 (1H, m, 0-HCH-CH3), 4.01-4.09 (1H, m, O-HCH- 
CH3), 2.26 (3H, s, CH3), 1.18 (3H, t, J  1.2 Hz, CH3-CH2); 5C (100 MHz; CDC13) 170.5 (s) 
(C=0), 149.4 (s) (C, Ar), 148.0 (s) (C, Ar), 147.6 (s) (C, Ar), 146.7 (s) (C, Ar), 146.0 (s) (C, 
Ar), 132.9 (s) (CH, Ar), 129.3 (s) (2 x CH, Ar), 126.8 (s) (CH, Ar), 123.8 (s) (2 x CH, Ar),
120.9 (s) (CH, Ar), 62.6 (s) (CH2), 56.2 (s) (C, quaternary), 25.6 (s) (CH3), 13.7 (s) (CH3- 
CH2); m/z (APCI) 389.9 [(M+H)+ , 100%], 345.1 (36); (Found (APCI) (M + H)+ 390.0943 
Ci7Hi5N30 8 requires (M + H)+ 390.0937).
c r  CQoEt
NO
1) NaH, DMF
COoEt
n o 2 NC NONC
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Ethyl 2-(4’-cyano-2y-nitro)-2-(4”-nitrophenyl)propionate (2571)—This was prepared by the 
General Method using sodium hydride (60% dispersion in oil) (0.68 g, 17.01 mmol), ethyl 2- 
chloropropionate (1.24 ml, 9.72 mmol), nitrobenzene (0.5 ml, 4.86 mmol) and 4-chloro-3- 
nitrobenzonitrile (0.89 g, 4.86 mmol) to give the crude product (4.02 g) as a brown oil. The 
crude product was then purified by column chromatography Rf 0.12 (silica, 3:1. hexane:ethyl 
acetate; v/v) to give the pure product (1.29 g, 72%) as a brown crystalline solid. M.p. 129-131 
°C umax (nujol NaCl plates/ cm'1) 2919 (s), 2234 (w), 1721 (s), (C=0), 1603 (w) 1464 (s), 1347 
(s), 1265 (m); 5H (400 MHz; CDC13) 8.17 (1H, d, J  1.8 Hz, H-3’), 8.15 (2H, d, J9 .0  Hz, H-3” 
& H-5”), 7.66 (1H, dd, J  1.7 & 8.2 Hz, H-5’), 7.58 (2H, d, J 9.0 Hz, H-2” & H-6 ”), 6.97 (1H, 
d, J  8.7 Hz, H-6 ’), 4.10 (1H, dq, J  3.7 & 7.2 Hz, HCH-CH3), 3.97 (1H, dq, J  3.7 & 7.2 Hz, 
HCH-CH3), 2.16 (3H, s, CH3), 1.11 (3H, t, J 7.2 Hz, CH2CH3); 5C(100 MHz; CDC13) 171.0 (s) 
(C=0), 149.8 (s) (C, Ar), 148.5 (s) (C, Ar), 147.9 (s) (C, Ar), 144.8 (s) (C, Ar), 136.0 (s) (CH, 
Ar), 133.0 (s) (CH, Ar), 129.7 (s) (2 x CH, Ar), 129.4 (s) (CH, Ar), 124.2 (s) (2 x CH, Ar),
116.5 (s) (C, Ar), 113.2 (s) (C, Ar), 62.0 (s) (CH2), 56.5 (s) (C, quaternary), 25.9 (s) (CH3),
14.1 (s) (CH3-CH2); m/z (APCI) 370.1 [(M+H)+ , 100%]; (Found (APCI) (M + NILO*, 
387.1308 C17H15N30 8 requires (M + NH4)+ 387.1305).
NO
1) NaH, DMF
COoEt
Ethyl 2,2-bis(4*-nitrophenyl)propionate230 (257m)—This was prepared by the General 
Method, cooling to 0 °C instead of -50 °C using sodium hydride (60% dispersion in oil) (1.3 g, 
32.54 mmol), ethyl 2-chloro-propionate (2.07 ml, 16.26mmol), nitrobenzene (0.84 ml, 8.13 
mmol) and 4-fluoronitrobenzene (0.86 ml, 8.13 mmol) to give the crude product (3.68 g) as an 
orange oil. The crude product was then purified by column chromatography Rf 0.24 (silica, 
3:1. hexane:ethyl acetate; v/v) to give the pure product (2.07 g, 74%) as an orange oil; umax 
(nujol on NaCl plates/cm'1) 3081 (w), 2989 (s), 2457(w), 1928 (w), 1721 (s), 1596 (s), 1530 
(s), 1463 (s) 1342 (s), 1248 (s), 1094 (s), 1014 (s), 858 (m); 6H(400 MHZ; CDC13) 8.10 (4H, d, 
J  8.9 Hz, H-3’& H-5’), 7.33 (4H, d, J  8.9 Hz, H-2’ & H-6’),4.19 (2H, q, J  7.1 Hz, CH2), 1.93 
(3H, s, CH3), 1.16 (3H, t, J 7.1 Hz, CH2CH3), 5C(100 MHZ; CDC13) 173.2 (s) (C=0), 150.9 (s) 
(C, Ar), 147.3 (s) (C, Ar), 129.4 (s) (4 x CH, Ar), 123.9 (s) (4 x CH, Ar), 62.8 (s) (CH2), 57.2
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(s) (C, quaternary), 27.0 (s) (CH3), 14.3 (s) (CH3); m/z (APCI) 345.1 [(M+H)+, 100%], (Found: 
MI (El) 344.1004 CnHieNjOa requires MI 344.1003).
Isopropyl 2-(4’-nitrophenyl)-2-(2”-nitro-4”-trifluoromethylphenyl)propionate (268)—In a
100 ml round bottom flask was added potassium tert-butoxide (0.75 g, 6.64 mmol) and DMF 
(5 ml). The mixture was flushed with nitrogen and cooled to -50 °C in a CC^/methanol 
cooling bath. Nitrobenzene (0.34 ml, 3.32 mmol) and isopropyl 2-chloropropionate (0.50 g,
3.32 mmol) dissolved in anhydrous DMF (5 ml) was added dropwise to the reaction mixture. 
The bright purple solution was stirred at -50 °C for 10 minutes and then slowly warmed to -20 
°C before cooling back to -50 °C. 4-Fluoro-3-nitrobenzotrifluoride (0.47 ml, 3.32 mmol) was 
added dropwise to the reaction mixture, which was then slowly warmed to room temperature. 
The reaction mixture was stirred at room temperature for 2 hours and then poured onto a 
ice/HCl (1M) solution. The product was extracted with dichloromethane (3 x 30 ml), then 
washed with water (3 x 30 ml), sodium bicarbonate (30 ml) and dried over sodium sulfate. 
The drying agent was filtered and the solvent removed on a rotary evaporator to give an orange 
oil (1.7 g). The crude product was then purified by column chromatography R f  0.25 (silica,
3:1. hexaneiethyl acetate; v/v) to give the pure product (0.86 g, 61%) as a yellow crystalline 
powder. M.p. 284-286 °C umax (nujol NaCl plates/ cm'1) 2922 (s), 1705 (s), (C=0), 1630 (w)
(s) (CH, Ar), 122.6 (q) (J 271.2 Hz) (CF3), 70.7 (s) (C-O), 56.2 (s) (C, quaternary), 25.5 (s) 
(CH3), 21.4 (s) (CH3), 21.1 (s) (CH3); m/z (APCI) 427 [(M+H)+ , 100%], 316 (8 ); (Found 
(ES+) (M + NH4)+ 444.1383. Ci9H17N2 0 6F3 requires (M + NH4)+ 444.1377).
N 0 2
1454 (s), 1376 (m), 1318 (m); 5H (400 MHz; CDC13) 8.13-8.16 (3H, m, H-3” & H-3’ & H-5’), 
7.64 (1H, dd, J  1.7 & 8.5 Hz, H-5”), 7.60 (2H, d, 79.0 Hz, H-2’ & H-6 ’), 7.0 (1H, d, 78.5 Hz, 
H-6 ”), 4.88 (1H, sept, 7  6.3 Hz, CH-(CH3)2), 2.16 (3H, s, CH3), 1.09 (3H, d, 7  6.3 Hz, CH3- 
CH-CH3), 1.03 (3H, d, 7  6.3 Hz, CH3-CH-CH3); 6C(100 MHz; CDC13) 170.6 (s) (C=0), 149.6 
(s) (C, Ar), 149.0 (s) (C, Ar), 147.8 (s) (C, Ar), 143.7 (s) (C, Ar), 132.8 (s) (CH, Ar), 130.9 (q) 
(734.3 Hz) (C-CF3), 129.3 (s) (2 x CH, Ar), 129.2 (s) (CH, Ar), 123.6 (s) (2 x CH, Ar), 122.9
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NO-
1) KOt-Bu, DMF
C 0 2f-Bu
C 0 2t-Bu
NOOoNo 2n
tert-Butyl 2 -(2 \4 ’-dinitrophenyl)-2-(4”-nitrophenyl)propionate (271)—This was prepared by 
the General Method using potassium tert-butoxide (0.85 g, 7.6 mmol), tert-butyl 2- 
chloropropionate (0.50 g, 3.04 mmol), nitrobenzene (0.31 ml, 3.04 mmol), 2,4- 
dinitrofluorobenzene (0.57 ml, 4.56 mmol) and anhydrous DMF (10 ml) to give the crude 
product as an orange oil (2.51 g). The crude product was then purified by column 
chromatography Rf 0.29 (silica, 7:3. hexane:acetone; v/v) to give the product as an orange oil 
(1.0 g). To remove the excess 2,4-dinitrofluorobenzene still present the product was dissolved 
in ethyl acetate (5 ml) and added to a plastic filter syringe containing poly(styrene-co 
divinylbenzene)amino methylated (0.75 g). The column was fitted with a cap and shaken 
vigorously for 24 hours. The filtrate was then collected and the solvent removed on a rotary 
evaporator to give the pure product as an orange oil (0.88 g, 69%). Umax (oil, NaCl plates/ cm' 
') 2918 (s), 1731 (s), 1603 (s), 1524 (s), 1463 (s), 1375 (s); 8H(400 MHz; CDClj) 8.72 (1H, d,
72.4 Hz, H-3’), 8.20 (1H, dd, 72.4 & 8 . 6  Hz, H-5’), 8.16 (2H, d, 79.0 Hz, H-3” & H-5”), 7.58 
(2H, d, 7  9.0 Hz, H-2” & H-6 ”), 7.04 (1H, d, 7  8 . 6  Hz, H-6 ’), 2.16 (3H, s, CH3), 1.25 (9H, s, 
(CH3)3); 8 c (100 MHz; CDC13) 169.4 (s) (C=0), 149.9 (s) (C, Ar), 148.9 (s) (C, Ar), 147.9 (s) 
(C, Ar), 146.9 (s) (C, Ar), 146.6 (s) (C, Ar), 133.4 (s) (CH,Ar), 129.6 (s) (2 x CH, Ar), 127.0 
(s) (CH, Ar), 124.0 (s) (2 x CH, Ar), 121.2 (s) (CH, Ar), 84.7 (s) (C-0), 57.5 (s) (C,quaternary),
27.8 (s) ((CH3)3), 25.9 (s) (CH3); m/z (ES+) 435.2 [(M+NH4)+ , 100%]; (Found (ES+) (M + 
NtL,)+ 435.1505. Ci9Hi9N30 8 requires (M + NH4)+ 435.1510).
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Phenyl (5 ’-chloro-2 '-nitrophenyl)(4"-trifluoromethyl-2 "-nitrophenyl)methyl sulfone 
(276a)—This was prepared by the General Method, cooling to 0 °C instead of -50 °C using 
sodium hydride (60% dispersion in oil) (0.26 g, 6 . 5 5  mmol), chloromethyl phenyl sulfone 
(0.42 g, 2.22 mmol), p-chloronitrobenzene (0.50 g, 2.62 mmol) and 4-fluoro-3- 
nitrobenzotrifluoride (0.38 ml, 2.64 mmol) to give the crude product (1.12 g) as a yellow oil. 
The crude product was then purified by column chromatography, Rf 0.38 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (0.98 g, 75%) as a yellow crystalline solid. 
M.p. 178-179.8 °C; Umax (nujol on NaCl plates/cm'1) 2922 (s), 1627 (w), 1602 (w), 1546 (m),
122.06 (q) (CF3, J  271 Hz), 121.0 (s) (CH, Ar), 61.3 (s) (CH); m/z (APCI) 501.1 [(M+H)+, 
100%], 500.4 (57), 360.9 (26), 358.7 (81) (Found (ES+) (M + H)+ 501.0136. C2 0H12CIF3N 2O6S 
requires (M + H)+ 501.0135).
Phenyl (5 '-chloro-2’-nitrophenyl)(2 ”,4 ”-dinitrophenyl)methyl sulfone (276b)—This was 
prepared by the General Method using sodium hydride (60% dispersion in oil) (0.23 g, 5.75 
mmol), chloromethyl phenyl sulfone (0.42 g, 2.22 mmol), p-chloronitrobenzene (0.35 g, 2.22 
mmol) and 2,4-dinitrofluorobenzene (0.28 ml, 2.62 mmol) to give the crude product (1.20 g) as 
an orange oil. The crude product was then purified by column chromatography, Rf 0.41 
(silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product (0.78 g, 74%) as a yellow 
crystalline solid. M.p. 178.1-179.7 °C; (Found C, 47.74; H, 2.57; N 8.71. C18H15F3N2O6 
requires C, 47.76; H, 2.53; N, 8.79%); Umax (nujol on NaCl plates/cm-1) 2925 (s), 2360 (w),
1462 (s), 1326 (s), 1154, (m), 912 (w), 892 (w), 847 (w), 784 (w), 720 (w); 6 H (400 MHz; 
CDCI3) 8.53 (1H, d, J8 .3  Hz, H-3’), 8.30 (1H, d, J 2.2 Hz, H-3”), 8.23 (1H, d, J  1.3 Hz, H-6 ’),
8.02 (1H, dd, J  1.3 & 8.3 Hz, H-4’), 7.93 (1H, d, J 8 . 8  Hz, H-6 ”), 7.69 (2H, d, J  7.6 Hz, -S02- 
Ph), 7.64 (1H, t, J1 .6  Hz, -S02-Ph), 7.55 (1H, dd, J2.2  & 8 . 8  Hz, H-5”), 7.48 (2H, t, J1.6  Hz, 
-S02-Ph), 7.40 (1H, s, CH); 5C(100 MHz; CDC13), 149.8 (s) (C, Ar), 147.8 (s) (C, Ar), 140.1 
(s) (C, Ar), 136.8 (s) (C, Ar), 135.1 (s) (CH, Ar), 132.7 (q) (C-CF3, J  32 Hz), 132.6 (s) (CH, 
Ar), 131.6 (s) (CH, Ar), 130.6 (s) (CH, Ar), 129.9 (s), (CH, Ar), 129.8 (s), (C, Ar), 129.5 (s) (2 
x CH, Ar), 129.1 (s) (2 x CH, Ar), 127.8, (s) (C, Ar), 127.3 (s) (CH, Ar), 123.1 (s) (CH, Ar),
C r  S 0 2Ph
NO Ph
n o 2
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1601 (m), 1570 (w), 1529 (m), 1465 (s), 1377 (w), 1339 (m), 1183 (w), 1152 (m), 1085 (w), 
914 (m), 848 (m), 723 (m); SH (400 MHz; CDCI3) 8.74 (1H, d, 7 2.2 Hz, H-3”), 8.46-8.53 (2H, 
m, H-3’ & H -5”), 8.26 (1H, d ,72 .2  Hz, H-6 ’), 7.88 (1H, d ,78 .8  Hz, H-4’), 7.63 (2H, d,78.2 
Hz, PhS02), 7.59 (1H, t,78 .2  Hz, -PhS02), 7.50 (1H, dd, J2 .2  & 8.7 Hz, H-6 ”), 7.42 (2H, t, J
8.2 Hz, PhS02), 7.35 (1H, s, CH); 5C (100 MHz; CDC13), 149.9 (s) (C, Ar), 147.9 (s) (C, Ar),
147.7 (s) (C, Ar), 140.3 (s) (C, Ar), 136.6 (s) (C, Ar), 135.2 (s) (CH, Ar), 133.1 (s) (CH, Ar), 
132.4 (s) (C, Ar), 131.5 (s) (CH, Ar), 130.7 (s) (CH, Ar), 129.6 (s) (2 x CH, Ar), 129.1, (s) (2 x 
CH, Ar), 127.5 (s) (C, Ar), 127.4 (s) (CH, Ar), 127.3 (s) (CH, Ar), 121.1 (s) (CH, Ar) 61.4 (s) 
(CH); m/z (APCI) 477.9 [(M+H)+, 100 %]; (Found: (Ammonia Cl): (M + NH4)+, 495.0379, 
C17H 13N3O6 requires (M + NFLt)+ 495.0377).
NO- PhI
c r  s o 2Ph
NO? SO? CN1) NaH, DMF
2) NOCN
Cl
Phenyl (5 ’-chloro-2J-nitrophenyl)(2”-nitrile-4”-nitrophenyl)methyl sulfone (276c)—This 
was prepared by the General Method, cooling to 0 °C instead of -50 °C using sodium hydride 
(60% dispersion in oil) (0.23 g, 5.75 mmol), chloromethyl phenyl sulfone (0.50 g, 2.62 mmol), 
/ 7-chloronitrobenzene (0.42 g, 2.62 mmol) and 2-fluoro-5-benzonitrile (0.44 g, 2.64 mmol) to 
give the crude product (1.20 g) as an orange solid. The crude product was then purified by 
column chromatography, Rf 0.18 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure 
product (0.78 g, 74%) as a yellow crystalline solid. M.p. 196-198 °C; (Found C, 52.49; H, 
2.64; N 9.23. C18H 15F3N2O6 requires C, 52.47; H, 2.64; N, 9.23%); umax (nujol on NaCl 
plates/cm'1) 2933 (s), 1608.0 (w), 1533.8 (m), 1460.0 (m), 1342.9 (m), 1152.7 (m); 5H (400 
MHz; CDCI3) 8.53 (1H, dd, 72.4  Hz & 8 . 8  Hz, H-5”), 8.47 (1H, d, 72.4 Hz, H-3”), 8.41 (1H, 
d, 7  2.4 Hz, H-6 ’), 8.29 (1H, d, 7  8 . 8  Hz, H-4’), 8.02 (1H, d, 7  8 . 8  Hz, H-6 ”), 7.71 (3H, m, - 
S02-Ph ), 7.60 (1H, dd, 7  2.2 Hz & 8 . 8  Hz, H-3’), 7.54 (1H, t, 7  7.8 Hz, -S02Ph), 6.90 (1H, s, 
HC-S02-Ph); 8 C (100 MHz; CDCI3), 147.7 (s) (C, Ar), 147.3 (s) (C, Ar), 140.8 (s) (C, Ar),
140.6 (s) (C, Ar), 136.1 (s) (C, Ar), 135.5 (s) (CH, Ar), 131.9 (s) (CH, Ar), 131.1 (s) (CH, Ar),
130.9 (s) (CH, Ar), 129.8 (s) (2 x CH, Ar), 129.3 (s) (2 x CH, Ar), 128.1 (s) (CH, Ar), 127.6 
(s) (CH, Ar), 127.5 (s) (C, Ar), 127.4 (s) (CH, Ar), 117.1 (s) (CN or C, Ar), 114.4 (s) (CN or C, 
Ar), 65.6 (s) (CH); m/z (APCI) 458.0 [(M+H)+, 100 %], 457.4 (31), 318.9 (50); (Found: (M+ 
NFL*)*, 457.0491. C20H12CIN3O6S requires( M + NH4)+ 475.0479).
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c r  s o 2Ph
1) NaH, DMF
Ph
n o 2 s o 2 c f 3
NO;
Phenyl (5f-chloro-2 ’-nitrophenyl)(2”-trifluoromethyl-4”-nitrophenyl)methyl sulfone 
(276d)—This was prepared by the General Method, cooling to 0 °C instead of -50 °C using 
sodium hydride (60% dispersion in oil) (0.23 g, 5.75 mmol), chloromethyl phenyl sulfone 
(0.42 g, 2.22 mmol), /?-chloronitrobenzene (0.35 g , 2.22 mmol) and 2-fluoro-5- 
benzotrifluoride (0.54 g, 2.64 mmol) to give the crude product (1.48 g) as an orange oil. The 
crude product was then purified by column chromatography, R f 0.41 (silica, 3:1. hexane:ethyl 
acetate; v/v to give the pure product (0.98 g, 75%) as a yellow crystalline solid. M.p. 178.2-
180.0 °C; (Found C, 48.12; H, 2.39; N 5.60. C18H 15F3N2O6 requires C, 47.96; H, 2.41; N, 
5.59%); Umax (nujol on NaCl plates/cm'1) 2925 (s), 2360 (w), 1734 (w), 1618 (w), 1597 (m), 
1532 (m), 1466 (s), 1376 (s), 1309 (s), 1154 (s), 1084 (w), 1051 (m), 917 (m), 842 (m), 757 
(w), 728 (m); 5H(400 MHz; CDCI3) 9.10 (1H, d, J 8 . 8  Hz, H-3’), 8.65 (1H, dd, J2 .3  & 8 . 8  Hz, 
H-5”), 8.50 (1H, d, J  2.2 Hz, H-3”), 8.10 (1H, d, J  8.7 Hz, H-4’), 7.75 (2H, d, J  8.1 Hz, 
PhS02), 7.62-7.65 (3H, m, H-6 ’ & PhS02 & CH), 7.57 (1H, dd, J  2.1 & 8.7 Hz, H-6 ”), 7.49 
(2 H, t ,y  8.1 Hz, PhS02); 6C(100 MHz; CDC13), 148.4 (s) (C, Ar), 148.1 (s) (C, Ar), 140.4 (s) 
(C, Ar), 137.0 (s) (C, Ar), 137.0 (s) (C, Ar), 135.4 (s) (CH, Ar), 133.6 (s) (CH, Ar), 132.4 (q) 
(C-CF3, J  32 Hz), 131.8 (s) (CH, Ar), 131.0 (s) (CH, Ar), 129.9 (s) (2 x CH, Ar), 129.3 (s) (2 x 
CH, Ar), 128.3 (s) (CH, Ar), 127.3 (s) (CH, Ar), 126.6 (s) (C, Ar), 122.8 (q) (CH, Ar, J  6.1 
Hz), 122.6 (q) (CF3, J  266 Hz), 61.5 (s) (CH); m/z (APCI) 501.0 [(M + H)+, 100 %]; (Found 
(ES+): (M + NH4)+, 518.0393, C20Hi2C1F3N2O6 requires (M + NH4)+ 518.0400).
Cr S 0 2Ph
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Phenyl (5 '-trifluoromethyl-2 nitrophenyl)(2 ”-trifluoromethyl-4”-nitrophenyl)methyl
sulfone (276e)—This was prepared by the General Method, cooling to 0 °C instead of -50 °C 
using sodium hydride (60% dispersion in oil) (0.13 g, 3.30 mmol), chloromethyl phenyl 
sulfone (0.25 g, 1.31 mmol), 4-nitro-a,a,a-trifluoro toluene (0.25 g , 1.31 mmol) and 4-fluoro-
3-benzotrifluoride (0.19 ml, 1.35 mmol) to give the crude product (0.80 g) as an orange oil. 
The crude product was then purified by column chromatography, Rf 0.38 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (0.57 g, 81%) as a yellow crystalline solid. 
M.p. 158-159.8 °C; Umax (nujol on NaCl plates/cm'1) 2925 (s), 2852 (s), 1628 (w), 1538 (s), 
1462 (s), 1375 (w), 1330 (s), 1248 (w), 1184 (m), 1155 (m), 1131 (m), 1094 (m), 935 (w), 854 
(m), 727 (m); 5H (400 MHz; CDC13) 8.63 (1H, s, H-3”), 8.46 (1H, d, J  8.4 Hz, H-3’), 8.25 (1H, 
s, H-6’), 8.04 (2H, d, J8 .3  Hz, H-4’ & H-5”), 7.86 (1H, d, J  8.5 Hz, H-6”), 7.68 (2H, d, J7.8 
Hz, PhS02 ), 7.64 (1H, t, J 7.50 Hz, PhS02), 7.48 (2H, t, J7 .8  Hz, PhS02), 7.38 (1H, s, CH); 
5C (100 MHz; CDC13), 151.7 (s) (C, Ar), 149.9 (s) (C, Ar), 136.6 (s) (C, Ar), 135.2 (s) (CH, 
Ar), 134.9 (q) (C-CF3, J3 4  Hz), 132.9 (q) (C-CF3, J 34 Hz), 132.4 (s) (CH, Ar), 130.0 (s) (CH, 
Ar), 129.6 (s) (2 x CH, Ar), 129.5 (s) (C, Ar), 128.6 (2 x CH, Ar), 128.6, (s) (CH, Ar), 127.7 
(s) (CH, Ar), 126.9 (s) (C, Ar), 126.4 (s) (CH, Ar), 123.2 (s) (CH, Ar), 122.51 (q) (CF3, J 272 
Hz), 122.31 (q) (CF3, J212  Hz), 61.2 (s) (CH); m/z (APCI) 535.2 [(M+H)+, 100%], 534.5 (65); 
Found (ES+): (M + NH4)+, 552.0663. C2iHi2F6N20 6 requires (M + NH4)+ 552.0664.
Phi
c r  sOoPh
N02 S02 NO;1) NaH, DMF
NO
n o 2
Phenyl (5’-trifluoromethyl-2’-nitrophenyl)(2”,4”-dinitrophenyl)methyl sulfone (276f)—This 
was prepared by the General Method, cooling to 0 °C instead o f -50 °C using sodium hydride 
(60% dispersion in oil) (0.13 g, 3.30 mmol), chloromethyl phenyl sulfone (0.25 g, 1.31 mmol), 
4-nitro-a,a,a-trifluorotoluene (0.25 g , 1.31 mmol) and 2,4-dinitrofluorobenzene (0.17 ml, 1.31 
mmol) to give the crude product (0.68 g) as an orange oil. The crude product was then purified 
by column chromatography, Rf 0.41 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure 
product (0.53 g, 79%) as a yellow crystalline solid. M.p. 215.1-217.3 °C; (Found C, 46.67; H, 
2.39; N 8.25. Ci8Hi5F3N206 requires C, 46.98; H, 2.37; N, 8.20%); i)max (nujol on NaCl 
plates/cm1) 2918 (s), 2852 (s), 1604 (s), 1539 (s), 1465 (s), 1400 (s), 1180 (m), 1154 (m),
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1127 (m), 1095 (m), 913 (m), 852 (m), 756 (m); 8H(400 MHz; CDC13) 8.84 (1H, d, J 2.4 Hz, 
H-3”), 8.65 (1H, s, H-6 ’), 8 . 6  (1H, dd, J  2.4 & 8.7 Hz, H-5”), 8.48 (1H, d, J  8 .8  Hz, H-6 ”),
8.06 (1H, d, J  8.4 Hz, H-4’), 7.88 (1H, d, J  8.5 Hz„ H-3’), 7.65-7.71 (3H, m, PhS02), 7.50 
(2H, t, J  7.8 Hz, PhS02), 7.40 (1H, s, CH); 8 C (100 MHz; CDC13), 151.7 (s) (C, Ar), 150.0 (s) 
(C, Ar), 148.0 (s) (C, Ar), 136.5 (s) (C, Ar), 135.3 (s) (CH, Ar), 133.0 (s) (CH, Ar), 132.0 (s) 
(C, Ar), 129.7 (s) (2 x CH, Ar), 129.0 (s) (2 x CH, Ar), 128.50 (s) (CH, Ar), 127.9 (s) (CH, 
Ar), 127.4, (s) (CH, Ar), 126.6 (s) (C, Ar), 126.5 (s) (CH, Ar), 121.3 (s) (CH, Ar), 61.29 (s) 
(HC-S02Ph); m/z (APCI) 512.0 [(M + H)+, 100%], 511.4 (75); Found (ES+): (M + NH4)+, 
529.0636, C20H 12F1N3O8S requires (M + NFLt)4" 529.0641.
NO, Ph
Cr S 0 2Ph
1) NaH, DMF
CN
N02 S 02 CN
NO:
Phenyl (5’-trifluoromethyl-2’-nitrophenyl)(2”-4”-dinitrophenyl)methyl sulfone (276g)—This 
was prepared by the General Method, cooling to 0 °C instead of -50 °C using sodium hydride 
(60% dispersion in oil) (0.13 g, 3.30 mmol), chloromethyl phenyl sulfone (0.25 g, 1.31 mmol),
4-nitro-a,a,a-trifluorotoluene (0.25 g , 1.31 mmol) and 2-fluoro-5-nitrobenzonitrile (0.22 g,
1.32 mmol) to give the crude product (1.03 g) as an orange oil. The crude product was then 
purified by column chromatography, Rf 0.26 (silica, 3:1. hexane:ethyl acetate; v/v) to give the 
pure product (0.51 g, 78%) as a yellow crystalline solid. M.p. 197.9-200 °C; (Found C, 51.41; 
H, 2.42; N 8.55. C2iHi2F6N0 6S requires C, 51.33; H, 2.46; N, 8.55%) Umax (nujol on NaCl 
plates/cm'1) 2924 (s), 1610 (w), 1581 (w), 1542 (s), 1464 (s), 1356 (m), 1334 (m), 1253 (w), 
1177 (m), 1129 (m), 1092 (m), 976 (w), 932 (m), 858 (s), 788 (m), 730 (m); 6 H (400 MHz; 
CDC13) 8.64 (1H, s, H-6 ’), 8.48 (1H, dd, J  2.4 & 8.7 Hz, H-5”), 8.42 (1H, d, J  2.4 Hz, H-3”),
8.17 (1H, d, J  8 . 8  Hz, H-6 ”), 8.06 (1H, d, J  8 . 6  Hz, H-4’), 7.83 (1H, d, J  8.5 Hz, H-3’), 7.62- 
7.66 (3H, m, PhS02), 7.47 (2 H, t, J  7.8 Hz, PhS02), 7.20 (1H, s, CH); 5C (400 MHz; CDCI3),
151.8 (s) (C, Ar), 147.8 (s) (C, Ar), 140.4 (s) (C, Ar), 136.8 (s) (C, Ar), 136.2 (s) (CH, Ar)
136.0 (s) (C, Ar), 135.3 (q) (C-CF3, J 34 Hz), 133.2 (s) (CH, Ar), 130.6 (s) (2 x CH, Ar), 129.9 
(s) (2 x CH, Ar), 128.3 (s) (CH, Ar), 127.6 (s) (CH, Ar), 126.9 (s) (CH, Ar), 126.7 (s) (CH, 
Ar), 123.8 (s) (CH, Ar), 122.1 (q) (CF3, 7268 Hz), 117.1 (s) (CN or C, Ar), 114.4 (s) (CN or
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C, Ar), 61.3 (s) (HC-S02Ph); m/z (APCI) 491.9 {(M + H)+, 100 %], 349.5 (85); (Found (M + 
NH4)+, 509.0748, C2iH12F3N 3 0 6 S requires (M + NH4)+ 509.0743).
NO, Ph
c r  so2Ph
1) NaH, DMF no2 s o 2 cf3
NO
Phenyl (5 ’-trifluoro-2 nitrophenyl)(2”-trifluoromethyl-4 ”-nitrophenyl)methyl sulfone
(276h)—This was prepared by the General Method, cooling to 0 °C instead of -50 °C using 
sodium hydride (60% dispersion in oil) (0.13 g, 3.30 mmol), chloromethyl phenyl sulfone 
(0.25 g, 1.31 mmol), 4-nitro-a,a,a-trifluorotoluene (0.25 g , 1.31 mmol) and 2-fluoro-5- 
nitrobenzotrifluoride (0.28 g, 1.34 mmol) to give the crude product (1.16 g) as an orange solid. 
The crude product was then purified by column chromatography, Rf 0.42 (silica, 3:1. 
hexane:ethyl acetate; v/v) to give the pure product (0.55 g, 78%) as a yellow crystalline solid. 
M.p. 190-192 °C; (Found C, 47.17; H, 2.26; N 5.34. C21Hi2F6N20 6S requires C, 47.2; H, 2.26; 
N, 5.24%) Umax (nujol on NaCl plates/cm'1) 2924 (s), 1621 (m), 1596 (m), 1537 (s), 1462 (s), 
1329 (s), 1127 (s), 919 (s), 854 (s), 797 (w), 784 (w); 6 H (400 MHZ; CDC13) 9.00 (1H, d, J  8.7 
Hz, H-5”), 8.57 (1H, dd, J 2.3 & 8.7 Hz, H-6 ”), 8.43 (1H, d, J2.3 Hz, H-3”), 8.17 (1H, d, J8.5 
Hz, H-3’), 7.85 (1H, s, H-6 ’), 7.80 (1H, d, J8 .5  Hz, H-4’), 7.66 (2H, t, J7 .7  Hz, PhS02), 7.56 
(1H, t, J  7.7 Hz, PhS02), 7.49 (1H, s, CH), 7.41 (2H, t, J  7.7 Hz, PhS02); 6 C (100 MHZ; 
CDC13), 149.8 (s) (C, Ar), 147.8 (s) (C, Ar), 140.1 (s) (C, Ar), 136.8 (s) (C, Ar), 135.1 (s) (CH, 
Ar), 132.9 (s) (CH, Ar), 131.6 (s) (CH, Ar), 130.6 (s) (CH, Ar), 129.9 (s) (CH, Ar), 129.5 (s) 
(CH, Ar), 129.1 (s) (CH, Ar), 127.8 (s) (C, Ar), 127.3 (s) (CH, Ar), 123.1 (s) (CH, Ar), 121.0 
(s) (C, Ar), 61.3 (s) (HC-S02Ph); m/z (APCI) 535.4 [(M+H)+, 100%)], 511.4 (75), 370.9 (25).
General Methods for the Formation o f Oxindoles
Method A
In a Multi-Parr reaction vessel the ester (0.51 mmol) was added followed by 5% Pd/C (25 mg) 
(Johnson Mattey type 58 paste) (47.5% H20), ethyl acetate (2.5 ml) and acetic acid (0.25 ml). 
The mixture was stirred, purged with nitrogen (5 times) and then hydrogen (5 times) and left 
under hydrogen (50 psi). Continual checking by LC led to complete conversion of the starting 
material after 16 hours. The product was then filtered through a celite plug and then the 
solvent removed on a rotary evaporator to give the crude product.
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Method B
In a 2-necked round bottom flask fitted with a condenser and nitrogen bubbler was added 
tin(II) chloride dihydrate (25.7 mmol), the ester (2.57 mmol), ethanol (40 ml), ethyl acetate (10 
ml) and conc. HC1 (3 drops). The solution was heated under reflux for 36 hours and then 
cooled to room temperature. The solution was reduced on a rotary evaporator to give a pale 
yellow oil. Ethyl acetate (50 ml) was added followed by sodium hydrogen carbonate (50 ml). 
The product was extracted with ethyl acetate (3 x 25 ml) and then washed with water (50 ml) 
and saturated sodium chloride (50 ml). The solution was then dried over magnesium sulfate 
and reduced on a rotary evaporator to give the crude product.
NHNO
Method A: H2, Pd/C 
EtOAc
Method B: SnCI2(H20 )2 
EtOH/EtOAc 
HCI
C 02Et
NH
o 2n NO
3-Methyl-3-(4’-aminophenyl)-6-aminooxindole (292a) Method A :—This was performed by 
the General Method using the ester 257b (200 mg, 0.51 mmol), 5% Pd/C (25 mg), ethyl 
acetate (2.5 ml) and acetic acid (0.25 ml). The product was left in the vessel for 16 hours, 
checking by LC until complete conversion had occurred. The crude product (115 mg) was 
obtained as an orange crystalline solid after being filtered through celite. The crude product 
was then washed with chloroform on a filter, dried and collected leaving a slightly brown 
crystalline solid (70 mg, 54%).
Method B :—This was prepared by the General Method using the ester 257b (1.0 g, 2.57 
mmol), tin(II) chloride dihydrate (5.81 g, 25.7 mmol), ethanol (40 ml), ethyl acetate (10 ml) 
and conc. hydrochloric acid (3 drops) and heating under reflux for 36 hours, to give the crude 
product as a brown crystalline solid (0.82 g). The crude product was then washed with 
chloroform on a filter, dried and collected leaving a slightly brown crystalline solid (0.46 g, 
71%). M.p. 149-151 °C; umax (nujol NaCl plates/ cm'1) 3350 (wk, br) (O-H), 1698 (s) (C=0); 
5h (400 MHz; MeOD) 7.05 (2H, d, J 8 . 6  Hz, H-2’ & H-6 ’), 6.87 (1H, d, J 8.0 Hz, H-4), 6.70 
(2H, d, J 8 . 6  Hz, H-3’ & H-5’), 6.56 (1H, d, J 2.0 Hz, H-7), 6.46 (1H, dd, J 2.0 & 8.0 Hz, H- 
5”); 1.66 (3H, s, CH3); 6 C (100 MHz; MeOD) 178.3 (s) (C=0), 150.6 (s) (C, Ar), 146.7 (s) (C, 
Ar), 144.0 (s) (C, Ar), 132.9 (s) (C, Ar), 128.9 (s) (2 x CH, Ar), 125.7 (s) (CH, Ar), 123.0 (s)
172
(C, Ar), 115.7 (s) ( 2  x CH, Ar), 111.0 (s) (CH, Ar), 97.3 (s) (CH, Ar), 51.6 (s) (C, q), 24.0 (s) 
(CH3); m/z (CI+) 271.2 [(M+NJL,)+, 100%], Found (ES+) (M + NH4)+, 271.1557 CuHijNjO 
requires (M + NH4)+ 271.1553.
C
. . . .  I -
n o 2 Method A: H2, Pd/C 
EtOAc
NH2
f 3c i n 0 2
Q2Et
Method B: SnCI2(H20 )2 __
EtOH/EtOAc
HCI
f3c
l-Hydroxy-3-methyl-3-(4’-aminophenyl)-6-trifluoromethyloxindole (292b) Method A :—This 
was prepared by the General Method using the ester 257a (100 mg, 0.24 mmol), 5% Pd/C (25 
mg), ethyl acetate (2.5 ml) and acetic acid (0.25 ml). The product was left in the vessel for 17 
hours, checking by LC until complete conversion had occurred. The crude product (130 mg) 
was obtained as a brown crystalline solid after being filtered through celite. This was then 
washed with chloroform to leave a white crystalline solid (60 mg, 77%).
Method B:—This was prepared by the General Method using the ester 257a (0.35 g, 0.85 
mmol), tin(II) chloride dihydrate (1.95 g, 8.5 mmol), ethanol (9 ml), ethyl acetate (3 ml) and 
conc. hydrochloric acid (3 drops). The reaction mixture was heated under reflux for 24 hours, 
and then worked up as before to give a brown crystalline solid (0.31 g). This solid was then
washed with chloroform as before to leave a white crystalline solid (0.23 g, 76%). M.p. 219- 
221 °C; Umax (nujol NaCl plates/ cm'1) 3420 (Br, s) (N-OH),1666 (s) (C=0) (s );.5h (400 MHz;
MeOD) 7.44 (1H, d, 73.6 Hz, H-7), 7.34-7.38 (2H, m, H-4 & H-5), 7.01 (2H, d, 78.8 Hz, H-2’ 
& H-6 ’), 6 . 6 8  (2H, d, 7  8 . 8  Hz, H-3’ & H-5’), 1.76 (3H, s, CH3); 6C(100 MHz; MeOD) 175.6 
(s) (C=0), 147.1 (s) (C, Ar), 142.3 (s) (C, Ar), 136.7 (s) (C, Ar), 130.2 (q, 7  32 Hz), (C-CF3)
128.0 (s) (C, Ar), 126.8 (s) (2 x CH, Ar), 124.1 (s) (CH, Ar), 119.9 (s) (CH, Ar), 115.1 (s) (2 x 
CH, Ar), 103.8 (s) (CH, Ar), 50.4 (s) (C, q), 21.5 (s) (CH3); m/z (ES+) 323.1 [(M +H)\ 100%], 
(Found (ES+) (M + NH4)+ 340.1266 Ci6Hi3N20 2F3 requires (M + NH4)+ 340.1266.
N
C 02Et Method B: SnCI2(H20)2 
EtOH/EtOAc 
HCI
Method A: H2, Pd/C 
EtOAc
N
173
l-Hydroxy-3-methyl-3-(4J-aminophenyl)-6-cyanooxindole (292c) Method A:—This was 
prepared by the General Method using the ester 2571 (200 mg, 0.54 mmol), 5% Pd/C (25 mg), 
ethyl acetate (2.5 ml) and acetic acid (0.25 ml). The product was left in the vessel for 20 hours, 
checking by LC until complete conversion had occurred. The crude product (124 mg) was 
obtained as a yellow crystalline solid after being filtered through celite. This was then washed 
with chloroform to leave a white crystalline solid (104 mg, 69%).
Method B :—This was prepared by the General Method using the ester 2571 (1.0 g, 2.71 mmol), 
tin(II) chloride dihydrate (6.12 g, 27.1 mmol), ethanol (40 ml), ethyl acetate (10 ml) and conc. 
hydrochloric acid (3 drops). The reaction mixture was heated under reflux for 36 hours, and 
then worked up as before to give a brown crystalline solid (0.80 g). This solid was then 
washed with chloroform as before to leave a white crystalline solid (0.60 g, 79%). M.p. 254- 
256 *C Umax (nujol NaCl plates/ cm'1) 3350 (wk, br) (O-H), 1712 (s) (C=0); 5H (400 MHz; 
DMSO) 11.10 (1H, s, O-H), 7.54 (1H, dd, J  1.6 & 7.6 Hz, H-5), 7.40-7.42 (2H, m, H-4 & H- 
7), 6 . 8 6  (2H, d, J8 .4  Hz, H-2’ & H-6 ’), 6.49 (2H, d, J8 .4  Hz, H-3’ & H-5’), 1.63 (3H, s, CH3); 
5c (100 MHz; DMSO).174.2 (s) (C=0), 148.5 (s) (C, Ar), 142.9 (s) (C, Ar), 138.0 (s) (C, Ar),
127.8 (s) (CH, Ar), 127.2 (s) (2 x CH, Ar), 126.2 (s) (C, Ar), 125.1 (s) (CH, Ar), 119.1 (s) (C, 
Ar), 114.1 (s) (2 x CH, Ar), 110.9 (s) (CN), 109.9 (s) (CH, Ar), 50.1 (s) (C, quaternary), 22.4 
(s) (CH3); m/z (ES+) 280.2 [(M+H)+, 1 0 0 %], Found (ES+) (M + NH4)+ 297.1348. Ci6Hi3N30 2 
requires (M + NH4)+ 297.1346.
Chloromethyl phenyl sulfone231 (322)— Sodium benzenesulfinate dihydrate (15 g, 75 mmol) 
and bromochloromethane (11.63 g, 90 mmol) in DMSO (40 ml) was heated at 100 °C for 4 
hours. The mixture was cooled, poured into water and extracted with dichloromethane (3 x 
100 ml). The combined extracts were washed with water (3 x 100 ml) and dried over 
magnesium sulfate. The solvent was removed to leave an orange crystalline solid (14.6 g). 
Recrystallisation from carbon tetrachloride provided white crystals of the sulfone (10.25 g, 72 
%). M.p. 52-54 °C (lit. M.p. 52-53 °C)231, I W  (nujol on NaCl plates/cm*1) 3055 (s), 3016 (s), 
2942 (s), 1584 (m), 1444 (m), 1376 (w), 1322 (s), 1309 (s), 1240 (s), 1161 (s), 1140 (s), 1079 
(s), 1015 (m), 8 6 6  (m); 5H(400 MHz; CDC13) 7.96 (2H, dd, J  1.1 & 7.9 Hz, ortho CH), 7.73 
(1H, dd, J  1.1 & 7.9 Hz,para  CH), 7.61 (2H, t, J  7.9 Hz, meta CH), 4.55 (2H, s, CH2); 5C(100 
MHz; CDC13) 135.5 (s) (C, Ar), 134.7 (s) (2 x CH, Ar), 129.3 (s) (CH, Ar), 129.2 (s) (2 x CH, 
Ar), 58.4 (s) (CH2); m/z (APCI) 191.2 [(M+H)+, 100%].
174
^  Me0H/H2S04 Cl
'C 0 2H C 02Me
Methyl 2-chlorobutanoate190 (259)—Chlorobutyric acid (10.59 g, 8.17 mmol) and methanol 
(100 ml) were added to a 250 ml 2-necked round bottomed flask fitted with a condenser and 
nitrogen bubbler. Sulfuric acid (0.5 ml) was added and the mixture was heated under reflux for 
3 hours. The mixture was then cooled and most of the methanol was removed on a rotary 
evaporator. The product was then extracted with ether (3 x 50 ml), dried followed by removal 
of the ether on a rotary evaporator to give the product as a clear oil (7.77 g, 70%). Umax (liquid 
film on NaCl plates/ cm'1) 2995 (m), 2975 (m, br), 2955 (w), 2886 (w), 1750 (s) (C=0), 1460 
(w), 1440 (w), 1380 (m), 1355 (m), 1170 (w); 8 H (400 MHz; CDC13) 3.68 (3H, t, 7  7.0 Hz, 
OCH3), 4.20 ( 1H, t , / 7 .0  Hz, CH-C1), 1.92 (2H, quintet, 7  7.0 Hz, CH2), 1.00 (3H, t, 7  7.0 Hz, 
CH3); 5c  (100 MHz; CDC13) 169.6 (s) (C=0), 58.7 (s) (C-O), 52.5 (s) (C-Cl), 28.7 (s) (CH2),
10.5 (s) (CH3); m/z (APCI) 138 [(M (37C1)+ H)+, 33%], 136 [(M (35C1) + H)+, 100%].
Cl ipa/h 2s o 4 Cl
C 02H ^  C 02/-Pr
Isopropyl 2-chloropropionate (267)—This was achieved using the General Method above 
as a yellow oil (69%). Umax (liquid film on NaCl plates/ cm"1) 3478 (wk, br), 2984 (m), 2936 
(w), 2360 (w), 1744 (s) (C O ), 1452 (m), 1379 (m), 1326 (m), 1278 (m), 1248 (m); 5H(400 
MHz; CDC13) 5.0 (1H, septet, 7  6.2 Hz, H3C-CH-CH3), 4.33 (1H, q, 7  6 . 8  Hz, CH-C1), 1.67 
(3H, d, 76.8 Hz, CH3), 1.27 (6 H, dd, 76.2 & 2.1 Hz, 2 x CH3); 5C(100 MHz; CDC13) 170.1 (s) 
(C=0), 70.1 (s) (C-O), 53.2 (s) (C-Cl), 21.8 (s) (2 x CH3); m/z (APCI) 152 [(M (37C1) +H)+, 
33%], 150 [(M (35C1) +H)+, 100%]
Cl f-BuOH/NEt3 01
COCI ^  C02f-bu
tert-Butyl 2-chloropropionate193 (269)—To a solution of 2-chloropropionyl chloride (10 ml,
108.5 mmol) and tert-butanol (28.0 g, 0.35 mol) in toluene (100 ml) was added dropwise over 
an hour a triethylamine (15.8 ml, 115 mmol) at room temperature. The solution was then 
stirred for 20 minutes before heated to 90 °C for 6  hours. Water (50 ml was added after 
cooling. The organic layer was separated and washed successively with water (50 ml), 
aqueous sodium bicarbonate (50 ml) and water (50 ml). The organic layer was then dried over
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magnesium sulfate. Removal of the solvent on a rotary evaporator gave a clear oil (53%). umax 
(liquid film on NaCl plates/ cm '1) 2981 (s), 2936 (m), 1739 (s) (C=0 ), 1480 (w), 1454 (m), 
1252 (m), 1157 (s), 1074 (m), 993 (m), 846 (m); 5H (400 MHz; CDC13) 4.22 (1H, q, J 7 . 0  Hz, 
Cl-CH), 1.58 (3H, d, J  7.0 Hz, CH3), 1.42 (9H, s, 3  x CH3); 8 C (100 MHz; CDC13) 169.6 (s) 
(C=0), 82.8 (s) (C-O), 54.1 (s) (C-Cl), 28.2 (s) (3 x CH3), 21.9 (s) (CH3); m/z (APCI) 166.0 
[(M (37C1) + H)+, 33%], 164 [(M (35C1) + H)+, 100%].
General Procedure for esterification of nitrophenylacetic/propionic acids—The acid 
(55.24 mmol) in ethanol (100 ml) and sulfuric acid (1 ml) was heated under reflux for 3 hours. 
Most of the ethanol was then removed on a rotary evaporator. Ether (50 ml) and sodium 
bicarbonate (sat. aq. 50 ml) was added and the organic product was extracted with ether (3 x 50 
ml). The solvent was then dried over Na2SC>4 and then removed on a rotary evaporator to give 
the pure product
EtOH/H
Ethyl 4-nitrophenylacetate233 (311)—This was prepared by the General Method using 4- 
nitrophenylacetic acid ( 1 0  g, 51.28 mmol), ethanol ( 1 0 0  ml) and sulfuric acid (1  ml) to give the 
pure product as a yellow crystalline solid (11.24 g, 97%). M.p. 65-67 °C (65-66 °C)233; Vmax 
(nujol on NaCl plates/cm'1) 1725 (s), 1601 (m), 1465 (s), 1375 (s); 5h (400 MHz, CDCI3) 5 8.20 
(2H, d, J  8 . 8  Hz, H-3 & H-5), 7.46 (2H, d, J  8 . 8  Hz, H-2 & H-6 ), 4.18 (2H, q, J 12  Hz, CH2), 
3.73 (2H, s, CH2), 1.27 (3H, t, J 1 2  Hz, CH3); 5C (100 MHz, CDC13) 171.9 (s) (C=0), 148.7 
(s) (C, Ar), 141.9 (s) (C, Ar), 131.5 (s) (2 x CH, Ar), 124.8 (s) (2 x CH, Ar), 57.1 (s) (CH2), 
41.3 (s) (CH2), 14.8 (s) (CH3);. m/z (APCI) 210.0 [(M + H)+, 100%].
EtOH/H
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Ethyl 2-(4'-nitrophenyl)propionate86 (313)—This was prepared by the General Method using
2-(4,-nitrophenyl)propionic acid (169) (10 g, 51.28 mmol), ethanol (100 ml) and sulfuric acid 
(1 ml) to give the product (10.38 g, 91%) as a yellow oil. %). vmax (liq. film on NaCl plates/cm' 
1) 1736 (s) (C=0), 1601 (m), 1521 (s), 1478 (s), 1210 (s), 6H(400 MHz, CDC13) 8.19 (2H, d,J
8 . 8  Hz, H-3 & H-5), 7.50 (2H, d, .78.8 Hz, H-2 & H-6 ), 4.09-4.21 (2H, m, CH2), 3.84 (1H, q, J
7.2 Hz, CH3), 1.55 (3H, d, J7 .2  Hz, CH3), 1.24 (3H, q, 77.4 Hz, CH3); 5C(100 MHz, CDC13),
174.1 (s) (C=0), 147.7 (s) (C, Ar), 146.3 (s) (C, Ar), 129.3 (s) (2 x CH, Ar), 124.5 (s) (2 x CH, 
Ar), 57.3 (s) (0-CH2), 41.9 (s) (CH), 19.8 (s) (CH3), 14.9 (s) (CH3). m/z (APCI) 224.0 [(M + 
H)+, 100 %].
MeOH/H
Methyl 4-nitrophenylacetate234 (167)—This was prepared by the General Method using 4- 
nitrophenyl acetic acid (166) (10 g, 55.24 mmol), methanol (100 ml) and sulfuric acid (1 ml) to 
give the pure product as a yellow crystalline solid (10.3 g, 95%). M.p. 53-55 °C (53-54 °C)234; 
Vmax (nujol on NaCl plates/cm'1) 1724 (s), 1600 (m), 1464 (s), 1377 (s) 1347 (m), 1108 (w), 
1014 (w), 854 (w); 5H(400 MHz, CDC13) 6  8.20 (2H, d, J  8.7 Hz, H-3 & H-5), 7.46 (2H, d, J
8.7 Hz, H-2 & H-6 ), 3.75 (3H, s, OCH3), 3.70 (3H, s, CH2), 6 C (100 MHz, CDC13) 172.1 (s) 
(C O ), 148.9 (s) (C, Ar), 141.7 (s) (C, Ar), 131.5 (s) (2 x CH, Ar), 124.7 (s) (2 x CH, Ar), 53.0 
(s) (0-CH3), 41.2 (s) (CH2); m/z (APCI) 196.0[(M + H)+, 100%], 89.2 (8 ), 61.3 (7.4), 60.5 
(16.7).
MeOH/H
Methyl 2-(4'-nitrophenyl)propionate235 (164)—This was prepared by the General Method 
using 2 -(4 '-nitrophenyl)propionic acid (163) (10 g, 51.28 mmol), methanol (100 ml) and 
sulfuric acid (1 ml) to give the pure product as a yellow oil (9.57 g, 90%). vmax (liq. film on
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NaCl plates/cm'1) 1738 (s) (C=0), 1606 (m), 1522 (s), 1211 (s), 859 (s), 5H(400 MHz, CDClj)
8.17 (2H, d, J  8.7 Hz, H-3 & H-5), 7.4 (2H, d, J  8.7 Hz, H-2 & H-6 ), 3.84 (1H, q, J 12 Hz, 
CH), 3.55 (3H, s, OCH3), 1.40 (3H, d, 7  7.2 Hz, CH3), 6C(100 MHz, CDC13) 174.2 (s) (C=0),
147.9 (s) (C, Ar), 146.5 (s) (C, Ar), 129.4 (s) (2 x CH, Ar), 124.6 (s) (2 x CH, Ar), 53.9 (s) (0- 
CH3), 45.1 (s) (-C-CO), 19.8 (s) (CH3). m/z (APCI) 209.9 [(M + H)+, 100 %], 192.9 (7), 177.9 
(14), 163.9 (3), 150.9 (6 ), 149.9 (13).
IPA/H
Isopropyl 2-nitrophenylacetate (315)—This was prepared by the General Method using 2-
nitrophenylacetic acid (8.0 g, 44.2 mmol), IP A (100 ml) and sulfuric acid (1 ml) to give the 
pure product as a pale yellow oil (7.90 g, 80%). Vmax (liq- film on NaCl plates/cm'1) 3444 (w), 
3070 (w), 2981 (m), 2936 (m), 2878 (w), 2363 (w), 1949 (w), 1729 (s) (C=0), 1613 (m), 1580 
(m), 1526 (s), 1467 (m), 1414 (m), 1348 (s), 1222 (s), 1105 (s), 1047 (w), 957 (s); 6H(400 
MHz, CDC13) 8.11 (1H, d, J  8.5 Hz, H-3), 7.60 (1H, t, J8 .5  Hz, H-5), 7.47 (1H, t, J8.5 Hz, H- 
4), 7.36 (1H, d, J  8.5 Hz, H-6 ), 5.04 (1H, septet, 76.4 Hz, HC(CH3)2), 3.99 (2H, s, CH2), 1.24 
(6 H, d, J6 .4  Hz, 2 x CH3), 5C(100 MHz, CDC13) 169.9 (s) (C=0), 149.2 (s) (C, Ar), 133.9 (s) 
(CH, Ar), 133.7 (s) (CH, Ar), 130.4 (s) (C, Ar), 128.9 (s) (CH, Ar), 125.6 (s) (CH, Ar), 69.3 (s) 
(CH) 40.6 (s) (CH2), 22.1 (s) (2 x CH3); m/z (APCI) 224.1 [(M+H)+, 100%].
EtOH/H
Ethyl 3-nitrophenylacetate237 (326)—This was prepared by the General Method using 3- 
nitrophenylacetic acid (325) (5 g, 27.7 mmol), ethanol (50 ml) and sulfuric acid (0.5 ml) to 
give the pure product as a pale yellow oil (4.04 g, 70%). Vmax (liq- film on NaCl plates/cm'1) 
3091 (w), 2983 (m), 2938 (w), 2360 (w), 1737 (s) (C=0), 1619 (w), 1583 (w), 1531 (s), 1480 
(w), 1445 (w), 1417 (w), 1352 (s), 1253 (m), 1227 (m), 1162 (s), 1098 (m), 1030 (s); 5H(400 
MHz, CDC13) 8.17 (1H, s, H-2), 8.14 (1H, d, J  8.4 Hz, H-6 ), 7.64 (1H, d, J  8.4 Hz, H-4), 7.52 
(1H, t, J  8.4 Hz, H-5), 4.19 (2H, q, J1.2 Hz, 0-CH2-), 3.74 (2H, s, Ar-CH2), 1.28 (3H, t, 7  7.2 
Hz, CH3), 8c(100 MHz, CDC13) 170.8 (s) (C O ), 148.6 (s) (C, Ar), 136.4 (s) (C, Ar), 136.1 (s)
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(CH, Ar), 129.8 (s) (CH, Ar), 124.7 (s) (CH, Ar), 122.6 (s) (CH, Ar), 61.7 (s) (CH2) 41.0 (s)
(CH2), 14.5 (s) (CH3); m/z (APCI) 216.1 [(M+H)+, 100%].
tert-Butyl 2-nitrophenylacetate238 (318)—Potassium tert-butoxide (0.6 g, 6.1 mmol) was 
dissolved in anhydrous THF (5 ml) under nitrogen, then cooled to -70 °C (bath temp). 
Nitrobenzene (0.25 ml, 2.43 mmol) and tert-butyl chloroacetate (0.35 ml, 2.43 mmol) 
dissolved in THF (2 ml) were slowly added to the basic solution. The solution was then stirred 
while slowly warming to around -20 °C for an hour. The reaction was then quenched with HCI 
(1M) (2 ml), then allowed to warm to room temperature. The product was then extracted with 
dichloromethane (3 x 20 ml), washed with water (3 x 20 ml), sodium bicarbonate (sat. aq. 20 
ml) and dried over Na2SC>4 . The solvent was then removed on a rotary evaporator to give an 
orange oil (0.75 g). The crude product was then purified by column chromatography R f 0.21 
(silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product (0.27 g, 47%) as a yellow oil. 
8h(400 MHz, CDC13) 8.10 (1H, d, /  8.3 Hz, H-6 ), 7.58 (1H, t, /8 .3  Hz, H-4), 7.46 (1H, t, J  8.3 
Hz, H-5), 7.34 (1H, d, /  8.3 Hz, H-3), 3.94 (2H, s, CH2), 1.44 (9H, s, 3 x CH3); 5C(100 MHz; 
CDC13) 169.3 (s) (C=0), 149.0 (s) (C, Ar), 133.6 (s) (C, Ar), 133.5 (s) (CH, Ar), 128.5 (s) 
(CH, Ar), 127.1 (s) (CH, Ar), 125.3 (s) (CH, Ar), 81.9 (s) (O-C), 41.2 (s) CH2), 28.1 (s) (3 
x CH3); [(M+H)+ 100%].
General Method for cross-coupling nitrophenylacetates with aryl halides—In a 100 ml
two-necked round bottom flask fitted with a condenser which was attached to a schlenk line, 
under a flow of nitrogen was added the base (2.39 mmol), and solvent (3 ml). The flask was 
cooled to 0 °C in an ice bath and the ester (2.39 mmol) dissolved in solvent (2 ml) was then 
added dropwise to the basic solution. The solution was allowed to warm to room temperature 
and a mixture of palladium acetate (5 mol %), the ligand (10 mol %) and electrophile (2.39 
mmol) dissolved in solvent were added to the bright purple solution. The mixture was heated 
in an oil bath while monitoring the reaction progress by HPLC. The mixture was then cooled 
to room temperature where ethyl acetate ( 2 0  ml) was added and the mixture was filtered 
through a silica gel plug to remove the palladium. The filtrate was collected and the solvent 
was removed on a rotary evaporator to give the crude product.
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no2 no2
1. KOf-Bu
1,4-Dioxane
OEt
2. Pd(OAc)2 
ligand 114 
Ph-Br Ph'
OEt
O O
Ethyl 2-(4’-nitrophenyl)-2-phenylacetate (312)—This was prepared by the General Method 
using potassium te/Y-butoxide (268 mg, 2.39 mmol), 1,4-dioxane ( 8  ml), ethyl 4- 
nitrophenylacetate (311) (0.50 g, 2.39 mmol), palladium acetate (26.8 mg, 0.12 mmol), 2- 
dicyclohexylphosphino-2’-(A,A/-dimethylamino)biphenyl (114) (94.5 mg, 0.24 mmol) and 
bromobenzene (0.26 ml, 2.39 mmol). The mixture was heated in an oil bath (110 °C) (bath 
temp) for 2 hours while monitoring the reaction progress by HPLC to give the crude product as 
a brown oil (0.76 g). The crude product was then purified by column chromatography R f 0.3
(silica, 3:1. hexaneiethyl acetate; v/v) to give the pure product (0.61 g, 90%) as a yellow oil. 
Vmax (liq. film on NaCl plates/cm'1) 3064 (w), 3030 (w), 2983 (m), 2937 (m), 2455 (w), 2364
286.0 [(M+H)+, 100%]; (Found (EI+): M+285.1014. C16H 15NO4 requires M+ 285.1001).
Ethyl 2-(4’-nitrophenyl)-2-(4”-methoxyphenyl)acetate (324a)—This was prepared by the 
General Method using 4-bromoanisole (0.30 ml, 2.39 mmol) instead of bromobenzene to give 
the pure product as a pale yellow oil after chromatography R f 0.5 (silica, 1:1. hexane:ethyl 
acetate; v/v) (0.35 g, 47%). vmax (liq. film on NaCl plates/cm'1) 3051 (w), 3049 (m), 1901 (w), 
1735 (s) (C=Q), 1549 (m), 1416 (m), 1361 (s), 1209 (m); 6H(400 MHz, CDC13) 8.16 (2H, d, J
(w), 1931 (w), 1732 (s), 1606 (s), 1522 (s), 1494 (m), 1453 (m), 1349 (s), 1194 (s), 1154 (s), 
1111 (m); 5h(400 MHz, CDC13) 8.16 (2H, d, J  8 . 6  Hz, H-3’ & H-5’), 7.50 (2H, d, / 8 . 6  Hz, H- 
2’ & H-6 ’), 7.28-7.37 (5H, m, Ph), 5.10 (1H, s, CH-Ph), 4.24 (2H, q, J 7.0 Hz, CH2), 1.26 (3H, 
t, J  7.0 Hz, CH3); 5c(100 MHz, CDC13) 171.8 (s) (C=0), 147.5 (s) (C, Ar), 146.4 (s) (C, Ar),
131.7 (s) (C, Ar), 130.0 (s) (2 x CH, Ar), 129.4 (s) (2 x CH, Ar), 128.8 (s) (2 x CH, Ar), 128.3 
(s) (CH, Ar) 124.1 (s) (2 x CH, Ar), 62.1 (s) (CH), 57.1 (s) (CH2), 14.5 (s) (CH3); m/z (APCI)
1. KOf-Bu 
1,4-Dioxane
2. Pd(OAc)2 
ligand 114 OEt
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8 . 8  Hz, H-3’ & H-5’), 7.48 (2H, d, J  8 . 8  Hz, H-2’ & H-6 ’), 7.23 (2H, d, J8 .2  Hz, H-2” & H- 
6 ”), 6 . 8 8  (2H, d, J  8.2 Hz, H-3” & H-5”), 5.05 (1H, s, CH), 4.24 (2H, q, J  6 . 8  Hz, CH2), 1.26 
(3H, t, J  6 . 8  Hz, CH3); 5c(100 MHz, CDC13) 171.7 (s) (C=0), 149.1 (s) (C, Ar), 148.2 (s) (C, 
Ar), 131.1 (s) (2 x CH, Ar), 129.6 (s) (C, Ar), 128.3 (s) (2 x CH, Ar), 123.9 (s) (2 x CH, Ar),
119.1 (s) (C, Ar), 109.1 (s) (2 x CH, Ar), 79.7 (s) (CH), 63.9 (s) (CH2), 56.7 (s) (0-CH3), 14.7 
(s) (CH3); m/z (APCI) 316.3 [(M+H)+, 100%]; (Found (EI+): M+ 315.1110. C17H17NO5 
requires M+ 315.1107).
1. KOf-Bu 
1,4-Dioxane
2 . Pd(OAc)2 
ligand 114
Ethyl 2-(4’-nitrophenyl)-2-(3”-trifluoromethylphenyl)acetate (324b)—This was prepared by 
the General Method using 3-bromonitrobenzotrifluoride (0.34 ml, 2.39 mmol) instead of 
bromobenzene to give the pure product as a pale yellow oil after chromatography R f 0.5 (silica, 
3:1. hexane:ethyl acetate; v/v) (0.55 g, 65%). Vmax (liq- fihn on NaCl plates/cm'1) 3049 (w), 
2981 (s), 1733 (s) (C=0), 1608 (s), 1521 (s), 1487 (m), 1350 (s), 1196 (s), 1160 (s), 1028 (s); 
5h(400 MHz, CDC13) 8.21 (2H, d, J 8 . 8  Hz, H-3’ & H-5’), 7.57-7.60 (2H, m, H-Ar), 7.48-7.51 
(5H, m, H-Ar), 5.15 (1H, s, CH), 4.26 (2H, q, J  1 2  Hz, CH2), 1.28 (3H, t, J  1 2  Hz, CH3); 
6C(100 MHz, CDC13) 171.8 (s) (C O ), 145.4 (s) (C, Ar), 138.6 (s) (C, Ar), 132.3 (s) (C, Ar),
130.8 (q) (C-CF3, 7  34.2 Hz) 129.9 (s) (2 x CH, Ar), 129.8 (s) (CH, Ar), 125.7 (s) (CH, Ar),
125.2 (s) (CH, Ar), 124.4 (s) (2 x CH, Ar), 123.9 (s) (CH, Ar), 122.7 (q) (CF3, J 2 1 \  Hz), 62.4 
(s) (CH2), 56.8 (s) (0-CH3), 14.4 (s) (CH3); m/z (APCI) 354.1 [(M+H)+, 100%]; (Found (EI+): 
M+ 353.0863. Ci7Hi4N 0 4F3 requires M+ 353.0875).
n o 2
14
O
'N CN
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Ethyl 2-(4’-nitrophenyl)-2-(3”-cyanophenyl)acetate (324c)—This was prepared by the 
General Method using 3-iodobenzonitrile (0.55 g, 2.39 mmol) instead of bromobenzene and 
DMF as the solvent to give the pure product as a pale yellow oil after chromatography R f 0.3 
(silica, 1:1. hexane:ethyl acetate; v/v) (0.55 g, 74%). vmax (liq. film on NaCl plates/cm'1) 3057 
(w), 3049 (w), 1941 (w), 1729 (s) (C=0), 1611 (m), 1594 (w), 1517 (s), 1479 (s), 1345 (s); 
6h(400 MHz, CDC13) 8.23 (2H, d, J8 .9  Hz, H-3’ & H-5’), 7.76 (1H, s, H-2”), 7.62-7.70 (4H, 
m, H-2’, H-6 ’, H-4” & H-6 ”), 7.50 (1H, t, y  8.2 Hz, H-5”), 4.50 (1H, s, CH-Ar), 4.40 (2H, q, J
7.8 Hz, CH2), 1.32 (3H, t, J  7.8 Hz, CH3); 6C(100 MHz, CDC13) 172.6 (s) (C=0), 148.2 (s) (C, 
Ar), 148.1 (s) (C, Ar), 142.9 (s) (C, Ar), 132.6 (s) (CH, Ar) 132.0 (s) (CH, Ar), 131.1 (s) (CH, 
Ar), 129.8 (s) (CH, Ar), 128.6 (s) (2 x CH, Ar), 124.0 (s) (2 x CH, Ar), 118.8 (s) (C, Ar), 113.1 
(s) (CN), 80.1 (s) (CH), 64.6 (s) (CH2), 14.4 (s) (CH3); m/z (APCI) 311.1 [(M+H)+, 100%]; 
(Found (EI+): M+ 310.0956. Ci7Hi4N20 4 requires M+ 310.0954).
OEt
1. KOf-Bu
1,4-Dioxane
2. Pd(OAc)2 
ligand 114 
Ph-Br
NO
OEt
Ph
Ethyl 2-(3’-nitrophenyl)-2-phenyacetate (327)—This was prepared by the General Method 
using ethyl 3-nitrophenylacetate (326) (0.50 g, 2.39 mmol) instead of ethyl 4- 
nitrophenylacetate (316) and DMF as the solvent to give the pure product as a pale yellow oil 
after chromatography R f 0.3 (silica, 3:1. hexane:ethyl acetate; v/v) (0.47 g, 69%). v^x (liq. film 
on NaCl plates/cm'1) 2924 (s), 1770 (s) (C=0), 1681 (s), 1604 (m), 1537 (m), 1401 (s), 1354 
(m), 1107 (m); 6H(400 MHz, CDC13) 8.21 (1H, s, H-2’), 8.12 (1H, d, J8.3 Hz, H-4’), 7.67 (1H, 
d, J  8.3 Hz, H-6 ’), 7.48 (1H, t, J  8.3 Hz, H-5’), 7.28-7.36 (5H, m, Ph), 5.11 (1H, s, CH-Ar),
4.24 (2H, q, J  1A Hz, CH2), 1.26 (3H, t, J  7.4 Hz, CH3); 5C(100 MHz, CDCI3) 171.9 (s) 
(C=0), 148.7 (s) (C, Ar), 141.3 (s) (C, Ar), 137.8 (s) (C, Ar), 135.3 (s) (CH, Ar) 129.9 (s) (CH, 
Ar), 129.4 (s) (2 x CH, Ar), 128.8 (s) (2 x CH, Ar), 128.3 (s) (CH, Ar), 124.1 (s) (CH, Ar),
122.8 (s) (CH, Ar), 62.2 (s) (CH), 57.0 (s) (CH2), 14.5 (s) (CH3); m/z (APCI) 286.3 [(M+H)+, 
100%]; (Found (ES+): (M + NH4)+, 303.1342. Ci6Hi9N20 4 requires (M + NH4)+303.1345).
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1. CDI
N02 Cl
OH
2 . H
N-(2’-Chlorophenyl)-N-methyl-2-(2”-nitrophenyl)acetamide (332)—This was prepared
fitted with a condenser connected to a Schlenk line was added, under nitrogen, 2- 
nitrophenylacetic acid (1.0 g, 5.52 mmol), dichloromethane (10 ml) and carbonyldiimidazole 
(0.96 g, 5.52 mmol). The mixture was heated under reflux for 1 hour. 2-Chloro-/V- 
methylaniline (0.68 ml, 5.52 mmol) was then added dropwise to the reaction mixture after 
cooling. The mixture was then heated under reflux for 1 hour. After checking the progress of 
the reaction by HPLC the mixture was left to stir at room temperature for 24 hours. The 
mixture was then diluted with ethyl acetate then washed with 1M HCI (20 ml), water (20 ml) 
and brine (20 ml). The solution was then dried over MgSC>4 and the solvent removed on a 
rotary evaporator to give an orange oil (2.18 g). The crude product was then purified by 
column chromatography R f 0.10 (silica, 3:1. hexane:ethyl acetate; v/v) to give the pure product 
(0.69 g, 49%) as a white crystalline powder. M.p. 154-156 °C. Found C, 59.17; H, 4.26; N
9.45. C15H13N2O3CI requires C, 59.12; H, 4.30; N, 9.19%); vmax (nujol on NaCl plates/cm'1) 
3058 (w), 2991 (s), 1691 (s) (C=Q), 1613 (m), 1518 (s), 1479 (s), 1360 (s); 5H(400 MHz,
Ar), 39.9 (s) (CH3), 36.8 (s) (CH2); m/z (APCI) 305.4 [(M+H)+, 100%]; 307.1 (34%); (Found 
(ES+): (M + H)+, 305.0686. C15H14N2O3CI requires (M + H)+ 305.0693).
according to the general method developed by Jones.240 In a 2-necked round bottom flask
CDCI3) 8.07 (1H, app. d, J  8.1 Hz, H-3”), 7.53-7.57 (3H, m, H-Ar), 7.38-7.42 (3H, m, H-Ar), 
7.29 (1H, app. d, J 8.4 Hz, H-6 ’), 3.97 (1H, d, J  16.6 Hz, HCH), 3.45 (1H, d, J  16.6 Hz, HCH),
3.25 (3H, s, CH3), 5c(100 MHz; CDC13) 169.5 (s) (C=0), 149.3 (s) (C, Ar), 141.1 (s) (C, Ar),
134.0 (s) (CH, Ar), 133.7 (s) (CH, Ar), 133.5 (s) (C, Ar), 131.5 (s) (C, Ar), 131.2 (s) (CH, Ar)
130.7 (s) (CH, Ar), 130.3 (s) (CH, Ar), 129.1 (s) (CH, Ar), 128.5 (s) (CH, Ar), 125.5 (s) (CH,
n o 2 Cl
2. Pd(OAc)2 
PCy3
1. NaOf-Bu
1,4-dioxane N—
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3-(2’-Nitrophenyl)oxindole (333)—This was prepared by the General Method using N-iT- 
chlorophenyl)-jV-methyl-2-(2”-nitrophenyl)acetamide (332) (187 mg, 0.58 mmol) instead of 
ethyl 4-nitrophenylacetate and tricyclohexyphosphine (8.2 mg, 0.058mmol) instead of 2- 
dicyclohexylphosphino-2’-(7V,7V-dimethylamino)biphenyl with no bromobenzene present and
1,4-dioxane (4 ml) in total to give the pure product as a white crystalline solid after 
chromatography Rf 0.3 (silica, 1:1. hexaneiethyl acetate; v/v) (104 mg, 67%). M.p. 145-157 
°C. (Found C, 67.41; H, 4.45; N 10.32. Ci5H12N20 3  requires C, 67.16; H, 4.51; N, 10.44%); 
Vmax (nujol on NaCl plates/cm'1) 3057 (w), 2990 (s), 1689 (s) (C=0), 1645 (m), 1609 (s), 1517 
(s), 1495 (s), 1375 (s), 1209 (m), 1173 (m); 5H(400 MHz, CDC13) 8.09 (1H, d, J  8.3 Hz, H-3’), 
7.52-7.57 (3H, m, H-Ar), 7.40-7.45 (3H, m, H-Ar), 7.27 (1H, d, J8 .3  Hz, H-Ar), 5.19 (1H, s, 
CH), 3.22 (3H, s, CH3), 6C(100 MHz; CDC13) 169.9 (s) (C=0), 149.2 (s) (C, Ar), 141.2 (s) (C, 
Ar), 133.7 (s) (CH, Ar), 133.5 (s) (CH, Ar), 133.2 (s) (C, Ar), 131.0 (s) (C, Ar), 130.7 (s) (CH, 
Ar) 130.4(s) (CH, Ar), 129.7 (CH, Ar), 128.4 (s) (CH, Ar), 128.0 (s) (CH, Ar), 124.9 (s) (CH, 
Ar), 99.7 (s) (CH), 38.7 (s) (CH3); m/z (APCI) 269.1 [(M+H)+, 100%]; (Found (ES+): (M + 
H)+, 269.0928. Ci5Hi3N20 3 requires (M + H)+ 269.0927).
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Table 1. Crystal data and structure refinement for 02LAWRENCE2.
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F (000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on FA2
Final R indices [I>2sigma (I)]
R indices (all data)
Largest diff. peak and hole
C17 H15 N 04
297.30 
150(2) K 
0.71073 A 
Monoclinic 
P2(l)/n
a = 6.9801(2) A alpha = 90 deg. 
b = 12.4598(4) A beta = 95.2175(14)
c = 16.6818(6) A gamma = 90 deg.
1444.82(8) A A3
4
1.367 Mg/mA3 
0.098 mmA-l 
624
0.25 x 0.20 x 0.20 mm 
2.95 to 27.51 deg.
-9<=h<=9, -16<=k<=16/ -21<=1<=21 
14145
3310 [R(int) = 0.1146]
0.9806 and 0.9759 
Full-matrix least-squares on FA2 
3310 / 0 / 200
1. 051
R1 = 0.0541, wR2 = 0.1285 
R1 = 0.0887, wR2 = 0.1451 
0.220 and -0.331 e.AA-3
Table 3. Bond lengths [A] and angles [deg] for 02LAWRENCE2.
0 1)-C(10) 1.348(2) 0(1)-C(1) 1.471(2)
0 2)- C (10) 1.205 (2) 0(3)-N(1) 1.218(2)
0 4)- N (1) 1.217 (2) N (1)-C(15) 1.468(2)
c 1)-C(2) 1.506(2) C (1)-C(8) 1.525(2)
c 2)-C(7) 1.385 (2) C (2)-C(3) 1.390(2)
c 3)-C(4) 1.391 (2) C (4)-C (5) 1 . 3 8 0 ( 3 )
c 5 ) - C (6) 1 . 3 8 5 ( 3 ) C ( 6 ) - C (7) 1 . 3 8 9 ( 3 )
c 8 ) - C (9) 1 . 5 3 3  (2) C ( 9 ) - C ( 1 0 ) 1 . 5 2 9 ( 2 )
c 9 ) - C ( l l ) 1 . 5 3 5 ( 2 ) C ( 9 ) - C (12) 1 . 5 3 6 ( 2 )
c 1 2 ) - C (17) 1 . 3 9 0  (2) C ( 1 2 ) - C (1 3) 1 . 3 9 4 ( 2 )
c 13)-C(14) 1.382(2) C (14)-C(15) 1.378(3)
c 15)-C(16) 1.381 (2) C (16)-C(17) 1.381(2)
c 10)-O(l)-C(l) 110.26(12) 0(4)-N(1)-0(3) 122.79 (16)
0 4)-N(1)-C(15) 118.45(15) 0(3)-N(1)-C(15) 118.75(14)
0 1)~ C(1)-C(2) 108.12(13) 0(1)-C(1)-C(8) 103.38 (12)
c 2)-C(1)-C(8) 115.83(15) C (7)-C(2)-C(3) 119.23 (16)
c 7)-C(2)-C(1) 119.83(15) C (3)-C(2)-C(1) 120.93(15)
c 2)-C(3)-C(4) 120.20(17) C (5)-C(4)-C(3) 120.15(17)
c 4)- C (5)-C(6) 119.94 (17) C (5)-C(6)-C(7) 119.94 (17)
c 2)-C(7)-C(6) 120.54(17) C (1)-C(8)-C(9) 103.63(14)
c 10)-C(9)-C(8) 100.41(13) C (10)-C(9)-C(11) 110.61(14)
c 8)-C(9)-C(11) 113.30 (15) C (10)-C(9)-C(12) 108.72 (14)
c 8)- C (9)-C(12) 115.19(13) C (11)-C(9)-C(12) 108.32(13)
0 2)- C (10)-0(1) 120.94(15) 0(2)-C(10)-C(9) 128.16(15)
0 1)- C (10)-C(9) 110.89(13) C(17)-C(12)-C(13) 118.16(15)
c 17)-C(12)-C(9) 119.46 (14) C(13)-C(12)-C(9) 122.26(15)
c 14)-C(13)-C(12) 120.94(16) C(15)-C(14)-C(13) 119.16(16)
c 14)-C(15)-C(16) 121.49(15) C (14 ) - C (15) - N  (1) 119.20(15)
c
c
16)- C (15)- N (1) 
16)-C(17)-C(12)
119.30(16) 
121.63 (15)
C (17)- C(16)-C(15) 118.58(16)
no2
Ph
Table 1. Crystal data and structure refinement for Lawrencel
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F (000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on FA2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
\C17 H15 N 04
297.30 
150(2) K 
0.71073 A 
Triclinic 
P-l
a = 8.1290(3) A alpha = 83.7880(11) deg.
b = 9.1740(3) A beta = 79.0930(11) deg.
c = 10.2670(4) A gamma = 72.8210(13) deg
717.18(5) A A3
2
1.377 Mg/mA3 
0.099 mmA-l 
312
0.15 x 0.12 x 0.12 mm 
3.00 to 27.46 deg.
-10<=h<=10, -ll<=k<=ll/ -13<=1<=13 
12481
3257 [R(int) = 0.0584]
0.9882 and 0.9853
Full-matrix least-squares on FA2
3257 / 0 / 200
1.060
R1 = 0.0450, wR2 = 0.1063 
R1 = 0.0589, wR2 = 0.1142 
0.303 and -0.277 e.AA-3
Table 3. Bond lengths [A] and angles [deg] for Lawrencel.
0 1 ) - C (10) 1 . 3 4 9 1 ( 1 6 ) 0 ( 1 ) - C (7) 1 . 4 7 4 9 ( 1 5 )
0 2 ) - C (10) 1 . 2 0 4 4 ( 1 6 ) 0 ( 3 ) -N (1) 1 . 2 2 8 0 ( 1 7 )
0 4 )-N (1 ) 1 . 2 2 6 1 ( 1 7 ) N ( 1 )- C (1 5 ) 1 . 4 7 3 4 ( 1 7 )
c 1) -C (2 ) 1 . 3 9 0  (2) C ( 1 ) - C (6) 1 . 3 9 2 3 ( 1 8 )
c 2 ) - C (3) 1 . 3 8 1  (2) C ( 3 ) - C (4) 1 . 3 9 0 ( 2 )
c 4 )- C (5) 1 . 3 8 4 ( 2 ) C ( 5 ) - C (6) 1 . 3 9 2 6 ( 1 8 )
c 6 ) -C (7) 1 . 4 9 7 4 ( 1 8 ) C ( 7 ) - C (8) 1 . 5 2 9 7 ( 1 7 )
c 8 ) - C ( 9 ) 1 . 5 4 0 7 ( 1 8 ) C ( 9 ) - C (12) 1 . 5 2 3 8 ( 1 8 )
c 9 ) - C (10) 1 . 5 3 2 0 ( 1 8 ) C ( 9 ) - C (11) 1 . 5 3 9 7 ( 1 8 )
c 1 2 ) - C (17) 1 . 3 9 2 2 ( 1 9 ) C ( 1 2 ) - C (13) 1 . 3 9 4 6 ( 1 8 )
c 1 3 ) - C (14) 1 . 3 8 4 6 ( 1 8 ) C ( 1 4 ) - C (15) 1 . 3 8 1  (2)
c 1 5 ) - C (16) 1 . 3 7 6 ( 2 ) C ( 1 6 ) - C (17) 1 . 3 9 0 2 ( 1 9 )
c 1 0 ) - 0 ( 1 ) - C (7) 1 1 0 . 4 9 ( 1 0 ) 0 ( 4 ) - N ( 1 ) - 0 ( 3 ) 1 2 3 . 7 6 ( 1 2 )
0 4 )-N ( 1)- C (1 5 ) 1 1 8 . 0 4 ( 1 3 ) 0 ( 3 ) - N ( 1 ) - C {15) 1 1 8 . 1 9  (12)
c 2 ) - C ( 1 ) - C (6) 1 2 0 . 4 5 ( 1 3 ) C ( 3 ) - C (2) - C (1) 1 2 0 . 1 1 ( 1 3 )
c 2 ) - C ( 3 ) - C (4) 1 1 9 . 6 8 ( 1 3 ) C ( 5 ) - C ( 4 ) - C (3) 1 2 0 . 4 2 ( 1 3 )
c 4 ) - C ( 5 ) - C (6) 1 2 0 . 2 5 ( 1 3 ) C ( 1 ) - C ( 6 ) - C (5) 1 1 9 . 1 0 ( 1 2 )
c 1 ) - C ( 6 ) - C (7) 1 1 9 . 6 4  (12) C ( 5 ) - C ( 6 ) - C (7) 1 2 1 . 2 2  (11)
0 1 ) - C ( 7 ) ~ C (6) 1 0 9 . 3 0 ( 1 0 ) 0 ( 1 ) - C ( 7 ) - C (8 ) 1 0 3 . 8 1  (9)
c 6)- C ( 7 )- C (8 ) 1 1 6 . 1 1 ( 1 1 ) C ( 7 ) - C ( 8 ) - C ( 9 ) 1 0 3 . 3 1 ( 1 0 )
c 1 2)- C (9 ) - C (10) 1 0 9 . 9 0 ( 1 0 ) C (1 2)- C (9 )- C (1 1 ) 1 1 3 . 8 5  (11)
c 1 0 ) - C (9 ) - C ( 1 1 ) 1 0 6 . 8 0 ( 1 1 ) C ( I 2 ) - C ( 9 ) - C ( 8 ) 1 1 4 . 1 7 ( 1 1 )
c 1 0 )-C(9 ) - C (8) 1 0 1 . 5 6 ( 1 0 ) C ( 1 1 ) -C ( 9 ) - C (8 ) 1 0 9 . 6 1 ( 1 0 )
0 2 )- C (1 0 ) - 0 (1 ) 1 2 1 . 4 8  (12) 0 ( 2 ) - C (1 0 )- C (9 ) 1 2 7 . 8 3  (12)
0 1 ) - C ( 1 0 ) - C (9) 1 1 0 . 6 7 ( 1 0 ) C ( 1 7 ) - C  ( 1 2 ) - C ( 1 3 ) 1 1 8 . 2 7  (12)
c 1 7) -C ("12) - C (9 ) 1 2 2 . 3 8 ( 1 2 ) C (1 3 ) - C (1 2 ) - C (9) 1 1 9 . 3 4  (11)
c 1 4 ) - C ( 1 3 ) - C (12) 1 2 1 . 5 6 ( 1 2 ) C ( 1 5 ) - C ( 1 4 ) - C ( 1 3 ) 1 1 8 . 3 1  (13)
c 1 6 ) - C (1 5 ) - C (1 4 ) 1 2 2 . 0 9  (12) C (1 6 ) - C (1 5 ) -N ( 1 ) 1 1 9 . 1 8 ( 1 3 )
c
c
1 4 ) - C (1 5 ) -N (1 ) 
1 6 ) - C ( 1 7 ) - C (12)
1 1 8 . 7 0 ( 1 3 )  
1 2 1 . 0 2 ( 1 3 )
C ( 1 5 ) - C ( 1 6 ) - C ( 1 7 ) 118.74 (13)
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ABSTRACT
The VNS and S*Ar reactions combine to form an efficient three-component one-pot route to diaryl methanes. The products of selected diaryl 
acetates provide modular 3-aryloxindole derivatives.
The vicarious nucleophilic substitution (VNSAr) of hydrogen 
in aromatic systems provides a direct and efficient route to 
functionalized aromatics. The reaction, pioneered by Mako­
sza and co-workers,1 is most often encountered with nitro- 
arenes, as illustrated in Scheme 1. In contrast to conventional 
nucleophilic aromatic substitution reactions, a good nucleo- 
fugal group is not required. We have shown that the anion 
2 produced by addition of the nucleophile 1 to nitrobenzene, 
and elimination of HX from the a-adduct, can react with a 
range of electrophiles.2 This aspect of VNS chemistry 
provides a powerful process in which simple precursors can 
be elaborated in a three-component coupling reaction.
t  C ardiff University and H. Lee Moffitt Cancer Center & Research 
Institute.
* GlaxoSmithKline.
(1) (a) M akosza, M.; Wojciechowski, K. Chem. Rev. 2004, 104, 2631 — 
2666. (b) Makosza, M.; Winiarski, J. Acc. Chem. Res. 1987, 20, 282 -  289. 
(c) Mgkosza, M.; Wojciechowski K. Heterocycles 2001, 54, 445 -4 7 4 .
(2) Lawrence, N. J.; Lamarche, O.; Thurrab, N. Chem. Commun. 1999,
689—690. Bushell, S. M.; Crump, J. P.; Lawrence, N. J.; Pineau, G.
Tetrahedron 1998, 54, 2269—2274. Lawrence, N. J.; Liddle, J.; Jackson,
D. A. Tetrahedron Lett. 1995, 36, 8477-8480 . Lawrence, N. J.; Liddle, J.; 
Jackson, D. A. Synlett 1996, 55—56. Drew, M. D.; Jackson, D. A.;
Lawrence, N. J.; Liddle, J.; Pritchard, R. G. Chem. Commun. 1997, 189—
190. Lawrence, N. J.; Liddle, J.; Bushell, S. M.; Jackson, D. A. J. Org. 
Chem. 2002, 67, 4 5 7 -4 6 4 .
We have shown that 2 exhibits reactivity similar to that 
of the malonate ion. This is not too surprising given that 
other properties such as acidity are similar. For example the 
pKa (DMSO) of ethyl p-nitrophenylacetate is 15.1,3 while 
that of diethyl malonate is 16.4.4 Malonate is an excellent 
nucleophile for many SnAj reactions,5 and some examples6 
of the use of nitrophenylacetates in the SNAr reaction have 
been reported. We were therefore hopeful that the anion 2, 
derived from the VNS reaction, would react in the SNAr 
reaction.
Scheme 1. One-Pot VN S—Electrophilic Quench Process"
o .s .o-
• LG =  leaving group (e.g., Cl or PhS); EWG =  electron- 
withdrawing group.
10.1021/oK)47890y CCC: $27.50 © 2004 American Chemical Society
Published on Web 11/24/2004
Scheme 2. Three-Component VNSAr—S\Ar Coupling Reaction
_  R1 R3
CO2R2 0°C to r.t, 2 h
r1 Cl 2. Sa-d, 0 ®C to r.t, 2 h 
4a R1 = Me. R2 = Et 3a-g
4b R1 = Me; R2 = Me 
4c R1 = Et, R2 = Me
electrophile
NO2
product
°2N-C5 -F
no2
—  5b
°2n~c 5 _fSc
02N-<C5“F
R*ChC R1 NO2
3 .R 3 = M e .g  = Et,< 
3* R1 = Me. R2 = Me. 
3t R1 = E t R2 = M e,!
77% 
71% 
80%
'3
NO,
'NO,
,73% 
e, 89% 
,60%
3d R1 = Me. R2 = E t 89% 
3h R1 = Me. R2 = Me. 86% 
3k R1 = E t R2 = Me. 69%
3c R2 = Et 88%
3g R2 = Me, 86%
Diarylmethanes are extremely useful synthetic intermedi­
ates,7 and the diarylmethyl motif is found in many pharma­
cologically important agents.* A versatile route to this 
important scaffold incorporating several points of diversity 
is potentially useful. The diarylmethyl group is also embed­
ded within many important drugs, e.g., 3-arylindole deriva­
tives. Makosza1* and Katritzky10 have described the synthesis
(3) Kahachnik. M. I.: Lobanov. D. I.: M atveeva. A. G.: Kovsheva. O. 
E.: Terekhova. M. I.: Petrov. E. S.; Petrovskii. P. V.; Matrosov. E. I. Izv. 
Akud. Sa u k  SSSR. Ser. Khim. 1991. 1598 1604.
(4) Olstead. W. V ; Bordwell. F. G. J. Org. Chem. 1980. 45. 3 2 9 9 - 
3305;
(5)G utjar. M.: Reddy. D. S.; Murugaiah. A.; Murugaiah. S. Synthesis 
2000. 1659 1661. Selvakumar. V : Reddv. B. Y.; Kumar. G. S.; Iqbal. J. 
Tetrahedron Lett. 2001. 42. 8395 8398.
(6) Bluhm. A. L.; Sousa. J. A.; W einstein. J. J. Org. Chem. 1964. 29. 
636 640. Borsche. W.; Fiedler. A. Chem. Ber. 1913. 46. 2 1 1 7 -2 1 3 1 . 
WrobcLZ.; Wojciechowski. K. Pol. J. Chem. 1992. 66. 1125- 1129. Cheng. 
X.-M.: Lee. C.: Klutchko. S.; Winters. T.; Reynolds. E. E.: W elch. K. M.: 
Flvnn. M. A.; Doherty. A. M. Bioorg. Med. Chem. Lett. 1996. 6. 2999— 
3002.
(7) For examples: (a) Itami. K.; Mineno. M.: Kamei. T.; Yoshida. J. 
Org Lett. 2002. 4. 3635 -3638 . (b) Hermanns. V : Dahmen. S.: Bolm. C.; 
Brase. S. Angew. Chem.. Int. Ed. 2002. 41, 3692 3694. (c) Vanier. C.: 
Lorge. F.: Wagner. A.: Mioskowski. C. Angew Chem.. Int. Ed. 2000. 39. 
1679-1683.
(8) For examples: (a) Plobeck. N.; Delorme. D.; W ei. Z. Y.; Yang. H.; 
Zhou. F.; Schwarz. P.: Gawell. L.: Gagnon. H.: Pelcman. B.: Schmidt. R.; 
Yue. S. Y.: W alpole. C.: Brown. W.: Zhou. E.: Labamc. M.: Payza. K.: 
St-Onge, S.: Kamassah. A.; Morin. P. E.: Projean. D.: Ducharme. J.: Roberts. 
E. J. Med. Chem. 2000. 43. 3878 3894. (b) Hsin, L. W.; Dersch. C. M.; 
Baumann. M. H.; StalTord. D.; Glowa. J. R.: Rothman. R. B.: Jacobson. A. 
E.: Rice. K. C. J. Med. Chem. 2002. 45. 1321 -1329 . (c) W ai. J. S.; 
Egbertson. M. S.; Payne. L. S.; Fisher. T. E.; Embrey. M. W'.: Tran. L. O.: 
Melamed. J. Y.: Langford, H. M.: Guare. J. P.; Zhuang. L. G.: G rey. V. E.: 
Vacca. J. P.: Hollowav. M. K.: Naylor-Olsen. A. M.: Hazuda. D. J.; Felock. 
P. J.: Wolfe. A. L.; Stiilmock. K. A.; Schlcif. W. A.: Gabryelski, L. J.: 
Young. S. D. J. Med. Chem. 2000. 43. 4923 4926. (d) Hewawasam. P.: 
GribkofT. V. K.; Pendri. Y.; Dworetzky. S. L: M canwcll. N. A.; M artinez.
E.: Boissard. C. G.; Post-Munson. D. J.: Trojnacki. J. T.; Yeleswaram. K.: 
Pajor. L. M.: Knipe. J.; Gao. Q.: Perrone. R.: Starrett. J. E. Bioorg. Med. 
Chem. Lett 2002. 12. 1023-1026.
(9) Makosza. M.: Surow'iec. M.; Voskresensky. S. Synthesis 2000. 1237—
1240.
of diarylmethanes via VNS reaction of nucleophiles of type 
1 in which the electron-withdrawing group comprises one 
of the aryl groups. The new method described below is 
ideally suited for the synthesis of functionalized diaryl­
methanes in which only one of the aryl groups is introduced 
in the VNS reaction.
We now report that the anion 2 can be arylated by the 
reaction with substituted o/7/jo-halonitroarenes. The process 
not only is efficient but also uniquely combines two different 
sequential modes of aromatic nucleophilic substitution.
Reaction of ethyl 2-chloropropionate (4a) with nitroben­
zene in the presence of Nal l gave the usual dark blue-colored 
solution of the intermediate anion 2 (Scheme 1). Addition 
of 2,4-dinitrofluorobenzene (5a) in DMT resulted in rapid 
decolorization of the solution. The desired diarylmethane 3a 
was isolated in 77% yield (Scheme 2)." The ‘H NMR 
spectrum clearly indicated the presence of both a 1,4- 
disubstituted and 1,2,4-trisubstituted aryl group.12 This is 
consistent with the expected para-selective VNS reaction 
followed by SNAr process.
To explore the scope of the reaction, a number of simple 
esters 4a—c were combined with nitrobenzene and different 
SNAr electrophiles 5a—d under the reaction conditions 
described above. The results shown in Table 1 clearly
Table 1. Yields o f  Product Diarylmethyl Sulfones 8 a -  h
R1 R3 R4 yield (%)
a Cl n o 2 n o 2 74
b Cl n o 2 c f 3 75
c Cl CN n o 2 74
d Cl c f 3 n o 2 75
e c f 3 n o 2 n o 2 79
f c f 3 n o 2 c f 3 81
g c f 3 CN n o 2 78
h c f 3 c f 3 n o 2 78
indicate that the process is general and efficient. The 
efficiency of the Ss Ar process is high, as the yields are close 
to that expected for the protonation of the anion 2.2 The use 
of activated arenes 5a—d allows the SNAr reaction to proceed 
conveniently at ambient temperature, avoiding the need for
(10) Katritzky. A. R.: Toader. D. J. Org. Chem. 1997. 62. 4137 -  4141.
(11) General Procedure fo r the V N S \r— S>-Ar Reaction. Sodium 
hydride (60%  dispersion in oil) (0.813 g. 20.3 mmol) was added to 
anhydrous DM F (5 m L) and the mixture flushed with nitrogen and cooled 
toO  °C. Chloroester 4 (8.13 mmol) and nitrobenzene (0.84 mL. 8.13 mmol) 
were dissolved in anhydrous DMF (5 mL) and added dropwise to the sodium 
hydride shirry. The reaction mixture was stirred at 0  °C for 30 min and 
then allowed to warm to room temperature. The reaction mixture was then 
cooled back to 0 °C using an ice-cooling bath. Aryl halide 5 (8.13 mmol) 
in anhydrous DMF (2 mL) was then added, and the resulting mixture was 
allowed to  warm to room temperature and stirred for a further 2 h. The 
reaction mixture was poured onto ice/hydrochloric acid (50 mL. 1 M 
solution) and extracted with dichloromethane (3 x  30 mL). The combined 
organic extracts were washed well with distilled water (5 X 50 mL) and 
then saturated aqueous sodium bicarbonate solution (3 x  50 mL) and dried 
(magnesium sulfate), and the solvent was removed under reduced pressure 
to give the crude product, w hich was purified by column chromatography
(12) O ther characterization data (e.g.. I3C NMR. MS. 1R) support the 
product assignment.
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Scheme 3. Further Examples o f the VNSAr—S\Ar Reaction
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heating. This can be problematic for NaH in DMF when the 
reaction is performed on a large scale.13 We have therefore 
shown that the process has potential for scale-up by using 
/tvv-BuOK as the base. In these cases, the VNS reaction 
between nitrobenzene (1 equiv) and 4a (2 equiv) was 
performed with /ert-BuOK. (3 equiv) while carefully main­
taining the temperature between —40 and —50 °C. The 
solution of the post-VNS anion was warmed to —20 °C 
before addition of 5a or 5d to give 3a and 3d in 57 and 
69% yields, respectively.
The process is not limited to the use of fluoronitroarenes 
(Scheme 3). 2,4-Dinitrochloronitrobenzene (5e) was used in 
place of 2,4-dinitrofluorobenzene (5a) to give 3a from 4a 
in 69% yield. Similarly, the VNS—SNAr reaction of 4-chloro- 
3-nitrobenzonitrile (5f) and 4a gives the nitrile 3n (Scheme 
3). The use of the less activated 4-fluoronitrobenzene (5g) 
is still sufficiently reactive to engage ion the VNS.v—SNAr 
process to give 3p in 74% yield.
Branched esters behave well in the reaction. The isopropyl 
ester 4d gave ester 3q when aryl fluoride 5b was used as 
the electrophile. The iert-butyl ester 3r was obtained in the 
same way from the VNS nucleophile 4e. In the synthesis of 
3r, we were unable to separate the product from unreacted 
5a by chromatography. The unreacted aryl fluoride was 
scavenged using dimethylamino-functionalized polystyrene. 
Simply shaking the mixture of 5b and 3r with the resin in 
EtOAc cleanly removed the aryl fluoride, leaving the product 
ester pure.
The VNS,v—SsAr reaction was used for the synthesis of 
diarylmethyl sulfones, to provide examples of the process 
with ortho selectivity. Reaction of chloromethyl phenyl 
sulfone (6) with /j-chloronitrobenzene (7a) and 5a gave the
(13) For a summary o f  the safety hazards associated with the large-scale 
use o f  sodium hvdride in DMF. see: am Ende. D. J.; Vogt. P. F. Org. 
PriK. Res. Dei 2003, 7. 1029-1033.
Scheme 4. VNSAr- S NAr Reaction of Sulfones 
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sulfone 8a (Scheme 4). Other examples (Table 1) indicate 
that the arylation of the o/v/zo-nitrobenzyl sulfonyl anion is 
not problematic.
The synthetic utility of the method is illustrated in Scheme 
5, by the synthesis of oxindole derivatives. This class of
Scheme 5- Use o f  VNS^—SNAr Products for Oxindole 
Synthesis
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heterocycle is an important synthetic building block and also 
includes members with important biological activity.8414 
Those products 3 possessing an ortho nitro group (R3 =  
N 02), are converted into their corresponding 3,3-disubstituted 
oxindole, by hydrogenation (method a), or Sn(ID-mediated 
reduction (method b). The presence of other nitro groups 
that are also reduced under these conditions provides 
additional points for further functionalization and incorpora­
tion of extra diversity. The ester 3a cleanly gave the oxindole
(14) (a) Henncssy. E. J.; Buchwald. S. L. J. Am. Chem. Soc. 2003. 125, 
12084- 12085. (b) Gunesekara, N. S.; Spencer. C. M.; Keating. G. M. Drugs 
2002. 62. 1217-1251. (c) Bromidge. S. M.; Dabbs. S.: Davies. D. T.; 
Duckworth. D. M.: Forbes. I. T.: Ham. P.: Jones. G. E.: King. F. D.: 
Saunders: D. V.; Starr. S.: Thewlis, K. M.; Wyman. P. A.: Blaney. F. E.: 
Navlor. C. B.; Bailey. F.: Blackburn. T. P.: Holland. V.; Kennett. G. A.: 
Riley. G. J.: Wood. M. D. J. Med. Chem. 1998. 41. 1598-1612. (d) 
Gallagher. G. J.: Lavanchy. P. G.; Wilson. J. W.: Hieble. J. P.: DeMarinis. 
R. M. J. Med. Chem. 1985. 28, 1533- 1536. (e) Natarajan. A.; Fan. Y. H.; 
Chen, H.; Guo. Y. H.: lyasere. J.; Harbinski. P.; Christ. W. J.: Aktas. H.; 
Halperin. J. A. J. Med. Chem. 2004. 47. 1882-1885.
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9a by both methods. However, reduction o f both 3b and 3c 
gave the 1-hydroxyoxindoles 9b and 9c.15 It seems that the 
presence of the electron-withdrawing group impedes reduc­
tion of the intermediate hydroxylamine such that cyclization 
to form the indole occurs faster. The formation of 9a from 
3a involves first reduction of the less hindered nitro group 
at position 4.
In conclusion, we have shown that the intriguing one-pot 
VNSAr—SNAr combination of two types of nucleophilic 
substitution reaction provides an excellent synthesis o f diaryl 
acetate derivatives.
(15) Achcson. R. M.: Prince. R. J.: Proctor. G. J. Chem. Soc.. Perkin  
Irons. /  1979. 595 598.
(16) Fletcher. D. A.: McM eeking. R. F.: Parkin. D . ./. Chem. Inf. Comput. 
Sei. 1996. 36. 74 6 - 749.
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